ontology	ID	Description	Count	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	log10q	geneID	cluster
BP	GO:0006090	pyruvate metabolic process	10	10/62	115/10965	7.373182024533647e-10	7.00386337481294e-7	5.331760156059507e-7	6.273129395125146	ENO1/DDIT4/PGAM1/LDHA/GAPDH/TPI1/ALDOA/SLC16A3/BSG/PGK1	14
BP	GO:0019674	NAD metabolic process	7	7/62	36/10965	9.574380836733299e-10	7.00386337481294e-7	5.331760156059507e-7	6.273129395125146	ENO1/PGAM1/LDHA/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0006735	NADH regeneration	6	6/62	22/10965	1.7737214578351044e-9	7.00386337481294e-7	5.331760156059507e-7	6.273129395125146	ENO1/PGAM1/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0061621	canonical glycolysis	6	6/62	22/10965	1.7737214578351044e-9	7.00386337481294e-7	5.331760156059507e-7	6.273129395125146	ENO1/PGAM1/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0061718	glucose catabolic process to pyruvate	6	6/62	22/10965	1.7737214578351044e-9	7.00386337481294e-7	5.331760156059507e-7	6.273129395125146	ENO1/PGAM1/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0061615	glycolytic process through fructose-6-phosphate	6	6/62	23/10965	2.389232145404024e-9	7.00386337481294e-7	5.331760156059507e-7	6.273129395125146	ENO1/PGAM1/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0061620	glycolytic process through glucose-6-phosphate	6	6/62	23/10965	2.389232145404024e-9	7.00386337481294e-7	5.331760156059507e-7	6.273129395125146	ENO1/PGAM1/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0006007	glucose catabolic process	6	6/62	29/10965	1.0950689458328163e-8	2.808851846061174e-6	2.1382662047577626e-6	5.669938228004459	ENO1/PGAM1/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0006734	NADH metabolic process	6	6/62	33/10965	2.5088628903878438e-8	5.517787572492297e-6	4.200470276792126e-6	5.376702084082511	ENO1/PGAM1/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0006096	glycolytic process	8	8/62	87/10965	2.7008354716746968e-8	5.517787572492297e-6	4.200470276792126e-6	5.376702084082511	ENO1/DDIT4/PGAM1/LDHA/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0006757	ATP generation from ADP	8	8/62	88/10965	2.9578783283340776e-8	5.517787572492297e-6	4.200470276792126e-6	5.376702084082511	ENO1/DDIT4/PGAM1/LDHA/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0046031	ADP metabolic process	8	8/62	95/10965	5.4238639403712943e-8	9.274807338034914e-6	7.060538673255264e-6	5.151162163835176	ENO1/DDIT4/PGAM1/LDHA/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0006165	nucleoside diphosphate phosphorylation	8	8/62	103/10965	1.0242475333987633e-7	1.4011706256895084e-5	1.0666549751324666e-5	4.971976036646583	ENO1/DDIT4/PGAM1/LDHA/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0009135	purine nucleoside diphosphate metabolic process	8	8/62	103/10965	1.0242475333987633e-7	1.4011706256895084e-5	1.0666549751324666e-5	4.971976036646583	ENO1/DDIT4/PGAM1/LDHA/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0009179	purine ribonucleoside diphosphate metabolic process	8	8/62	103/10965	1.0242475333987633e-7	1.4011706256895084e-5	1.0666549751324666e-5	4.971976036646583	ENO1/DDIT4/PGAM1/LDHA/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0046939	nucleotide phosphorylation	8	8/62	105/10965	1.1905898060584962e-7	1.5067217282830627e-5	1.1470067942813507e-5	4.940434009552821	ENO1/DDIT4/PGAM1/LDHA/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0009185	ribonucleoside diphosphate metabolic process	8	8/62	106/10965	1.282125881606843e-7	1.5067217282830627e-5	1.1470067942813507e-5	4.940434009552821	ENO1/DDIT4/PGAM1/LDHA/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0019320	hexose catabolic process	6	6/62	43/10965	1.32168572656409e-7	1.5067217282830627e-5	1.1470067942813507e-5	4.940434009552821	ENO1/PGAM1/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0008285	negative regulation of cell population proliferation	14	14/62	451/10965	1.5405855956154444e-7	1.66383244326468e-5	1.266608877503224e-5	4.89735747238232	SOX11/FRZB/FZD5/IGFBP5/SOX2/SFRP2/SOX4/HMGA1/CLDN3/SFRP1/IFITM1/CDKN1C/APOE/GPC3	14
BP	GO:0001666	response to hypoxia	11	11/62	266/10965	2.366149688277434e-7	2.4276695801726473e-5	1.848087440738796e-5	4.733277484343207	ENO1/SLC2A1/FAM162A/HILPDA/CLDN3/SFRP1/DDIT4/BNIP3/LDHA/HSP90B1/PGK1	14
BP	GO:0009132	nucleoside diphosphate metabolic process	8	8/62	119/10965	3.148688725849213e-7	3.0767186978298023e-5	2.342182490807134e-5	4.630379269954136	ENO1/DDIT4/PGAM1/LDHA/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0036293	response to decreased oxygen levels	11	11/62	276/10965	3.4265683018184486e-7	3.196053706968844e-5	2.4330274449275493e-5	4.613852992132328	ENO1/SLC2A1/FAM162A/HILPDA/CLDN3/SFRP1/DDIT4/BNIP3/LDHA/HSP90B1/PGK1	14
BP	GO:0046365	monosaccharide catabolic process	6	6/62	52/10965	4.2427708159762053e-7	3.785289441036163e-5	2.881588966090933e-5	4.540367967480885	ENO1/PGAM1/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0070482	response to oxygen levels	11	11/62	296/10965	6.876799461390298e-7	5.8796635394887046e-5	4.475951930132983e-5	4.349114586261224	ENO1/SLC2A1/FAM162A/HILPDA/CLDN3/SFRP1/DDIT4/BNIP3/LDHA/HSP90B1/PGK1	14
BP	GO:0035455	response to interferon-alpha	4	4/62	15/10965	1.2072716868182663e-6	9.909286005404329e-5	7.543541824161293e-5	4.122424697428899	IFITM2/IFITM1/IFITM3/BST2	14
BP	GO:0006094	gluconeogenesis	6	6/62	63/10965	1.3493033552656055e-6	1.0649117250019317e-4	8.10674566483465e-5	4.091153452009434	ENO1/PGAM1/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0016052	carbohydrate catabolic process	8	8/62	149/10965	1.7508860280213316e-6	1.3050307447967183e-4	9.934675414375346e-5	4.002846317587733	ENO1/DDIT4/PGAM1/LDHA/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0019319	hexose biosynthetic process	6	6/62	66/10965	1.7807437063502978e-6	1.3050307447967183e-4	9.934675414375346e-5	4.002846317587733	ENO1/PGAM1/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0050673	epithelial cell proliferation	10	10/62	263/10965	1.9038811883747298e-6	1.3471600684637744e-4	0.00010255389050991285	3.98904785947955	SOX11/NRP2/IGFBP5/SOX2/SFRP2/FGFR1/SFRP1/CDKN1C/APOE/GPC3	14
BP	GO:0048729	tissue morphogenesis	13	13/62	488/10965	2.572564051791902e-6	1.759633811425661e-4	1.3395386150383097e-4	3.8730447624168516	SOX11/SIX3/NRP2/FRZB/FZD5/IGFBP5/SHROOM3/SFRP2/SOX4/FGFR1/SFRP1/TNNI3/GPC3	14
BP	GO:0040013	negative regulation of locomotion	9	9/62	214/10965	2.8729791136149203e-6	1.901726819721876e-4	1.447708320748571e-4	3.8393189294714083	IGFBP5/SFRP2/SEMA6A/CLDN3/SFRP1/IFITM1/APOE/BST2/MIF	14
BP	GO:0046364	monosaccharide biosynthetic process	6	6/62	72/10965	2.982608968707169e-6	1.9125980011834722e-4	1.4559841149873156e-4	3.8368433632173407	ENO1/PGAM1/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0051271	negative regulation of cellular component movement	9	9/62	218/10965	3.345486866898456e-6	2.0802845608714035e-4	1.5836371644265739e-4	3.800344314878917	IGFBP5/SFRP2/SEMA6A/CLDN3/SFRP1/IFITM1/APOE/BST2/MIF	14
BP	GO:0050678	regulation of epithelial cell proliferation	9	9/62	227/10965	4.6593024747752985e-6	2.812026081834974e-4	2.140682623085617e-4	3.66944771629257	SOX11/NRP2/SOX2/SFRP2/FGFR1/SFRP1/CDKN1C/APOE/GPC3	14
BP	GO:0035456	response to interferon-beta	4	4/62	21/10965	5.160570765293329e-6	3.025568917251975e-4	2.303244215246707e-4	3.637660010923763	IFITM2/IFITM1/IFITM3/BST2	14
BP	GO:0030178	negative regulation of Wnt signaling pathway	8	8/62	175/10965	5.818852247002478e-6	3.3167457807914126e-4	2.524905477939087e-4	3.5977548754375346	SIX3/IGFBP2/FRZB/SOX2/SFRP2/SFRP1/APOE/GPC3	14
BP	GO:0045926	negative regulation of growth	8	8/62	176/10965	6.069134558357206e-6	3.365909219932159e-4	2.562331631465745e-4	3.591364662103087	ENO1/FRZB/IGFBP5/SFRP2/SEMA6A/SFRP1/BST2/GPC3	14
BP	GO:0030336	negative regulation of cell migration	8	8/62	180/10965	7.163565744734214e-6	3.8683255021564755e-4	2.9448009875860314e-4	3.530944049913776	IGFBP5/SFRP2/CLDN3/SFRP1/IFITM1/APOE/BST2/MIF	14
BP	GO:0050680	negative regulation of epithelial cell proliferation	6	6/62	88/10965	9.644606541866244e-6	5.07454682664347e-4	3.863048882086236e-4	3.4130697963630747	SOX2/SFRP2/SFRP1/CDKN1C/APOE/GPC3	14
BP	GO:2000146	negative regulation of cell motility	8	8/62	190/10965	1.0653447067834668e-5	5.465218345799184e-4	4.160451433859644e-4	3.3808595432681563	IGFBP5/SFRP2/CLDN3/SFRP1/IFITM1/APOE/BST2/MIF	14
BP	GO:0048598	embryonic morphogenesis	11	11/62	401/10965	1.291089930969966e-5	6.461747654513098e-4	4.919069210678895e-4	3.3081170669294924	SOX11/SIX3/FRZB/FZD5/SOX2/SHROOM3/SFRP2/SOX4/FGFR1/SFRP1/GPC3	14
BP	GO:0060070	canonical Wnt signaling pathway	9	9/62	268/10965	1.7773075804369886e-5	8.533736483607263e-4	6.496391167371078e-4	3.187327832794574	IGFBP2/FRZB/FZD5/SOX2/SFRP2/SOX4/SFRP1/APOE/GPC3	14
BP	GO:0090090	negative regulation of canonical Wnt signaling pathway	7	7/62	147/10965	1.7907908790517608e-5	8.533736483607263e-4	6.496391167371078e-4	3.187327832794574	IGFBP2/FRZB/SOX2/SFRP2/SFRP1/APOE/GPC3	14
BP	GO:0009615	response to virus	8	8/62	205/10965	1.8517290085906782e-5	8.533736483607263e-4	6.496391167371078e-4	3.187327832794574	ENO1/HMGA1/DDIT4/BNIP3/IFITM2/IFITM1/IFITM3/BST2	14
BP	GO:0016051	carbohydrate biosynthetic process	7	7/62	148/10965	1.8714334393875577e-5	8.533736483607263e-4	6.496391167371078e-4	3.187327832794574	ENO1/SLC2A1/PGAM1/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0005996	monosaccharide metabolic process	8	8/62	210/10965	2.2038058606717127e-5	9.830890491518162e-4	7.483862465072819e-4	3.1258742023597335	ENO1/SLC2A1/PGAM1/GAPDH/TPI1/SLC2A3/ALDOA/PGK1	14
BP	GO:0032787	monocarboxylic acid metabolic process	11	11/62	427/10965	2.320037595856087e-5	0.0010129185418503597	7.710942423853154e-4	3.112892539657663	ENO1/DDIT4/PGAM1/LDHA/GAPDH/TPI1/ALDOA/SLC16A3/BSG/MIF/PGK1	14
BP	GO:0046597	negative regulation of viral entry into host cell	3	3/62	11/10965	2.7504653669118104e-5	0.0011758239443547989	8.951075887055103e-4	3.0481247609154773	IFITM2/IFITM1/IFITM3	14
BP	GO:0046034	ATP metabolic process	8	8/62	221/10965	3.180099471823874e-5	0.0013317477788127735	0.0010138061474085133	2.994045079676534	ENO1/DDIT4/PGAM1/LDHA/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0014033	neural crest cell differentiation	5	5/62	68/10965	3.889471478065732e-5	0.0015781329210805715	0.0012013692699720778	2.920323481138657	SOX11/NRP2/FRZB/SEMA6A/SFRP1	14
BP	GO:0048762	mesenchymal cell differentiation	7	7/62	166/10965	3.922260183972181e-5	0.0015781329210805715	0.0012013692699720778	2.920323481138657	SOX11/NRP2/FRZB/SFRP2/SEMA6A/FGFR1/SFRP1	14
BP	GO:0051961	negative regulation of nervous system development	8	8/62	229/10965	4.0985338886054636e-5	0.0015886317969471646	0.0012093616429001703	2.917443809949499	LIN28A/SOX11/SIX3/SOX2/SEMA6A/CTSC/APOE/SOX3	14
BP	GO:0030111	regulation of Wnt signaling pathway	9	9/62	298/10965	4.103191288411292e-5	0.0015886317969471646	0.0012093616429001703	2.917443809949499	SIX3/IGFBP2/FRZB/SOX2/SFRP2/SOX4/SFRP1/APOE/GPC3	14
BP	GO:0045071	negative regulation of viral genome replication	4	4/62	36/10965	4.7667176903162274e-5	0.0018113527223201664	0.0013789101466723747	2.860464032646307	IFITM2/IFITM1/IFITM3/BST2	14
BP	GO:0001568	blood vessel development	11	11/62	463/10965	4.878508441631173e-5	0.0018201271494958488	0.0013855897660058683	2.8583653330227397	NRP2/FZD5/SFRP2/SEMA6A/SOX4/FGFR1/SFRP1/APOE/TNNI3/PGK1/GPC3	14
BP	GO:0010721	negative regulation of cell development	8	8/62	236/10965	5.075053289847633e-5	0.0018500651958536687	0.0014083803994289752	2.8512800276795813	LIN28A/SOX11/SIX3/FRZB/SOX2/SEMA6A/APOE/SOX3	14
BP	GO:0006091	generation of precursor metabolites and energy	10	10/62	384/10965	5.211722547944243e-5	0.0018500651958536687	0.0014083803994289752	2.8512800276795813	SH3BGRL3/ENO1/DDIT4/PGAM1/BNIP3/LDHA/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0060828	regulation of canonical Wnt signaling pathway	8	8/62	237/10965	5.2292291110873675e-5	0.0018500651958536687	0.0014083803994289752	2.8512800276795813	IGFBP2/FRZB/SOX2/SFRP2/SOX4/SFRP1/APOE/GPC3	14
BP	GO:0048485	sympathetic nervous system development	3	3/62	14/10965	5.994639957934237e-5	0.0020165575727345993	0.001535124365414048	2.813856435154098	SOX11/NRP2/SOX4	14
BP	GO:0060026	convergent extension	3	3/62	14/10965	5.994639957934237e-5	0.0020165575727345993	0.001535124365414048	2.813856435154098	FRZB/SFRP2/SFRP1	14
BP	GO:2000095	regulation of Wnt signaling pathway, planar cell polarity pathway	3	3/62	14/10965	5.994639957934237e-5	0.0020165575727345993	0.001535124365414048	2.813856435154098	SFRP2/SFRP1/GPC3	14
BP	GO:0045596	negative regulation of cell differentiation	11	11/62	480/10965	6.762539987771391e-5	0.002238182589501112	0.0017038385979376476	2.7685715476825745	LIN28A/SOX11/SIX3/FRZB/IGFBP5/SOX2/SFRP2/SEMA6A/SFRP1/APOE/SOX3	14
BP	GO:0048514	blood vessel morphogenesis	10	10/62	397/10965	6.893873909735935e-5	0.00224543321631399	0.001709358209197682	2.767166917983467	NRP2/FZD5/SFRP2/SEMA6A/SOX4/FGFR1/SFRP1/APOE/TNNI3/PGK1	14
BP	GO:0045667	regulation of osteoblast differentiation	5	5/62	78/10965	7.543344172760887e-5	0.002387475863821999	0.001817489577260617	2.7405280710060245	SOX11/IGFBP5/SFRP2/SFRP1/IFITM1	14
BP	GO:0001944	vasculature development	11	11/62	486/10965	7.562667209962473e-5	0.002387475863821999	0.001817489577260617	2.7405280710060245	NRP2/FZD5/SFRP2/SEMA6A/SOX4/FGFR1/SFRP1/APOE/TNNI3/PGK1/GPC3	14
BP	GO:0040008	regulation of growth	11	11/62	487/10965	7.703642472449314e-5	0.0023951324777978776	0.001823318250257541	2.739137520995197	ENO1/IGFBP2/FRZB/IGFBP5/SFRP2/SEMA6A/FGFR1/SFRP1/APOE/BST2/GPC3	14
BP	GO:0002009	morphogenesis of an epithelium	10	10/62	416/10965	1.0174252257699379e-4	0.0031131916566524906	0.002369947890875293	2.625261202915681	SOX11/FRZB/FZD5/IGFBP5/SHROOM3/SFRP2/SOX4/FGFR1/SFRP1/GPC3	14
BP	GO:0050708	regulation of protein secretion	7	7/62	194/10965	1.0518515854946123e-4	0.0031131916566524906	0.002369947890875293	2.625261202915681	SLC2A1/SOX4/SFRP1/GAPDH/APOE/NNAT/MIF	14
BP	GO:0016055	Wnt signaling pathway	10	10/62	418/10965	1.0586214559333571e-4	0.0031131916566524906	0.002369947890875293	2.625261202915681	SIX3/IGFBP2/FRZB/FZD5/SOX2/SFRP2/SOX4/SFRP1/APOE/GPC3	14
BP	GO:0021536	diencephalon development	4	4/62	44/10965	1.0620049510997775e-4	0.0031131916566524906	0.002369947890875293	2.625261202915681	SIX3/NRP2/SOX2/SOX3	14
BP	GO:0198738	cell-cell signaling by wnt	10	10/62	419/10965	1.079745802541409e-4	0.0031206174462182694	0.002375600846510676	2.6242265286404907	SIX3/IGFBP2/FRZB/FZD5/SOX2/SFRP2/SOX4/SFRP1/APOE/GPC3	14
BP	GO:0048863	stem cell differentiation	7	7/62	196/10965	1.1215009197779436e-4	0.003185663266365786	0.0024251176194146026	2.615267193051834	LIN28A/SOX11/SIX3/NRP2/FRZB/SEMA6A/SFRP1	14
BP	GO:0030308	negative regulation of cell growth	6	6/62	136/10965	1.133301259477107e-4	0.003185663266365786	0.0024251176194146026	2.615267193051834	ENO1/FRZB/SFRP2/SEMA6A/SFRP1/BST2	14
BP	GO:0090287	regulation of cellular response to growth factor stimulus	7	7/62	198/10965	1.1948633808440376e-4	0.0033133238614756286	0.0025223005080690637	2.598203172631533	SOX11/SFRP2/SEMA6A/FGFR1/SFRP1/CDKN1C/GPC3	14
BP	GO:0003206	cardiac chamber morphogenesis	5	5/62	88/10965	1.3405525419976814e-4	0.0036677517549056566	0.0027921122418590304	2.554067127223584	SOX11/NRP2/SFRP2/SOX4/TNNI3	14
BP	GO:0003208	cardiac ventricle morphogenesis	4	4/62	47/10965	1.3778123235841673e-4	0.0037189131256957055	0.0028310593405829624	2.5480510274849	SOX11/SFRP2/SOX4/TNNI3	14
BP	GO:0060485	mesenchyme development	7	7/62	203/10965	1.3954985900515074e-4	0.0037189131256957055	0.0028310593405829624	2.5480510274849	SOX11/NRP2/FRZB/SFRP2/SEMA6A/FGFR1/SFRP1	14
BP	GO:0009150	purine ribonucleotide metabolic process	8	8/62	276/10965	1.5148985697505685e-4	0.0039853485450361105	0.0030338859345611924	2.518000751473442	ENO1/DDIT4/PGAM1/LDHA/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0005975	carbohydrate metabolic process	10	10/62	439/10965	1.584063041355567e-4	0.0041108526126975966	0.003129427145400243	2.504535154581672	ENO1/SLC2A1/DDIT4/PGAM1/LDHA/GAPDH/TPI1/SLC2A3/ALDOA/PGK1	14
BP	GO:0046883	regulation of hormone secretion	6	6/62	145/10965	1.6116078923421407e-4	0.0041108526126975966	0.003129427145400243	2.504535154581672	SLC2A1/SOX11/SOX4/FGFR1/SFRP1/NNAT	14
BP	GO:0002791	regulation of peptide secretion	7	7/62	208/10965	1.6227049786964197e-4	0.0041108526126975966	0.003129427145400243	2.504535154581672	SLC2A1/SOX4/SFRP1/GAPDH/APOE/NNAT/MIF	14
BP	GO:0030900	forebrain development	8	8/62	284/10965	1.8432604445923104e-4	0.004612646868662708	0.003511422977888304	2.45451685327502	POU3F1/SLC2A1/SIX3/NRP2/SOX2/FGFR1/BNIP3/SOX3	14
BP	GO:0050768	negative regulation of neurogenesis	7	7/62	213/10965	1.8790590888907897e-4	0.0046367125867677154	0.0035297432434406944	2.452256884417388	LIN28A/SOX11/SIX3/SOX2/SEMA6A/APOE/SOX3	14
BP	GO:1903901	negative regulation of viral life cycle	4	4/62	51/10965	1.8980694799633924e-4	0.0046367125867677154	0.0035297432434406944	2.452256884417388	IFITM2/IFITM1/IFITM3/BST2	14
BP	GO:0016049	cell growth	9	9/62	367/10965	2.0188099858989639e-4	0.004749421792006169	0.0036155442389130786	2.441826320176766	ENO1/NRP2/FRZB/IGFBP5/SFRP2/SEMA6A/SFRP1/APOE/BST2	14
BP	GO:1903530	regulation of secretion by cell	9	9/62	367/10965	2.0188099858989639e-4	0.004749421792006169	0.0036155442389130786	2.441826320176766	SLC2A1/SOX11/SOX4/FGFR1/SFRP1/GAPDH/APOE/NNAT/MIF	14
BP	GO:0001649	osteoblast differentiation	6	6/62	152/10965	2.0841392294557924e-4	0.004749421792006169	0.0036155442389130786	2.441826320176766	SOX11/IGFBP5/SOX2/SFRP2/SFRP1/IFITM1	14
BP	GO:0051607	defense response to virus	6	6/62	152/10965	2.0841392294557924e-4	0.004749421792006169	0.0036155442389130786	2.441826320176766	DDIT4/BNIP3/IFITM2/IFITM1/IFITM3/BST2	14
BP	GO:0007389	pattern specification process	8	8/62	290/10965	2.126296229463881e-4	0.004749421792006169	0.0036155442389130786	2.441826320176766	SIX3/NRP2/FZD5/SHROOM3/SFRP2/FGFR1/SFRP1/GPC3	14
BP	GO:0009259	ribonucleotide metabolic process	8	8/62	290/10965	2.126296229463881e-4	0.004749421792006169	0.0036155442389130786	2.441826320176766	ENO1/DDIT4/PGAM1/LDHA/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0048596	embryonic camera-type eye morphogenesis	3	3/62	21/10965	2.12937039407684e-4	0.004749421792006169	0.0036155442389130786	2.441826320176766	SOX11/SIX3/FZD5	14
BP	GO:2000050	regulation of non-canonical Wnt signaling pathway	3	3/62	21/10965	2.12937039407684e-4	0.004749421792006169	0.0036155442389130786	2.441826320176766	SFRP2/SFRP1/GPC3	14
BP	GO:0002443	leukocyte mediated immunity	10	10/62	462/10965	2.397848942574331e-4	0.005268110449977708	0.004010401101757936	2.3968121890833816	FZD5/BRI3/PGAM1/CTSC/MGST1/SLC2A3/CLEC2A/ALDOA/BST2/MIF	14
BP	GO:0001841	neural tube formation	5	5/62	100/10965	2.4460204421560434e-4	0.005268110449977708	0.004010401101757936	2.3968121890833816	SOX11/SHROOM3/SFRP2/SOX4/SFRP1	14
BP	GO:0060795	cell fate commitment involved in formation of primary germ layer	3	3/62	22/10965	2.455669860427893e-4	0.005268110449977708	0.004010401101757936	2.3968121890833816	SOX2/SFRP2/FGFR1	14
BP	GO:0006006	glucose metabolic process	6	6/62	157/10965	2.484033022120601e-4	0.005268110449977708	0.004010401101757936	2.3968121890833816	ENO1/PGAM1/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0003002	regionalization	7	7/62	223/10965	2.490286128888098e-4	0.005268110449977708	0.004010401101757936	2.3968121890833816	SIX3/NRP2/FZD5/SFRP2/FGFR1/SFRP1/GPC3	14
BP	GO:0071456	cellular response to hypoxia	6	6/62	159/10965	2.659961563904116e-4	0.005450562658449542	0.00414929464714226	2.382025724225149	ENO1/FAM162A/HILPDA/SFRP1/BNIP3/PGK1	14
BP	GO:0019693	ribose phosphate metabolic process	8	8/62	300/10965	2.677074559802889e-4	0.005450562658449542	0.00414929464714226	2.382025724225149	ENO1/DDIT4/PGAM1/LDHA/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0035107	appendage morphogenesis	5	5/62	102/10965	2.682781815318732e-4	0.005450562658449542	0.00414929464714226	2.382025724225149	SOX11/SFRP2/SOX4/FGFR1/GPC3	14
BP	GO:0035108	limb morphogenesis	5	5/62	102/10965	2.682781815318732e-4	0.005450562658449542	0.00414929464714226	2.382025724225149	SOX11/SFRP2/SOX4/FGFR1/GPC3	14
BP	GO:0009798	axis specification	4	4/62	56/10965	2.7314381220807244e-4	0.005495010810303575	0.004183131241659232	2.3784985096401994	SIX3/FZD5/SFRP1/GPC3	14
BP	GO:0010001	glial cell differentiation	6	6/62	161/10965	2.8455605030935287e-4	0.005669019565386331	0.004315597124773426	2.3649591049192455	LIN28A/POU3F1/SOX11/SOX2/SOX4/BNIP3	14
BP	GO:0007423	sensory organ development	9	9/62	385/10965	2.882510149223475e-4	0.005687414255967856	0.0043296002646231145	2.3635521985385974	SOX11/SIX3/FRZB/FZD5/SOX2/FGFR1/FJX1/SIX6/SOX3	14
BP	GO:0006163	purine nucleotide metabolic process	8	8/62	305/10965	2.9934949232345405e-4	0.005850144364264074	0.0044534801664962995	2.3513004774675945	ENO1/DDIT4/PGAM1/LDHA/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:1905114	cell surface receptor signaling pathway involved in cell-cell signaling	10	10/62	479/10965	3.20447379243953e-4	0.006152573249869674	0.004683707142098387	2.3294102678581847	SIX3/IGFBP2/FRZB/FZD5/SOX2/SFRP2/SOX4/SFRP1/APOE/GPC3	14
BP	GO:0034341	response to interferon-gamma	5	5/62	106/10965	3.208213146861867e-4	0.006152573249869674	0.004683707142098387	2.3294102678581847	IFITM2/IFITM1/IFITM3/GAPDH/BST2	14
BP	GO:0051046	regulation of secretion	9	9/62	392/10965	3.292418011485564e-4	0.0062345185093286015	0.00474608878005727	2.323664142155689	SLC2A1/SOX11/SOX4/FGFR1/SFRP1/GAPDH/APOE/NNAT/MIF	14
BP	GO:0060337	type I interferon signaling pathway	4	4/62	59/10965	3.342090818840868e-4	0.0062345185093286015	0.00474608878005727	2.323664142155689	IFITM2/IFITM1/IFITM3/BST2	14
BP	GO:0071357	cellular response to type I interferon	4	4/62	59/10965	3.342090818840868e-4	0.0062345185093286015	0.00474608878005727	2.323664142155689	IFITM2/IFITM1/IFITM3/BST2	14
BP	GO:0001558	regulation of cell growth	8	8/62	313/10965	3.5631275090003243e-4	0.006439342225534962	0.004902012856619414	2.3096255540485378	ENO1/FRZB/IGFBP5/SFRP2/SEMA6A/SFRP1/APOE/BST2	14
BP	GO:0035019	somatic stem cell population maintenance	4	4/62	60/10965	3.5657426977504374e-4	0.006439342225534962	0.004902012856619414	2.3096255540485378	LIN28A/SOX2/SOX4/SFRP1	14
BP	GO:0021983	pituitary gland development	3	3/62	25/10965	3.62350037200223e-4	0.006439342225534962	0.004902012856619414	2.3096255540485378	SIX3/SOX2/SOX3	14
BP	GO:0031128	developmental induction	3	3/62	25/10965	3.62350037200223e-4	0.006439342225534962	0.004902012856619414	2.3096255540485378	SIX3/FZD5/FGFR1	14
BP	GO:0046596	regulation of viral entry into host cell	3	3/62	25/10965	3.62350037200223e-4	0.006439342225534962	0.004902012856619414	2.3096255540485378	IFITM2/IFITM1/IFITM3	14
BP	GO:2001233	regulation of apoptotic signaling pathway	8	8/62	314/10965	3.640173967651343e-4	0.006439342225534962	0.004902012856619414	2.3096255540485378	ENO1/FAM162A/SFRP2/FGFR1/SFRP1/BNIP3/CTSC/MIF	14
BP	GO:0036294	cellular response to decreased oxygen levels	6	6/62	169/10965	3.6922420760100277e-4	0.006475624564079126	0.004929633145118201	2.3071853989740787	ENO1/FAM162A/HILPDA/SFRP1/BNIP3/PGK1	14
BP	GO:0023061	signal release	8	8/62	316/10965	3.7983566752573426e-4	0.00660527787934582	0.005028333011669845	2.298575967990561	SLC2A1/SOX11/SOX4/FGFR1/SFRP1/GAPDH/NNAT/MIF	14
BP	GO:0034340	response to type I interferon	4	4/62	62/10965	4.0448867587022854e-4	0.006861869769806964	0.005223666122085532	2.2820245893841626	IFITM2/IFITM1/IFITM3/BST2	14
BP	GO:0061053	somite development	4	4/62	62/10965	4.0448867587022854e-4	0.006861869769806964	0.005223666122085532	2.2820245893841626	SOX11/FRZB/SFRP2/SFRP1	14
BP	GO:0043903	regulation of symbiotic process	6	6/62	172/10965	4.056281394731021e-4	0.006861869769806964	0.005223666122085532	2.2820245893841626	IFITM2/IFITM1/IFITM3/GAPDH/APOE/BST2	14
BP	GO:0048048	embryonic eye morphogenesis	3	3/62	26/10965	4.079669161386207e-4	0.006861869769806964	0.005223666122085532	2.2820245893841626	SOX11/SIX3/FZD5	14
BP	GO:0072521	purine-containing compound metabolic process	8	8/62	320/10965	4.131593285901755e-4	0.006892706847699513	0.0052471411521422375	2.28007725278814	ENO1/DDIT4/PGAM1/LDHA/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:1903532	positive regulation of secretion by cell	6	6/62	173/10965	4.183674869522674e-4	0.006923307122790747	0.0052704359137280546	2.2781534631370897	SOX11/SOX4/FGFR1/GAPDH/NNAT/MIF	14
BP	GO:0030855	epithelial cell differentiation	9	9/62	406/10965	4.2581830634107724e-4	0.0069706263791277125	0.005306458164884336	2.2751952553165955	POU3F1/SOX11/SIX3/FRZB/SHROOM3/SOX4/CLDN3/FGFR1/PGK1	14
BP	GO:0030510	regulation of BMP signaling pathway	4	4/62	63/10965	4.3009467561619033e-4	0.0069706263791277125	0.005306458164884336	2.2751952553165955	SOX11/SFRP2/SFRP1/GPC3	14
BP	GO:0046879	hormone secretion	6	6/62	174/10965	4.314179094294442e-4	0.0069706263791277125	0.005306458164884336	2.2751952553165955	SLC2A1/SOX11/SOX4/FGFR1/SFRP1/NNAT	14
BP	GO:0043312	neutrophil degranulation	8	8/62	323/10965	4.396871158224953e-4	0.007048734075529377	0.005365918420070584	2.270355934344382	BRI3/PGAM1/CTSC/MGST1/SLC2A3/ALDOA/BST2/MIF	14
BP	GO:0002283	neutrophil activation involved in immune response	8	8/62	324/10965	4.4883226315751615e-4	0.007086690695407203	0.005394813271767872	2.268023582759433	BRI3/PGAM1/CTSC/MGST1/SLC2A3/ALDOA/BST2/MIF	14
BP	GO:0001838	embryonic epithelial tube formation	5	5/62	114/10965	4.48961886161275e-4	0.007086690695407203	0.005394813271767872	2.268023582759433	SOX11/SHROOM3/SFRP2/SOX4/SFRP1	14
BP	GO:0048525	negative regulation of viral process	4	4/62	64/10965	4.568379368808639e-4	0.007155965240301777	0.005447549203143447	2.263798838446151	IFITM2/IFITM1/IFITM3/BST2	14
BP	GO:0009914	hormone transport	6	6/62	178/10965	4.8683709974947447e-4	0.007513369608560656	0.00571962680778907	2.2426323069771326	SLC2A1/SOX11/SOX4/FGFR1/SFRP1/NNAT	14
BP	GO:0042119	neutrophil activation	8	8/62	328/10965	4.869776598141166e-4	0.007513369608560656	0.00571962680778907	2.2426323069771326	BRI3/PGAM1/CTSC/MGST1/SLC2A3/ALDOA/BST2/MIF	14
BP	GO:0035282	segmentation	4	4/62	66/10965	5.138511195452007e-4	0.007747956579979697	0.005898208456289049	2.229279882544438	NRP2/FZD5/SFRP2/SFRP1	14
BP	GO:0090596	sensory organ morphogenesis	6	6/62	180/10965	5.165531969053744e-4	0.007747956579979697	0.005898208456289049	2.229279882544438	SOX11/SIX3/FRZB/FZD5/FGFR1/FJX1	14
BP	GO:0002446	neutrophil mediated immunity	8	8/62	331/10965	5.172856001253502e-4	0.007747956579979697	0.005898208456289049	2.229279882544438	BRI3/PGAM1/CTSC/MGST1/SLC2A3/ALDOA/BST2/MIF	14
BP	GO:0036230	granulocyte activation	8	8/62	331/10965	5.172856001253502e-4	0.007747956579979697	0.005898208456289049	2.229279882544438	BRI3/PGAM1/CTSC/MGST1/SLC2A3/ALDOA/BST2/MIF	14
BP	GO:0071453	cellular response to oxygen levels	6	6/62	182/10965	5.476659518679473e-4	0.00814355458864513	0.006199361346849991	2.207653048860664	ENO1/FAM162A/HILPDA/SFRP1/BNIP3/PGK1	14
BP	GO:0051047	positive regulation of secretion	6	6/62	184/10965	5.802205000662113e-4	0.008565557310329968	0.0065206150859390966	2.1857114355825256	SOX11/SOX4/FGFR1/GAPDH/NNAT/MIF	14
BP	GO:0072175	epithelial tube formation	5	5/62	121/10965	5.898627595418356e-4	0.00864570273271319	0.006581626580151008	2.1816667617834224	SOX11/SHROOM3/SFRP2/SOX4/SFRP1	14
BP	GO:0031076	embryonic camera-type eye development	3	3/62	30/10965	6.268819031088499e-4	0.008912248425027755	0.0067845371205197446	2.1684797770184625	SOX11/SIX3/FZD5	14
BP	GO:0048546	digestive tract morphogenesis	3	3/62	30/10965	6.268819031088499e-4	0.008912248425027755	0.0067845371205197446	2.1684797770184625	SOX11/SFRP2/SFRP1	14
BP	GO:0052372	modulation by symbiont of entry into host	3	3/62	30/10965	6.268819031088499e-4	0.008912248425027755	0.0067845371205197446	2.1684797770184625	IFITM2/IFITM1/IFITM3	14
BP	GO:0030278	regulation of ossification	5	5/62	123/10965	6.356231740819767e-4	0.008912248425027755	0.0067845371205197446	2.1684797770184625	SOX11/IGFBP5/SFRP2/SFRP1/IFITM1	14
BP	GO:0048736	appendage development	5	5/62	123/10965	6.356231740819767e-4	0.008912248425027755	0.0067845371205197446	2.1684797770184625	SOX11/SFRP2/SOX4/FGFR1/GPC3	14
BP	GO:0060173	limb development	5	5/62	123/10965	6.356231740819767e-4	0.008912248425027755	0.0067845371205197446	2.1684797770184625	SOX11/SFRP2/SOX4/FGFR1/GPC3	14
BP	GO:0045069	regulation of viral genome replication	4	4/62	70/10965	6.427937460546334e-4	0.008912248425027755	0.0067845371205197446	2.1684797770184625	IFITM2/IFITM1/IFITM3/BST2	14
BP	GO:0046887	positive regulation of hormone secretion	4	4/62	70/10965	6.427937460546334e-4	0.008912248425027755	0.0067845371205197446	2.1684797770184625	SOX11/SOX4/FGFR1/NNAT	14
BP	GO:0019318	hexose metabolic process	6	6/62	188/10965	6.498390360007232e-4	0.008949461086399222	0.0068128656264576	2.1666701767825285	ENO1/PGAM1/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0003205	cardiac chamber development	5	5/62	124/10965	6.594782323804254e-4	0.009021662218964218	0.006867829451596852	2.163180498186433	SOX11/NRP2/SFRP2/SOX4/TNNI3	14
BP	GO:0009306	protein secretion	7	7/62	263/10965	6.724269774457296e-4	0.00907776419551735	0.006910537635245587	2.1604881634886905	SLC2A1/SOX4/SFRP1/GAPDH/APOE/NNAT/MIF	14
BP	GO:0035592	establishment of protein localization to extracellular region	7	7/62	263/10965	6.724269774457296e-4	0.00907776419551735	0.006910537635245587	2.1604881634886905	SLC2A1/SOX4/SFRP1/GAPDH/APOE/NNAT/MIF	14
BP	GO:0046683	response to organophosphorus	4	4/62	71/10965	6.783066091003704e-4	0.009097288639699086	0.0069254008111795645	2.159555086516759	IGFBP5/LDHA/HSP90B1/BSG	14
BP	GO:0001503	ossification	7	7/62	264/10965	6.877077566133993e-4	0.009163482575134385	0.006975791598183763	2.1564065024319623	SOX11/IGFBP5/SOX2/SFRP2/SFRP1/IFITM1/GPC3	14
BP	GO:0043299	leukocyte degranulation	8	8/62	348/10965	7.193812624154354e-4	0.009523679680493375	0.00724999520152466	2.1396622808706685	BRI3/PGAM1/CTSC/MGST1/SLC2A3/ALDOA/BST2/MIF	14
BP	GO:0016331	morphogenesis of embryonic epithelium	5	5/62	127/10965	7.350842024720829e-4	0.009548479868327325	0.007268874589410973	2.1385328240024584	SOX11/SHROOM3/SFRP2/SOX4/SFRP1	14
BP	GO:0052547	regulation of peptidase activity	7	7/62	267/10965	7.352143368400182e-4	0.009548479868327325	0.007268874589410973	2.1385328240024584	FAM162A/SOX2/SFRP2/CLDN3/GAPDH/BST2/GPC3	14
BP	GO:0071692	protein localization to extracellular region	7	7/62	267/10965	7.352143368400182e-4	0.009548479868327325	0.007268874589410973	2.1385328240024584	SLC2A1/SOX4/SFRP1/GAPDH/APOE/NNAT/MIF	14
BP	GO:0048483	autonomic nervous system development	3	3/62	32/10965	7.597095737153448e-4	0.009804553743798034	0.007463813355799879	2.1270392293311815	SOX11/NRP2/SOX4	14
BP	GO:0002275	myeloid cell activation involved in immune response	8	8/62	353/10965	7.89651071060416e-4	0.010127274986349834	0.007709488088510904	2.112974458228658	BRI3/PGAM1/CTSC/MGST1/SLC2A3/ALDOA/BST2/MIF	14
BP	GO:0007369	gastrulation	5	5/62	130/10965	8.170021796036851e-4	0.010412971879172433	0.007926977669381292	2.100892365230108	SOX2/SFRP2/FGFR1/SFRP1/GPC3	14
BP	GO:0009952	anterior/posterior pattern specification	5	5/62	131/10965	8.457672189213154e-4	0.010713051439669994	0.008155416198045693	2.0885538705645583	SIX3/FZD5/SFRP2/SFRP1/GPC3	14
BP	GO:0035148	tube formation	5	5/62	132/10965	8.752821380975413e-4	0.01095170089863509	0.008337090455306492	2.0789854864929675	SOX11/SHROOM3/SFRP2/SOX4/SFRP1	14
BP	GO:0061138	morphogenesis of a branching epithelium	5	5/62	132/10965	8.752821380975413e-4	0.01095170089863509	0.008337090455306492	2.0789854864929675	FZD5/SFRP2/FGFR1/SFRP1/GPC3	14
BP	GO:0002444	myeloid leukocyte mediated immunity	8	8/62	361/10965	9.135354471511462e-4	0.01136105901547971	0.008648718364097615	2.063048244979051	BRI3/PGAM1/CTSC/MGST1/SLC2A3/ALDOA/BST2/MIF	14
BP	GO:0035567	non-canonical Wnt signaling pathway	5	5/62	134/10965	9.366109164320663e-4	0.011577865063365061	0.008813764108973915	2.054838577100649	FRZB/FZD5/SFRP2/SFRP1/GPC3	14
BP	GO:0097190	apoptotic signaling pathway	9	9/62	455/10965	9.655590557374843e-4	0.011739903740042202	0.008937117651699305	2.0488025248058697	ENO1/FAM162A/SFRP2/FGFR1/SFRP1/DDIT4/BNIP3/CTSC/MIF	14
BP	GO:0014074	response to purine-containing compound	4	4/62	78/10965	9.668829103640994e-4	0.011739903740042202	0.008937117651699305	2.0488025248058697	IGFBP5/LDHA/HSP90B1/BSG	14
BP	GO:0035270	endocrine system development	4	4/62	78/10965	9.668829103640994e-4	0.011739903740042202	0.008937117651699305	2.0488025248058697	SIX3/SOX2/SOX4/SOX3	14
BP	GO:0002790	peptide secretion	7	7/62	283/10965	0.0010344609092911479	0.012486551681561384	0.009505510770204728	2.0220245417420886	SLC2A1/SOX4/SFRP1/GAPDH/APOE/NNAT/MIF	14
BP	GO:0009117	nucleotide metabolic process	8	8/62	369/10965	0.0010526270720451292	0.012631524864541551	0.00961587303733439	2.017011279487456	ENO1/DDIT4/PGAM1/LDHA/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0001763	morphogenesis of a branching structure	5	5/62	139/10965	0.0011039248430824526	0.013170080104681353	0.010025853532034026	1.9988786442964777	FZD5/SFRP2/FGFR1/SFRP1/GPC3	14
BP	GO:0006753	nucleoside phosphate metabolic process	8	8/62	373/10965	0.0011282880373190962	0.013382930939761766	0.0101878883321055	1.9919158239180974	ENO1/DDIT4/PGAM1/LDHA/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0001822	kidney development	6	6/62	210/10965	0.001156414979209133	0.013559791641926519	0.010322525288098367	1.9862140445183485	LIN28A/SOX11/SOX4/FGFR1/SFRP1/GPC3	14
BP	GO:0042063	gliogenesis	6	6/62	210/10965	0.001156414979209133	0.013559791641926519	0.010322525288098367	1.9862140445183485	LIN28A/POU3F1/SOX11/SOX2/SOX4/BNIP3	14
BP	GO:0015909	long-chain fatty acid transport	3	3/62	38/10965	0.001261333449958944	0.014701650640820537	0.011191776726673684	1.9511009625030762	SLC2A1/APOE/MIF	14
BP	GO:0072001	renal system development	6	6/62	214/10965	0.001274328618734967	0.014701650640820537	0.011191776726673684	1.9511009625030762	LIN28A/SOX11/SOX4/FGFR1/SFRP1/GPC3	14
BP	GO:0048593	camera-type eye morphogenesis	4	4/62	84/10965	0.0012752893830731266	0.014701650640820537	0.011191776726673684	1.9511009625030762	SOX11/SIX3/FZD5/FJX1	14
BP	GO:0045669	positive regulation of osteoblast differentiation	3	3/62	39/10965	0.0013609678665083354	0.015250340651820867	0.011609472415770065	1.9351875160173242	SOX11/SFRP2/IFITM1	14
BP	GO:0021915	neural tube development	5	5/62	146/10965	0.0013742283809606724	0.015250340651820867	0.011609472415770065	1.9351875160173242	SOX11/SHROOM3/SFRP2/SOX4/SFRP1	14
BP	GO:1905330	regulation of morphogenesis of an epithelium	5	5/62	146/10965	0.0013742283809606724	0.015250340651820867	0.011609472415770065	1.9351875160173242	FZD5/SFRP2/FGFR1/SFRP1/GPC3	14
BP	GO:0001710	mesodermal cell fate commitment	2	2/62	10/10965	0.0013749088794282945	0.015250340651820867	0.011609472415770065	1.9351875160173242	SFRP2/FGFR1	14
BP	GO:0019852	L-ascorbic acid metabolic process	2	2/62	10/10965	0.0013749088794282945	0.015250340651820867	0.011609472415770065	1.9351875160173242	SLC2A1/SLC2A3	14
BP	GO:0042659	regulation of cell fate specification	2	2/62	10/10965	0.0013749088794282945	0.015250340651820867	0.011609472415770065	1.9351875160173242	SFRP2/FGFR1	14
BP	GO:0050715	positive regulation of cytokine secretion	2	2/62	10/10965	0.0013749088794282945	0.015250340651820867	0.011609472415770065	1.9351875160173242	GAPDH/MIF	14
BP	GO:0043065	positive regulation of apoptotic process	9	9/62	479/10965	0.0013847152538462718	0.015276536026304032	0.011629413903270332	1.9344421722010046	FRZB/FAM162A/SFRP2/SOX4/SFRP1/BNIP3/LDHA/CTSC/GAPDH	14
BP	GO:0043068	positive regulation of programmed cell death	9	9/62	483/10965	0.001467091340389393	0.01609877770309644	0.012255353499228029	1.9116741572352467	FRZB/FAM162A/SFRP2/SOX4/SFRP1/BNIP3/LDHA/CTSC/GAPDH	14
BP	GO:0072089	stem cell proliferation	4	4/62	88/10965	0.0015155445888246643	0.016542007958873464	0.01259276690826317	1.8998788353435956	SOX11/SIX3/SFRP2/FGFR1	14
BP	GO:0002718	regulation of cytokine production involved in immune response	3	3/62	41/10965	0.0015747775200138626	0.017097584503007652	0.013015705038711068	1.8855323019205865	FZD5/BST2/MIF	14
BP	GO:0003231	cardiac ventricle development	4	4/62	90/10965	0.0016467726546562718	0.0176920287296056	0.01346823157624639	1.8706894248484494	SOX11/SFRP2/SOX4/TNNI3	14
BP	GO:0015718	monocarboxylic acid transport	4	4/62	90/10965	0.0016467726546562718	0.0176920287296056	0.01346823157624639	1.8706894248484494	SLC2A1/SLC16A3/APOE/MIF	14
BP	GO:0043508	negative regulation of JUN kinase activity	2	2/62	11/10965	0.0016743320407081124	0.017709945090376527	0.013481870582804336	1.8702498461219943	SFRP2/SFRP1	14
BP	GO:0071481	cellular response to X-ray	2	2/62	11/10965	0.0016743320407081124	0.017709945090376527	0.013481870582804336	1.8702498461219943	SFRP2/SFRP1	14
BP	GO:1904948	midbrain dopaminergic neuron differentiation	2	2/62	11/10965	0.0016743320407081124	0.017709945090376527	0.013481870582804336	1.8702498461219943	SFRP2/SFRP1	14
BP	GO:0060563	neuroepithelial cell differentiation	3	3/62	42/10965	0.0016891213340655116	0.017774753730781693	0.013531206800287285	1.8686634684923087	SOX11/SOX4/FGFR1	14
BP	GO:0019079	viral genome replication	4	4/62	91/10965	0.0017152641658851166	0.017893229407677094	0.013621397579251468	1.8657783307625697	IFITM2/IFITM1/IFITM3/BST2	14
BP	GO:0050865	regulation of cell activation	7	7/62	309/10965	0.0017178197823159785	0.017893229407677094	0.013621397579251468	1.8657783307625697	SOX11/IGFBP2/SOX4/SFRP1/CTSC/APOE/MIF	14
BP	GO:0071363	cellular response to growth factor stimulus	9	9/62	496/10965	0.0017626197963211334	0.01826715061641902	0.013906048791815853	1.8567962511492229	SOX11/NRP2/SFRP2/SEMA6A/FGFR1/SFRP1/DDIT4/CDKN1C/GPC3	14
BP	GO:0050714	positive regulation of protein secretion	4	4/62	92/10965	0.0017857128391968271	0.018413481135838638	0.014017444344713522	1.8533311595620372	SOX4/GAPDH/NNAT/MIF	14
BP	GO:1903578	regulation of ATP metabolic process	4	4/62	93/10965	0.0018581477242607303	0.019064595650915093	0.014513111698962758	1.838239462213882	ENO1/DDIT4/PGAM1/PGK1	14
BP	GO:0048732	gland development	7	7/62	314/10965	0.0018823404954325382	0.019216729833968004	0.01462892534811148	1.8347875763030803	SIX3/FRZB/IGFBP5/SOX2/FGFR1/SFRP1/SOX3	14
BP	GO:0002274	myeloid leukocyte activation	8	8/62	406/10965	0.0019334826431214862	0.019641120711313315	0.014951997094279757	1.8253007960285281	BRI3/PGAM1/CTSC/MGST1/SLC2A3/ALDOA/BST2/MIF	14
BP	GO:0031639	plasminogen activation	2	2/62	12/10965	0.0020018934347998158	0.02003846501565474	0.015254479369668431	1.8166026100955528	ENO1/PGK1	14
BP	GO:0043567	regulation of insulin-like growth factor receptor signaling pathway	2	2/62	12/10965	0.0020018934347998158	0.02003846501565474	0.015254479369668431	1.8166026100955528	IGFBP2/IGFBP5	14
BP	GO:2000052	positive regulation of non-canonical Wnt signaling pathway	2	2/62	12/10965	0.0020018934347998158	0.02003846501565474	0.015254479369668431	1.8166026100955528	SFRP1/GPC3	14
BP	GO:0044282	small molecule catabolic process	7	7/62	320/10965	0.0020956973327018176	0.02087558702283558	0.0158917467640751	1.7988283640697995	ENO1/PGAM1/GAPDH/TPI1/ALDOA/APOE/PGK1	14
BP	GO:0001655	urogenital system development	6	6/62	237/10965	0.0021412918008893904	0.021226718721860043	0.016159049237324464	1.791584195735364	LIN28A/SOX11/SOX4/FGFR1/SFRP1/GPC3	14
BP	GO:0050792	regulation of viral process	5	5/62	163/10965	0.002231548045128631	0.02201507975290361	0.016759196857140127	1.7757467976908132	IFITM2/IFITM1/IFITM3/APOE/BST2	14
BP	GO:0060071	Wnt signaling pathway, planar cell polarity pathway	4	4/62	99/10965	0.002336084578076865	0.02293610313020922	0.01746033499806632	1.7579474280751248	FZD5/SFRP2/SFRP1/GPC3	14
BP	GO:0090179	planar cell polarity pathway involved in neural tube closure	2	2/62	13/10965	0.002357275647975882	0.023033950617364334	0.017534822363890774	1.7560986293703194	SFRP2/SFRP1	14
BP	GO:0002793	positive regulation of peptide secretion	4	4/62	100/10965	0.0024232296836544146	0.02356619578606094	0.01793999925439337	1.7461775793416956	SOX4/GAPDH/NNAT/MIF	14
BP	GO:0051223	regulation of protein transport	8	8/62	422/10965	0.002460867336585449	0.023819338559779912	0.01813270669062962	1.7415373634132558	SLC2A1/FZD5/SOX4/SFRP1/GAPDH/APOE/NNAT/MIF	14
BP	GO:0046323	glucose import	3	3/62	48/10965	0.0024843579084194095	0.023869608888675845	0.01817097547491277	1.7406217577772494	SLC2A1/SLC2A3/GPC3	14
BP	GO:0031667	response to nutrient levels	7	7/62	330/10965	0.0024925695556106743	0.023869608888675845	0.01817097547491277	1.7406217577772494	SLC2A1/IGFBP2/SFRP2/SFRP1/BNIP3/LDHA/APOE	14
BP	GO:0030509	BMP signaling pathway	4	4/62	101/10965	0.0025125904093342994	0.023869608888675845	0.01817097547491277	1.7406217577772494	SOX11/SFRP2/SFRP1/GPC3	14
BP	GO:0090175	regulation of establishment of planar polarity	4	4/62	101/10965	0.0025125904093342994	0.023869608888675845	0.01817097547491277	1.7406217577772494	FZD5/SFRP2/SFRP1/GPC3	14
BP	GO:0001525	angiogenesis	7	7/62	331/10965	0.0025352454435378304	0.023955229416641414	0.018236154947315	1.7390667263802526	NRP2/FZD5/SFRP2/SEMA6A/FGFR1/SFRP1/PGK1	14
BP	GO:0045665	negative regulation of neuron differentiation	5	5/62	168/10965	0.0025449512733079086	0.023955229416641414	0.018236154947315	1.7390667263802526	SIX3/SOX2/SEMA6A/APOE/SOX3	14
BP	GO:0090092	regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	5	5/62	169/10965	0.0026112844155550667	0.024467377263557064	0.01862603255315414	1.7298796423537774	SOX11/SFRP2/SFRP1/CDKN1C/GPC3	14
BP	GO:0001708	cell fate specification	3	3/62	49/10965	0.0026357970532211302	0.02458479796913527	0.018715420224785444	1.7278004170530818	SOX2/SFRP2/FGFR1	14
BP	GO:0048592	eye morphogenesis	4	4/62	103/10965	0.002698071548580512	0.02505177745559824	0.01907091297019995	1.7196285157411377	SOX11/SIX3/FZD5/FJX1	14
BP	GO:0021854	hypothalamus development	2	2/62	14/10965	0.002740163856041971	0.025113960949369248	0.019118250768884765	1.7185518461694125	NRP2/SOX3	14
BP	GO:0090178	regulation of establishment of planar polarity involved in neural tube closure	2	2/62	14/10965	0.002740163856041971	0.025113960949369248	0.019118250768884765	1.7185518461694125	SFRP2/SFRP1	14
BP	GO:0060562	epithelial tube morphogenesis	6	6/62	249/10965	0.002741485015915551	0.025113960949369248	0.019118250768884765	1.7185518461694125	SOX11/SHROOM3/SFRP2/SOX4/SFRP1/GPC3	14
BP	GO:0043627	response to estrogen	3	3/62	50/10965	0.0027928270715438302	0.02534558810939199	0.019294579231731668	1.7145646879052103	IGFBP2/SFRP1/LDHA	14
BP	GO:0043405	regulation of MAP kinase activity	6	6/62	250/10965	0.0027966715819055694	0.02534558810939199	0.019294579231731668	1.7145646879052103	FZD5/SFRP2/FGFR1/SFRP1/APOE/MIF	14
BP	GO:0055086	nucleobase-containing small molecule metabolic process	8	8/62	431/10965	0.0028038248054736755	0.02534558810939199	0.019294579231731668	1.7145646879052103	ENO1/DDIT4/PGAM1/LDHA/GAPDH/TPI1/ALDOA/PGK1	14
BP	GO:0015908	fatty acid transport	3	3/62	51/10965	0.0029555158292655483	0.02625419256126799	0.019986263343039753	1.69926839453573	SLC2A1/APOE/MIF	14
BP	GO:0044070	regulation of anion transport	3	3/62	51/10965	0.0029555158292655483	0.02625419256126799	0.019986263343039753	1.69926839453573	FGFR1/APOE/MIF	14
BP	GO:0045600	positive regulation of fat cell differentiation	3	3/62	51/10965	0.0029555158292655483	0.02625419256126799	0.019986263343039753	1.69926839453573	FRZB/SFRP2/SFRP1	14
BP	GO:0051591	response to cAMP	3	3/62	51/10965	0.0029555158292655483	0.02625419256126799	0.019986263343039753	1.69926839453573	IGFBP5/LDHA/BSG	14
BP	GO:0002366	leukocyte activation involved in immune response	8	8/62	438/10965	0.0030956633665512167	0.027157043748924675	0.020673567725148362	1.6845845688666552	BRI3/PGAM1/CTSC/MGST1/SLC2A3/ALDOA/BST2/MIF	14
BP	GO:0090087	regulation of peptide transport	8	8/62	438/10965	0.0030956633665512167	0.027157043748924675	0.020673567725148362	1.6845845688666552	SLC2A1/FZD5/SOX4/SFRP1/GAPDH/APOE/NNAT/MIF	14
BP	GO:0050796	regulation of insulin secretion	4	4/62	107/10965	0.003096855866105445	0.027157043748924675	0.020673567725148362	1.6845845688666552	SLC2A1/SOX4/SFRP1/NNAT	14
BP	GO:0048569	post-embryonic animal organ development	2	2/62	15/10965	0.0031502458059634304	0.02727554596555679	0.020763778707749193	1.682693608309637	FZD5/LDHA	14
BP	GO:0072111	cell proliferation involved in kidney development	2	2/62	15/10965	0.0031502458059634304	0.02727554596555679	0.020763778707749193	1.682693608309637	LIN28A/GPC3	14
BP	GO:0090177	establishment of planar polarity involved in neural tube closure	2	2/62	15/10965	0.0031502458059634304	0.02727554596555679	0.020763778707749193	1.682693608309637	SFRP2/SFRP1	14
BP	GO:0001654	eye development	6	6/62	257/10965	0.003206715167225144	0.027532131896008352	0.020959107281048727	1.6786272193586877	SOX11/SIX3/FZD5/SOX2/FJX1/SIX6	14
BP	GO:0150063	visual system development	6	6/62	257/10965	0.003206715167225144	0.027532131896008352	0.020959107281048727	1.6786272193586877	SOX11/SIX3/FZD5/SOX2/FJX1/SIX6	14
BP	GO:0002263	cell activation involved in immune response	8	8/62	441/10965	0.003227793723477308	0.027597636335730986	0.021008973182633006	1.6775951732967584	BRI3/PGAM1/CTSC/MGST1/SLC2A3/ALDOA/BST2/MIF	14
BP	GO:0045087	innate immune response	8	8/62	442/10965	0.003272804349818567	0.027841621578705233	0.02119470935816075	1.67377253451036	IFITM2/IFITM1/IFITM3/GAPDH/CLEC2A/APOE/BST2/MIF	14
BP	GO:0002367	cytokine production involved in immune response	3	3/62	53/10965	0.0032981329245943647	0.027841621578705233	0.02119470935816075	1.67377253451036	FZD5/BST2/MIF	14
BP	GO:0071901	negative regulation of protein serine/threonine kinase activity	4	4/62	109/10965	0.0033106021760253785	0.027841621578705233	0.02119470935816075	1.67377253451036	SFRP2/SFRP1/CDKN1C/APOE	14
BP	GO:1903900	regulation of viral life cycle	4	4/62	109/10965	0.0033106021760253785	0.027841621578705233	0.02119470935816075	1.67377253451036	IFITM2/IFITM1/IFITM3/BST2	14
BP	GO:0048880	sensory system development	6	6/62	259/10965	0.0033317387830712818	0.02790501217494804	0.02124296607552216	1.6727848444503515	SOX11/SIX3/FZD5/SOX2/FJX1/SIX6	14
BP	GO:0003007	heart morphogenesis	5	5/62	179/10965	0.0033455905237854354	0.0279071209545029	0.021244571404782142	1.6727520260908548	SOX11/NRP2/SFRP2/SOX4/TNNI3	14
BP	GO:0070201	regulation of establishment of protein localization	8	8/62	444/10965	0.003364298079503187	0.027949553275872632	0.021276873428436947	1.6720921899361239	SLC2A1/FZD5/SOX4/SFRP1/GAPDH/APOE/NNAT/MIF	14
BP	GO:0071772	response to BMP	4	4/62	110/10965	0.0034211597692525852	0.02819365400203335	0.021462697516680774	1.6683156950920714	SOX11/SFRP2/SFRP1/GPC3	14
BP	GO:0071773	cellular response to BMP stimulus	4	4/62	110/10965	0.0034211597692525852	0.02819365400203335	0.021462697516680774	1.6683156950920714	SOX11/SFRP2/SFRP1/GPC3	14
BP	GO:0003151	outflow tract morphogenesis	3	3/62	54/10965	0.0034781889494507894	0.028210449503055412	0.02147548325768659	1.6680570545614368	SOX11/NRP2/SFRP2	14
BP	GO:0045778	positive regulation of ossification	3	3/62	54/10965	0.0034781889494507894	0.028210449503055412	0.02147548325768659	1.6680570545614368	SOX11/SFRP2/IFITM1	14
BP	GO:0060411	cardiac septum morphogenesis	3	3/62	54/10965	0.0034781889494507894	0.028210449503055412	0.02147548325768659	1.6680570545614368	SOX11/NRP2/SOX4	14
BP	GO:1905954	positive regulation of lipid localization	3	3/62	54/10965	0.0034781889494507894	0.028210449503055412	0.02147548325768659	1.6680570545614368	HILPDA/APOE/MIF	14
BP	GO:0009991	response to extracellular stimulus	7	7/62	351/10965	0.0035137116204715735	0.02838636317010893	0.021609399273849212	1.6653573060310898	SLC2A1/IGFBP2/SFRP2/SFRP1/BNIP3/LDHA/APOE	14
BP	GO:0007584	response to nutrient	4	4/62	111/10965	0.0035342098187565946	0.028439994306229538	0.02165022650581955	1.6645375556749127	IGFBP2/SFRP2/SFRP1/LDHA	14
BP	GO:0042249	establishment of planar polarity of embryonic epithelium	2	2/62	16/10965	0.00358721179761164	0.02853084732053909	0.02171938926012107	1.6631523910854233	SFRP2/SFRP1	14
BP	GO:0044342	type B pancreatic cell proliferation	2	2/62	16/10965	0.00358721179761164	0.02853084732053909	0.02171938926012107	1.6631523910854233	IGFBP5/SFRP1	14
BP	GO:1903319	positive regulation of protein maturation	2	2/62	16/10965	0.00358721179761164	0.02853084732053909	0.02171938926012107	1.6631523910854233	ENO1/SOX4	14
BP	GO:0001736	establishment of planar polarity	4	4/62	112/10965	0.0036497792667186217	0.02880518098194851	0.021928228468868157	1.6589964525574021	FZD5/SFRP2/SFRP1/GPC3	14
BP	GO:0007164	establishment of tissue polarity	4	4/62	112/10965	0.0036497792667186217	0.02880518098194851	0.021928228468868157	1.6589964525574021	FZD5/SFRP2/SFRP1/GPC3	14
BP	GO:0001906	cell killing	3	3/62	56/10965	0.003856103389054113	0.0303169507829082	0.02307907815832347	1.6367815420825433	CTSC/GAPDH/CLEC2A	14
BP	GO:0070663	regulation of leukocyte proliferation	4	4/62	114/10965	0.0038885833801090993	0.030455622503755237	0.023184643375178397	1.634799580008992	SOX11/IGFBP2/BST2/MIF	14
BP	GO:0048562	embryonic organ morphogenesis	5	5/62	186/10965	0.003941280424516149	0.03075097882550242	0.023409486291702884	1.630608116552271	SOX11/SIX3/FRZB/FZD5/FGFR1	14
BP	GO:1905276	regulation of epithelial tube formation	2	2/62	17/10965	0.00405075466562953	0.03148541126466589	0.023968580238413965	1.6203576903252883	SFRP2/SFRP1	14
BP	GO:0060560	developmental growth involved in morphogenesis	5	5/62	189/10965	0.004218536665333987	0.03266580089534091	0.024867163500916133	1.6043737501605015	NRP2/SFRP2/SEMA6A/SFRP1/APOE	14
BP	GO:2000027	regulation of animal organ morphogenesis	5	5/62	190/10965	0.0043139836890431545	0.033279302744047196	0.02533419784147227	1.5962928422530192	FZD5/SFRP2/FGFR1/SFRP1/GPC3	14
BP	GO:0045862	positive regulation of proteolysis	6	6/62	275/10965	0.004467465259019115	0.03433422738392219	0.02613726964078205	1.5827397817851019	ENO1/FAM162A/SFRP2/CLDN3/CTSC/APOE	14
BP	GO:0001764	neuron migration	4	4/62	119/10965	0.004531539683340932	0.034380993174998625	0.02617287056104338	1.5821486426465852	NRP2/SEMA6A/FGFR1/DDIT4	14
BP	GO:0002089	lens morphogenesis in camera-type eye	2	2/62	18/10965	0.004540569761415511	0.034380993174998625	0.02617287056104338	1.5821486426465852	SOX11/SIX3	14
BP	GO:0010453	regulation of cell fate commitment	2	2/62	18/10965	0.004540569761415511	0.034380993174998625	0.02617287056104338	1.5821486426465852	SFRP2/FGFR1	14
BP	GO:2000810	regulation of bicellular tight junction assembly	2	2/62	18/10965	0.004540569761415511	0.034380993174998625	0.02617287056104338	1.5821486426465852	FZD5/CLDN3	14
BP	GO:0007565	female pregnancy	4	4/62	120/10965	0.004668215738010093	0.03508445816454662	0.026708390230936276	1.5733522870025731	SLC2A1/IGFBP2/IGFBP5/BSG	14
BP	GO:0030324	lung development	4	4/62	120/10965	0.004668215738010093	0.03508445816454662	0.026708390230936276	1.5733522870025731	SOX11/IGFBP5/FGFR1/GPC3	14
BP	GO:0043407	negative regulation of MAP kinase activity	3	3/62	60/10965	0.0046847668309384855	0.03508445816454662	0.026708390230936276	1.5733522870025731	SFRP2/SFRP1/APOE	14
BP	GO:0090276	regulation of peptide hormone secretion	4	4/62	122/10965	0.004949857615705323	0.03693493755428117	0.02811708593954718	1.5510296916875548	SLC2A1/SOX4/SFRP1/NNAT	14
BP	GO:0048333	mesodermal cell differentiation	2	2/62	19/10965	0.005056354935225131	0.037457185296324795	0.028514652190287267	1.5449319213876682	SFRP2/FGFR1	14
BP	GO:0050707	regulation of cytokine secretion	2	2/62	19/10965	0.005056354935225131	0.037457185296324795	0.028514652190287267	1.5449319213876682	GAPDH/MIF	14
BP	GO:0043467	regulation of generation of precursor metabolites and energy	4	4/62	123/10965	0.005094873899457377	0.0376067670564264	0.028628522782259556	1.5432010607826183	DDIT4/PGAM1/BNIP3/PGK1	14
BP	GO:0014032	neural crest cell development	3	3/62	62/10965	0.00513639062892486	0.03777732462564091	0.02875836141605166	1.5412358626646752	SOX11/NRP2/SEMA6A	14
BP	GO:0010817	regulation of hormone levels	6	6/62	284/10965	0.00522043065922561	0.03825829897403911	0.029124507888311297	1.5357414041014261	SLC2A1/SOX11/SOX4/FGFR1/SFRP1/NNAT	14
BP	GO:0030323	respiratory tube development	4	4/62	124/10965	0.005242720421693269	0.038284919235994974	0.029144772825595848	1.5354393255212275	SOX11/IGFBP5/FGFR1/GPC3	14
BP	GO:0030901	midbrain development	3	3/62	63/10965	0.0053717054265903	0.03887801742843557	0.029596274681337024	1.5287629506693377	SFRP2/FGFR1/SFRP1	14
BP	GO:0043408	regulation of MAPK cascade	8	8/62	480/10965	0.005380020495456555	0.03887801742843557	0.029596274681337024	1.5287629506693377	FZD5/SOX2/SFRP2/SEMA6A/FGFR1/SFRP1/APOE/MIF	14
BP	GO:0090263	positive regulation of canonical Wnt signaling pathway	4	4/62	125/10965	0.005393421961157731	0.03887801742843557	0.029596274681337024	1.5287629506693377	SFRP2/SOX4/SFRP1/GPC3	14
BP	GO:0002694	regulation of leukocyte activation	6	6/62	286/10965	0.005399724642838274	0.03887801742843557	0.029596274681337024	1.5287629506693377	SOX11/IGFBP2/SOX4/SFRP1/CTSC/MIF	14
BP	GO:0071542	dopaminergic neuron differentiation	2	2/62	20/10965	0.005597810518389645	0.04013497663356435	0.0305531472885039	1.5149440463174015	SFRP2/SFRP1	14
BP	GO:0048864	stem cell development	3	3/62	64/10965	0.005613420221166164	0.04013497663356435	0.0305531472885039	1.5149440463174015	SOX11/NRP2/SEMA6A	14
BP	GO:0030073	insulin secretion	4	4/62	127/10965	0.005703488279358047	0.04063735399042608	0.030935587012307534	1.509541638694014	SLC2A1/SOX4/SFRP1/NNAT	14
BP	GO:0043506	regulation of JUN kinase activity	3	3/62	65/10965	0.0058615818212837375	0.04148508362059903	0.031580929564465454	1.5005750909592488	FZD5/SFRP2/SFRP1	14
BP	GO:0050679	positive regulation of epithelial cell proliferation	4	4/62	128/10965	0.005862901681273742	0.04148508362059903	0.031580929564465454	1.5005750909592488	SOX11/NRP2/FGFR1/SFRP1	14
BP	GO:0071900	regulation of protein serine/threonine kinase activity	7	7/62	387/10965	0.005974766529112254	0.042131343359925584	0.03207290117273499	1.493861753937391	FZD5/SFRP2/FGFR1/SFRP1/CDKN1C/APOE/MIF	14
BP	GO:0021953	central nervous system neuron differentiation	4	4/62	129/10965	0.006025267342311957	0.042197435448546546	0.03212321442784604	1.4931810032928743	NRP2/SFRP2/SOX4/SFRP1	14
BP	GO:0043409	negative regulation of MAPK cascade	4	4/62	129/10965	0.006025267342311957	0.042197435448546546	0.03212321442784604	1.4931810032928743	SFRP2/SEMA6A/SFRP1/APOE	14
BP	GO:0046649	lymphocyte activation	7	7/62	388/10965	0.006057865612676785	0.042281429378274706	0.03218715563627766	1.4923174000167347	SOX11/IGFBP2/FZD5/SOX4/SFRP1/BST2/MIF	14
BP	GO:0014031	mesenchymal cell development	3	3/62	66/10965	0.006116235664223658	0.04240039048306401	0.032277715952019594	1.4910972045735675	SOX11/NRP2/SEMA6A	14
BP	GO:1904659	glucose transmembrane transport	3	3/62	66/10965	0.006116235664223658	0.04240039048306401	0.032277715952019594	1.4910972045735675	SLC2A1/SLC2A3/GPC3	14
BP	GO:0003401	axis elongation	2	2/62	21/10965	0.006164639305650907	0.042592053384497175	0.032423621228374784	1.489138482649893	SFRP2/SFRP1	14
BP	GO:0001738	morphogenesis of a polarized epithelium	4	4/62	130/10965	0.006190609093509045	0.04262795254993477	0.03245094982256243	1.4887725871021105	FZD5/SFRP2/SFRP1/GPC3	14
BP	GO:1902532	negative regulation of intracellular signal transduction	7	7/62	390/10965	0.0062266683099635725	0.04273285408710786	0.03253080715362064	1.4877051608800085	ENO1/SFRP2/SEMA6A/SFRP1/DDIT4/APOE/MIF	14
BP	GO:0007568	aging	5	5/62	208/10965	0.006307931527516689	0.04314625164821415	0.0328455101292448	1.4835239886418425	IGFBP2/IGFBP5/HMGA1/CTSC/MIF	14
BP	GO:0044706	multi-multicellular organism process	4	4/62	131/10965	0.0063589505698740155	0.04335071949960624	0.033001163300202974	1.4814707508507683	SLC2A1/IGFBP2/IGFBP5/BSG	14
BP	GO:0044283	small molecule biosynthetic process	8	8/62	495/10965	0.0064521218594326395	0.0438402452170721	0.033373819586608705	1.4765940861094093	ENO1/PGAM1/GAPDH/TPI1/ALDOA/APOE/MIF/PGK1	14
BP	GO:0008645	hexose transmembrane transport	3	3/62	68/10965	0.00664519507178542	0.04500310325842799	0.03425905675362016	1.4652245985315457	SLC2A1/SLC2A3/GPC3	14
BP	GO:0010466	negative regulation of peptidase activity	4	4/62	133/10965	0.006704726245936431	0.04525690216007091	0.034452263673717676	1.4627822376545685	SFRP2/GAPDH/BST2/GPC3	14
BP	GO:0034249	negative regulation of cellular amide metabolic process	4	4/62	134/10965	0.006882206717613482	0.046151268576937465	0.035133108940276596	1.4542834176470492	LIN28A/IGFBP5/GAPDH/APOE	14
BP	GO:0048705	skeletal system morphogenesis	4	4/62	134/10965	0.006882206717613482	0.046151268576937465	0.035133108940276596	1.4542834176470492	SOX11/SFRP2/FGFR1/SFRP1	14
BP	GO:0015749	monosaccharide transmembrane transport	3	3/62	69/10965	0.006919584804936242	0.04625077530856407	0.035208859422339735	1.45334804350713	SLC2A1/SLC2A3/GPC3	14
BP	GO:0019827	stem cell population maintenance	4	4/62	135/10965	0.007062779454664208	0.047054621561594005	0.03582079532030651	1.4458647758463958	LIN28A/SOX2/SOX4/SFRP1	14
BP	GO:0002700	regulation of production of molecular mediator of immune response	3	3/62	70/10965	0.0072006351508563165	0.0475103000950391	0.03616768510364114	1.441679287171129	FZD5/BST2/MIF	14
BP	GO:0070665	positive regulation of leukocyte proliferation	3	3/62	70/10965	0.0072006351508563165	0.0475103000950391	0.03616768510364114	1.441679287171129	IGFBP2/BST2/MIF	14
BP	GO:1901890	positive regulation of cell junction assembly	3	3/62	70/10965	0.0072006351508563165	0.0475103000950391	0.03616768510364114	1.441679287171129	TPBG/CLDN3/SFRP1	14
BP	GO:0098727	maintenance of cell number	4	4/62	136/10965	0.007246467082797238	0.047659456583012606	0.036281231953006414	1.4403179746078383	LIN28A/SOX2/SOX4/SFRP1	14
BP	GO:0010665	regulation of cardiac muscle cell apoptotic process	2	2/62	23/10965	0.007373239883301067	0.04787939316624617	0.036448660848830056	1.43831842335828	SFRP2/BNIP3	14
BP	GO:0021846	cell proliferation in forebrain	2	2/62	23/10965	0.007373239883301067	0.04787939316624617	0.036448660848830056	1.43831842335828	SIX3/FGFR1	14
BP	GO:0048009	insulin-like growth factor receptor signaling pathway	2	2/62	23/10965	0.007373239883301067	0.04787939316624617	0.036448660848830056	1.43831842335828	IGFBP2/IGFBP5	14
BP	GO:1902742	apoptotic process involved in development	2	2/62	23/10965	0.007373239883301067	0.04787939316624617	0.036448660848830056	1.43831842335828	SIX3/FZD5	14
BP	GO:0034219	carbohydrate transmembrane transport	3	3/62	71/10965	0.0074883849394632015	0.04832127640181915	0.03678504882543327	1.4343286631745018	SLC2A1/SLC2A3/GPC3	14
BP	GO:0090100	positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	3	3/62	71/10965	0.0074883849394632015	0.04832127640181915	0.03678504882543327	1.4343286631745018	SOX11/CDKN1C/GPC3	14
BP	GO:0007507	heart development	7	7/62	408/10965	0.00790919451480498	0.05087669951216244	0.038730389902559274	1.411948130907601	SOX11/NRP2/SFRP2/SOX4/FGFR1/TNNI3/GPC3	14
BP	GO:0006754	ATP biosynthetic process	2	2/62	24/10965	0.008014429422853436	0.051232427338614495	0.03900119122319888	1.4089221280052633	ENO1/ALDOA	14
BP	GO:0090200	positive regulation of release of cytochrome c from mitochondria	2	2/62	24/10965	0.008014429422853436	0.051232427338614495	0.03900119122319888	1.4089221280052633	FAM162A/BNIP3	14
BP	GO:0001933	negative regulation of protein phosphorylation	6	6/62	313/10965	0.008286859425957941	0.05280942714927235	0.0402016979016724	1.3957556042848023	SFRP2/SEMA6A/SFRP1/DDIT4/CDKN1C/APOE	14
BP	GO:0001657	ureteric bud development	3	3/62	74/10965	0.008392200265794944	0.05329655975796996	0.04057253241039675	1.3917678841483456	FGFR1/SFRP1/GPC3	14
BP	GO:2001235	positive regulation of apoptotic signaling pathway	4	4/62	142/10965	0.008415246277574204	0.05329655975796996	0.04057253241039675	1.3917678841483456	FAM162A/SFRP1/BNIP3/CTSC	14
BP	GO:0060541	respiratory system development	4	4/62	143/10965	0.008621354045263324	0.05365462938293526	0.040845116448279435	1.3888598614412229	SOX11/IGFBP5/FGFR1/GPC3	14
BP	GO:1901888	regulation of cell junction assembly	4	4/62	143/10965	0.008621354045263324	0.05365462938293526	0.040845116448279435	1.3888598614412229	FZD5/TPBG/CLDN3/SFRP1	14
BP	GO:0010470	regulation of gastrulation	2	2/62	25/10965	0.008679827630301534	0.05365462938293526	0.040845116448279435	1.3888598614412229	SFRP2/FGFR1	14
BP	GO:0010662	regulation of striated muscle cell apoptotic process	2	2/62	25/10965	0.008679827630301534	0.05365462938293526	0.040845116448279435	1.3888598614412229	SFRP2/BNIP3	14
BP	GO:0030513	positive regulation of BMP signaling pathway	2	2/62	25/10965	0.008679827630301534	0.05365462938293526	0.040845116448279435	1.3888598614412229	SOX11/GPC3	14
BP	GO:0043030	regulation of macrophage activation	2	2/62	25/10965	0.008679827630301534	0.05365462938293526	0.040845116448279435	1.3888598614412229	CTSC/MIF	14
BP	GO:0050663	cytokine secretion	2	2/62	25/10965	0.008679827630301534	0.05365462938293526	0.040845116448279435	1.3888598614412229	GAPDH/MIF	14
BP	GO:0072163	mesonephric epithelium development	3	3/62	75/10965	0.008707110908634231	0.05365462938293526	0.040845116448279435	1.3888598614412229	FGFR1/SFRP1/GPC3	14
BP	GO:0072164	mesonephric tubule development	3	3/62	75/10965	0.008707110908634231	0.05365462938293526	0.040845116448279435	1.3888598614412229	FGFR1/SFRP1/GPC3	14
BP	GO:0045165	cell fate commitment	4	4/62	144/10965	0.008830750112554178	0.0542535905118598	0.04130108152231453	1.3840385756311688	SOX2/SFRP2/FGFR1/SFRP1	14
BP	GO:0001501	skeletal system development	6	6/62	318/10965	0.00892427897616694	0.05466453868386436	0.041613919876297686	1.3807613733571524	SOX11/FRZB/SFRP2/SOX4/FGFR1/SFRP1	14
BP	GO:0001823	mesonephros development	3	3/62	76/10965	0.0090288963696509	0.055140759971796564	0.04197644803434191	1.3769943133560303	FGFR1/SFRP1/GPC3	14
BP	GO:0010659	cardiac muscle cell apoptotic process	2	2/62	26/10965	0.00936914935648178	0.05704894504302853	0.04342907276282668	1.3622194429906753	SFRP2/BNIP3	14
BP	GO:0021761	limbic system development	3	3/62	78/10965	0.009693216285156911	0.058847573423496995	0.0447982963786137	1.3487385013463953	NRP2/FGFR1/SOX3	14
BP	GO:0097193	intrinsic apoptotic signaling pathway	5	5/62	232/10965	0.009875174124264014	0.05977539027430607	0.04550460611832883	1.3419446404741882	ENO1/SFRP2/DDIT4/BNIP3/MIF	14
BP	GO:0030072	peptide hormone secretion	4	4/62	149/10965	0.009927771836958914	0.05991702296894027	0.04561242540571835	1.3409168338692552	SLC2A1/SOX4/SFRP1/NNAT	14
BP	GO:0009948	anterior/posterior axis specification	2	2/62	27/10965	0.010082111812051712	0.06014096929747126	0.04578290675974523	1.3392966374010538	FZD5/GPC3	14
BP	GO:0010719	negative regulation of epithelial to mesenchymal transition	2	2/62	27/10965	0.010082111812051712	0.06014096929747126	0.04578290675974523	1.3392966374010538	SFRP2/SFRP1	14
BP	GO:1902230	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage	2	2/62	27/10965	0.010082111812051712	0.06014096929747126	0.04578290675974523	1.3392966374010538	SFRP2/MIF	14
BP	GO:1903793	positive regulation of anion transport	2	2/62	27/10965	0.010082111812051712	0.06014096929747126	0.04578290675974523	1.3392966374010538	APOE/MIF	14
BP	GO:0070661	leukocyte proliferation	4	4/62	150/10965	0.010157324723940335	0.06041400096674078	0.045990754814118864	1.3373294625956385	SOX11/IGFBP2/BST2/MIF	14
BP	GO:0002065	columnar/cuboidal epithelial cell differentiation	3	3/62	80/10965	0.010385397386096269	0.06126697773483423	0.04664009180183339	1.3312406034250621	SOX11/SOX4/FGFR1	14
BP	GO:0006766	vitamin metabolic process	3	3/62	80/10965	0.010385397386096269	0.06126697773483423	0.04664009180183339	1.3312406034250621	SLC2A1/FGFR1/SLC2A3	14
BP	GO:0030177	positive regulation of Wnt signaling pathway	4	4/62	151/10965	0.010390306165556683	0.06126697773483423	0.04664009180183339	1.3312406034250621	SFRP2/SOX4/SFRP1/GPC3	14
BP	GO:0021782	glial cell development	3	3/62	81/10965	0.01074200501817705	0.0628878971611043	0.04787403272139057	1.3198999877075264	POU3F1/SOX11/SOX4	14
BP	GO:2001243	negative regulation of intrinsic apoptotic signaling pathway	3	3/62	81/10965	0.01074200501817705	0.0628878971611043	0.04787403272139057	1.3198999877075264	ENO1/SFRP2/MIF	14
BP	GO:0010658	striated muscle cell apoptotic process	2	2/62	28/10965	0.010818434550618818	0.0628878971611043	0.04787403272139057	1.3198999877075264	SFRP2/BNIP3	14
BP	GO:0038084	vascular endothelial growth factor signaling pathway	2	2/62	28/10965	0.010818434550618818	0.0628878971611043	0.04787403272139057	1.3198999877075264	NRP2/SEMA6A	14
BP	GO:1903580	positive regulation of ATP metabolic process	2	2/62	28/10965	0.010818434550618818	0.0628878971611043	0.04787403272139057	1.3198999877075264	ENO1/PGK1	14
BP	GO:0030326	embryonic limb morphogenesis	3	3/62	82/10965	0.011105658653287956	0.06381702354605996	0.04858133935690622	1.3135305161406992	SFRP2/FGFR1/GPC3	14
BP	GO:0035113	embryonic appendage morphogenesis	3	3/62	82/10965	0.011105658653287956	0.06381702354605996	0.04858133935690622	1.3135305161406992	SFRP2/FGFR1/GPC3	14
BP	GO:0048565	digestive tract development	3	3/62	82/10965	0.011105658653287956	0.06381702354605996	0.04858133935690622	1.3135305161406992	SOX11/SFRP2/SFRP1	14
BP	GO:0048640	negative regulation of developmental growth	3	3/62	82/10965	0.011105658653287956	0.06381702354605996	0.04858133935690622	1.3135305161406992	SFRP2/SEMA6A/SFRP1	14
BP	GO:0051222	positive regulation of protein transport	5	5/62	239/10965	0.011133769215150812	0.06381702354605996	0.04858133935690622	1.3135305161406992	FZD5/SOX4/GAPDH/NNAT/MIF	14
BP	GO:0002064	epithelial cell development	4	4/62	155/10965	0.011356896772773453	0.06491463002153516	0.049416903125042676	1.306124474592525	SIX3/SHROOM3/CLDN3/FGFR1	14
BP	GO:0010165	response to X-ray	2	2/62	29/10965	0.01157783945197996	0.06561483935402199	0.049949944393848686	1.301464990910634	SFRP2/SFRP1	14
BP	GO:0045668	negative regulation of osteoblast differentiation	2	2/62	29/10965	0.01157783945197996	0.06561483935402199	0.049949944393848686	1.301464990910634	IGFBP5/SFRP1	14
BP	GO:0045880	positive regulation of smoothened signaling pathway	2	2/62	29/10965	0.01157783945197996	0.06561483935402199	0.049949944393848686	1.301464990910634	SFRP1/GPC3	14
BP	GO:0051701	interaction with host	4	4/62	156/10965	0.011607303452977573	0.06561483935402199	0.049949944393848686	1.301464990910634	IFITM2/IFITM1/IFITM3/GAPDH	14
BP	GO:0042326	negative regulation of phosphorylation	6	6/62	337/10965	0.011670524636777691	0.06579097954579073	0.05008403285418767	1.3003007082360578	SFRP2/SEMA6A/SFRP1/DDIT4/CDKN1C/APOE	14
BP	GO:0001704	formation of primary germ layer	3	3/62	84/10965	0.011854201144399095	0.06646125887515558	0.05059428961256329	1.295898497581181	SOX2/SFRP2/FGFR1	14
BP	GO:1905952	regulation of lipid localization	3	3/62	84/10965	0.011854201144399095	0.06646125887515558	0.05059428961256329	1.295898497581181	HILPDA/APOE/MIF	14
BP	GO:0019221	cytokine-mediated signaling pathway	7	7/62	442/10965	0.011978241392562936	0.06697370936659168	0.05098439760953219	1.2925627076038133	SOX2/IFITM2/IFITM1/IFITM3/HSP90B1/BST2/MIF	14
BP	GO:0052548	regulation of endopeptidase activity	5	5/62	244/10965	0.012097417367537283	0.0674562511907242	0.05135173733817314	1.2894448587148393	FAM162A/SOX2/SFRP2/GAPDH/BST2	14
BP	GO:0001936	regulation of endothelial cell proliferation	3	3/62	85/10965	0.01223913589219534	0.06769462763014782	0.05153320375661197	1.287912857139798	NRP2/FGFR1/APOE	14
BP	GO:0046718	viral entry into host cell	3	3/62	85/10965	0.01223913589219534	0.06769462763014782	0.05153320375661197	1.287912857139798	IFITM2/IFITM1/IFITM3	14
BP	GO:1900542	regulation of purine nucleotide metabolic process	3	3/62	85/10965	0.01223913589219534	0.06769462763014782	0.05153320375661197	1.287912857139798	ENO1/DDIT4/PGAM1	14
BP	GO:0044057	regulation of system process	6	6/62	341/10965	0.012317427008545023	0.06781503756049724	0.05162486700511845	1.287141054154285	ENO1/IGFBP5/FGFR1/CTSC/APOE/TNNI3	14
BP	GO:0002720	positive regulation of cytokine production involved in immune response	2	2/62	30/10965	0.012360050705470745	0.06781503756049724	0.05162486700511845	1.287141054154285	FZD5/MIF	14
BP	GO:0046329	negative regulation of JNK cascade	2	2/62	30/10965	0.012360050705470745	0.06781503756049724	0.05162486700511845	1.287141054154285	SFRP2/SFRP1	14
BP	GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	5	5/62	246/10965	0.012498336625313154	0.06820900732750688	0.05192478038064032	1.2846253316667724	SOX11/SFRP2/SFRP1/CDKN1C/GPC3	14
BP	GO:0048638	regulation of developmental growth	5	5/62	246/10965	0.012498336625313154	0.06820900732750688	0.05192478038064032	1.2846253316667724	SFRP2/SEMA6A/FGFR1/SFRP1/APOE	14
BP	GO:0006140	regulation of nucleotide metabolic process	3	3/62	86/10965	0.012631208454874454	0.06856941732646132	0.05219914605133303	1.282336601753053	ENO1/DDIT4/PGAM1	14
BP	GO:0022612	gland morphogenesis	3	3/62	86/10965	0.012631208454874454	0.06856941732646132	0.05219914605133303	1.282336601753053	IGFBP5/FGFR1/SFRP1	14
BP	GO:0045444	fat cell differentiation	4	4/62	161/10965	0.01291278742553423	0.0698040282069936	0.053139005775714857	1.2745865754462553	FRZB/SFRP2/SFRP1/BNIP3	14
BP	GO:0001843	neural tube closure	3	3/62	87/10965	0.013030439127581799	0.0698040282069936	0.053139005775714857	1.2745865754462553	SHROOM3/SFRP2/SFRP1	14
BP	GO:0003279	cardiac septum development	3	3/62	87/10965	0.013030439127581799	0.0698040282069936	0.053139005775714857	1.2745865754462553	SOX11/NRP2/SOX4	14
BP	GO:0008630	intrinsic apoptotic signaling pathway in response to DNA damage	3	3/62	87/10965	0.013030439127581799	0.0698040282069936	0.053139005775714857	1.2745865754462553	SFRP2/DDIT4/MIF	14
BP	GO:0060606	tube closure	3	3/62	87/10965	0.013030439127581799	0.0698040282069936	0.053139005775714857	1.2745865754462553	SHROOM3/SFRP2/SFRP1	14
BP	GO:0051249	regulation of lymphocyte activation	5	5/62	249/10965	0.013116559422038591	0.0698040282069936	0.053139005775714857	1.2745865754462553	SOX11/IGFBP2/SOX4/SFRP1/MIF	14
BP	GO:0014014	negative regulation of gliogenesis	2	2/62	31/10965	0.013164794793424235	0.0698040282069936	0.053139005775714857	1.2745865754462553	LIN28A/SOX11	14
BP	GO:0048846	axon extension involved in axon guidance	2	2/62	31/10965	0.013164794793424235	0.0698040282069936	0.053139005775714857	1.2745865754462553	NRP2/SEMA6A	14
BP	GO:1902284	neuron projection extension involved in neuron projection guidance	2	2/62	31/10965	0.013164794793424235	0.0698040282069936	0.053139005775714857	1.2745865754462553	NRP2/SEMA6A	14
BP	GO:0019058	viral life cycle	5	5/62	250/10965	0.013327169377959679	0.07048286485457025	0.0536557768770813	1.2703835126397818	IFITM2/IFITM1/IFITM3/APOE/BST2	14
BP	GO:0010463	mesenchymal cell proliferation	2	2/62	32/10965	0.013991800474738171	0.07343011400041619	0.05589939939295046	1.2525928583341257	FGFR1/GPC3	14
BP	GO:0014009	glial cell proliferation	2	2/62	32/10965	0.013991800474738171	0.07343011400041619	0.05589939939295046	1.2525928583341257	SOX11/SOX4	14
BP	GO:0044275	cellular carbohydrate catabolic process	2	2/62	32/10965	0.013991800474738171	0.07343011400041619	0.05589939939295046	1.2525928583341257	PGAM1/TPI1	14
BP	GO:1904951	positive regulation of establishment of protein localization	5	5/62	254/10965	0.014192576122036423	0.07429379133270086	0.056556882290821835	1.2475145391194213	FZD5/SOX4/GAPDH/NNAT/MIF	14
BP	GO:0042493	response to drug	5	5/62	255/10965	0.014414722810382127	0.07526465955955249	0.0572959653156745	1.241875959233871	IGFBP2/SFRP2/SFRP1/LDHA/MGST1	14
BP	GO:0055123	digestive system development	3	3/62	91/10965	0.014699312870826464	0.07655581221049722	0.05827886802112336	1.2344888923336559	SOX11/SFRP2/SFRP1	14
BP	GO:0031638	zymogen activation	2	2/62	33/10965	0.014840798768550162	0.07690232089157811	0.05854265117631165	1.232527613894519	ENO1/PGK1	14
BP	GO:1902229	regulation of intrinsic apoptotic signaling pathway in response to DNA damage	2	2/62	33/10965	0.014840798768550162	0.07690232089157811	0.05854265117631165	1.232527613894519	SFRP2/MIF	14
BP	GO:0070997	neuron death	5	5/62	259/10965	0.015326803646490493	0.07922065763878713	0.06030750791831339	1.2196286174697946	FAM162A/DDIT4/BNIP3/GAPDH/APOE	14
BP	GO:0008643	carbohydrate transport	3	3/62	93/10965	0.015577151260708818	0.07980209175449866	0.06075013038046374	1.2164527856563137	SLC2A1/SLC2A3/GPC3	14
BP	GO:0014020	primary neural tube formation	3	3/62	93/10965	0.015577151260708818	0.07980209175449866	0.06075013038046374	1.2164527856563137	SHROOM3/SFRP2/SFRP1	14
BP	GO:0045598	regulation of fat cell differentiation	3	3/62	93/10965	0.015577151260708818	0.07980209175449866	0.06075013038046374	1.2164527856563137	FRZB/SFRP2/SFRP1	14
BP	GO:0017145	stem cell division	2	2/62	34/10965	0.015711522938020205	0.07980209175449866	0.06075013038046374	1.2164527856563137	SFRP2/FGFR1	14
BP	GO:0030199	collagen fibril organization	2	2/62	34/10965	0.015711522938020205	0.07980209175449866	0.06075013038046374	1.2164527856563137	SFRP2/P4HA1	14
BP	GO:0060412	ventricular septum morphogenesis	2	2/62	34/10965	0.015711522938020205	0.07980209175449866	0.06075013038046374	1.2164527856563137	SOX11/SOX4	14
BP	GO:0071526	semaphorin-plexin signaling pathway	2	2/62	34/10965	0.015711522938020205	0.07980209175449866	0.06075013038046374	1.2164527856563137	NRP2/SEMA6A	14
BP	GO:0045785	positive regulation of cell adhesion	5	5/62	261/10965	0.015797084171894505	0.08003855980426548	0.06093014401843131	1.2151677953477762	IGFBP2/SOX2/SFRP2/SOX4/SFRP1	14
BP	GO:0008584	male gonad development	3	3/62	94/10965	0.016026971704513296	0.08060624004328745	0.061362296206134495	1.2120983972501627	SFRP2/SFRP1/MGST1	14
BP	GO:0033135	regulation of peptidyl-serine phosphorylation	3	3/62	94/10965	0.016026971704513296	0.08060624004328745	0.061362296206134495	1.2120983972501627	SFRP2/DDIT4/MIF	14
BP	GO:0045995	regulation of embryonic development	3	3/62	94/10965	0.016026971704513296	0.08060624004328745	0.061362296206134495	1.2120983972501627	SFRP2/FGFR1/SFRP1	14
BP	GO:0002696	positive regulation of leukocyte activation	4	4/62	172/10965	0.016106756287029626	0.08067902938616586	0.06141770781218331	1.2117063960189092	IGFBP2/SOX4/CTSC/MIF	14
BP	GO:0034248	regulation of cellular amide metabolic process	6	6/62	362/10965	0.01613515803868562	0.08067902938616586	0.06141770781218331	1.2117063960189092	LIN28A/IGFBP5/SOX4/PGAM1/GAPDH/APOE	14
BP	GO:0031400	negative regulation of protein modification process	7	7/62	469/10965	0.016159396236702813	0.08067902938616586	0.06141770781218331	1.2117063960189092	SFRP2/SEMA6A/SOX4/SFRP1/DDIT4/CDKN1C/APOE	14
BP	GO:0046546	development of primary male sexual characteristics	3	3/62	95/10965	0.01648407647869402	0.08208264141511082	0.062486221329652425	1.2042157372192759	SFRP2/SFRP1/MGST1	14
BP	GO:0009617	response to bacterium	5	5/62	264/10965	0.016520531629844428	0.08208264141511082	0.062486221329652425	1.2042157372192759	FZD5/BNIP3/MGST1/MIF/GPC3	14
BP	GO:0009206	purine ribonucleoside triphosphate biosynthetic process	2	2/62	35/10965	0.016603708474219735	0.08209833684120216	0.06249816962775418	1.2041327015712275	ENO1/ALDOA	14
BP	GO:0030514	negative regulation of BMP signaling pathway	2	2/62	35/10965	0.016603708474219735	0.08209833684120216	0.06249816962775418	1.2041327015712275	SFRP2/SFRP1	14
BP	GO:0044409	entry into host	3	3/62	96/10965	0.01694847704135382	0.08340113882220153	0.06348994050074232	1.1972950799222049	IFITM2/IFITM1/IFITM3	14
BP	GO:0048469	cell maturation	3	3/62	96/10965	0.01694847704135382	0.08340113882220153	0.06348994050074232	1.1972950799222049	SIX3/FZD5/FGFR1	14
BP	GO:0048589	developmental growth	7	7/62	476/10965	0.017395159902085476	0.08531316809483529	0.06494549166550506	1.187450991053612	NRP2/SOX2/SFRP2/SEMA6A/FGFR1/SFRP1/APOE	14
BP	GO:0001935	endothelial cell proliferation	3	3/62	97/10965	0.017420183933594534	0.08531316809483529	0.06494549166550506	1.187450991053612	NRP2/FGFR1/APOE	14
BP	GO:0009145	purine nucleoside triphosphate biosynthetic process	2	2/62	36/10965	0.017517093080126618	0.08538022565420385	0.0649965398947566	1.1871097625050169	ENO1/ALDOA	14
BP	GO:0046164	alcohol catabolic process	2	2/62	36/10965	0.017517093080126618	0.08538022565420385	0.0649965398947566	1.1871097625050169	TPI1/APOE	14
BP	GO:0050867	positive regulation of cell activation	4	4/62	178/10965	0.01804121593686977	0.08751909007672995	0.06662477155733418	1.1763642670694507	IGFBP2/SOX4/CTSC/MIF	14
BP	GO:0051402	neuron apoptotic process	4	4/62	178/10965	0.01804121593686977	0.08751909007672995	0.06662477155733418	1.1763642670694507	FAM162A/BNIP3/GAPDH/APOE	14
BP	GO:0060688	regulation of morphogenesis of a branching structure	2	2/62	37/10965	0.018451416654725415	0.08929789381013338	0.06797890346477785	1.1676258450933092	FGFR1/SFRP1	14
BP	GO:0051897	positive regulation of protein kinase B signaling	3	3/62	100/10965	0.018879234505891126	0.09115338636726728	0.06939141549657567	1.1586942533645685	LIN28A/IGFBP5/FGFR1	14
BP	GO:0032873	negative regulation of stress-activated MAPK cascade	2	2/62	38/10965	0.019406421277212458	0.0928336093623461	0.07067050184350139	1.1507618246738216	SFRP2/SFRP1	14
BP	GO:0050919	negative chemotaxis	2	2/62	38/10965	0.019406421277212458	0.0928336093623461	0.07067050184350139	1.1507618246738216	NRP2/SEMA6A	14
BP	GO:0070303	negative regulation of stress-activated protein kinase signaling cascade	2	2/62	38/10965	0.019406421277212458	0.0928336093623461	0.07067050184350139	1.1507618246738216	SFRP2/SFRP1	14
BP	GO:0006469	negative regulation of protein kinase activity	4	4/62	182/10965	0.019408196109379373	0.0928336093623461	0.07067050184350139	1.1507618246738216	SFRP2/SFRP1/CDKN1C/APOE	14
BP	GO:0043009	chordate embryonic development	7	7/62	488/10965	0.01966799456060415	0.09385749962409237	0.07144994841600137	1.1459980804161047	SOX11/FZD5/SHROOM3/SFRP2/SOX4/FGFR1/SFRP1	14
BP	GO:0010822	positive regulation of mitochondrion organization	3	3/62	102/10965	0.019888619654437903	0.09469013348238184	0.07208379916274478	1.1421623320187984	FZD5/FAM162A/BNIP3	14
BP	GO:0090342	regulation of cell aging	2	2/62	39/10965	0.02038185119130459	0.0968137931586968	0.07370045606212479	1.1325298246965607	HMGA1/MIF	14
BP	GO:0046942	carboxylic acid transport	4	4/62	185/10965	0.02047459718083432	0.09702973075074371	0.07386484068641821	1.1315622345335015	SLC2A1/SLC16A3/APOE/MIF	14
BP	GO:0072073	kidney epithelium development	3	3/62	104/10965	0.02092740801858947	0.09894709966392992	0.07532445670527958	1.123063992090716	FGFR1/SFRP1/GPC3	14
BP	GO:0015849	organic acid transport	4	4/62	187/10965	0.021205305973450512	0.09916440794560012	0.07548988478058406	1.1221112374871032	SLC2A1/SLC16A3/APOE/MIF	14
BP	GO:0003407	neural retina development	2	2/62	40/10965	0.02137745278965152	0.09916440794560012	0.07548988478058406	1.1221112374871032	SIX3/FJX1	14
BP	GO:0032370	positive regulation of lipid transport	2	2/62	40/10965	0.02137745278965152	0.09916440794560012	0.07548988478058406	1.1221112374871032	APOE/MIF	14
BP	GO:0042771	intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	2	2/62	40/10965	0.02137745278965152	0.09916440794560012	0.07548988478058406	1.1221112374871032	DDIT4/MIF	14
BP	GO:0050922	negative regulation of chemotaxis	2	2/62	40/10965	0.02137745278965152	0.09916440794560012	0.07548988478058406	1.1221112374871032	SEMA6A/MIF	14
BP	GO:0090199	regulation of release of cytochrome c from mitochondria	2	2/62	40/10965	0.02137745278965152	0.09916440794560012	0.07548988478058406	1.1221112374871032	FAM162A/BNIP3	14
BP	GO:1903146	regulation of autophagy of mitochondrion	2	2/62	40/10965	0.02137745278965152	0.09916440794560012	0.07548988478058406	1.1221112374871032	FZD5/BNIP3	14
BP	GO:0001817	regulation of cytokine production	6	6/62	386/10965	0.021428228247701374	0.09916440794560012	0.07548988478058406	1.1221112374871032	FZD5/HILPDA/FGFR1/GAPDH/BST2/MIF	14
BP	GO:0048675	axon extension	3	3/62	105/10965	0.021457839063107123	0.09916440794560012	0.07548988478058406	1.1221112374871032	NRP2/SEMA6A/APOE	14
BP	GO:0050670	regulation of lymphocyte proliferation	3	3/62	105/10965	0.021457839063107123	0.09916440794560012	0.07548988478058406	1.1221112374871032	SOX11/IGFBP2/MIF	14
BP	GO:0009792	embryo development ending in birth or egg hatching	7	7/62	497/10965	0.021504952015493205	0.09916440794560012	0.07548988478058406	1.1221112374871032	SOX11/FZD5/SHROOM3/SFRP2/SOX4/FGFR1/SFRP1	14
BP	GO:0045765	regulation of angiogenesis	4	4/62	188/10965	0.021576625388710004	0.09927182802159851	0.07557165937419316	1.1216410416019482	SFRP2/SEMA6A/SFRP1/PGK1	14
BP	GO:0043687	post-translational protein modification	5	5/62	284/10965	0.021914513227536053	0.10052346771523538	0.07652448245070756	1.116199598934965	IGFBP5/PRSS23/HSP90B1/APOE/GPC3	14
BP	GO:0032944	regulation of mononuclear cell proliferation	3	3/62	106/10965	0.021995632068294683	0.10052346771523538	0.07652448245070756	1.116199598934965	SOX11/IGFBP2/MIF	14
BP	GO:0050866	negative regulation of cell activation	3	3/62	106/10965	0.021995632068294683	0.10052346771523538	0.07652448245070756	1.116199598934965	SOX11/SFRP1/APOE	14
BP	GO:0009201	ribonucleoside triphosphate biosynthetic process	2	2/62	41/10965	0.022392974598350893	0.10166014131817706	0.07738978645540924	1.1113163517039832	ENO1/ALDOA	14
BP	GO:0009880	embryonic pattern specification	2	2/62	41/10965	0.022392974598350893	0.10166014131817706	0.07738978645540924	1.1113163517039832	NRP2/FZD5	14
BP	GO:0050732	negative regulation of peptidyl-tyrosine phosphorylation	2	2/62	41/10965	0.022392974598350893	0.10166014131817706	0.07738978645540924	1.1113163517039832	SFRP2/SFRP1	14
BP	GO:0007050	cell cycle arrest	4	4/62	192/10965	0.023101909498551575	0.10464706024509456	0.07966360798385161	1.098740028180347	SOX2/SOX4/CDKN1C/MIF	14
BP	GO:0051962	positive regulation of nervous system development	6	6/62	393/10965	0.023171453262653092	0.1047308856717272	0.07972742091763782	1.098392284562791	LIN28A/SOX11/SEMA6A/TPBG/FGFR1/APOE	14
BP	GO:0051346	negative regulation of hydrolase activity	5	5/62	289/10965	0.023423338795361563	0.1051960595639643	0.08008153913661796	1.0964675884743365	SFRP2/GAPDH/BST2/TNNI3/GPC3	14
BP	GO:0001755	neural crest cell migration	2	2/62	42/10965	0.02342816726156515	0.1051960595639643	0.08008153913661796	1.0964675884743365	NRP2/SEMA6A	14
BP	GO:1903317	regulation of protein maturation	2	2/62	42/10965	0.02342816726156515	0.1051960595639643	0.08008153913661796	1.0964675884743365	ENO1/SOX4	14
BP	GO:0007601	visual perception	3	3/62	109/10965	0.02365319932983228	0.1055138370104692	0.08032345035576911	1.0951576443438928	SIX3/ZIC2/SIX6	14
BP	GO:0046661	male sex differentiation	3	3/62	109/10965	0.02365319932983228	0.1055138370104692	0.08032345035576911	1.0951576443438928	SFRP2/SFRP1/MGST1	14
BP	GO:0050953	sensory perception of light stimulus	3	3/62	109/10965	0.02365319932983228	0.1055138370104692	0.08032345035576911	1.0951576443438928	SIX3/ZIC2/SIX6	14
BP	GO:0033673	negative regulation of kinase activity	4	4/62	194/10965	0.023888691752662384	0.10633317890772931	0.080947182465923	1.0917982631650562	SFRP2/SFRP1/CDKN1C/APOE	14
BP	GO:0010660	regulation of muscle cell apoptotic process	2	2/62	43/10965	0.02448278352624018	0.10804015439966635	0.08224663441525847	1.0848818646216007	SFRP2/BNIP3	14
BP	GO:0021872	forebrain generation of neurons	2	2/62	43/10965	0.02448278352624018	0.10804015439966635	0.08224663441525847	1.0848818646216007	NRP2/FGFR1	14
BP	GO:0061045	negative regulation of wound healing	2	2/62	43/10965	0.02448278352624018	0.10804015439966635	0.08224663441525847	1.0848818646216007	CLDN3/APOE	14
BP	GO:1901616	organic hydroxy compound catabolic process	2	2/62	43/10965	0.02448278352624018	0.10804015439966635	0.08224663441525847	1.0848818646216007	TPI1/APOE	14
BP	GO:0001837	epithelial to mesenchymal transition	3	3/62	111/10965	0.024795070635364368	0.10918344408533837	0.08311697497827135	1.0803102712034165	SFRP2/FGFR1/SFRP1	14
BP	GO:0051604	protein maturation	4	4/62	197/10965	0.025099246206135815	0.11028619532117923	0.08395645524603979	1.0759459061971093	ENO1/SOX4/NNAT/PGK1	14
BP	GO:0001909	leukocyte mediated cytotoxicity	2	2/62	44/10965	0.02555657822692447	0.11157893302478514	0.08494056458847908	1.0708848566388864	CTSC/CLEC2A	14
BP	GO:0035924	cellular response to vascular endothelial growth factor stimulus	2	2/62	44/10965	0.02555657822692447	0.11157893302478514	0.08494056458847908	1.0708848566388864	NRP2/SEMA6A	14
BP	GO:0048844	artery morphogenesis	2	2/62	44/10965	0.02555657822692447	0.11157893302478514	0.08494056458847908	1.0708848566388864	SOX4/APOE	14
BP	GO:0090288	negative regulation of cellular response to growth factor stimulus	3	3/62	113/10965	0.025966391756070347	0.11312746472071412	0.08611939963349736	1.0648990064468788	SFRP2/SEMA6A/SFRP1	14
BP	GO:0048568	embryonic organ development	5	5/62	299/10965	0.026640415353961597	0.11488315246103614	0.08745593426294124	1.0582107164287593	SOX11/SIX3/FRZB/FZD5/FGFR1	14
BP	GO:0007405	neuroblast proliferation	2	2/62	45/10965	0.026649308270688697	0.11488315246103614	0.08745593426294124	1.0582107164287593	SIX3/FGFR1	14
BP	GO:0030279	negative regulation of ossification	2	2/62	45/10965	0.026649308270688697	0.11488315246103614	0.08745593426294124	1.0582107164287593	IGFBP5/SFRP1	14
BP	GO:0032024	positive regulation of insulin secretion	2	2/62	45/10965	0.026649308270688697	0.11488315246103614	0.08745593426294124	1.0582107164287593	SOX4/NNAT	14
BP	GO:0043954	cellular component maintenance	2	2/62	45/10965	0.026649308270688697	0.11488315246103614	0.08745593426294124	1.0582107164287593	CLDN3/APOE	14
BP	GO:0001667	ameboidal-type cell migration	5	5/62	301/10965	0.027316228616236154	0.11726548351572509	0.08926950730344517	1.0492968621790402	NRP2/SEMA6A/FGFR1/APOE/GPC3	14
BP	GO:0048608	reproductive structure development	5	5/62	301/10965	0.027316228616236154	0.11726548351572509	0.08926950730344517	1.0492968621790402	FZD5/SFRP2/SFRP1/MGST1/BSG	14
BP	GO:0009205	purine ribonucleoside triphosphate metabolic process	2	2/62	46/10965	0.027760732622144728	0.11843040195559455	0.09015631296917119	1.0450038574975045	ENO1/ALDOA	14
BP	GO:0042116	macrophage activation	2	2/62	46/10965	0.027760732622144728	0.11843040195559455	0.09015631296917119	1.0450038574975045	CTSC/MIF	14
BP	GO:1902041	regulation of extrinsic apoptotic signaling pathway via death domain receptors	2	2/62	46/10965	0.027760732622144728	0.11843040195559455	0.09015631296917119	1.0450038574975045	SFRP2/SFRP1	14
BP	GO:0044262	cellular carbohydrate metabolic process	4	4/62	204/10965	0.028066800920363788	0.11948770848254459	0.09096119800353758	1.0411438284115766	SLC2A1/DDIT4/PGAM1/TPI1	14
BP	GO:0002440	production of molecular mediator of immune response	3	3/62	117/10965	0.028397280381893802	0.1201468440075177	0.0914629714307768	1.038754693453619	FZD5/BST2/MIF	14
BP	GO:0002449	lymphocyte mediated immunity	3	3/62	117/10965	0.028397280381893802	0.1201468440075177	0.0914629714307768	1.038754693453619	FZD5/CTSC/CLEC2A	14
BP	GO:0052126	movement in host environment	3	3/62	117/10965	0.028397280381893802	0.1201468440075177	0.0914629714307768	1.038754693453619	IFITM2/IFITM1/IFITM3	14
BP	GO:0061458	reproductive system development	5	5/62	305/10965	0.02870068324830148	0.12118066260393959	0.09224997604608924	1.0350337379391201	FZD5/SFRP2/SFRP1/MGST1/BSG	14
BP	GO:0001707	mesoderm formation	2	2/62	47/10965	0.028890612288563496	0.12123422579986154	0.09229075155791246	1.0348418173771963	SFRP2/FGFR1	14
BP	GO:0010657	muscle cell apoptotic process	2	2/62	47/10965	0.028890612288563496	0.12123422579986154	0.09229075155791246	1.0348418173771963	SFRP2/BNIP3	14
BP	GO:0050709	negative regulation of protein secretion	2	2/62	47/10965	0.028890612288563496	0.12123422579986154	0.09229075155791246	1.0348418173771963	SFRP1/APOE	14
BP	GO:0010594	regulation of endothelial cell migration	3	3/62	118/10965	0.02902335918444387	0.12129517932073079	0.09233715302758003	1.034623519902626	NRP2/FGFR1/APOE	14
BP	GO:0051216	cartilage development	3	3/62	118/10965	0.02902335918444387	0.12129517932073079	0.09233715302758003	1.034623519902626	FRZB/SFRP2/FGFR1	14
BP	GO:0017148	negative regulation of translation	3	3/62	119/10965	0.029656768309472392	0.12343953057005548	0.09396956159123952	1.0270127993120413	LIN28A/IGFBP5/GAPDH	14
BP	GO:2001236	regulation of extrinsic apoptotic signaling pathway	3	3/62	119/10965	0.029656768309472392	0.12343953057005548	0.09396956159123952	1.0270127993120413	SFRP2/FGFR1/SFRP1	14
BP	GO:0001756	somitogenesis	2	2/62	48/10965	0.030038710305091493	0.12402300512283249	0.09441373735625495	1.0249648105328557	SFRP2/SFRP1	14
BP	GO:0002456	T cell mediated immunity	2	2/62	48/10965	0.030038710305091493	0.12402300512283249	0.09441373735625495	1.0249648105328557	FZD5/CTSC	14
BP	GO:0048332	mesoderm morphogenesis	2	2/62	48/10965	0.030038710305091493	0.12402300512283249	0.09441373735625495	1.0249648105328557	SFRP2/FGFR1	14
BP	GO:0072091	regulation of stem cell proliferation	2	2/62	48/10965	0.030038710305091493	0.12402300512283249	0.09441373735625495	1.0249648105328557	SOX11/SIX3	14
BP	GO:0045861	negative regulation of proteolysis	4	4/62	210/10965	0.030771171627766332	0.12679205658669981	0.09652170512704551	1.0153750145634404	SFRP2/GAPDH/BST2/GPC3	14
BP	GO:0002792	negative regulation of peptide secretion	2	2/62	49/10965	0.031204791720064715	0.12832110743401362	0.09768571018368535	1.0101689617906215	SFRP1/APOE	14
BP	GO:1901342	regulation of vasculature development	4	4/62	212/10965	0.031705848559830024	0.13012080248954241	0.09905574581639527	1.0041203277581465	SFRP2/SEMA6A/SFRP1/PGK1	14
BP	GO:0001816	cytokine production	6	6/62	425/10965	0.032364537287349136	0.13186796743456605	0.10038579238375707	0.9983277486049008	FZD5/HILPDA/FGFR1/GAPDH/BST2/MIF	14
BP	GO:0001836	release of cytochrome c from mitochondria	2	2/62	50/10965	0.03238862358041973	0.13186796743456605	0.10038579238375707	0.9983277486049008	FAM162A/BNIP3	14
BP	GO:0002702	positive regulation of production of molecular mediator of immune response	2	2/62	50/10965	0.03238862358041973	0.13186796743456605	0.10038579238375707	0.9983277486049008	FZD5/MIF	14
BP	GO:0009142	nucleoside triphosphate biosynthetic process	2	2/62	50/10965	0.03238862358041973	0.13186796743456605	0.10038579238375707	0.9983277486049008	ENO1/ALDOA	14
BP	GO:0045936	negative regulation of phosphate metabolic process	6	6/62	426/10965	0.03268533606624191	0.13281249427312555	0.10110482276665553	0.9952281277819893	SFRP2/SEMA6A/SFRP1/DDIT4/CDKN1C/APOE	14
BP	GO:0010563	negative regulation of phosphorus metabolic process	6	6/62	427/10965	0.03300821996681143	0.133859421683591	0.10190180659610601	0.9918181164080498	SFRP2/SEMA6A/SFRP1/DDIT4/CDKN1C/APOE	14
BP	GO:0001523	retinoid metabolic process	2	2/62	51/10965	0.03358997491720154	0.1354157731436101	0.10308659451375678	0.9867978071435546	APOE/GPC3	14
BP	GO:0010827	regulation of glucose transmembrane transport	2	2/62	51/10965	0.03358997491720154	0.1354157731436101	0.10308659451375678	0.9867978071435546	SLC2A1/GPC3	14
BP	GO:0070830	bicellular tight junction assembly	2	2/62	51/10965	0.03358997491720154	0.1354157731436101	0.10308659451375678	0.9867978071435546	FZD5/CLDN3	14
BP	GO:0043010	camera-type eye development	4	4/62	218/10965	0.03461009268026752	0.13925472584295873	0.10600903516515377	0.974657118177245	SOX11/SIX3/FZD5/FJX1	14
BP	GO:0009199	ribonucleoside triphosphate metabolic process	2	2/62	52/10965	0.03480861673116691	0.13950640924287988	0.10620063163867537	0.9738729002378312	ENO1/ALDOA	14
BP	GO:0071260	cellular response to mechanical stimulus	2	2/62	52/10965	0.03480861673116691	0.13950640924287988	0.10620063163867537	0.9738729002378312	SLC2A1/BNIP3	14
BP	GO:0051348	negative regulation of transferase activity	4	4/62	219/10965	0.03510879088052425	0.140435163522097	0.10690765500502307	0.9709911964992379	SFRP2/SFRP1/CDKN1C/APOE	14
BP	GO:0010951	negative regulation of endopeptidase activity	3	3/62	128/10965	0.03568589606553198	0.14246587300869964	0.10845355265461695	0.9647562170658753	SFRP2/GAPDH/BST2	14
BP	GO:0120192	tight junction assembly	2	2/62	53/10965	0.03604432197848349	0.14361737611620995	0.10933014576611037	0.9612600728650198	FZD5/CLDN3	14
BP	GO:0032102	negative regulation of response to external stimulus	4	4/62	221/10965	0.036118782320980064	0.143635157602037	0.10934368209778542	0.9612063055329471	SEMA6A/CLDN3/APOE/MIF	14
BP	GO:0009612	response to mechanical stimulus	3	3/62	130/10965	0.037105522592058626	0.14714815325428598	0.11201798472830637	0.9507122448189377	SLC2A1/IGFBP2/BNIP3	14
BP	GO:0006874	cellular calcium ion homeostasis	4	4/62	223/10965	0.03714558644528272	0.14714815325428598	0.11201798472830637	0.9507122448189377	BNIP3/HSP90B1/APOE/TNNI3	14
BP	GO:0009144	purine nucleoside triphosphate metabolic process	2	2/62	54/10965	0.03729686555652323	0.14717916946535706	0.11204159612526413	0.950620712920077	ENO1/ALDOA	14
BP	GO:0120193	tight junction organization	2	2/62	54/10965	0.03729686555652323	0.14717916946535706	0.11204159612526413	0.950620712920077	FZD5/CLDN3	14
BP	GO:2001242	regulation of intrinsic apoptotic signaling pathway	3	3/62	131/10965	0.03782614537382859	0.1489812865779199	0.11341347557280862	0.9453353403354053	ENO1/SFRP2/MIF	14
BP	GO:0016101	diterpenoid metabolic process	2	2/62	55/10965	0.03856602428975021	0.1507380606525094	0.11475083718494097	0.9402441373072685	APOE/GPC3	14
BP	GO:0019915	lipid storage	2	2/62	55/10965	0.03856602428975021	0.1507380606525094	0.11475083718494097	0.9402441373072685	HILPDA/APOE	14
BP	GO:0090277	positive regulation of peptide hormone secretion	2	2/62	55/10965	0.03856602428975021	0.1507380606525094	0.11475083718494097	0.9402441373072685	SOX4/NNAT	14
BP	GO:1903035	negative regulation of response to wounding	2	2/62	55/10965	0.03856602428975021	0.1507380606525094	0.11475083718494097	0.9402441373072685	CLDN3/APOE	14
BP	GO:0018108	peptidyl-tyrosine phosphorylation	4	4/62	227/10965	0.039249709839337434	0.15298083478446936	0.11645817113991618	0.9338300343385818	SFRP2/FGFR1/SFRP1/MIF	14
BP	GO:0071695	anatomical structure maturation	3	3/62	133/10965	0.03928893758840905	0.15298083478446936	0.11645817113991618	0.9338300343385818	SIX3/FZD5/FGFR1	14
BP	GO:0009749	response to glucose	3	3/62	135/10965	0.04078035594078205	0.15794626781687648	0.12023815606865944	0.9199576925620885	LIN28A/SOX4/LDHA	14
BP	GO:0018212	peptidyl-tyrosine modification	4	4/62	230/10965	0.040872060531560145	0.15794626781687648	0.12023815606865944	0.9199576925620885	SFRP2/FGFR1/SFRP1/MIF	14
BP	GO:0055074	calcium ion homeostasis	4	4/62	230/10965	0.040872060531560145	0.15794626781687648	0.12023815606865944	0.9199576925620885	BNIP3/HSP90B1/APOE/TNNI3	14
BP	GO:0071496	cellular response to external stimulus	4	4/62	230/10965	0.040872060531560145	0.15794626781687648	0.12023815606865944	0.9199576925620885	SLC2A1/SFRP2/SFRP1/BNIP3	14
BP	GO:0051702	interaction with symbiont	2	2/62	57/10965	0.04115330407106353	0.15873417284553076	0.1208379565521533	0.9177966275366881	GAPDH/APOE	14
BP	GO:0043410	positive regulation of MAPK cascade	5	5/62	337/10965	0.04139287789551441	0.15935869688854704	0.12131338164697025	0.9160912910138963	FZD5/SOX2/FGFR1/APOE/MIF	14
BP	GO:0009746	response to hexose	3	3/62	137/10965	0.042300269913672445	0.16163902022878188	0.12304930030753682	0.9099208514730823	LIN28A/SOX4/LDHA	14
BP	GO:0046328	regulation of JNK cascade	3	3/62	137/10965	0.042300269913672445	0.16163902022878188	0.12304930030753682	0.9099208514730823	FZD5/SFRP2/SFRP1	14
BP	GO:0046651	lymphocyte proliferation	3	3/62	137/10965	0.042300269913672445	0.16163902022878188	0.12304930030753682	0.9099208514730823	SOX11/IGFBP2/MIF	14
BP	GO:0048839	inner ear development	3	3/62	137/10965	0.042300269913672445	0.16163902022878188	0.12304930030753682	0.9099208514730823	FRZB/SOX2/FGFR1	14
BP	GO:0003281	ventricular septum development	2	2/62	58/10965	0.04247098827783458	0.16198971737196388	0.12331627197085997	0.9089796130969804	SOX11/SOX4	14
BP	GO:0010952	positive regulation of peptidase activity	3	3/62	138/10965	0.04307086976782085	0.16366930511771924	0.1245948747279652	0.9044998222285637	FAM162A/SFRP2/CLDN3	14
BP	GO:0032943	mononuclear cell proliferation	3	3/62	138/10965	0.04307086976782085	0.16366930511771924	0.1245948747279652	0.9044998222285637	SOX11/IGFBP2/MIF	14
BP	GO:0006767	water-soluble vitamin metabolic process	2	2/62	59/10965	0.04380441392958738	0.165399275821875	0.12591183200967607	0.8999334570639639	SLC2A1/SLC2A3	14
BP	GO:0043297	apical junction assembly	2	2/62	59/10965	0.04380441392958738	0.165399275821875	0.12591183200967607	0.8999334570639639	FZD5/CLDN3	14
BP	GO:0050920	regulation of chemotaxis	3	3/62	139/10965	0.04384854095862573	0.165399275821875	0.12591183200967607	0.8999334570639639	SEMA6A/FGFR1/MIF	14
BP	GO:1990138	neuron projection extension	3	3/62	139/10965	0.04384854095862573	0.165399275821875	0.12591183200967607	0.8999334570639639	NRP2/SEMA6A/APOE	14
BP	GO:0022411	cellular component disassembly	6	6/62	458/10965	0.04407357959428909	0.1656229468901775	0.12608210381913584	0.8993465531110338	FZD5/HMGA1/DDIT4/BNIP3/BSG/BLCAP	14
BP	GO:0001819	positive regulation of cytokine production	4	4/62	236/10965	0.044230689520378785	0.1656229468901775	0.12608210381913584	0.8993465531110338	FZD5/HILPDA/GAPDH/MIF	14
BP	GO:0071214	cellular response to abiotic stimulus	4	4/62	236/10965	0.044230689520378785	0.1656229468901775	0.12608210381913584	0.8993465531110338	SLC2A1/SFRP2/SFRP1/BNIP3	14
BP	GO:0104004	cellular response to environmental stimulus	4	4/62	236/10965	0.044230689520378785	0.1656229468901775	0.12608210381913584	0.8993465531110338	SLC2A1/SFRP2/SFRP1/BNIP3	14
BP	GO:0051896	regulation of protein kinase B signaling	3	3/62	140/10965	0.04463326495633074	0.16682597393513787	0.12699792003680344	0.8962033918309409	LIN28A/IGFBP5/FGFR1	14
BP	GO:0006110	regulation of glycolytic process	2	2/62	60/10965	0.04515336727781663	0.16785273488057922	0.12777955194561383	0.8935386390391322	DDIT4/PGAM1	14
BP	GO:0048145	regulation of fibroblast proliferation	2	2/62	60/10965	0.04515336727781663	0.16785273488057922	0.12777955194561383	0.8935386390391322	SFRP1/MIF	14
BP	GO:0098869	cellular oxidant detoxification	2	2/62	60/10965	0.04515336727781663	0.16785273488057922	0.12777955194561383	0.8935386390391322	MGST1/APOE	14
BP	GO:0034284	response to monosaccharide	3	3/62	141/10965	0.045425022762202026	0.1682529723971815	0.12808423670740607	0.8925043154718251	LIN28A/SOX4/LDHA	14
BP	GO:0042113	B cell activation	3	3/62	141/10965	0.045425022762202026	0.1682529723971815	0.12808423670740607	0.8925043154718251	SFRP1/BST2/MIF	14
BP	GO:0055082	cellular chemical homeostasis	6	6/62	462/10965	0.04565335636816717	0.16879403111257482	0.12849612299736382	0.8911099757276462	LIN28A/SOX4/BNIP3/HSP90B1/APOE/TNNI3	14
BP	GO:0002088	lens development in camera-type eye	2	2/62	61/10965	0.04651763641838003	0.1702837381876591	0.12963017721888073	0.8872938852398058	SOX11/SIX3	14
BP	GO:0006721	terpenoid metabolic process	2	2/62	61/10965	0.04651763641838003	0.1702837381876591	0.12963017721888073	0.8872938852398058	APOE/GPC3	14
BP	GO:0030316	osteoclast differentiation	2	2/62	61/10965	0.04651763641838003	0.1702837381876591	0.12963017721888073	0.8872938852398058	SFRP1/GPC3	14
BP	GO:0032368	regulation of lipid transport	2	2/62	61/10965	0.04651763641838003	0.1702837381876591	0.12963017721888073	0.8872938852398058	APOE/MIF	14
BP	GO:0048144	fibroblast proliferation	2	2/62	61/10965	0.04651763641838003	0.1702837381876591	0.12963017721888073	0.8872938852398058	SFRP1/MIF	14
BP	GO:0010876	lipid localization	4	4/62	240/10965	0.046554179884637795	0.1702837381876591	0.12963017721888073	0.8872938852398058	SLC2A1/HILPDA/APOE/MIF	14
BP	GO:0030155	regulation of cell adhesion	6	6/62	466/10965	0.04726850195883656	0.1725889075080652	0.13138501012720258	0.8814541811262697	IGFBP2/SOX2/SFRP2/SEMA6A/SOX4/SFRP1	14
BP	GO:0072503	cellular divalent inorganic cation homeostasis	4	4/62	242/10965	0.0477412319077952	0.17400534258400666	0.1324632853158233	0.8779044779103011	BNIP3/HSP90B1/APOE/TNNI3	14
BP	GO:0009953	dorsal/ventral pattern formation	2	2/62	62/10965	0.04789701127802855	0.17426359422431661	0.13265988192720113	0.8772603935775778	SIX3/SFRP1	14
BP	GO:0090257	regulation of muscle system process	3	3/62	145/10965	0.04866199612512316	0.1767334797323057	0.13454010665986543	0.8711482323558133	ENO1/IGFBP5/TNNI3	14
BP	GO:0050671	positive regulation of lymphocyte proliferation	2	2/62	63/10965	0.04929128360102654	0.17870267482209623	0.13603917586744166	0.8663360077104018	IGFBP2/MIF	14
BP	GO:0002683	negative regulation of immune system process	4	4/62	245/10965	0.04955341316765732	0.17933616194009316	0.13652142419159652	0.8647991898094158	SOX11/SFRP1/BST2/MIF	14
BP	GO:0006820	anion transport	5	5/62	355/10965	0.049829666874326085	0.18001844441217804	0.1370408184608968	0.863150056259784	SLC2A1/FGFR1/SLC16A3/APOE/MIF	14
BP	GO:0032946	positive regulation of mononuclear cell proliferation	2	2/62	64/10965	0.05070024693586071	0.18220123767493202	0.1387024913868878	0.8579157380192879	IGFBP2/MIF	14
BP	GO:0050864	regulation of B cell activation	2	2/62	64/10965	0.05070024693586071	0.18220123767493202	0.1387024913868878	0.8579157380192879	SFRP1/MIF	14
BP	GO:0071479	cellular response to ionizing radiation	2	2/62	64/10965	0.05070024693586071	0.18220123767493202	0.1387024913868878	0.8579157380192879	SFRP2/SFRP1	14
BP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	3	3/62	148/10965	0.05116258331873518	0.18281816139069557	0.13917213065753167	0.8564477238737027	SFRP2/SFRP1/MIF	14
BP	GO:0050769	positive regulation of neurogenesis	5	5/62	358/10965	0.05132823006346284	0.18281816139069557	0.13917213065753167	0.8564477238737027	LIN28A/SOX11/SEMA6A/FGFR1/APOE	14
BP	GO:0008406	gonad development	3	3/62	149/10965	0.05200987396562099	0.18281816139069557	0.13917213065753167	0.8564477238737027	SFRP2/SFRP1/MGST1	14
BP	GO:0043535	regulation of blood vessel endothelial cell migration	2	2/62	65/10965	0.052123696622037745	0.18281816139069557	0.13917213065753167	0.8564477238737027	FGFR1/APOE	14
BP	GO:0043542	endothelial cell migration	3	3/62	150/10965	0.052864007623614435	0.18281816139069557	0.13917213065753167	0.8564477238737027	NRP2/FGFR1/APOE	14
BP	GO:0030335	positive regulation of cell migration	5	5/62	362/10965	0.05336757485176063	0.18281816139069557	0.13917213065753167	0.8564477238737027	NRP2/IGFBP5/SEMA6A/CLDN3/FGFR1	14
BP	GO:0001938	positive regulation of endothelial cell proliferation	2	2/62	66/10965	0.053561429776969455	0.18281816139069557	0.13917213065753167	0.8564477238737027	NRP2/FGFR1	14
BP	GO:0060840	artery development	2	2/62	66/10965	0.053561429776969455	0.18281816139069557	0.13917213065753167	0.8564477238737027	SOX4/APOE	14
BP	GO:0022409	positive regulation of cell-cell adhesion	3	3/62	151/10965	0.053724961031548064	0.18281816139069557	0.13917213065753167	0.8564477238737027	IGFBP2/SOX2/SOX4	14
BP	GO:0007600	sensory perception	4	4/62	253/10965	0.054570888280450244	0.18281816139069557	0.13917213065753167	0.8564477238737027	SIX3/FGFR1/ZIC2/SIX6	14
BP	GO:0060537	muscle tissue development	4	4/62	253/10965	0.054570888280450244	0.18281816139069557	0.13917213065753167	0.8564477238737027	SOX11/IGFBP5/FGFR1/TNNI3	14
BP	GO:0072507	divalent inorganic cation homeostasis	4	4/62	253/10965	0.054570888280450244	0.18281816139069557	0.13917213065753167	0.8564477238737027	BNIP3/HSP90B1/APOE/TNNI3	14
BP	GO:0033138	positive regulation of peptidyl-serine phosphorylation	2	2/62	67/10965	0.05501324528294544	0.18281816139069557	0.13917213065753167	0.8564477238737027	SFRP2/MIF	14
BP	GO:0072332	intrinsic apoptotic signaling pathway by p53 class mediator	2	2/62	67/10965	0.05501324528294544	0.18281816139069557	0.13917213065753167	0.8564477238737027	DDIT4/MIF	14
BP	GO:0072395	signal transduction involved in cell cycle checkpoint	2	2/62	67/10965	0.05501324528294544	0.18281816139069557	0.13917213065753167	0.8564477238737027	SOX11/SOX4	14
BP	GO:0001711	endodermal cell fate commitment	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	SOX2	14
BP	GO:0002328	pro-B cell differentiation	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	SOX4	14
BP	GO:0002719	negative regulation of cytokine production involved in immune response	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	BST2	14
BP	GO:0002903	negative regulation of B cell apoptotic process	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	MIF	14
BP	GO:0003215	cardiac right ventricle morphogenesis	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	SOX4	14
BP	GO:0009950	dorsal/ventral axis specification	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	SFRP1	14
BP	GO:0010635	regulation of mitochondrial fusion	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	BNIP3	14
BP	GO:0014733	regulation of skeletal muscle adaptation	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	IGFBP5	14
BP	GO:0017014	protein nitrosylation	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	GAPDH	14
BP	GO:0018119	peptidyl-cysteine S-nitrosylation	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	GAPDH	14
BP	GO:0021561	facial nerve development	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	NRP2	14
BP	GO:0021610	facial nerve morphogenesis	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	NRP2	14
BP	GO:0021781	glial cell fate commitment	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	SOX2	14
BP	GO:0033630	positive regulation of cell adhesion mediated by integrin	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	SFRP2	14
BP	GO:0034367	protein-containing complex remodeling	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	APOE	14
BP	GO:0034433	steroid esterification	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	APOE	14
BP	GO:0034434	sterol esterification	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	APOE	14
BP	GO:0034435	cholesterol esterification	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	APOE	14
BP	GO:0036500	ATF6-mediated unfolded protein response	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	HSP90B1	14
BP	GO:0046629	gamma-delta T cell activation	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	SOX4	14
BP	GO:0046851	negative regulation of bone remodeling	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	SFRP1	14
BP	GO:0048102	autophagic cell death	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	BNIP3	14
BP	GO:0051044	positive regulation of membrane protein ectodomain proteolysis	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	APOE	14
BP	GO:0051561	positive regulation of mitochondrial calcium ion concentration	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	BNIP3	14
BP	GO:0060670	branching involved in labyrinthine layer morphogenesis	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	FZD5	14
BP	GO:0061029	eyelid development in camera-type eye	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	SOX11	14
BP	GO:0070365	hepatocyte differentiation	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	FRZB	14
BP	GO:0071318	cellular response to ATP	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	HSP90B1	14
BP	GO:0071380	cellular response to prostaglandin E stimulus	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	SFRP1	14
BP	GO:1900037	regulation of cellular response to hypoxia	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	ENO1	14
BP	GO:1901722	regulation of cell proliferation involved in kidney development	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	LIN28A	14
BP	GO:1902931	negative regulation of alcohol biosynthetic process	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	APOE	14
BP	GO:1903800	positive regulation of production of miRNAs involved in gene silencing by miRNA	1	1/62	10/10965	0.05514836349943497	0.18281816139069557	0.13917213065753167	0.8564477238737027	LIN28A	14
BP	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	3	3/62	153/10965	0.05546723213324503	0.1832830279185488	0.1395260148923394	0.8553448098036711	FAM162A/SOX2/SFRP2	14
BP	GO:0045137	development of primary sexual characteristics	3	3/62	153/10965	0.05546723213324503	0.1832830279185488	0.1395260148923394	0.8553448098036711	SFRP2/SFRP1/MGST1	14
BP	GO:0002062	chondrocyte differentiation	2	2/62	68/10965	0.056478943774192714	0.18466403285458663	0.1405773185370917	0.8520847449548827	SFRP2/FGFR1	14
BP	GO:0008589	regulation of smoothened signaling pathway	2	2/62	68/10965	0.056478943774192714	0.18466403285458663	0.1405773185370917	0.8520847449548827	SFRP1/GPC3	14
BP	GO:0016525	negative regulation of angiogenesis	2	2/62	68/10965	0.056478943774192714	0.18466403285458663	0.1405773185370917	0.8520847449548827	SEMA6A/PGK1	14
BP	GO:0043470	regulation of carbohydrate catabolic process	2	2/62	68/10965	0.056478943774192714	0.18466403285458663	0.1405773185370917	0.8520847449548827	DDIT4/PGAM1	14
BP	GO:1990748	cellular detoxification	2	2/62	68/10965	0.056478943774192714	0.18466403285458663	0.1405773185370917	0.8520847449548827	MGST1/APOE	14
BP	GO:2001021	negative regulation of response to DNA damage stimulus	2	2/62	68/10965	0.056478943774192714	0.18466403285458663	0.1405773185370917	0.8520847449548827	SFRP2/MIF	14
BP	GO:2000147	positive regulation of cell motility	5	5/62	368/10965	0.05651511336875263	0.18466403285458663	0.1405773185370917	0.8520847449548827	NRP2/IGFBP5/SEMA6A/CLDN3/FGFR1	14
BP	GO:0008625	extrinsic apoptotic signaling pathway via death domain receptors	2	2/62	69/10965	0.0579583276240213	0.18780228919239159	0.14296634716400386	0.8447661790452788	SFRP2/SFRP1	14
BP	GO:0010717	regulation of epithelial to mesenchymal transition	2	2/62	69/10965	0.0579583276240213	0.18780228919239159	0.14296634716400386	0.8447661790452788	SFRP2/SFRP1	14
BP	GO:0021510	spinal cord development	2	2/62	69/10965	0.0579583276240213	0.18780228919239159	0.14296634716400386	0.8447661790452788	SOX11/SOX4	14
BP	GO:0060993	kidney morphogenesis	2	2/62	69/10965	0.0579583276240213	0.18780228919239159	0.14296634716400386	0.8447661790452788	SOX4/GPC3	14
BP	GO:1901655	cellular response to ketone	2	2/62	69/10965	0.0579583276240213	0.18780228919239159	0.14296634716400386	0.8447661790452788	SFRP1/DDIT4	14
BP	GO:0043491	protein kinase B signaling	3	3/62	156/10965	0.05813118360634094	0.18780228919239159	0.14296634716400386	0.8447661790452788	LIN28A/IGFBP5/FGFR1	14
BP	GO:0043583	ear development	3	3/62	157/10965	0.05903254594805588	0.18780228919239159	0.14296634716400386	0.8447661790452788	FRZB/SOX2/FGFR1	14
BP	GO:0050807	regulation of synapse organization	3	3/62	157/10965	0.05903254594805588	0.18780228919239159	0.14296634716400386	0.8447661790452788	NRP2/TPBG/APOE	14
BP	GO:0062014	negative regulation of small molecule metabolic process	2	2/62	70/10965	0.059451200932055505	0.18780228919239159	0.14296634716400386	0.8447661790452788	DDIT4/APOE	14
BP	GO:2000181	negative regulation of blood vessel morphogenesis	2	2/62	70/10965	0.059451200932055505	0.18780228919239159	0.14296634716400386	0.8447661790452788	SEMA6A/PGK1	14
BP	GO:0009743	response to carbohydrate	3	3/62	158/10965	0.05994055481743692	0.18780228919239159	0.14296634716400386	0.8447661790452788	LIN28A/SOX4/LDHA	14
BP	GO:0033500	carbohydrate homeostasis	3	3/62	158/10965	0.05994055481743692	0.18780228919239159	0.14296634716400386	0.8447661790452788	LIN28A/IGFBP5/SOX4	14
BP	GO:0042593	glucose homeostasis	3	3/62	158/10965	0.05994055481743692	0.18780228919239159	0.14296634716400386	0.8447661790452788	LIN28A/IGFBP5/SOX4	14
BP	GO:0003283	atrial septum development	1	1/62	11/10965	0.060495766645307425	0.18780228919239159	0.14296634716400386	0.8447661790452788	SOX4	14
BP	GO:0009312	oligosaccharide biosynthetic process	1	1/62	11/10965	0.060495766645307425	0.18780228919239159	0.14296634716400386	0.8447661790452788	SLC2A1	14
BP	GO:0010917	negative regulation of mitochondrial membrane potential	1	1/62	11/10965	0.060495766645307425	0.18780228919239159	0.14296634716400386	0.8447661790452788	BNIP3	14
BP	GO:0014029	neural crest formation	1	1/62	11/10965	0.060495766645307425	0.18780228919239159	0.14296634716400386	0.8447661790452788	SFRP1	14
BP	GO:0016338	calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules	1	1/62	11/10965	0.060495766645307425	0.18780228919239159	0.14296634716400386	0.8447661790452788	CLDN3	14
BP	GO:0019042	viral latency	1	1/62	11/10965	0.060495766645307425	0.18780228919239159	0.14296634716400386	0.8447661790452788	HMGA1	14
BP	GO:0019511	peptidyl-proline hydroxylation	1	1/62	11/10965	0.060495766645307425	0.18780228919239159	0.14296634716400386	0.8447661790452788	P4HA1	14
BP	GO:0034380	high-density lipoprotein particle assembly	1	1/62	11/10965	0.060495766645307425	0.18780228919239159	0.14296634716400386	0.8447661790452788	APOE	14
BP	GO:0043117	positive regulation of vascular permeability	1	1/62	11/10965	0.060495766645307425	0.18780228919239159	0.14296634716400386	0.8447661790452788	APOE	14
BP	GO:0043518	negative regulation of DNA damage response, signal transduction by p53 class mediator	1	1/62	11/10965	0.060495766645307425	0.18780228919239159	0.14296634716400386	0.8447661790452788	MIF	14
BP	GO:0043901	negative regulation of multi-organism process	1	1/62	11/10965	0.060495766645307425	0.18780228919239159	0.14296634716400386	0.8447661790452788	BST2	14
BP	GO:0045176	apical protein localization	1	1/62	11/10965	0.060495766645307425	0.18780228919239159	0.14296634716400386	0.8447661790452788	SHROOM3	14
BP	GO:0061430	bone trabecula morphogenesis	1	1/62	11/10965	0.060495766645307425	0.18780228919239159	0.14296634716400386	0.8447661790452788	SFRP1	14
BP	GO:0072176	nephric duct development	1	1/62	11/10965	0.060495766645307425	0.18780228919239159	0.14296634716400386	0.8447661790452788	GPC3	14
BP	GO:0072578	neurotransmitter-gated ion channel clustering	1	1/62	11/10965	0.060495766645307425	0.18780228919239159	0.14296634716400386	0.8447661790452788	APOE	14
BP	GO:0090343	positive regulation of cell aging	1	1/62	11/10965	0.060495766645307425	0.18780228919239159	0.14296634716400386	0.8447661790452788	HMGA1	14
BP	GO:0150077	regulation of neuroinflammatory response	1	1/62	11/10965	0.060495766645307425	0.18780228919239159	0.14296634716400386	0.8447661790452788	CTSC	14
BP	GO:1900221	regulation of amyloid-beta clearance	1	1/62	11/10965	0.060495766645307425	0.18780228919239159	0.14296634716400386	0.8447661790452788	APOE	14
BP	GO:1902430	negative regulation of amyloid-beta formation	1	1/62	11/10965	0.060495766645307425	0.18780228919239159	0.14296634716400386	0.8447661790452788	APOE	14
BP	GO:2000767	positive regulation of cytoplasmic translation	1	1/62	11/10965	0.060495766645307425	0.18780228919239159	0.14296634716400386	0.8447661790452788	LIN28A	14
BP	GO:0051251	positive regulation of lymphocyte activation	3	3/62	159/10965	0.06085518406642842	0.1884162553964809	0.14343373499968076	0.8433486924537418	IGFBP2/SOX4/MIF	14
BP	GO:0040017	positive regulation of locomotion	5	5/62	376/10965	0.060877181933658306	0.1884162553964809	0.14343373499968076	0.8433486924537418	NRP2/IGFBP5/SEMA6A/CLDN3/FGFR1	14
BP	GO:0003012	muscle system process	4	4/62	263/10965	0.061219078168966747	0.18918907891975867	0.14402205453827943	0.8415709979681432	ENO1/IGFBP5/ALDOA/TNNI3	14
BP	GO:0007254	JNK cascade	3	3/62	160/10965	0.06177640721662865	0.1903381195323153	0.14489677305117263	0.8389412864520454	FZD5/SFRP2/SFRP1	14
BP	GO:0061448	connective tissue development	3	3/62	160/10965	0.06177640721662865	0.1903381195323153	0.14489677305117263	0.8389412864520454	FRZB/SFRP2/FGFR1	14
BP	GO:0009141	nucleoside triphosphate metabolic process	2	2/62	72/10965	0.06247664087679531	0.19163238726335421	0.14588204714210407	0.8359981509225463	ENO1/ALDOA	14
BP	GO:0048709	oligodendrocyte differentiation	2	2/62	72/10965	0.06247664087679531	0.19163238726335421	0.14588204714210407	0.8359981509225463	SOX11/BNIP3	14
BP	GO:0097237	cellular response to toxic substance	2	2/62	72/10965	0.06247664087679531	0.19163238726335421	0.14588204714210407	0.8359981509225463	MGST1/APOE	14
BP	GO:0002237	response to molecule of bacterial origin	3	3/62	161/10965	0.06270419746582664	0.19204330328339742	0.14619486102008913	0.8350678932457618	FZD5/MGST1/MIF	14
BP	GO:0051272	positive regulation of cellular component movement	5	5/62	381/10965	0.0636993968821748	0.19375764608658458	0.14749992140786475	0.8312082110901555	NRP2/IGFBP5/SEMA6A/CLDN3/FGFR1	14
BP	GO:0045807	positive regulation of endocytosis	2	2/62	73/10965	0.06400882423059372	0.19375764608658458	0.14749992140786475	0.8312082110901555	APOE/GPC3	14
BP	GO:0090559	regulation of membrane permeability	2	2/62	73/10965	0.06400882423059372	0.19375764608658458	0.14749992140786475	0.8312082110901555	CLDN3/BNIP3	14
BP	GO:0010821	regulation of mitochondrion organization	3	3/62	163/10965	0.06457937047205162	0.19375764608658458	0.14749992140786475	0.8312082110901555	FZD5/FAM162A/BNIP3	14
BP	GO:0050803	regulation of synapse structure or activity	3	3/62	163/10965	0.06457937047205162	0.19375764608658458	0.14749992140786475	0.8312082110901555	NRP2/TPBG/APOE	14
BP	GO:2000116	regulation of cysteine-type endopeptidase activity	3	3/62	163/10965	0.06457937047205162	0.19375764608658458	0.14749992140786475	0.8312082110901555	FAM162A/SOX2/SFRP2	14
BP	GO:0000422	autophagy of mitochondrion	2	2/62	74/10965	0.06555373045183814	0.19375764608658458	0.14749992140786475	0.8312082110901555	FZD5/BNIP3	14
BP	GO:0042472	inner ear morphogenesis	2	2/62	74/10965	0.06555373045183814	0.19375764608658458	0.14749992140786475	0.8312082110901555	FRZB/FGFR1	14
BP	GO:0061726	mitochondrion disassembly	2	2/62	74/10965	0.06555373045183814	0.19375764608658458	0.14749992140786475	0.8312082110901555	FZD5/BNIP3	14
BP	GO:0006089	lactate metabolic process	1	1/62	12/10965	0.06581339148262644	0.19375764608658458	0.14749992140786475	0.8312082110901555	LDHA	14
BP	GO:0030810	positive regulation of nucleotide biosynthetic process	1	1/62	12/10965	0.06581339148262644	0.19375764608658458	0.14749992140786475	0.8312082110901555	ENO1	14
BP	GO:0031640	killing of cells of other organism	1	1/62	12/10965	0.06581339148262644	0.19375764608658458	0.14749992140786475	0.8312082110901555	GAPDH	14
BP	GO:0035640	exploration behavior	1	1/62	12/10965	0.06581339148262644	0.19375764608658458	0.14749992140786475	0.8312082110901555	APOE	14
BP	GO:0043476	pigment accumulation	1	1/62	12/10965	0.06581339148262644	0.19375764608658458	0.14749992140786475	0.8312082110901555	SHROOM3	14
BP	GO:0043482	cellular pigment accumulation	1	1/62	12/10965	0.06581339148262644	0.19375764608658458	0.14749992140786475	0.8312082110901555	SHROOM3	14
BP	GO:0044539	long-chain fatty acid import into cell	1	1/62	12/10965	0.06581339148262644	0.19375764608658458	0.14749992140786475	0.8312082110901555	SLC2A1	14
BP	GO:0045837	negative regulation of membrane potential	1	1/62	12/10965	0.06581339148262644	0.19375764608658458	0.14749992140786475	0.8312082110901555	BNIP3	14
BP	GO:0046184	aldehyde biosynthetic process	1	1/62	12/10965	0.06581339148262644	0.19375764608658458	0.14749992140786475	0.8312082110901555	TPI1	14
BP	GO:0046716	muscle cell cellular homeostasis	1	1/62	12/10965	0.06581339148262644	0.19375764608658458	0.14749992140786475	0.8312082110901555	ALDOA	14
BP	GO:0055089	fatty acid homeostasis	1	1/62	12/10965	0.06581339148262644	0.19375764608658458	0.14749992140786475	0.8312082110901555	APOE	14
BP	GO:0061548	ganglion development	1	1/62	12/10965	0.06581339148262644	0.19375764608658458	0.14749992140786475	0.8312082110901555	NRP2	14
BP	GO:0071474	cellular hyperosmotic response	1	1/62	12/10965	0.06581339148262644	0.19375764608658458	0.14749992140786475	0.8312082110901555	SLC2A1	14
BP	GO:0140354	lipid import into cell	1	1/62	12/10965	0.06581339148262644	0.19375764608658458	0.14749992140786475	0.8312082110901555	SLC2A1	14
BP	GO:1900373	positive regulation of purine nucleotide biosynthetic process	1	1/62	12/10965	0.06581339148262644	0.19375764608658458	0.14749992140786475	0.8312082110901555	ENO1	14
BP	GO:1902285	semaphorin-plexin signaling pathway involved in neuron projection guidance	1	1/62	12/10965	0.06581339148262644	0.19375764608658458	0.14749992140786475	0.8312082110901555	NRP2	14
BP	GO:2000105	positive regulation of DNA-dependent DNA replication	1	1/62	12/10965	0.06581339148262644	0.19375764608658458	0.14749992140786475	0.8312082110901555	FGFR1	14
BP	GO:2000191	regulation of fatty acid transport	1	1/62	12/10965	0.06581339148262644	0.19375764608658458	0.14749992140786475	0.8312082110901555	MIF	14
BP	GO:0008037	cell recognition	2	2/62	76/10965	0.06868096331865903	0.2012414829380344	0.15319706611267214	0.8147495518266381	ALDOA/BSG	14
BP	GO:0070372	regulation of ERK1 and ERK2 cascade	3	3/62	168/10965	0.06938029155131957	0.2012414829380344	0.15319706611267214	0.8147495518266381	SEMA6A/APOE/MIF	14
BP	GO:0002726	positive regulation of T cell cytokine production	1	1/62	13/10965	0.07110140113551411	0.2012414829380344	0.15319706611267214	0.8147495518266381	FZD5	14
BP	GO:0006071	glycerol metabolic process	1	1/62	13/10965	0.07110140113551411	0.2012414829380344	0.15319706611267214	0.8147495518266381	TPI1	14
BP	GO:0009954	proximal/distal pattern formation	1	1/62	13/10965	0.07110140113551411	0.2012414829380344	0.15319706611267214	0.8147495518266381	SIX3	14
BP	GO:0019934	cGMP-mediated signaling	1	1/62	13/10965	0.07110140113551411	0.2012414829380344	0.15319706611267214	0.8147495518266381	APOE	14
BP	GO:0031054	pre-miRNA processing	1	1/62	13/10965	0.07110140113551411	0.2012414829380344	0.15319706611267214	0.8147495518266381	LIN28A	14
BP	GO:0031664	regulation of lipopolysaccharide-mediated signaling pathway	1	1/62	13/10965	0.07110140113551411	0.2012414829380344	0.15319706611267214	0.8147495518266381	MIF	14
BP	GO:0032802	low-density lipoprotein particle receptor catabolic process	1	1/62	13/10965	0.07110140113551411	0.2012414829380344	0.15319706611267214	0.8147495518266381	APOE	14
BP	GO:0034695	response to prostaglandin E	1	1/62	13/10965	0.07110140113551411	0.2012414829380344	0.15319706611267214	0.8147495518266381	SFRP1	14
BP	GO:0042159	lipoprotein catabolic process	1	1/62	13/10965	0.07110140113551411	0.2012414829380344	0.15319706611267214	0.8147495518266381	APOE	14
BP	GO:0044794	positive regulation by host of viral process	1	1/62	13/10965	0.07110140113551411	0.2012414829380344	0.15319706611267214	0.8147495518266381	APOE	14
BP	GO:0055057	neuroblast division	1	1/62	13/10965	0.07110140113551411	0.2012414829380344	0.15319706611267214	0.8147495518266381	FGFR1	14
BP	GO:0055094	response to lipoprotein particle	1	1/62	13/10965	0.07110140113551411	0.2012414829380344	0.15319706611267214	0.8147495518266381	APOE	14
BP	GO:0060253	negative regulation of glial cell proliferation	1	1/62	13/10965	0.07110140113551411	0.2012414829380344	0.15319706611267214	0.8147495518266381	SOX11	14
BP	GO:0060766	negative regulation of androgen receptor signaling pathway	1	1/62	13/10965	0.07110140113551411	0.2012414829380344	0.15319706611267214	0.8147495518266381	SFRP1	14
BP	GO:0061081	positive regulation of myeloid leukocyte cytokine production involved in immune response	1	1/62	13/10965	0.07110140113551411	0.2012414829380344	0.15319706611267214	0.8147495518266381	MIF	14
BP	GO:0061844	antimicrobial humoral immune response mediated by antimicrobial peptide	1	1/62	13/10965	0.07110140113551411	0.2012414829380344	0.15319706611267214	0.8147495518266381	GAPDH	14
BP	GO:0071305	cellular response to vitamin D	1	1/62	13/10965	0.07110140113551411	0.2012414829380344	0.15319706611267214	0.8147495518266381	SFRP1	14
BP	GO:0071379	cellular response to prostaglandin stimulus	1	1/62	13/10965	0.07110140113551411	0.2012414829380344	0.15319706611267214	0.8147495518266381	SFRP1	14
BP	GO:0071391	cellular response to estrogen stimulus	1	1/62	13/10965	0.07110140113551411	0.2012414829380344	0.15319706611267214	0.8147495518266381	SFRP1	14
BP	GO:1900543	negative regulation of purine nucleotide metabolic process	1	1/62	13/10965	0.07110140113551411	0.2012414829380344	0.15319706611267214	0.8147495518266381	DDIT4	14
BP	GO:1900746	regulation of vascular endothelial growth factor signaling pathway	1	1/62	13/10965	0.07110140113551411	0.2012414829380344	0.15319706611267214	0.8147495518266381	SEMA6A	14
BP	GO:1902043	positive regulation of extrinsic apoptotic signaling pathway via death domain receptors	1	1/62	13/10965	0.07110140113551411	0.2012414829380344	0.15319706611267214	0.8147495518266381	SFRP1	14
BP	GO:1902166	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	1	1/62	13/10965	0.07110140113551411	0.2012414829380344	0.15319706611267214	0.8147495518266381	MIF	14
BP	GO:1902992	negative regulation of amyloid precursor protein catabolic process	1	1/62	13/10965	0.07110140113551411	0.2012414829380344	0.15319706611267214	0.8147495518266381	APOE	14
BP	GO:1905564	positive regulation of vascular endothelial cell proliferation	1	1/62	13/10965	0.07110140113551411	0.2012414829380344	0.15319706611267214	0.8147495518266381	FGFR1	14
BP	GO:2001169	regulation of ATP biosynthetic process	1	1/62	13/10965	0.07110140113551411	0.2012414829380344	0.15319706611267214	0.8147495518266381	ENO1	14
BP	GO:0032872	regulation of stress-activated MAPK cascade	3	3/62	170/10965	0.07134525471456996	0.20137615223424696	0.15329958444425082	0.8144590224046816	FZD5/SFRP2/SFRP1	14
BP	GO:0097191	extrinsic apoptotic signaling pathway	3	3/62	170/10965	0.07134525471456996	0.20137615223424696	0.15329958444425082	0.8144590224046816	SFRP2/FGFR1/SFRP1	14
BP	GO:0006720	isoprenoid metabolic process	2	2/62	78/10965	0.07185685956295731	0.20198667920984714	0.15376435413327852	0.8131443316182798	APOE/GPC3	14
BP	GO:0010595	positive regulation of endothelial cell migration	2	2/62	78/10965	0.07185685956295731	0.20198667920984714	0.15376435413327852	0.8131443316182798	NRP2/FGFR1	14
BP	GO:0098754	detoxification	2	2/62	78/10965	0.07185685956295731	0.20198667920984714	0.15376435413327852	0.8131443316182798	MGST1/APOE	14
BP	GO:0022604	regulation of cell morphogenesis	5	5/62	396/10965	0.0726074194643294	0.20310503887072354	0.1546157164687359	0.8107463627544973	SHROOM3/SEMA6A/CLDN3/ALDOA/APOE	14
BP	GO:0000302	response to reactive oxygen species	3	3/62	172/10965	0.07333534824283215	0.20310503887072354	0.1546157164687359	0.8107463627544973	BNIP3/LDHA/APOE	14
BP	GO:0010632	regulation of epithelial cell migration	3	3/62	172/10965	0.07333534824283215	0.20310503887072354	0.1546157164687359	0.8107463627544973	NRP2/FGFR1/APOE	14
BP	GO:0021700	developmental maturation	3	3/62	172/10965	0.07333534824283215	0.20310503887072354	0.1546157164687359	0.8107463627544973	SIX3/FZD5/FGFR1	14
BP	GO:0007498	mesoderm development	2	2/62	79/10965	0.07346260110808324	0.20310503887072354	0.1546157164687359	0.8107463627544973	SFRP2/FGFR1	14
BP	GO:0014013	regulation of gliogenesis	2	2/62	79/10965	0.07346260110808324	0.20310503887072354	0.1546157164687359	0.8107463627544973	LIN28A/SOX11	14
BP	GO:0051817	modulation of process of other organism involved in symbiotic interaction	2	2/62	79/10965	0.07346260110808324	0.20310503887072354	0.1546157164687359	0.8107463627544973	GAPDH/APOE	14
BP	GO:1901343	negative regulation of vasculature development	2	2/62	79/10965	0.07346260110808324	0.20310503887072354	0.1546157164687359	0.8107463627544973	SEMA6A/PGK1	14
BP	GO:0006935	chemotaxis	5	5/62	398/10965	0.07384497734971143	0.20310503887072354	0.1546157164687359	0.8107463627544973	NRP2/SEMA6A/FGFR1/BSG/MIF	14
BP	GO:0070302	regulation of stress-activated protein kinase signaling cascade	3	3/62	173/10965	0.07433974385772457	0.20310503887072354	0.1546157164687359	0.8107463627544973	FZD5/SFRP2/SFRP1	14
BP	GO:0032006	regulation of TOR signaling	2	2/62	80/10965	0.07507996530608285	0.20310503887072354	0.1546157164687359	0.8107463627544973	LIN28A/DDIT4	14
BP	GO:0042330	taxis	5	5/62	400/10965	0.07509420400062257	0.20310503887072354	0.1546157164687359	0.8107463627544973	NRP2/SEMA6A/FGFR1/BSG/MIF	14
BP	GO:0002902	regulation of B cell apoptotic process	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	MIF	14
BP	GO:0003209	cardiac atrium morphogenesis	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	SOX4	14
BP	GO:0006098	pentose-phosphate shunt	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	PGAM1	14
BP	GO:0006268	DNA unwinding involved in DNA replication	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	HMGA1	14
BP	GO:0006474	N-terminal protein amino acid acetylation	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	SOX4	14
BP	GO:0006706	steroid catabolic process	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	APOE	14
BP	GO:0010544	negative regulation of platelet activation	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	APOE	14
BP	GO:0021783	preganglionic parasympathetic fiber development	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	NRP2	14
BP	GO:0033194	response to hydroperoxide	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	MGST1	14
BP	GO:0034104	negative regulation of tissue remodeling	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	SFRP1	14
BP	GO:0042104	positive regulation of activated T cell proliferation	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	IGFBP2	14
BP	GO:0042474	middle ear morphogenesis	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	FGFR1	14
BP	GO:0043501	skeletal muscle adaptation	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	IGFBP5	14
BP	GO:0045730	respiratory burst	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	PGAM1	14
BP	GO:0045940	positive regulation of steroid metabolic process	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	APOE	14
BP	GO:0045980	negative regulation of nucleotide metabolic process	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	DDIT4	14
BP	GO:0048486	parasympathetic nervous system development	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	NRP2	14
BP	GO:0051000	positive regulation of nitric-oxide synthase activity	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	APOE	14
BP	GO:0060117	auditory receptor cell development	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	FGFR1	14
BP	GO:0062009	secondary palate development	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	SOX11	14
BP	GO:0090141	positive regulation of mitochondrial fission	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	BNIP3	14
BP	GO:0097062	dendritic spine maintenance	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	APOE	14
BP	GO:0101023	vascular endothelial cell proliferation	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	FGFR1	14
BP	GO:1902969	mitotic DNA replication	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	FGFR1	14
BP	GO:1904754	positive regulation of vascular associated smooth muscle cell migration	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	IGFBP5	14
BP	GO:1905562	regulation of vascular endothelial cell proliferation	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	FGFR1	14
BP	GO:2000269	regulation of fibroblast apoptotic process	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	SFRP1	14
BP	GO:2001028	positive regulation of endothelial cell chemotaxis	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	FGFR1	14
BP	GO:2001224	positive regulation of neuron migration	1	1/62	14/10965	0.07635995784931959	0.20310503887072354	0.1546157164687359	0.8107463627544973	SEMA6A	14
BP	GO:0032984	protein-containing complex disassembly	4	4/62	284/10965	0.07651978822930022	0.20310503887072354	0.1546157164687359	0.8107463627544973	FZD5/HMGA1/DDIT4/BNIP3	14
BP	GO:0035821	modulation of process of other organism	2	2/62	81/10965	0.07670877442729568	0.20310503887072354	0.1546157164687359	0.8107463627544973	GAPDH/APOE	14
BP	GO:0051250	negative regulation of lymphocyte activation	2	2/62	81/10965	0.07670877442729568	0.20310503887072354	0.1546157164687359	0.8107463627544973	SOX11/SFRP1	14
BP	GO:0099175	regulation of postsynapse organization	2	2/62	81/10965	0.07670877442729568	0.20310503887072354	0.1546157164687359	0.8107463627544973	NRP2/APOE	14
BP	GO:0015711	organic anion transport	4	4/62	286/10965	0.07806992622871706	0.2063678145722536	0.15709953669089172	0.8038250957549715	SLC2A1/SLC16A3/APOE/MIF	14
BP	GO:0010720	positive regulation of cell development	5	5/62	405/10965	0.07826818318541061	0.2063678145722536	0.15709953669089172	0.8038250957549715	LIN28A/SOX11/SEMA6A/FGFR1/APOE	14
BP	GO:0030516	regulation of axon extension	2	2/62	82/10965	0.07834885232164589	0.2063678145722536	0.15709953669089172	0.8038250957549715	SEMA6A/APOE	14
BP	GO:0048588	developmental cell growth	3	3/62	179/10965	0.08049506846282245	0.2063678145722536	0.15709953669089172	0.8038250957549715	NRP2/SEMA6A/APOE	14
BP	GO:0070371	ERK1 and ERK2 cascade	3	3/62	179/10965	0.08049506846282245	0.2063678145722536	0.15709953669089172	0.8038250957549715	SEMA6A/APOE/MIF	14
BP	GO:0071560	cellular response to transforming growth factor beta stimulus	3	3/62	179/10965	0.08049506846282245	0.2063678145722536	0.15709953669089172	0.8038250957549715	SOX11/SFRP1/CDKN1C	14
BP	GO:2001234	negative regulation of apoptotic signaling pathway	3	3/62	179/10965	0.08049506846282245	0.2063678145722536	0.15709953669089172	0.8038250957549715	ENO1/SFRP2/MIF	14
BP	GO:0001759	organ induction	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	FGFR1	14
BP	GO:0002021	response to dietary excess	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	APOE	14
BP	GO:0002701	negative regulation of production of molecular mediator of immune response	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	BST2	14
BP	GO:0006337	nucleosome disassembly	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	HMGA1	14
BP	GO:0007263	nitric oxide mediated signal transduction	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	APOE	14
BP	GO:0009620	response to fungus	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	GAPDH	14
BP	GO:0010226	response to lithium ion	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	IGFBP2	14
BP	GO:0010884	positive regulation of lipid storage	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	HILPDA	14
BP	GO:0010954	positive regulation of protein processing	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	ENO1	14
BP	GO:0031645	negative regulation of nervous system process	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	CTSC	14
BP	GO:0032309	icosanoid secretion	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	MIF	14
BP	GO:0032780	negative regulation of ATPase activity	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	TNNI3	14
BP	GO:0033032	regulation of myeloid cell apoptotic process	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	MIF	14
BP	GO:0033262	regulation of nuclear cell cycle DNA replication	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	FGFR1	14
BP	GO:0033688	regulation of osteoblast proliferation	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	SFRP1	14
BP	GO:0035116	embryonic hindlimb morphogenesis	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	GPC3	14
BP	GO:0036342	post-anal tail morphogenesis	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	SFRP2	14
BP	GO:0048339	paraxial mesoderm development	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	FGFR1	14
BP	GO:0048532	anatomical structure arrangement	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	NRP2	14
BP	GO:0055093	response to hyperoxia	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	BNIP3	14
BP	GO:0060045	positive regulation of cardiac muscle cell proliferation	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	FGFR1	14
BP	GO:0071157	negative regulation of cell cycle arrest	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	MIF	14
BP	GO:0071402	cellular response to lipoprotein particle stimulus	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	APOE	14
BP	GO:1901685	glutathione derivative metabolic process	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	MGST1	14
BP	GO:1901687	glutathione derivative biosynthetic process	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	MGST1	14
BP	GO:1902165	regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	MIF	14
BP	GO:1902547	regulation of cellular response to vascular endothelial growth factor stimulus	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	SEMA6A	14
BP	GO:1905048	regulation of metallopeptidase activity	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	CLDN3	14
BP	GO:1990000	amyloid fibril formation	1	1/62	15/10965	0.08158922299527349	0.2063678145722536	0.15709953669089172	0.8038250957549715	APOE	14
BP	GO:1903531	negative regulation of secretion by cell	2	2/62	84/10965	0.08166211765724654	0.2063678145722536	0.15709953669089172	0.8038250957549715	SFRP1/APOE	14
BP	GO:0010975	regulation of neuron projection development	5	5/62	411/10965	0.08217254401394879	0.2074022882123283	0.15788703996465334	0.8016535172547481	SFRP2/SEMA6A/FGFR1/SFRP1/APOE	14
BP	GO:0007548	sex differentiation	3	3/62	181/10965	0.08259521602378013	0.20821300157346048	0.15850420351647448	0.7999592158449531	SFRP2/SFRP1/MGST1	14
BP	GO:0045666	positive regulation of neuron differentiation	4	4/62	292/10965	0.0828153782672314	0.20851184810350779	0.15873170338853265	0.7993363232035134	LIN28A/SOX11/FGFR1/APOE	14
BP	GO:0007569	cell aging	2	2/62	85/10965	0.08333496059134414	0.209050536837944	0.15914178550708366	0.7982157736374893	HMGA1/MIF	14
BP	GO:0043534	blood vessel endothelial cell migration	2	2/62	85/10965	0.08333496059134414	0.209050536837944	0.15914178550708366	0.7982157736374893	FGFR1/APOE	14
BP	GO:0061041	regulation of wound healing	2	2/62	85/10965	0.08333496059134414	0.209050536837944	0.15914178550708366	0.7982157736374893	CLDN3/APOE	14
BP	GO:0032355	response to estradiol	2	2/62	86/10965	0.08501838326126003	0.21100919516367425	0.16063283349897026	0.7941656797920387	IGFBP2/SFRP1	14
BP	GO:0042471	ear morphogenesis	2	2/62	86/10965	0.08501838326126003	0.21100919516367425	0.16063283349897026	0.7941656797920387	FRZB/FGFR1	14
BP	GO:0098739	import across plasma membrane	2	2/62	86/10965	0.08501838326126003	0.21100919516367425	0.16063283349897026	0.7941656797920387	SLC2A1/SLC2A3	14
BP	GO:0031668	cellular response to extracellular stimulus	3	3/62	184/10965	0.08578990808623405	0.21100919516367425	0.16063283349897026	0.7941656797920387	SLC2A1/SFRP2/SFRP1	14
BP	GO:0071559	response to transforming growth factor beta	3	3/62	184/10965	0.08578990808623405	0.21100919516367425	0.16063283349897026	0.7941656797920387	SOX11/SFRP1/CDKN1C	14
BP	GO:0002320	lymphoid progenitor cell differentiation	1	1/62	16/10965	0.08678935707511748	0.21100919516367425	0.16063283349897026	0.7941656797920387	SOX4	14
BP	GO:0002724	regulation of T cell cytokine production	1	1/62	16/10965	0.08678935707511748	0.21100919516367425	0.16063283349897026	0.7941656797920387	FZD5	14
BP	GO:0006740	NADPH regeneration	1	1/62	16/10965	0.08678935707511748	0.21100919516367425	0.16063283349897026	0.7941656797920387	PGAM1	14
BP	GO:0006817	phosphate ion transport	1	1/62	16/10965	0.08678935707511748	0.21100919516367425	0.16063283349897026	0.7941656797920387	FGFR1	14
BP	GO:0007271	synaptic transmission, cholinergic	1	1/62	16/10965	0.08678935707511748	0.21100919516367425	0.16063283349897026	0.7941656797920387	APOE	14
BP	GO:0007530	sex determination	1	1/62	16/10965	0.08678935707511748	0.21100919516367425	0.16063283349897026	0.7941656797920387	SOX3	14
BP	GO:0010661	positive regulation of muscle cell apoptotic process	1	1/62	16/10965	0.08678935707511748	0.21100919516367425	0.16063283349897026	0.7941656797920387	BNIP3	14
BP	GO:0010667	negative regulation of cardiac muscle cell apoptotic process	1	1/62	16/10965	0.08678935707511748	0.21100919516367425	0.16063283349897026	0.7941656797920387	SFRP2	14
BP	GO:0010738	regulation of protein kinase A signaling	1	1/62	16/10965	0.08678935707511748	0.21100919516367425	0.16063283349897026	0.7941656797920387	MIF	14
BP	GO:0010875	positive regulation of cholesterol efflux	1	1/62	16/10965	0.08678935707511748	0.21100919516367425	0.16063283349897026	0.7941656797920387	APOE	14
BP	GO:0019400	alditol metabolic process	1	1/62	16/10965	0.08678935707511748	0.21100919516367425	0.16063283349897026	0.7941656797920387	TPI1	14
BP	GO:0031069	hair follicle morphogenesis	1	1/62	16/10965	0.08678935707511748	0.21100919516367425	0.16063283349897026	0.7941656797920387	IGFBP5	14
BP	GO:0031498	chromatin disassembly	1	1/62	16/10965	0.08678935707511748	0.21100919516367425	0.16063283349897026	0.7941656797920387	HMGA1	14
BP	GO:0032892	positive regulation of organic acid transport	1	1/62	16/10965	0.08678935707511748	0.21100919516367425	0.16063283349897026	0.7941656797920387	MIF	14
BP	GO:0033198	response to ATP	1	1/62	16/10965	0.08678935707511748	0.21100919516367425	0.16063283349897026	0.7941656797920387	HSP90B1	14
BP	GO:0035330	regulation of hippo signaling	1	1/62	16/10965	0.08678935707511748	0.21100919516367425	0.16063283349897026	0.7941656797920387	SOX11	14
BP	GO:0042311	vasodilation	1	1/62	16/10965	0.08678935707511748	0.21100919516367425	0.16063283349897026	0.7941656797920387	APOE	14
BP	GO:0045577	regulation of B cell differentiation	1	1/62	16/10965	0.08678935707511748	0.21100919516367425	0.16063283349897026	0.7941656797920387	SFRP1	14
BP	GO:0051043	regulation of membrane protein ectodomain proteolysis	1	1/62	16/10965	0.08678935707511748	0.21100919516367425	0.16063283349897026	0.7941656797920387	APOE	14
BP	GO:0060561	apoptotic process involved in morphogenesis	1	1/62	16/10965	0.08678935707511748	0.21100919516367425	0.16063283349897026	0.7941656797920387	FZD5	14
BP	GO:2001026	regulation of endothelial cell chemotaxis	1	1/62	16/10965	0.08678935707511748	0.21100919516367425	0.16063283349897026	0.7941656797920387	FGFR1	14
BP	GO:0051384	response to glucocorticoid	2	2/62	88/10965	0.08841629561461435	0.2144565468099157	0.1632571639816943	0.7871277521083041	IGFBP2/DDIT4	14
BP	GO:0071156	regulation of cell cycle arrest	2	2/62	88/10965	0.08841629561461435	0.2144565468099157	0.1632571639816943	0.7871277521083041	SOX4/MIF	14
BP	GO:0045732	positive regulation of protein catabolic process	3	3/62	187/10965	0.08903718152712435	0.2157075519405657	0.16420950399086875	0.7846017107284962	CTSC/APOE/GPC3	14
BP	GO:0006875	cellular metal ion homeostasis	4	4/62	300/10965	0.08936152407921674	0.21623802760678393	0.1646133338301361	0.7835349894499093	BNIP3/HSP90B1/APOE/TNNI3	14
BP	GO:0060968	regulation of gene silencing	2	2/62	89/10965	0.09013045296619987	0.2164025074279337	0.1647385457181972	0.7832047722078029	LIN28A/HMGA1	14
BP	GO:0043406	positive regulation of MAP kinase activity	3	3/62	188/10965	0.09013113649153102	0.2164025074279337	0.1647385457181972	0.7832047722078029	FZD5/FGFR1/MIF	14
BP	GO:0045927	positive regulation of growth	3	3/62	188/10965	0.09013113649153102	0.2164025074279337	0.1647385457181972	0.7832047722078029	SFRP2/FGFR1/SFRP1	14
BP	GO:0051224	negative regulation of protein transport	2	2/62	90/10965	0.0918545253674971	0.2164025074279337	0.1647385457181972	0.7832047722078029	SFRP1/APOE	14
BP	GO:0001913	T cell mediated cytotoxicity	1	1/62	17/10965	0.09196051972571062	0.2164025074279337	0.1647385457181972	0.7832047722078029	CTSC	14
BP	GO:0010758	regulation of macrophage chemotaxis	1	1/62	17/10965	0.09196051972571062	0.2164025074279337	0.1647385457181972	0.7832047722078029	MIF	14
BP	GO:0010801	negative regulation of peptidyl-threonine phosphorylation	1	1/62	17/10965	0.09196051972571062	0.2164025074279337	0.1647385457181972	0.7832047722078029	DDIT4	14
BP	GO:0021871	forebrain regionalization	1	1/62	17/10965	0.09196051972571062	0.2164025074279337	0.1647385457181972	0.7832047722078029	SIX3	14
BP	GO:0032770	positive regulation of monooxygenase activity	1	1/62	17/10965	0.09196051972571062	0.2164025074279337	0.1647385457181972	0.7832047722078029	APOE	14
BP	GO:0032986	protein-DNA complex disassembly	1	1/62	17/10965	0.09196051972571062	0.2164025074279337	0.1647385457181972	0.7832047722078029	HMGA1	14
BP	GO:0044346	fibroblast apoptotic process	1	1/62	17/10965	0.09196051972571062	0.2164025074279337	0.1647385457181972	0.7832047722078029	SFRP1	14
BP	GO:0055090	acylglycerol homeostasis	1	1/62	17/10965	0.09196051972571062	0.2164025074279337	0.1647385457181972	0.7832047722078029	APOE	14
BP	GO:0060445	branching involved in salivary gland morphogenesis	1	1/62	17/10965	0.09196051972571062	0.2164025074279337	0.1647385457181972	0.7832047722078029	FGFR1	14
BP	GO:0060512	prostate gland morphogenesis	1	1/62	17/10965	0.09196051972571062	0.2164025074279337	0.1647385457181972	0.7832047722078029	SFRP1	14
BP	GO:0060713	labyrinthine layer morphogenesis	1	1/62	17/10965	0.09196051972571062	0.2164025074279337	0.1647385457181972	0.7832047722078029	FZD5	14
BP	GO:0060740	prostate gland epithelium morphogenesis	1	1/62	17/10965	0.09196051972571062	0.2164025074279337	0.1647385457181972	0.7832047722078029	SFRP1	14
BP	GO:0061037	negative regulation of cartilage development	1	1/62	17/10965	0.09196051972571062	0.2164025074279337	0.1647385457181972	0.7832047722078029	FRZB	14
BP	GO:0070328	triglyceride homeostasis	1	1/62	17/10965	0.09196051972571062	0.2164025074279337	0.1647385457181972	0.7832047722078029	APOE	14
BP	GO:0071715	icosanoid transport	1	1/62	17/10965	0.09196051972571062	0.2164025074279337	0.1647385457181972	0.7832047722078029	MIF	14
BP	GO:0140353	lipid export from cell	1	1/62	17/10965	0.09196051972571062	0.2164025074279337	0.1647385457181972	0.7832047722078029	MIF	14
BP	GO:1901571	fatty acid derivative transport	1	1/62	17/10965	0.09196051972571062	0.2164025074279337	0.1647385457181972	0.7832047722078029	MIF	14
BP	GO:1902254	negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator	1	1/62	17/10965	0.09196051972571062	0.2164025074279337	0.1647385457181972	0.7832047722078029	MIF	14
BP	GO:1904738	vascular associated smooth muscle cell migration	1	1/62	17/10965	0.09196051972571062	0.2164025074279337	0.1647385457181972	0.7832047722078029	IGFBP5	14
BP	GO:1904752	regulation of vascular associated smooth muscle cell migration	1	1/62	17/10965	0.09196051972571062	0.2164025074279337	0.1647385457181972	0.7832047722078029	IGFBP5	14
BP	GO:0002695	negative regulation of leukocyte activation	2	2/62	91/10965	0.09358835036742232	0.21947805137594353	0.16707983391910342	0.7770759651046228	SOX11/SFRP1	14
BP	GO:0034728	nucleosome organization	2	2/62	91/10965	0.09358835036742232	0.21947805137594353	0.16707983391910342	0.7770759651046228	PTMA/HMGA1	14
BP	GO:1905039	carboxylic acid transmembrane transport	2	2/62	91/10965	0.09358835036742232	0.21947805137594353	0.16707983391910342	0.7770759651046228	SLC2A1/SLC16A3	14
BP	GO:0050808	synapse organization	4	4/62	306/10965	0.09443238834236682	0.21992835394354163	0.16742263119535028	0.7761858370300736	NRP2/FZD5/TPBG/APOE	14
BP	GO:0021987	cerebral cortex development	2	2/62	92/10965	0.09533176698093096	0.21992835394354163	0.16742263119535028	0.7761858370300736	SLC2A1/BNIP3	14
BP	GO:0030330	DNA damage response, signal transduction by p53 class mediator	2	2/62	92/10965	0.09533176698093096	0.21992835394354163	0.16742263119535028	0.7761858370300736	SOX4/MIF	14
BP	GO:0090101	negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway	2	2/62	92/10965	0.09533176698093096	0.21992835394354163	0.16742263119535028	0.7761858370300736	SFRP2/SFRP1	14
BP	GO:1903825	organic acid transmembrane transport	2	2/62	92/10965	0.09533176698093096	0.21992835394354163	0.16742263119535028	0.7761858370300736	SLC2A1/SLC16A3	14
BP	GO:0017015	regulation of transforming growth factor beta receptor signaling pathway	2	2/62	93/10965	0.09708461567807869	0.21992835394354163	0.16742263119535028	0.7761858370300736	SOX11/CDKN1C	14
BP	GO:0001516	prostaglandin biosynthetic process	1	1/62	18/10965	0.09710286972361049	0.21992835394354163	0.16742263119535028	0.7761858370300736	MIF	14
BP	GO:0003148	outflow tract septum morphogenesis	1	1/62	18/10965	0.09710286972361049	0.21992835394354163	0.16742263119535028	0.7761858370300736	NRP2	14
BP	GO:0003171	atrioventricular valve development	1	1/62	18/10965	0.09710286972361049	0.21992835394354163	0.16742263119535028	0.7761858370300736	SOX4	14
BP	GO:0003181	atrioventricular valve morphogenesis	1	1/62	18/10965	0.09710286972361049	0.21992835394354163	0.16742263119535028	0.7761858370300736	SOX4	14
BP	GO:0003230	cardiac atrium development	1	1/62	18/10965	0.09710286972361049	0.21992835394354163	0.16742263119535028	0.7761858370300736	SOX4	14
BP	GO:0007339	binding of sperm to zona pellucida	1	1/62	18/10965	0.09710286972361049	0.21992835394354163	0.16742263119535028	0.7761858370300736	ALDOA	14
BP	GO:0010842	retina layer formation	1	1/62	18/10965	0.09710286972361049	0.21992835394354163	0.16742263119535028	0.7761858370300736	FJX1	14
BP	GO:0021602	cranial nerve morphogenesis	1	1/62	18/10965	0.09710286972361049	0.21992835394354163	0.16742263119535028	0.7761858370300736	NRP2	14
BP	GO:0032799	low-density lipoprotein receptor particle metabolic process	1	1/62	18/10965	0.09710286972361049	0.21992835394354163	0.16742263119535028	0.7761858370300736	APOE	14
BP	GO:0033028	myeloid cell apoptotic process	1	1/62	18/10965	0.09710286972361049	0.21992835394354163	0.16742263119535028	0.7761858370300736	MIF	14
BP	GO:0034694	response to prostaglandin	1	1/62	18/10965	0.09710286972361049	0.21992835394354163	0.16742263119535028	0.7761858370300736	SFRP1	14
BP	GO:0044060	regulation of endocrine process	1	1/62	18/10965	0.09710286972361049	0.21992835394354163	0.16742263119535028	0.7761858370300736	FGFR1	14
BP	GO:0045686	negative regulation of glial cell differentiation	1	1/62	18/10965	0.09710286972361049	0.21992835394354163	0.16742263119535028	0.7761858370300736	LIN28A	14
BP	GO:0046457	prostanoid biosynthetic process	1	1/62	18/10965	0.09710286972361049	0.21992835394354163	0.16742263119535028	0.7761858370300736	MIF	14
BP	GO:0046697	decidualization	1	1/62	18/10965	0.09710286972361049	0.21992835394354163	0.16742263119535028	0.7761858370300736	BSG	14
BP	GO:0048566	embryonic digestive tract development	1	1/62	18/10965	0.09710286972361049	0.21992835394354163	0.16742263119535028	0.7761858370300736	SOX11	14
BP	GO:0048730	epidermis morphogenesis	1	1/62	18/10965	0.09710286972361049	0.21992835394354163	0.16742263119535028	0.7761858370300736	IGFBP5	14
BP	GO:0050869	negative regulation of B cell activation	1	1/62	18/10965	0.09710286972361049	0.21992835394354163	0.16742263119535028	0.7761858370300736	SFRP1	14
BP	GO:0060343	trabecula formation	1	1/62	18/10965	0.09710286972361049	0.21992835394354163	0.16742263119535028	0.7761858370300736	SFRP1	14
BP	GO:0060716	labyrinthine layer blood vessel development	1	1/62	18/10965	0.09710286972361049	0.21992835394354163	0.16742263119535028	0.7761858370300736	FZD5	14
BP	GO:0060969	negative regulation of gene silencing	1	1/62	18/10965	0.09710286972361049	0.21992835394354163	0.16742263119535028	0.7761858370300736	HMGA1	14
BP	GO:0071295	cellular response to vitamin	1	1/62	18/10965	0.09710286972361049	0.21992835394354163	0.16742263119535028	0.7761858370300736	SFRP1	14
BP	GO:0071425	hematopoietic stem cell proliferation	1	1/62	18/10965	0.09710286972361049	0.21992835394354163	0.16742263119535028	0.7761858370300736	SFRP2	14
BP	GO:0090103	cochlea morphogenesis	1	1/62	18/10965	0.09710286972361049	0.21992835394354163	0.16742263119535028	0.7761858370300736	FRZB	14
BP	GO:1904886	beta-catenin destruction complex disassembly	1	1/62	18/10965	0.09710286972361049	0.21992835394354163	0.16742263119535028	0.7761858370300736	FZD5	14
BP	GO:0002521	leukocyte differentiation	4	4/62	310/10965	0.097888418287301	0.22135112455369138	0.16850572937194933	0.773385328072639	FZD5/SOX4/SFRP1/GPC3	14
BP	GO:0021537	telencephalon development	3	3/62	195/10965	0.09794679390582445	0.22135112455369138	0.16850572937194933	0.773385328072639	SLC2A1/SIX3/BNIP3	14
BP	GO:0034329	cell junction assembly	4	4/62	311/10965	0.09876175037569716	0.22191849796686705	0.16893764798544716	0.7722735565251759	FZD5/TPBG/CLDN3/SFRP1	14
BP	GO:0051048	negative regulation of secretion	2	2/62	94/10965	0.09884673837315619	0.22191849796686705	0.16893764798544716	0.7722735565251759	SFRP1/APOE	14
BP	GO:0061387	regulation of extent of cell growth	2	2/62	94/10965	0.09884673837315619	0.22191849796686705	0.16893764798544716	0.7722735565251759	SEMA6A/APOE	14
BP	GO:0071333	cellular response to glucose stimulus	2	2/62	94/10965	0.09884673837315619	0.22191849796686705	0.16893764798544716	0.7722735565251759	LIN28A/SOX4	14
BP	GO:1903844	regulation of cellular response to transforming growth factor beta stimulus	2	2/62	94/10965	0.09884673837315619	0.22191849796686705	0.16893764798544716	0.7722735565251759	SOX11/CDKN1C	14
BP	GO:1904950	negative regulation of establishment of protein localization	2	2/62	94/10965	0.09884673837315619	0.22191849796686705	0.16893764798544716	0.7722735565251759	SFRP1/APOE	14
BP	GO:0008544	epidermis development	3	3/62	197/10965	0.10022959159029604	0.22282718926425654	0.16962939820876	0.7704988786511076	POU3F1/IGFBP5/FGFR1	14
BP	GO:0071326	cellular response to monosaccharide stimulus	2	2/62	95/10965	0.10061797841389734	0.22282718926425654	0.16962939820876	0.7704988786511076	LIN28A/SOX4	14
BP	GO:0071331	cellular response to hexose stimulus	2	2/62	95/10965	0.10061797841389734	0.22282718926425654	0.16962939820876	0.7704988786511076	LIN28A/SOX4	14
BP	GO:1901861	regulation of muscle tissue development	2	2/62	95/10965	0.10061797841389734	0.22282718926425654	0.16962939820876	0.7704988786511076	IGFBP5/FGFR1	14
BP	GO:0001774	microglial cell activation	1	1/62	19/10965	0.10221656498963161	0.22282718926425654	0.16962939820876	0.7704988786511076	CTSC	14
BP	GO:0002053	positive regulation of mesenchymal cell proliferation	1	1/62	19/10965	0.10221656498963161	0.22282718926425654	0.16962939820876	0.7704988786511076	FGFR1	14
BP	GO:0002269	leukocyte activation involved in inflammatory response	1	1/62	19/10965	0.10221656498963161	0.22282718926425654	0.16962939820876	0.7704988786511076	CTSC	14
BP	GO:0006775	fat-soluble vitamin metabolic process	1	1/62	19/10965	0.10221656498963161	0.22282718926425654	0.16962939820876	0.7704988786511076	FGFR1	14
BP	GO:0010543	regulation of platelet activation	1	1/62	19/10965	0.10221656498963161	0.22282718926425654	0.16962939820876	0.7704988786511076	APOE	14
BP	GO:0010664	negative regulation of striated muscle cell apoptotic process	1	1/62	19/10965	0.10221656498963161	0.22282718926425654	0.16962939820876	0.7704988786511076	SFRP2	14
BP	GO:0010894	negative regulation of steroid biosynthetic process	1	1/62	19/10965	0.10221656498963161	0.22282718926425654	0.16962939820876	0.7704988786511076	APOE	14
BP	GO:0014912	negative regulation of smooth muscle cell migration	1	1/62	19/10965	0.10221656498963161	0.22282718926425654	0.16962939820876	0.7704988786511076	IGFBP5	14
BP	GO:0021522	spinal cord motor neuron differentiation	1	1/62	19/10965	0.10221656498963161	0.22282718926425654	0.16962939820876	0.7704988786511076	SOX4	14
BP	GO:0030890	positive regulation of B cell proliferation	1	1/62	19/10965	0.10221656498963161	0.22282718926425654	0.16962939820876	0.7704988786511076	MIF	14
BP	GO:0031343	positive regulation of cell killing	1	1/62	19/10965	0.10221656498963161	0.22282718926425654	0.16962939820876	0.7704988786511076	GAPDH	14
BP	GO:0032722	positive regulation of chemokine production	1	1/62	19/10965	0.10221656498963161	0.22282718926425654	0.16962939820876	0.7704988786511076	MIF	14
BP	GO:0033687	osteoblast proliferation	1	1/62	19/10965	0.10221656498963161	0.22282718926425654	0.16962939820876	0.7704988786511076	SFRP1	14
BP	GO:0042908	xenobiotic transport	1	1/62	19/10965	0.10221656498963161	0.22282718926425654	0.16962939820876	0.7704988786511076	SLC2A1	14
BP	GO:0045671	negative regulation of osteoclast differentiation	1	1/62	19/10965	0.10221656498963161	0.22282718926425654	0.16962939820876	0.7704988786511076	SFRP1	14
BP	GO:0045939	negative regulation of steroid metabolic process	1	1/62	19/10965	0.10221656498963161	0.22282718926425654	0.16962939820876	0.7704988786511076	APOE	14
BP	GO:0051156	glucose 6-phosphate metabolic process	1	1/62	19/10965	0.10221656498963161	0.22282718926425654	0.16962939820876	0.7704988786511076	PGAM1	14
BP	GO:0060986	endocrine hormone secretion	1	1/62	19/10965	0.10221656498963161	0.22282718926425654	0.16962939820876	0.7704988786511076	FGFR1	14
BP	GO:0090344	negative regulation of cell aging	1	1/62	19/10965	0.10221656498963161	0.22282718926425654	0.16962939820876	0.7704988786511076	MIF	14
BP	GO:1902001	fatty acid transmembrane transport	1	1/62	19/10965	0.10221656498963161	0.22282718926425654	0.16962939820876	0.7704988786511076	SLC2A1	14
BP	GO:1903599	positive regulation of autophagy of mitochondrion	1	1/62	19/10965	0.10221656498963161	0.22282718926425654	0.16962939820876	0.7704988786511076	BNIP3	14
BP	GO:1903671	negative regulation of sprouting angiogenesis	1	1/62	19/10965	0.10221656498963161	0.22282718926425654	0.16962939820876	0.7704988786511076	SEMA6A	14
BP	GO:2000678	negative regulation of transcription regulatory region DNA binding	1	1/62	19/10965	0.10221656498963161	0.22282718926425654	0.16962939820876	0.7704988786511076	SOX11	14
BP	GO:0006417	regulation of translation	4	4/62	315/10965	0.10229201378505344	0.22282718926425654	0.16962939820876	0.7704988786511076	LIN28A/IGFBP5/SOX4/GAPDH	14
BP	GO:0010675	regulation of cellular carbohydrate metabolic process	2	2/62	97/10965	0.10418719102627927	0.22599589427687639	0.17204160619005057	0.7643665115014635	DDIT4/PGAM1	14
BP	GO:0031960	response to corticosteroid	2	2/62	97/10965	0.10418719102627927	0.22599589427687639	0.17204160619005057	0.7643665115014635	IGFBP2/DDIT4	14
BP	GO:0048771	tissue remodeling	2	2/62	97/10965	0.10418719102627927	0.22599589427687639	0.17204160619005057	0.7643665115014635	IGFBP5/SFRP1	14
BP	GO:0060041	retina development in camera-type eye	2	2/62	97/10965	0.10418719102627927	0.22599589427687639	0.17204160619005057	0.7643665115014635	SIX3/FJX1	14
BP	GO:0002697	regulation of immune effector process	3	3/62	201/10965	0.10485972354013334	0.2272145223910809	0.1729692988757382	0.7620309749757269	FZD5/BST2/MIF	14
BP	GO:0002703	regulation of leukocyte mediated immunity	2	2/62	98/10965	0.10598485736449258	0.22816913662343905	0.17369600838677723	0.7602101617228214	FZD5/BST2	14
BP	GO:0000578	embryonic axis specification	1	1/62	20/10965	0.10730176259338142	0.22816913662343905	0.17369600838677723	0.7602101617228214	FZD5	14
BP	GO:0001783	B cell apoptotic process	1	1/62	20/10965	0.10730176259338142	0.22816913662343905	0.17369600838677723	0.7602101617228214	MIF	14
BP	GO:0006972	hyperosmotic response	1	1/62	20/10965	0.10730176259338142	0.22816913662343905	0.17369600838677723	0.7602101617228214	SLC2A1	14
BP	GO:0014741	negative regulation of muscle hypertrophy	1	1/62	20/10965	0.10730176259338142	0.22816913662343905	0.17369600838677723	0.7602101617228214	IGFBP5	14
BP	GO:0018126	protein hydroxylation	1	1/62	20/10965	0.10730176259338142	0.22816913662343905	0.17369600838677723	0.7602101617228214	P4HA1	14
BP	GO:0032373	positive regulation of sterol transport	1	1/62	20/10965	0.10730176259338142	0.22816913662343905	0.17369600838677723	0.7602101617228214	APOE	14
BP	GO:0032376	positive regulation of cholesterol transport	1	1/62	20/10965	0.10730176259338142	0.22816913662343905	0.17369600838677723	0.7602101617228214	APOE	14
BP	GO:0034377	plasma lipoprotein particle assembly	1	1/62	20/10965	0.10730176259338142	0.22816913662343905	0.17369600838677723	0.7602101617228214	APOE	14
BP	GO:0034389	lipid droplet organization	1	1/62	20/10965	0.10730176259338142	0.22816913662343905	0.17369600838677723	0.7602101617228214	HILPDA	14
BP	GO:0035137	hindlimb morphogenesis	1	1/62	20/10965	0.10730176259338142	0.22816913662343905	0.17369600838677723	0.7602101617228214	GPC3	14
BP	GO:0046006	regulation of activated T cell proliferation	1	1/62	20/10965	0.10730176259338142	0.22816913662343905	0.17369600838677723	0.7602101617228214	IGFBP2	14
BP	GO:0060706	cell differentiation involved in embryonic placenta development	1	1/62	20/10965	0.10730176259338142	0.22816913662343905	0.17369600838677723	0.7602101617228214	FZD5	14
BP	GO:0070229	negative regulation of lymphocyte apoptotic process	1	1/62	20/10965	0.10730176259338142	0.22816913662343905	0.17369600838677723	0.7602101617228214	MIF	14
BP	GO:0070920	regulation of production of small RNA involved in gene silencing by RNA	1	1/62	20/10965	0.10730176259338142	0.22816913662343905	0.17369600838677723	0.7602101617228214	LIN28A	14
BP	GO:0071549	cellular response to dexamethasone stimulus	1	1/62	20/10965	0.10730176259338142	0.22816913662343905	0.17369600838677723	0.7602101617228214	DDIT4	14
BP	GO:1903579	negative regulation of ATP metabolic process	1	1/62	20/10965	0.10730176259338142	0.22816913662343905	0.17369600838677723	0.7602101617228214	DDIT4	14
BP	GO:1903798	regulation of production of miRNAs involved in gene silencing by miRNA	1	1/62	20/10965	0.10730176259338142	0.22816913662343905	0.17369600838677723	0.7602101617228214	LIN28A	14
BP	GO:0006937	regulation of muscle contraction	2	2/62	99/10965	0.10779102856043632	0.22873546081283902	0.17412712826831492	0.7591335623725082	ENO1/TNNI3	14
BP	GO:0071219	cellular response to molecule of bacterial origin	2	2/62	99/10965	0.10779102856043632	0.22873546081283902	0.17412712826831492	0.7591335623725082	FZD5/MIF	14
BP	GO:0006936	muscle contraction	3	3/62	205/10965	0.10957403002693622	0.2316278051471169	0.17632895395420206	0.7536763688686507	ENO1/ALDOA/TNNI3	14
BP	GO:0030098	lymphocyte differentiation	3	3/62	205/10965	0.10957403002693622	0.2316278051471169	0.17632895395420206	0.7536763688686507	FZD5/SOX4/SFRP1	14
BP	GO:0007043	cell-cell junction assembly	2	2/62	100/10965	0.10960555496971272	0.2316278051471169	0.17632895395420206	0.7536763688686507	FZD5/CLDN3	14
BP	GO:0031929	TOR signaling	2	2/62	100/10965	0.10960555496971272	0.2316278051471169	0.17632895395420206	0.7536763688686507	LIN28A/DDIT4	14
BP	GO:0071322	cellular response to carbohydrate stimulus	2	2/62	101/10965	0.11142828831812845	0.23265376961749712	0.17710997953850713	0.7517569671193626	LIN28A/SOX4	14
BP	GO:1903008	organelle disassembly	2	2/62	101/10965	0.11142828831812845	0.23265376961749712	0.17710997953850713	0.7517569671193626	FZD5/BNIP3	14
BP	GO:0001782	B cell homeostasis	1	1/62	21/10965	0.11235861875776787	0.23265376961749712	0.17710997953850713	0.7517569671193626	MIF	14
BP	GO:0001937	negative regulation of endothelial cell proliferation	1	1/62	21/10965	0.11235861875776787	0.23265376961749712	0.17710997953850713	0.7517569671193626	APOE	14
BP	GO:0002063	chondrocyte development	1	1/62	21/10965	0.11235861875776787	0.23265376961749712	0.17710997953850713	0.7517569671193626	SFRP2	14
BP	GO:0002369	T cell cytokine production	1	1/62	21/10965	0.11235861875776787	0.23265376961749712	0.17710997953850713	0.7517569671193626	FZD5	14
BP	GO:0010863	positive regulation of phospholipase C activity	1	1/62	21/10965	0.11235861875776787	0.23265376961749712	0.17710997953850713	0.7517569671193626	FGFR1	14
BP	GO:0010882	regulation of cardiac muscle contraction by calcium ion signaling	1	1/62	21/10965	0.11235861875776787	0.23265376961749712	0.17710997953850713	0.7517569671193626	TNNI3	14
BP	GO:0010939	regulation of necrotic cell death	1	1/62	21/10965	0.11235861875776787	0.23265376961749712	0.17710997953850713	0.7517569671193626	BNIP3	14
BP	GO:0030049	muscle filament sliding	1	1/62	21/10965	0.11235861875776787	0.23265376961749712	0.17710997953850713	0.7517569671193626	TNNI3	14
BP	GO:0032731	positive regulation of interleukin-1 beta production	1	1/62	21/10965	0.11235861875776787	0.23265376961749712	0.17710997953850713	0.7517569671193626	FZD5	14
BP	GO:0032897	negative regulation of viral transcription	1	1/62	21/10965	0.11235861875776787	0.23265376961749712	0.17710997953850713	0.7517569671193626	IFITM3	14
BP	GO:0033275	actin-myosin filament sliding	1	1/62	21/10965	0.11235861875776787	0.23265376961749712	0.17710997953850713	0.7517569671193626	TNNI3	14
BP	GO:0033280	response to vitamin D	1	1/62	21/10965	0.11235861875776787	0.23265376961749712	0.17710997953850713	0.7517569671193626	SFRP1	14
BP	GO:0046174	polyol catabolic process	1	1/62	21/10965	0.11235861875776787	0.23265376961749712	0.17710997953850713	0.7517569671193626	TPI1	14
BP	GO:0048147	negative regulation of fibroblast proliferation	1	1/62	21/10965	0.11235861875776787	0.23265376961749712	0.17710997953850713	0.7517569671193626	SFRP1	14
BP	GO:0055023	positive regulation of cardiac muscle tissue growth	1	1/62	21/10965	0.11235861875776787	0.23265376961749712	0.17710997953850713	0.7517569671193626	FGFR1	14
BP	GO:0060669	embryonic placenta morphogenesis	1	1/62	21/10965	0.11235861875776787	0.23265376961749712	0.17710997953850713	0.7517569671193626	FZD5	14
BP	GO:0061082	myeloid leukocyte cytokine production	1	1/62	21/10965	0.11235861875776787	0.23265376961749712	0.17710997953850713	0.7517569671193626	MIF	14
BP	GO:0097150	neuronal stem cell population maintenance	1	1/62	21/10965	0.11235861875776787	0.23265376961749712	0.17710997953850713	0.7517569671193626	SOX2	14
BP	GO:0006869	lipid transport	3	3/62	208/10965	0.1131636332223176	0.23357551319674105	0.17781166594027073	0.7500397490616365	SLC2A1/APOE/MIF	14
BP	GO:0002699	positive regulation of immune effector process	2	2/62	102/10965	0.11325908169140222	0.23357551319674105	0.17781166594027073	0.7500397490616365	FZD5/MIF	14
BP	GO:0008637	apoptotic mitochondrial changes	2	2/62	102/10965	0.11325908169140222	0.23357551319674105	0.17781166594027073	0.7500397490616365	FAM162A/BNIP3	14
BP	GO:0044344	cellular response to fibroblast growth factor stimulus	2	2/62	102/10965	0.11325908169140222	0.23357551319674105	0.17781166594027073	0.7500397490616365	FGFR1/SFRP1	14
BP	GO:0062012	regulation of small molecule metabolic process	4	4/62	328/10965	0.11416508284581747	0.23520758032090106	0.17905409315492826	0.7470157466192354	ENO1/DDIT4/PGAM1/APOE	14
BP	GO:0051403	stress-activated MAPK cascade	3	3/62	209/10965	0.11437023843140671	0.2353939109942293	0.1791959392199837	0.7466718361601404	FZD5/SFRP2/SFRP1	14
BP	GO:0007015	actin filament organization	4	4/62	330/10965	0.1160447141903907	0.23569346061436441	0.17942397432631416	0.7461195277245731	SHROOM3/SFRP1/HSP90B1/ALDOA	14
BP	GO:0006941	striated muscle contraction	2	2/62	104/10965	0.11694426759369471	0.23569346061436441	0.17942397432631416	0.7461195277245731	ALDOA/TNNI3	14
BP	GO:0042542	response to hydrogen peroxide	2	2/62	104/10965	0.11694426759369471	0.23569346061436441	0.17942397432631416	0.7461195277245731	BNIP3/LDHA	14
BP	GO:0042552	myelination	2	2/62	104/10965	0.11694426759369471	0.23569346061436441	0.17942397432631416	0.7461195277245731	POU3F1/CTSC	14
BP	GO:0045619	regulation of lymphocyte differentiation	2	2/62	104/10965	0.11694426759369471	0.23569346061436441	0.17942397432631416	0.7461195277245731	SOX4/SFRP1	14
BP	GO:0070374	positive regulation of ERK1 and ERK2 cascade	2	2/62	104/10965	0.11694426759369471	0.23569346061436441	0.17942397432631416	0.7461195277245731	APOE/MIF	14
BP	GO:0002711	positive regulation of T cell mediated immunity	1	1/62	22/10965	0.11738728886348948	0.23569346061436441	0.17942397432631416	0.7461195277245731	FZD5	14
BP	GO:0008053	mitochondrial fusion	1	1/62	22/10965	0.11738728886348948	0.23569346061436441	0.17942397432631416	0.7461195277245731	BNIP3	14
BP	GO:0010737	protein kinase A signaling	1	1/62	22/10965	0.11738728886348948	0.23569346061436441	0.17942397432631416	0.7461195277245731	MIF	14
BP	GO:0010874	regulation of cholesterol efflux	1	1/62	22/10965	0.11738728886348948	0.23569346061436441	0.17942397432631416	0.7461195277245731	APOE	14
BP	GO:0021884	forebrain neuron development	1	1/62	22/10965	0.11738728886348948	0.23569346061436441	0.17942397432631416	0.7461195277245731	NRP2	14
BP	GO:0022011	myelination in peripheral nervous system	1	1/62	22/10965	0.11738728886348948	0.23569346061436441	0.17942397432631416	0.7461195277245731	POU3F1	14
BP	GO:0032292	peripheral nervous system axon ensheathment	1	1/62	22/10965	0.11738728886348948	0.23569346061436441	0.17942397432631416	0.7461195277245731	POU3F1	14
BP	GO:0033137	negative regulation of peptidyl-serine phosphorylation	1	1/62	22/10965	0.11738728886348948	0.23569346061436441	0.17942397432631416	0.7461195277245731	DDIT4	14
BP	GO:0035767	endothelial cell chemotaxis	1	1/62	22/10965	0.11738728886348948	0.23569346061436441	0.17942397432631416	0.7461195277245731	FGFR1	14
BP	GO:0036296	response to increased oxygen levels	1	1/62	22/10965	0.11738728886348948	0.23569346061436441	0.17942397432631416	0.7461195277245731	BNIP3	14
BP	GO:0043537	negative regulation of blood vessel endothelial cell migration	1	1/62	22/10965	0.11738728886348948	0.23569346061436441	0.17942397432631416	0.7461195277245731	APOE	14
BP	GO:0044788	modulation by host of viral process	1	1/62	22/10965	0.11738728886348948	0.23569346061436441	0.17942397432631416	0.7461195277245731	APOE	14
BP	GO:0045736	negative regulation of cyclin-dependent protein serine/threonine kinase activity	1	1/62	22/10965	0.11738728886348948	0.23569346061436441	0.17942397432631416	0.7461195277245731	CDKN1C	14
BP	GO:0045992	negative regulation of embryonic development	1	1/62	22/10965	0.11738728886348948	0.23569346061436441	0.17942397432631416	0.7461195277245731	SFRP2	14
BP	GO:0048843	negative regulation of axon extension involved in axon guidance	1	1/62	22/10965	0.11738728886348948	0.23569346061436441	0.17942397432631416	0.7461195277245731	SEMA6A	14
BP	GO:0051560	mitochondrial calcium ion homeostasis	1	1/62	22/10965	0.11738728886348948	0.23569346061436441	0.17942397432631416	0.7461195277245731	BNIP3	14
BP	GO:0065005	protein-lipid complex assembly	1	1/62	22/10965	0.11738728886348948	0.23569346061436441	0.17942397432631416	0.7461195277245731	APOE	14
BP	GO:0090140	regulation of mitochondrial fission	1	1/62	22/10965	0.11738728886348948	0.23569346061436441	0.17942397432631416	0.7461195277245731	BNIP3	14
BP	GO:0097242	amyloid-beta clearance	1	1/62	22/10965	0.11738728886348948	0.23569346061436441	0.17942397432631416	0.7461195277245731	APOE	14
BP	GO:0071774	response to fibroblast growth factor	2	2/62	105/10965	0.11879837300205559	0.23829351065514964	0.1814032880949226	0.7413548452332616	FGFR1/SFRP1	14
BP	GO:0006979	response to oxidative stress	4	4/62	334/10965	0.11984533607092819	0.24015881798588345	0.18282327172004262	0.7379685233925507	BNIP3/LDHA/MGST1/APOE	14
BP	GO:0001678	cellular glucose homeostasis	2	2/62	106/10965	0.12065996417385869	0.2403253848177775	0.18295007236564165	0.7376674143927734	LIN28A/SOX4	14
BP	GO:0007272	ensheathment of neurons	2	2/62	106/10965	0.12065996417385869	0.2403253848177775	0.18295007236564165	0.7376674143927734	POU3F1/CTSC	14
BP	GO:0008366	axon ensheathment	2	2/62	106/10965	0.12065996417385869	0.2403253848177775	0.18295007236564165	0.7376674143927734	POU3F1/CTSC	14
BP	GO:0003156	regulation of animal organ formation	1	1/62	23/10965	0.1223879274534978	0.2403253848177775	0.18295007236564165	0.7376674143927734	FGFR1	14
BP	GO:0030511	positive regulation of transforming growth factor beta receptor signaling pathway	1	1/62	23/10965	0.1223879274534978	0.2403253848177775	0.18295007236564165	0.7376674143927734	CDKN1C	14
BP	GO:0031365	N-terminal protein amino acid modification	1	1/62	23/10965	0.1223879274534978	0.2403253848177775	0.18295007236564165	0.7376674143927734	SOX4	14
BP	GO:0032729	positive regulation of interferon-gamma production	1	1/62	23/10965	0.1223879274534978	0.2403253848177775	0.18295007236564165	0.7376674143927734	FZD5	14
BP	GO:0035036	sperm-egg recognition	1	1/62	23/10965	0.1223879274534978	0.2403253848177775	0.18295007236564165	0.7376674143927734	ALDOA	14
BP	GO:0035909	aorta morphogenesis	1	1/62	23/10965	0.1223879274534978	0.2403253848177775	0.18295007236564165	0.7376674143927734	SOX4	14
BP	GO:0046676	negative regulation of insulin secretion	1	1/62	23/10965	0.1223879274534978	0.2403253848177775	0.18295007236564165	0.7376674143927734	SFRP1	14
BP	GO:0048246	macrophage chemotaxis	1	1/62	23/10965	0.1223879274534978	0.2403253848177775	0.18295007236564165	0.7376674143927734	MIF	14
BP	GO:0051180	vitamin transport	1	1/62	23/10965	0.1223879274534978	0.2403253848177775	0.18295007236564165	0.7376674143927734	SLC2A1	14
BP	GO:0051894	positive regulation of focal adhesion assembly	1	1/62	23/10965	0.1223879274534978	0.2403253848177775	0.18295007236564165	0.7376674143927734	SFRP1	14
BP	GO:0071392	cellular response to estradiol stimulus	1	1/62	23/10965	0.1223879274534978	0.2403253848177775	0.18295007236564165	0.7376674143927734	SFRP1	14
BP	GO:1900274	regulation of phospholipase C activity	1	1/62	23/10965	0.1223879274534978	0.2403253848177775	0.18295007236564165	0.7376674143927734	FGFR1	14
BP	GO:1902668	negative regulation of axon guidance	1	1/62	23/10965	0.1223879274534978	0.2403253848177775	0.18295007236564165	0.7376674143927734	SEMA6A	14
BP	GO:1902692	regulation of neuroblast proliferation	1	1/62	23/10965	0.1223879274534978	0.2403253848177775	0.18295007236564165	0.7376674143927734	SIX3	14
BP	GO:1903846	positive regulation of cellular response to transforming growth factor beta stimulus	1	1/62	23/10965	0.1223879274534978	0.2403253848177775	0.18295007236564165	0.7376674143927734	CDKN1C	14
BP	GO:1904030	negative regulation of cyclin-dependent protein kinase activity	1	1/62	23/10965	0.1223879274534978	0.2403253848177775	0.18295007236564165	0.7376674143927734	CDKN1C	14
BP	GO:1905521	regulation of macrophage migration	1	1/62	23/10965	0.1223879274534978	0.2403253848177775	0.18295007236564165	0.7376674143927734	MIF	14
BP	GO:2000637	positive regulation of gene silencing by miRNA	1	1/62	23/10965	0.1223879274534978	0.2403253848177775	0.18295007236564165	0.7376674143927734	LIN28A	14
BP	GO:0010631	epithelial cell migration	3	3/62	216/10965	0.12295376278978122	0.2412056608457276	0.18362019118449768	0.7360795647585772	NRP2/FGFR1/APOE	14
BP	GO:0048754	branching morphogenesis of an epithelial tube	2	2/62	108/10965	0.12440504404068253	0.2435869755453059	0.1854329905146373	0.7318129976787389	SFRP2/GPC3	14
BP	GO:1903034	regulation of response to wounding	2	2/62	108/10965	0.12440504404068253	0.2435869755453059	0.1854329905146373	0.7318129976787389	CLDN3/APOE	14
BP	GO:0090132	epithelium migration	3	3/62	218/10965	0.12544923773381106	0.2444753342032041	0.186109262315356	0.7302320122945469	NRP2/FGFR1/APOE	14
BP	GO:0055065	metal ion homeostasis	4	4/62	341/10965	0.1266267287540667	0.2444753342032041	0.186109262315356	0.7302320122945469	BNIP3/HSP90B1/APOE/TNNI3	14
BP	GO:0051235	maintenance of location	3	3/62	219/10965	0.12670396616232898	0.2444753342032041	0.186109262315356	0.7302320122945469	HILPDA/HSP90B1/APOE	14
BP	GO:0002082	regulation of oxidative phosphorylation	1	1/62	24/10965	0.12736068823743918	0.2444753342032041	0.186109262315356	0.7302320122945469	PGK1	14
BP	GO:0002686	negative regulation of leukocyte migration	1	1/62	24/10965	0.12736068823743918	0.2444753342032041	0.186109262315356	0.7302320122945469	MIF	14
BP	GO:0010092	specification of animal organ identity	1	1/62	24/10965	0.12736068823743918	0.2444753342032041	0.186109262315356	0.7302320122945469	FGFR1	14
BP	GO:0032732	positive regulation of interleukin-1 production	1	1/62	24/10965	0.12736068823743918	0.2444753342032041	0.186109262315356	0.7302320122945469	FZD5	14
BP	GO:0035633	maintenance of blood-brain barrier	1	1/62	24/10965	0.12736068823743918	0.2444753342032041	0.186109262315356	0.7302320122945469	CLDN3	14
BP	GO:0044068	modulation by symbiont of host cellular process	1	1/62	24/10965	0.12736068823743918	0.2444753342032041	0.186109262315356	0.7302320122945469	GAPDH	14
BP	GO:0045933	positive regulation of muscle contraction	1	1/62	24/10965	0.12736068823743918	0.2444753342032041	0.186109262315356	0.7302320122945469	ENO1	14
BP	GO:0046456	icosanoid biosynthetic process	1	1/62	24/10965	0.12736068823743918	0.2444753342032041	0.186109262315356	0.7302320122945469	MIF	14
BP	GO:0050798	activated T cell proliferation	1	1/62	24/10965	0.12736068823743918	0.2444753342032041	0.186109262315356	0.7302320122945469	IGFBP2	14
BP	GO:0060148	positive regulation of posttranscriptional gene silencing	1	1/62	24/10965	0.12736068823743918	0.2444753342032041	0.186109262315356	0.7302320122945469	LIN28A	14
BP	GO:0060251	regulation of glial cell proliferation	1	1/62	24/10965	0.12736068823743918	0.2444753342032041	0.186109262315356	0.7302320122945469	SOX11	14
BP	GO:0060421	positive regulation of heart growth	1	1/62	24/10965	0.12736068823743918	0.2444753342032041	0.186109262315356	0.7302320122945469	FGFR1	14
BP	GO:0060765	regulation of androgen receptor signaling pathway	1	1/62	24/10965	0.12736068823743918	0.2444753342032041	0.186109262315356	0.7302320122945469	SFRP1	14
BP	GO:0061900	glial cell activation	1	1/62	24/10965	0.12736068823743918	0.2444753342032041	0.186109262315356	0.7302320122945469	CTSC	14
BP	GO:0071827	plasma lipoprotein particle organization	1	1/62	24/10965	0.12736068823743918	0.2444753342032041	0.186109262315356	0.7302320122945469	APOE	14
BP	GO:0090278	negative regulation of peptide hormone secretion	1	1/62	24/10965	0.12736068823743918	0.2444753342032041	0.186109262315356	0.7302320122945469	SFRP1	14
BP	GO:1901797	negative regulation of signal transduction by p53 class mediator	1	1/62	24/10965	0.12736068823743918	0.2444753342032041	0.186109262315356	0.7302320122945469	MIF	14
BP	GO:1902253	regulation of intrinsic apoptotic signaling pathway by p53 class mediator	1	1/62	24/10965	0.12736068823743918	0.2444753342032041	0.186109262315356	0.7302320122945469	MIF	14
BP	GO:0007411	axon guidance	3	3/62	220/10965	0.1279633064354259	0.24517339384266473	0.18664066710911795	0.7289937219142021	NRP2/SEMA6A/BSG	14
BP	GO:0031098	stress-activated protein kinase signaling cascade	3	3/62	220/10965	0.1279633064354259	0.24517339384266473	0.18664066710911795	0.7289937219142021	FZD5/SFRP2/SFRP1	14
BP	GO:0090130	tissue migration	3	3/62	221/10965	0.12922722190489083	0.2471335129066505	0.18813282710242604	0.7255354182425191	NRP2/FGFR1/APOE	14
BP	GO:0097485	neuron projection guidance	3	3/62	221/10965	0.12922722190489083	0.2471335129066505	0.18813282710242604	0.7255354182425191	NRP2/SEMA6A/BSG	14
BP	GO:0007224	smoothened signaling pathway	2	2/62	112/10965	0.13197894772772137	0.24907462921572035	0.18961052106090542	0.7221375683063689	SFRP1/GPC3	14
BP	GO:0051260	protein homooligomerization	2	2/62	112/10965	0.13197894772772137	0.24907462921572035	0.18961052106090542	0.7221375683063689	ALDOA/MIF	14
BP	GO:1902652	secondary alcohol metabolic process	2	2/62	112/10965	0.13197894772772137	0.24907462921572035	0.18961052106090542	0.7221375683063689	FGFR1/APOE	14
BP	GO:0001662	behavioral fear response	1	1/62	25/10965	0.13230572409606978	0.24907462921572035	0.18961052106090542	0.7221375683063689	APOE	14
BP	GO:0003009	skeletal muscle contraction	1	1/62	25/10965	0.13230572409606978	0.24907462921572035	0.18961052106090542	0.7221375683063689	TNNI3	14
BP	GO:0007435	salivary gland morphogenesis	1	1/62	25/10965	0.13230572409606978	0.24907462921572035	0.18961052106090542	0.7221375683063689	FGFR1	14
BP	GO:0007616	long-term memory	1	1/62	25/10965	0.13230572409606978	0.24907462921572035	0.18961052106090542	0.7221375683063689	APOE	14
BP	GO:0014044	Schwann cell development	1	1/62	25/10965	0.13230572409606978	0.24907462921572035	0.18961052106090542	0.7221375683063689	POU3F1	14
BP	GO:0032760	positive regulation of tumor necrosis factor production	1	1/62	25/10965	0.13230572409606978	0.24907462921572035	0.18961052106090542	0.7221375683063689	MIF	14
BP	GO:0034331	cell junction maintenance	1	1/62	25/10965	0.13230572409606978	0.24907462921572035	0.18961052106090542	0.7221375683063689	CLDN3	14
BP	GO:0042491	inner ear auditory receptor cell differentiation	1	1/62	25/10965	0.13230572409606978	0.24907462921572035	0.18961052106090542	0.7221375683063689	FGFR1	14
BP	GO:0042596	fear response	1	1/62	25/10965	0.13230572409606978	0.24907462921572035	0.18961052106090542	0.7221375683063689	APOE	14
BP	GO:0045981	positive regulation of nucleotide metabolic process	1	1/62	25/10965	0.13230572409606978	0.24907462921572035	0.18961052106090542	0.7221375683063689	ENO1	14
BP	GO:0048286	lung alveolus development	1	1/62	25/10965	0.13230572409606978	0.24907462921572035	0.18961052106090542	0.7221375683063689	IGFBP5	14
BP	GO:0071548	response to dexamethasone	1	1/62	25/10965	0.13230572409606978	0.24907462921572035	0.18961052106090542	0.7221375683063689	DDIT4	14
BP	GO:1900544	positive regulation of purine nucleotide metabolic process	1	1/62	25/10965	0.13230572409606978	0.24907462921572035	0.18961052106090542	0.7221375683063689	ENO1	14
BP	GO:1904707	positive regulation of vascular associated smooth muscle cell proliferation	1	1/62	25/10965	0.13230572409606978	0.24907462921572035	0.18961052106090542	0.7221375683063689	IGFBP5	14
BP	GO:0050776	regulation of immune response	5	5/62	478/10965	0.13257079491923118	0.24934488650253198	0.1898162570892364	0.721666594533642	FZD5/IFITM1/APOE/BST2/MIF	14
BP	GO:0048284	organelle fusion	2	2/62	113/10965	0.1338890838713547	0.2514124820533572	0.19139023461946347	0.7180802251750336	ENO1/BNIP3	14
BP	GO:1901615	organic hydroxy compound metabolic process	4	4/62	350/10965	0.13558226168326404	0.2514124820533572	0.19139023461946347	0.7180802251750336	FGFR1/LDHA/TPI1/APOE	14
BP	GO:0001890	placenta development	2	2/62	114/10965	0.13580561948906217	0.2514124820533572	0.19139023461946347	0.7180802251750336	FZD5/BSG	14
BP	GO:0009152	purine ribonucleotide biosynthetic process	2	2/62	114/10965	0.13580561948906217	0.2514124820533572	0.19139023461946347	0.7180802251750336	ENO1/ALDOA	14
BP	GO:0010634	positive regulation of epithelial cell migration	2	2/62	114/10965	0.13580561948906217	0.2514124820533572	0.19139023461946347	0.7180802251750336	NRP2/FGFR1	14
BP	GO:0042770	signal transduction in response to DNA damage	2	2/62	114/10965	0.13580561948906217	0.2514124820533572	0.19139023461946347	0.7180802251750336	SOX4/MIF	14
BP	GO:0048545	response to steroid hormone	3	3/62	227/10965	0.1369047370338909	0.2514124820533572	0.19139023461946347	0.7180802251750336	IGFBP2/SFRP1/DDIT4	14
BP	GO:0001569	branching involved in blood vessel morphogenesis	1	1/62	26/10965	0.13722318708565306	0.2514124820533572	0.19139023461946347	0.7180802251750336	SFRP2	14
BP	GO:0002209	behavioral defense response	1	1/62	26/10965	0.13722318708565306	0.2514124820533572	0.19139023461946347	0.7180802251750336	APOE	14
BP	GO:0002704	negative regulation of leukocyte mediated immunity	1	1/62	26/10965	0.13722318708565306	0.2514124820533572	0.19139023461946347	0.7180802251750336	BST2	14
BP	GO:0010464	regulation of mesenchymal cell proliferation	1	1/62	26/10965	0.13722318708565306	0.2514124820533572	0.19139023461946347	0.7180802251750336	FGFR1	14
BP	GO:0010586	miRNA metabolic process	1	1/62	26/10965	0.13722318708565306	0.2514124820533572	0.19139023461946347	0.7180802251750336	LIN28A	14
BP	GO:0021517	ventral spinal cord development	1	1/62	26/10965	0.13722318708565306	0.2514124820533572	0.19139023461946347	0.7180802251750336	SOX4	14
BP	GO:0030195	negative regulation of blood coagulation	1	1/62	26/10965	0.13722318708565306	0.2514124820533572	0.19139023461946347	0.7180802251750336	APOE	14
BP	GO:0030808	regulation of nucleotide biosynthetic process	1	1/62	26/10965	0.13722318708565306	0.2514124820533572	0.19139023461946347	0.7180802251750336	ENO1	14
BP	GO:0030970	retrograde protein transport, ER to cytosol	1	1/62	26/10965	0.13722318708565306	0.2514124820533572	0.19139023461946347	0.7180802251750336	HSP90B1	14
BP	GO:0031670	cellular response to nutrient	1	1/62	26/10965	0.13722318708565306	0.2514124820533572	0.19139023461946347	0.7180802251750336	SFRP1	14
BP	GO:0043243	positive regulation of protein-containing complex disassembly	1	1/62	26/10965	0.13722318708565306	0.2514124820533572	0.19139023461946347	0.7180802251750336	BNIP3	14
BP	GO:0043457	regulation of cellular respiration	1	1/62	26/10965	0.13722318708565306	0.2514124820533572	0.19139023461946347	0.7180802251750336	BNIP3	14
BP	GO:0045494	photoreceptor cell maintenance	1	1/62	26/10965	0.13722318708565306	0.2514124820533572	0.19139023461946347	0.7180802251750336	SLC2A1	14
BP	GO:0045879	negative regulation of smoothened signaling pathway	1	1/62	26/10965	0.13722318708565306	0.2514124820533572	0.19139023461946347	0.7180802251750336	GPC3	14
BP	GO:0060416	response to growth hormone	1	1/62	26/10965	0.13722318708565306	0.2514124820533572	0.19139023461946347	0.7180802251750336	IGFBP5	14
BP	GO:0071825	protein-lipid complex subunit organization	1	1/62	26/10965	0.13722318708565306	0.2514124820533572	0.19139023461946347	0.7180802251750336	APOE	14
BP	GO:1900047	negative regulation of hemostasis	1	1/62	26/10965	0.13722318708565306	0.2514124820533572	0.19139023461946347	0.7180802251750336	APOE	14
BP	GO:1900371	regulation of purine nucleotide biosynthetic process	1	1/62	26/10965	0.13722318708565306	0.2514124820533572	0.19139023461946347	0.7180802251750336	ENO1	14
BP	GO:1902003	regulation of amyloid-beta formation	1	1/62	26/10965	0.13722318708565306	0.2514124820533572	0.19139023461946347	0.7180802251750336	APOE	14
BP	GO:1903513	endoplasmic reticulum to cytosol transport	1	1/62	26/10965	0.13722318708565306	0.2514124820533572	0.19139023461946347	0.7180802251750336	HSP90B1	14
BP	GO:1903557	positive regulation of tumor necrosis factor superfamily cytokine production	1	1/62	26/10965	0.13722318708565306	0.2514124820533572	0.19139023461946347	0.7180802251750336	MIF	14
BP	GO:2000765	regulation of cytoplasmic translation	1	1/62	26/10965	0.13722318708565306	0.2514124820533572	0.19139023461946347	0.7180802251750336	LIN28A	14
BP	GO:0045727	positive regulation of translation	2	2/62	115/10965	0.13772842443993524	0.2518883484409511	0.19175249260612057	0.7172589819132824	LIN28A/SOX4	14
BP	GO:0061351	neural precursor cell proliferation	2	2/62	115/10965	0.13772842443993524	0.2518883484409511	0.19175249260612057	0.7172589819132824	SIX3/FGFR1	14
BP	GO:0030003	cellular cation homeostasis	4	4/62	355/10965	0.1406688410553601	0.25557961854834516	0.19456250842605122	0.7109408431651218	BNIP3/HSP90B1/APOE/TNNI3	14
BP	GO:0050900	leukocyte migration	3	3/62	230/10965	0.14080228119188787	0.25557961854834516	0.19456250842605122	0.7109408431651218	SLC16A3/BSG/MIF	14
BP	GO:0002228	natural killer cell mediated immunity	1	1/62	27/10965	0.14211322844233032	0.25557961854834516	0.19456250842605122	0.7109408431651218	CLEC2A	14
BP	GO:0006739	NADP metabolic process	1	1/62	27/10965	0.14211322844233032	0.25557961854834516	0.19456250842605122	0.7109408431651218	PGAM1	14
BP	GO:0010656	negative regulation of muscle cell apoptotic process	1	1/62	27/10965	0.14211322844233032	0.25557961854834516	0.19456250842605122	0.7109408431651218	SFRP2	14
BP	GO:0014888	striated muscle adaptation	1	1/62	27/10965	0.14211322844233032	0.25557961854834516	0.19456250842605122	0.7109408431651218	IGFBP5	14
BP	GO:0030262	apoptotic nuclear changes	1	1/62	27/10965	0.14211322844233032	0.25557961854834516	0.19456250842605122	0.7109408431651218	BLCAP	14
BP	GO:0033144	negative regulation of intracellular steroid hormone receptor signaling pathway	1	1/62	27/10965	0.14211322844233032	0.25557961854834516	0.19456250842605122	0.7109408431651218	SFRP1	14
BP	GO:0042267	natural killer cell mediated cytotoxicity	1	1/62	27/10965	0.14211322844233032	0.25557961854834516	0.19456250842605122	0.7109408431651218	CLEC2A	14
BP	GO:0043516	regulation of DNA damage response, signal transduction by p53 class mediator	1	1/62	27/10965	0.14211322844233032	0.25557961854834516	0.19456250842605122	0.7109408431651218	MIF	14
BP	GO:0046326	positive regulation of glucose import	1	1/62	27/10965	0.14211322844233032	0.25557961854834516	0.19456250842605122	0.7109408431651218	GPC3	14
BP	GO:0048841	regulation of axon extension involved in axon guidance	1	1/62	27/10965	0.14211322844233032	0.25557961854834516	0.19456250842605122	0.7109408431651218	SEMA6A	14
BP	GO:0060043	regulation of cardiac muscle cell proliferation	1	1/62	27/10965	0.14211322844233032	0.25557961854834516	0.19456250842605122	0.7109408431651218	FGFR1	14
BP	GO:0071320	cellular response to cAMP	1	1/62	27/10965	0.14211322844233032	0.25557961854834516	0.19456250842605122	0.7109408431651218	IGFBP5	14
BP	GO:0090184	positive regulation of kidney development	1	1/62	27/10965	0.14211322844233032	0.25557961854834516	0.19456250842605122	0.7109408431651218	LIN28A	14
BP	GO:0090207	regulation of triglyceride metabolic process	1	1/62	27/10965	0.14211322844233032	0.25557961854834516	0.19456250842605122	0.7109408431651218	APOE	14
BP	GO:0150117	positive regulation of cell-substrate junction organization	1	1/62	27/10965	0.14211322844233032	0.25557961854834516	0.19456250842605122	0.7109408431651218	SFRP1	14
BP	GO:1903955	positive regulation of protein targeting to mitochondrion	1	1/62	27/10965	0.14211322844233032	0.25557961854834516	0.19456250842605122	0.7109408431651218	FZD5	14
BP	GO:2000107	negative regulation of leukocyte apoptotic process	1	1/62	27/10965	0.14211322844233032	0.25557961854834516	0.19456250842605122	0.7109408431651218	MIF	14
BP	GO:0030198	extracellular matrix organization	3	3/62	232/10965	0.14342174083363676	0.2570070412692719	0.19564914806791803	0.7085220388453747	SFRP2/P4HA1/BSG	14
BP	GO:0043062	extracellular structure organization	3	3/62	232/10965	0.14342174083363676	0.2570070412692719	0.19564914806791803	0.7085220388453747	SFRP2/P4HA1/BSG	14
BP	GO:0072331	signal transduction by p53 class mediator	3	3/62	232/10965	0.14342174083363676	0.2570070412692719	0.19564914806791803	0.7085220388453747	SOX4/DDIT4/MIF	14
BP	GO:0050870	positive regulation of T cell activation	2	2/62	118/10965	0.14353317217085065	0.2570070412692719	0.19564914806791803	0.7085220388453747	IGFBP2/SOX4	14
BP	GO:0071216	cellular response to biotic stimulus	2	2/62	118/10965	0.14353317217085065	0.2570070412692719	0.19564914806791803	0.7085220388453747	FZD5/MIF	14
BP	GO:0010950	positive regulation of endopeptidase activity	2	2/62	119/10965	0.14547977736506226	0.26026547790157606	0.19812966513077818	0.7030504944863666	FAM162A/SFRP2	14
BP	GO:0006873	cellular ion homeostasis	4	4/62	360/10965	0.14583242850019043	0.2604445156299069	0.1982659593694377	0.7027518441762263	BNIP3/HSP90B1/APOE/TNNI3	14
BP	GO:0001893	maternal placenta development	1	1/62	28/10965	0.14697599858646793	0.2604445156299069	0.1982659593694377	0.7027518441762263	BSG	14
BP	GO:0007431	salivary gland development	1	1/62	28/10965	0.14697599858646793	0.2604445156299069	0.1982659593694377	0.7027518441762263	FGFR1	14
BP	GO:0010677	negative regulation of cellular carbohydrate metabolic process	1	1/62	28/10965	0.14697599858646793	0.2604445156299069	0.1982659593694377	0.7027518441762263	DDIT4	14
BP	GO:0019730	antimicrobial humoral response	1	1/62	28/10965	0.14697599858646793	0.2604445156299069	0.1982659593694377	0.7027518441762263	GAPDH	14
BP	GO:0030888	regulation of B cell proliferation	1	1/62	28/10965	0.14697599858646793	0.2604445156299069	0.1982659593694377	0.7027518441762263	MIF	14
BP	GO:0050819	negative regulation of coagulation	1	1/62	28/10965	0.14697599858646793	0.2604445156299069	0.1982659593694377	0.7027518441762263	APOE	14
BP	GO:0060674	placenta blood vessel development	1	1/62	28/10965	0.14697599858646793	0.2604445156299069	0.1982659593694377	0.7027518441762263	FZD5	14
BP	GO:0070306	lens fiber cell differentiation	1	1/62	28/10965	0.14697599858646793	0.2604445156299069	0.1982659593694377	0.7027518441762263	SIX3	14
BP	GO:0120009	intermembrane lipid transfer	1	1/62	28/10965	0.14697599858646793	0.2604445156299069	0.1982659593694377	0.7027518441762263	APOE	14
BP	GO:2000758	positive regulation of peptidyl-lysine acetylation	1	1/62	28/10965	0.14697599858646793	0.2604445156299069	0.1982659593694377	0.7027518441762263	SOX4	14
BP	GO:0010038	response to metal ion	3	3/62	236/10965	0.14870996371707892	0.2630627978857293	0.20025915259178326	0.6984076259090388	IGFBP2/BNIP3/BSG	14
BP	GO:0018105	peptidyl-serine phosphorylation	3	3/62	236/10965	0.14870996371707892	0.2630627978857293	0.20025915259178326	0.6984076259090388	SFRP2/DDIT4/MIF	14
BP	GO:0051017	actin filament bundle assembly	2	2/62	121/10965	0.14938977517546234	0.26381051519797655	0.2008283597793153	0.6971749587282494	SFRP1/HSP90B1	14
BP	GO:0061572	actin filament bundle organization	2	2/62	121/10965	0.14938977517546234	0.26381051519797655	0.2008283597793153	0.6971749587282494	SFRP1/HSP90B1	14
BP	GO:0007416	synapse assembly	2	2/62	122/10965	0.15135292307696	0.2646707730710057	0.2014832395800618	0.6957610748858288	FZD5/TPBG	14
BP	GO:0009913	epidermal cell differentiation	2	2/62	122/10965	0.15135292307696	0.2646707730710057	0.2014832395800618	0.6957610748858288	POU3F1/FGFR1	14
BP	GO:0010977	negative regulation of neuron projection development	2	2/62	122/10965	0.15135292307696	0.2646707730710057	0.2014832395800618	0.6957610748858288	SEMA6A/APOE	14
BP	GO:0014706	striated muscle tissue development	3	3/62	238/10965	0.15137813623511515	0.2646707730710057	0.2014832395800618	0.6957610748858288	SOX11/FGFR1/TNNI3	14
BP	GO:0003382	epithelial cell morphogenesis	1	1/62	29/10965	0.15181164712698525	0.2646707730710057	0.2014832395800618	0.6957610748858288	CLDN3	14
BP	GO:0006921	cellular component disassembly involved in execution phase of apoptosis	1	1/62	29/10965	0.15181164712698525	0.2646707730710057	0.2014832395800618	0.6957610748858288	BLCAP	14
BP	GO:0021515	cell differentiation in spinal cord	1	1/62	29/10965	0.15181164712698525	0.2646707730710057	0.2014832395800618	0.6957610748858288	SOX4	14
BP	GO:0031018	endocrine pancreas development	1	1/62	29/10965	0.15181164712698525	0.2646707730710057	0.2014832395800618	0.6957610748858288	SOX4	14
BP	GO:0032890	regulation of organic acid transport	1	1/62	29/10965	0.15181164712698525	0.2646707730710057	0.2014832395800618	0.6957610748858288	MIF	14
BP	GO:0035987	endodermal cell differentiation	1	1/62	29/10965	0.15181164712698525	0.2646707730710057	0.2014832395800618	0.6957610748858288	SOX2	14
BP	GO:0043114	regulation of vascular permeability	1	1/62	29/10965	0.15181164712698525	0.2646707730710057	0.2014832395800618	0.6957610748858288	APOE	14
BP	GO:0048011	neurotrophin TRK receptor signaling pathway	1	1/62	29/10965	0.15181164712698525	0.2646707730710057	0.2014832395800618	0.6957610748858288	DDIT4	14
BP	GO:0048512	circadian behavior	1	1/62	29/10965	0.15181164712698525	0.2646707730710057	0.2014832395800618	0.6957610748858288	SIX3	14
BP	GO:0048662	negative regulation of smooth muscle cell proliferation	1	1/62	29/10965	0.15181164712698525	0.2646707730710057	0.2014832395800618	0.6957610748858288	IGFBP5	14
BP	GO:0150076	neuroinflammatory response	1	1/62	29/10965	0.15181164712698525	0.2646707730710057	0.2014832395800618	0.6957610748858288	CTSC	14
BP	GO:0009896	positive regulation of catabolic process	4	4/62	366/10965	0.1521275609774386	0.26499639654134466	0.2017311236623348	0.695227092406735	BNIP3/CTSC/APOE/GPC3	14
BP	GO:0008360	regulation of cell shape	2	2/62	124/10965	0.15529491379330457	0.2696182068123585	0.20524952237074998	0.6877178448394061	SHROOM3/ALDOA	14
BP	GO:0007622	rhythmic behavior	1	1/62	30/10965	0.15662032286565852	0.2696182068123585	0.20524952237074998	0.6877178448394061	SIX3	14
BP	GO:0010518	positive regulation of phospholipase activity	1	1/62	30/10965	0.15662032286565852	0.2696182068123585	0.20524952237074998	0.6877178448394061	FGFR1	14
BP	GO:0010828	positive regulation of glucose transmembrane transport	1	1/62	30/10965	0.15662032286565852	0.2696182068123585	0.20524952237074998	0.6877178448394061	GPC3	14
BP	GO:0014911	positive regulation of smooth muscle cell migration	1	1/62	30/10965	0.15662032286565852	0.2696182068123585	0.20524952237074998	0.6877178448394061	IGFBP5	14
BP	GO:0033344	cholesterol efflux	1	1/62	30/10965	0.15662032286565852	0.2696182068123585	0.20524952237074998	0.6877178448394061	APOE	14
BP	GO:0033628	regulation of cell adhesion mediated by integrin	1	1/62	30/10965	0.15662032286565852	0.2696182068123585	0.20524952237074998	0.6877178448394061	SFRP2	14
BP	GO:0035315	hair cell differentiation	1	1/62	30/10965	0.15662032286565852	0.2696182068123585	0.20524952237074998	0.6877178448394061	FGFR1	14
BP	GO:0046622	positive regulation of organ growth	1	1/62	30/10965	0.15662032286565852	0.2696182068123585	0.20524952237074998	0.6877178448394061	FGFR1	14
BP	GO:0050999	regulation of nitric-oxide synthase activity	1	1/62	30/10965	0.15662032286565852	0.2696182068123585	0.20524952237074998	0.6877178448394061	APOE	14
BP	GO:0055025	positive regulation of cardiac muscle tissue development	1	1/62	30/10965	0.15662032286565852	0.2696182068123585	0.20524952237074998	0.6877178448394061	FGFR1	14
BP	GO:1902042	negative regulation of extrinsic apoptotic signaling pathway via death domain receptors	1	1/62	30/10965	0.15662032286565852	0.2696182068123585	0.20524952237074998	0.6877178448394061	SFRP2	14
BP	GO:1905517	macrophage migration	1	1/62	30/10965	0.15662032286565852	0.2696182068123585	0.20524952237074998	0.6877178448394061	MIF	14
BP	GO:2000648	positive regulation of stem cell proliferation	1	1/62	30/10965	0.15662032286565852	0.2696182068123585	0.20524952237074998	0.6877178448394061	SOX11	14
BP	GO:0010212	response to ionizing radiation	2	2/62	125/10965	0.15727351882224117	0.27028916300103756	0.20576029439496243	0.6866384273813764	SFRP2/SFRP1	14
BP	GO:0033002	muscle cell proliferation	2	2/62	125/10965	0.15727351882224117	0.27028916300103756	0.20576029439496243	0.6866384273813764	IGFBP5/FGFR1	14
BP	GO:0010035	response to inorganic substance	4	4/62	371/10965	0.15745346678000371	0.270371978102567	0.20582333820878704	0.6865053823401871	IGFBP2/BNIP3/LDHA/BSG	14
BP	GO:0009260	ribonucleotide biosynthetic process	2	2/62	126/10965	0.1592570403349273	0.2728148769690861	0.20768301909414372	0.6825990114822065	ENO1/ALDOA	14
BP	GO:1903039	positive regulation of leukocyte cell-cell adhesion	2	2/62	126/10965	0.1592570403349273	0.2728148769690861	0.20768301909414372	0.6825990114822065	IGFBP2/SOX4	14
BP	GO:0015850	organic hydroxy compound transport	2	2/62	127/10965	0.1612453622661318	0.2728148769690861	0.20768301909414372	0.6825990114822065	SLC16A3/APOE	14
BP	GO:0098657	import into cell	2	2/62	127/10965	0.1612453622661318	0.2728148769690861	0.20768301909414372	0.6825990114822065	SLC2A1/SLC2A3	14
BP	GO:1903364	positive regulation of cellular protein catabolic process	2	2/62	127/10965	0.1612453622661318	0.2728148769690861	0.20768301909414372	0.6825990114822065	CTSC/APOE	14
BP	GO:0002709	regulation of T cell mediated immunity	1	1/62	31/10965	0.16140217380139887	0.2728148769690861	0.20768301909414372	0.6825990114822065	FZD5	14
BP	GO:0002762	negative regulation of myeloid leukocyte differentiation	1	1/62	31/10965	0.16140217380139887	0.2728148769690861	0.20768301909414372	0.6825990114822065	SFRP1	14
BP	GO:0006692	prostanoid metabolic process	1	1/62	31/10965	0.16140217380139887	0.2728148769690861	0.20768301909414372	0.6825990114822065	MIF	14
BP	GO:0006693	prostaglandin metabolic process	1	1/62	31/10965	0.16140217380139887	0.2728148769690861	0.20768301909414372	0.6825990114822065	MIF	14
BP	GO:0021545	cranial nerve development	1	1/62	31/10965	0.16140217380139887	0.2728148769690861	0.20768301909414372	0.6825990114822065	NRP2	14
BP	GO:0030857	negative regulation of epithelial cell differentiation	1	1/62	31/10965	0.16140217380139887	0.2728148769690861	0.20768301909414372	0.6825990114822065	FRZB	14
BP	GO:0031663	lipopolysaccharide-mediated signaling pathway	1	1/62	31/10965	0.16140217380139887	0.2728148769690861	0.20768301909414372	0.6825990114822065	MIF	14
BP	GO:0032642	regulation of chemokine production	1	1/62	31/10965	0.16140217380139887	0.2728148769690861	0.20768301909414372	0.6825990114822065	MIF	14
BP	GO:0034661	ncRNA catabolic process	1	1/62	31/10965	0.16140217380139887	0.2728148769690861	0.20768301909414372	0.6825990114822065	LIN28A	14
BP	GO:0046850	regulation of bone remodeling	1	1/62	31/10965	0.16140217380139887	0.2728148769690861	0.20768301909414372	0.6825990114822065	SFRP1	14
BP	GO:0060119	inner ear receptor cell development	1	1/62	31/10965	0.16140217380139887	0.2728148769690861	0.20768301909414372	0.6825990114822065	FGFR1	14
BP	GO:0061028	establishment of endothelial barrier	1	1/62	31/10965	0.16140217380139887	0.2728148769690861	0.20768301909414372	0.6825990114822065	CLDN3	14
BP	GO:0070228	regulation of lymphocyte apoptotic process	1	1/62	31/10965	0.16140217380139887	0.2728148769690861	0.20768301909414372	0.6825990114822065	MIF	14
BP	GO:2001222	regulation of neuron migration	1	1/62	31/10965	0.16140217380139887	0.2728148769690861	0.20768301909414372	0.6825990114822065	SEMA6A	14
BP	GO:0030307	positive regulation of cell growth	2	2/62	128/10965	0.16323836966614122	0.275691468769483	0.2098728530080603	0.6780437336485174	SFRP2/SFRP1	14
BP	GO:0007409	axonogenesis	4	4/62	378/10965	0.16502767506420557	0.27630054807133697	0.2103365206411532	0.6770853143992506	NRP2/SEMA6A/BSG/APOE	14
BP	GO:0071407	cellular response to organic cyclic compound	4	4/62	378/10965	0.16502767506420557	0.27630054807133697	0.2103365206411532	0.6770853143992506	IGFBP5/SFRP1/DDIT4/HSP90B1	14
BP	GO:0002573	myeloid leukocyte differentiation	2	2/62	129/10965	0.16523594869220118	0.27630054807133697	0.2103365206411532	0.6770853143992506	SFRP1/GPC3	14
BP	GO:0006164	purine nucleotide biosynthetic process	2	2/62	129/10965	0.16523594869220118	0.27630054807133697	0.2103365206411532	0.6770853143992506	ENO1/ALDOA	14
BP	GO:1901654	response to ketone	2	2/62	129/10965	0.16523594869220118	0.27630054807133697	0.2103365206411532	0.6770853143992506	SFRP1/DDIT4	14
BP	GO:0009988	cell-cell recognition	1	1/62	32/10965	0.16615734713451746	0.27630054807133697	0.2103365206411532	0.6770853143992506	ALDOA	14
BP	GO:0010596	negative regulation of endothelial cell migration	1	1/62	32/10965	0.16615734713451746	0.27630054807133697	0.2103365206411532	0.6770853143992506	APOE	14
BP	GO:0032371	regulation of sterol transport	1	1/62	32/10965	0.16615734713451746	0.27630054807133697	0.2103365206411532	0.6770853143992506	APOE	14
BP	GO:0032374	regulation of cholesterol transport	1	1/62	32/10965	0.16615734713451746	0.27630054807133697	0.2103365206411532	0.6770853143992506	APOE	14
BP	GO:0034205	amyloid-beta formation	1	1/62	32/10965	0.16615734713451746	0.27630054807133697	0.2103365206411532	0.6770853143992506	APOE	14
BP	GO:0042181	ketone biosynthetic process	1	1/62	32/10965	0.16615734713451746	0.27630054807133697	0.2103365206411532	0.6770853143992506	TPI1	14
BP	GO:0044003	modulation by symbiont of host process	1	1/62	32/10965	0.16615734713451746	0.27630054807133697	0.2103365206411532	0.6770853143992506	GAPDH	14
BP	GO:0050873	brown fat cell differentiation	1	1/62	32/10965	0.16615734713451746	0.27630054807133697	0.2103365206411532	0.6770853143992506	BNIP3	14
BP	GO:0055010	ventricular cardiac muscle tissue morphogenesis	1	1/62	32/10965	0.16615734713451746	0.27630054807133697	0.2103365206411532	0.6770853143992506	TNNI3	14
BP	GO:0060443	mammary gland morphogenesis	1	1/62	32/10965	0.16615734713451746	0.27630054807133697	0.2103365206411532	0.6770853143992506	IGFBP5	14
BP	GO:0097755	positive regulation of blood vessel diameter	1	1/62	32/10965	0.16615734713451746	0.27630054807133697	0.2103365206411532	0.6770853143992506	APOE	14
BP	GO:1901998	toxin transport	1	1/62	32/10965	0.16615734713451746	0.27630054807133697	0.2103365206411532	0.6770853143992506	BNIP3	14
BP	GO:1902991	regulation of amyloid precursor protein catabolic process	1	1/62	32/10965	0.16615734713451746	0.27630054807133697	0.2103365206411532	0.6770853143992506	APOE	14
BP	GO:2001239	regulation of extrinsic apoptotic signaling pathway in absence of ligand	1	1/62	32/10965	0.16615734713451746	0.27630054807133697	0.2103365206411532	0.6770853143992506	FGFR1	14
BP	GO:0009267	cellular response to starvation	2	2/62	130/10965	0.1672379866000159	0.2778723469661803	0.2115330680711047	0.6746217315597177	SLC2A1/SFRP1	14
BP	GO:0018209	peptidyl-serine modification	3	3/62	250/10965	0.1677054421219529	0.27819851837853465	0.2117813692796478	0.6741122480761762	SFRP2/DDIT4/MIF	14
BP	GO:0071902	positive regulation of protein serine/threonine kinase activity	3	3/62	250/10965	0.1677054421219529	0.27819851837853465	0.2117813692796478	0.6741122480761762	FZD5/FGFR1/MIF	14
BP	GO:0021543	pallium development	2	2/62	131/10965	0.1692443717353057	0.2791863455286601	0.21253336245230928	0.6725728868293651	SLC2A1/BNIP3	14
BP	GO:0006066	alcohol metabolic process	3	3/62	252/10965	0.1704769591160979	0.2791863455286601	0.21253336245230928	0.6725728868293651	FGFR1/TPI1/APOE	14
BP	GO:0007517	muscle organ development	3	3/62	252/10965	0.1704769591160979	0.2791863455286601	0.21253336245230928	0.6725728868293651	SOX11/FGFR1/TNNI3	14
BP	GO:0000266	mitochondrial fission	1	1/62	33/10965	0.17088598927095378	0.2791863455286601	0.21253336245230928	0.6725728868293651	BNIP3	14
BP	GO:0006509	membrane protein ectodomain proteolysis	1	1/62	33/10965	0.17088598927095378	0.2791863455286601	0.21253336245230928	0.6725728868293651	APOE	14
BP	GO:0007223	Wnt signaling pathway, calcium modulating pathway	1	1/62	33/10965	0.17088598927095378	0.2791863455286601	0.21253336245230928	0.6725728868293651	FZD5	14
BP	GO:0010883	regulation of lipid storage	1	1/62	33/10965	0.17088598927095378	0.2791863455286601	0.21253336245230928	0.6725728868293651	HILPDA	14
BP	GO:0014003	oligodendrocyte development	1	1/62	33/10965	0.17088598927095378	0.2791863455286601	0.21253336245230928	0.6725728868293651	SOX11	14
BP	GO:0014037	Schwann cell differentiation	1	1/62	33/10965	0.17088598927095378	0.2791863455286601	0.21253336245230928	0.6725728868293651	POU3F1	14
BP	GO:0030850	prostate gland development	1	1/62	33/10965	0.17088598927095378	0.2791863455286601	0.21253336245230928	0.6725728868293651	SFRP1	14
BP	GO:0031341	regulation of cell killing	1	1/62	33/10965	0.17088598927095378	0.2791863455286601	0.21253336245230928	0.6725728868293651	GAPDH	14
BP	GO:0032801	receptor catabolic process	1	1/62	33/10965	0.17088598927095378	0.2791863455286601	0.21253336245230928	0.6725728868293651	APOE	14
BP	GO:0045620	negative regulation of lymphocyte differentiation	1	1/62	33/10965	0.17088598927095378	0.2791863455286601	0.21253336245230928	0.6725728868293651	SFRP1	14
BP	GO:0045912	negative regulation of carbohydrate metabolic process	1	1/62	33/10965	0.17088598927095378	0.2791863455286601	0.21253336245230928	0.6725728868293651	DDIT4	14
BP	GO:0046888	negative regulation of hormone secretion	1	1/62	33/10965	0.17088598927095378	0.2791863455286601	0.21253336245230928	0.6725728868293651	SFRP1	14
BP	GO:0050886	endocrine process	1	1/62	33/10965	0.17088598927095378	0.2791863455286601	0.21253336245230928	0.6725728868293651	FGFR1	14
BP	GO:0051353	positive regulation of oxidoreductase activity	1	1/62	33/10965	0.17088598927095378	0.2791863455286601	0.21253336245230928	0.6725728868293651	APOE	14
BP	GO:0071470	cellular response to osmotic stress	1	1/62	33/10965	0.17088598927095378	0.2791863455286601	0.21253336245230928	0.6725728868293651	SLC2A1	14
BP	GO:0090303	positive regulation of wound healing	1	1/62	33/10965	0.17088598927095378	0.2791863455286601	0.21253336245230928	0.6725728868293651	CLDN3	14
BP	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	2	2/62	132/10965	0.17125499352542303	0.2793443932545056	0.21265367784430406	0.6723271017640933	FZD5/CTSC	14
BP	GO:0006261	DNA-dependent DNA replication	2	2/62	132/10965	0.17125499352542303	0.2793443932545056	0.21265367784430406	0.6723271017640933	HMGA1/FGFR1	14
BP	GO:0022407	regulation of cell-cell adhesion	3	3/62	253/10965	0.17186783196612568	0.280121359169571	0.21324515081955644	0.6711208358755767	IGFBP2/SOX2/SOX4	14
BP	GO:0046390	ribose phosphate biosynthetic process	2	2/62	133/10965	0.17326974247102636	0.2821821520242429	0.21481394973016132	0.6679375195547902	ENO1/ALDOA	14
BP	GO:0001941	postsynaptic membrane organization	1	1/62	34/10965	0.17558824582649724	0.28415384892426837	0.21631492346548392	0.66491351775398	APOE	14
BP	GO:0006940	regulation of smooth muscle contraction	1	1/62	34/10965	0.17558824582649724	0.28415384892426837	0.21631492346548392	0.66491351775398	TNNI3	14
BP	GO:0032602	chemokine production	1	1/62	34/10965	0.17558824582649724	0.28415384892426837	0.21631492346548392	0.66491351775398	MIF	14
BP	GO:0034381	plasma lipoprotein particle clearance	1	1/62	34/10965	0.17558824582649724	0.28415384892426837	0.21631492346548392	0.66491351775398	APOE	14
BP	GO:0050879	multicellular organismal movement	1	1/62	34/10965	0.17558824582649724	0.28415384892426837	0.21631492346548392	0.66491351775398	TNNI3	14
BP	GO:0050881	musculoskeletal movement	1	1/62	34/10965	0.17558824582649724	0.28415384892426837	0.21631492346548392	0.66491351775398	TNNI3	14
BP	GO:0060038	cardiac muscle cell proliferation	1	1/62	34/10965	0.17558824582649724	0.28415384892426837	0.21631492346548392	0.66491351775398	FGFR1	14
BP	GO:2000772	regulation of cellular senescence	1	1/62	34/10965	0.17558824582649724	0.28415384892426837	0.21631492346548392	0.66491351775398	HMGA1	14
BP	GO:0006636	unsaturated fatty acid biosynthetic process	1	1/62	35/10965	0.18026426163097609	0.2876378420425839	0.21896714763065284	0.6596210389177782	MIF	14
BP	GO:0030521	androgen receptor signaling pathway	1	1/62	35/10965	0.18026426163097609	0.2876378420425839	0.21896714763065284	0.6596210389177782	SFRP1	14
BP	GO:0031641	regulation of myelination	1	1/62	35/10965	0.18026426163097609	0.2876378420425839	0.21896714763065284	0.6596210389177782	CTSC	14
BP	GO:0032007	negative regulation of TOR signaling	1	1/62	35/10965	0.18026426163097609	0.2876378420425839	0.21896714763065284	0.6596210389177782	DDIT4	14
BP	GO:0032008	positive regulation of TOR signaling	1	1/62	35/10965	0.18026426163097609	0.2876378420425839	0.21896714763065284	0.6596210389177782	LIN28A	14
BP	GO:0032651	regulation of interleukin-1 beta production	1	1/62	35/10965	0.18026426163097609	0.2876378420425839	0.21896714763065284	0.6596210389177782	FZD5	14
BP	GO:0032768	regulation of monooxygenase activity	1	1/62	35/10965	0.18026426163097609	0.2876378420425839	0.21896714763065284	0.6596210389177782	APOE	14
BP	GO:0035722	interleukin-12-mediated signaling pathway	1	1/62	35/10965	0.18026426163097609	0.2876378420425839	0.21896714763065284	0.6596210389177782	MIF	14
BP	GO:0038179	neurotrophin signaling pathway	1	1/62	35/10965	0.18026426163097609	0.2876378420425839	0.21896714763065284	0.6596210389177782	DDIT4	14
BP	GO:0043486	histone exchange	1	1/62	35/10965	0.18026426163097609	0.2876378420425839	0.21896714763065284	0.6596210389177782	PTMA	14
BP	GO:0043900	regulation of multi-organism process	1	1/62	35/10965	0.18026426163097609	0.2876378420425839	0.21896714763065284	0.6596210389177782	BST2	14
BP	GO:0050795	regulation of behavior	1	1/62	35/10965	0.18026426163097609	0.2876378420425839	0.21896714763065284	0.6596210389177782	APOE	14
BP	GO:0070265	necrotic cell death	1	1/62	35/10965	0.18026426163097609	0.2876378420425839	0.21896714763065284	0.6596210389177782	BNIP3	14
BP	GO:0071398	cellular response to fatty acid	1	1/62	35/10965	0.18026426163097609	0.2876378420425839	0.21896714763065284	0.6596210389177782	SFRP1	14
BP	GO:1900271	regulation of long-term synaptic potentiation	1	1/62	35/10965	0.18026426163097609	0.2876378420425839	0.21896714763065284	0.6596210389177782	APOE	14
BP	GO:1901985	positive regulation of protein acetylation	1	1/62	35/10965	0.18026426163097609	0.2876378420425839	0.21896714763065284	0.6596210389177782	SOX4	14
BP	GO:1904705	regulation of vascular associated smooth muscle cell proliferation	1	1/62	35/10965	0.18026426163097609	0.2876378420425839	0.21896714763065284	0.6596210389177782	IGFBP5	14
BP	GO:1990874	vascular associated smooth muscle cell proliferation	1	1/62	35/10965	0.18026426163097609	0.2876378420425839	0.21896714763065284	0.6596210389177782	IGFBP5	14
BP	GO:0002244	hematopoietic progenitor cell differentiation	2	2/62	137/10965	0.18136785692565605	0.28894941181012906	0.21996559306772934	0.6576452460388496	SOX4/SFRP1	14
BP	GO:0099173	postsynapse organization	2	2/62	137/10965	0.18136785692565605	0.28894941181012906	0.21996559306772934	0.6576452460388496	NRP2/APOE	14
BP	GO:0001818	negative regulation of cytokine production	2	2/62	138/10965	0.1834016361485654	0.29127363050622773	0.22173492750140658	0.6541658917913541	FGFR1/BST2	14
BP	GO:0072522	purine-containing compound biosynthetic process	2	2/62	138/10965	0.1834016361485654	0.29127363050622773	0.22173492750140658	0.6541658917913541	ENO1/ALDOA	14
BP	GO:0001706	endoderm formation	1	1/62	36/10965	0.18491418073242905	0.29127363050622773	0.22173492750140658	0.6541658917913541	SOX2	14
BP	GO:0006342	chromatin silencing	1	1/62	36/10965	0.18491418073242905	0.29127363050622773	0.22173492750140658	0.6541658917913541	HMGA1	14
BP	GO:0008038	neuron recognition	1	1/62	36/10965	0.18491418073242905	0.29127363050622773	0.22173492750140658	0.6541658917913541	BSG	14
BP	GO:0021879	forebrain neuron differentiation	1	1/62	36/10965	0.18491418073242905	0.29127363050622773	0.22173492750140658	0.6541658917913541	NRP2	14
BP	GO:0030517	negative regulation of axon extension	1	1/62	36/10965	0.18491418073242905	0.29127363050622773	0.22173492750140658	0.6541658917913541	SEMA6A	14
BP	GO:0042100	B cell proliferation	1	1/62	36/10965	0.18491418073242905	0.29127363050622773	0.22173492750140658	0.6541658917913541	MIF	14
BP	GO:0048168	regulation of neuronal synaptic plasticity	1	1/62	36/10965	0.18491418073242905	0.29127363050622773	0.22173492750140658	0.6541658917913541	APOE	14
BP	GO:0050918	positive chemotaxis	1	1/62	36/10965	0.18491418073242905	0.29127363050622773	0.22173492750140658	0.6541658917913541	MIF	14
BP	GO:0055081	anion homeostasis	1	1/62	36/10965	0.18491418073242905	0.29127363050622773	0.22173492750140658	0.6541658917913541	APOE	14
BP	GO:0060042	retina morphogenesis in camera-type eye	1	1/62	36/10965	0.18491418073242905	0.29127363050622773	0.22173492750140658	0.6541658917913541	FJX1	14
BP	GO:1902667	regulation of axon guidance	1	1/62	36/10965	0.18491418073242905	0.29127363050622773	0.22173492750140658	0.6541658917913541	SEMA6A	14
BP	GO:1903214	regulation of protein targeting to mitochondrion	1	1/62	36/10965	0.18491418073242905	0.29127363050622773	0.22173492750140658	0.6541658917913541	FZD5	14
BP	GO:0009611	response to wounding	4	4/62	396/10965	0.18509786266087766	0.29127363050622773	0.22173492750140658	0.6541658917913541	SOX2/CLDN3/BNIP3/APOE	14
BP	GO:0055080	cation homeostasis	4	4/62	396/10965	0.18509786266087766	0.29127363050622773	0.22173492750140658	0.6541658917913541	BNIP3/HSP90B1/APOE/TNNI3	14
BP	GO:0034250	positive regulation of cellular amide metabolic process	2	2/62	139/10965	0.18543890761119225	0.2913634291103878	0.2218032875755697	0.6540320210121634	LIN28A/SOX4	14
BP	GO:0048738	cardiac muscle tissue development	2	2/62	139/10965	0.18543890761119225	0.2913634291103878	0.2218032875755697	0.6540320210121634	FGFR1/TNNI3	14
BP	GO:0016485	protein processing	2	2/62	140/10965	0.18747956909894384	0.2943443579120373	0.22407254906200028	0.649611345254902	ENO1/PGK1	14
BP	GO:0003229	ventricular cardiac muscle tissue development	1	1/62	37/10965	0.18953814640125377	0.29462224924142166	0.22428409658062468	0.6492015200511965	TNNI3	14
BP	GO:0010799	regulation of peptidyl-threonine phosphorylation	1	1/62	37/10965	0.18953814640125377	0.29462224924142166	0.22428409658062468	0.6492015200511965	DDIT4	14
BP	GO:0031507	heterochromatin assembly	1	1/62	37/10965	0.18953814640125377	0.29462224924142166	0.22428409658062468	0.6492015200511965	HMGA1	14
BP	GO:0032945	negative regulation of mononuclear cell proliferation	1	1/62	37/10965	0.18953814640125377	0.29462224924142166	0.22428409658062468	0.6492015200511965	SOX11	14
BP	GO:0035272	exocrine system development	1	1/62	37/10965	0.18953814640125377	0.29462224924142166	0.22428409658062468	0.6492015200511965	FGFR1	14
BP	GO:0042769	DNA damage response, detection of DNA damage	1	1/62	37/10965	0.18953814640125377	0.29462224924142166	0.22428409658062468	0.6492015200511965	SOX4	14
BP	GO:0045740	positive regulation of DNA replication	1	1/62	37/10965	0.18953814640125377	0.29462224924142166	0.22428409658062468	0.6492015200511965	FGFR1	14
BP	GO:0048146	positive regulation of fibroblast proliferation	1	1/62	37/10965	0.18953814640125377	0.29462224924142166	0.22428409658062468	0.6492015200511965	MIF	14
BP	GO:0050672	negative regulation of lymphocyte proliferation	1	1/62	37/10965	0.18953814640125377	0.29462224924142166	0.22428409658062468	0.6492015200511965	SOX11	14
BP	GO:0060425	lung morphogenesis	1	1/62	37/10965	0.18953814640125377	0.29462224924142166	0.22428409658062468	0.6492015200511965	SOX11	14
BP	GO:0060976	coronary vasculature development	1	1/62	37/10965	0.18953814640125377	0.29462224924142166	0.22428409658062468	0.6492015200511965	GPC3	14
BP	GO:0071349	cellular response to interleukin-12	1	1/62	37/10965	0.18953814640125377	0.29462224924142166	0.22428409658062468	0.6492015200511965	MIF	14
BP	GO:0090183	regulation of kidney development	1	1/62	37/10965	0.18953814640125377	0.29462224924142166	0.22428409658062468	0.6492015200511965	LIN28A	14
BP	GO:0098771	inorganic ion homeostasis	4	4/62	400/10965	0.1896666624015195	0.29462224924142166	0.22428409658062468	0.6492015200511965	BNIP3/HSP90B1/APOE/TNNI3	14
BP	GO:0042110	T cell activation	3	3/62	266/10965	0.19024180632027574	0.2952921229721678	0.22479404457304658	0.6482151986337753	IGFBP2/FZD5/SOX4	14
BP	GO:0030217	T cell differentiation	2	2/62	142/10965	0.1915706583272245	0.2971300006707972	0.2261931471198641	0.6455205568513751	FZD5/SOX4	14
BP	GO:0051651	maintenance of location in cell	2	2/62	143/10965	0.1936208866509206	0.2979563873804467	0.22682224216301577	0.6443143608239466	HSP90B1/APOE	14
BP	GO:0006027	glycosaminoglycan catabolic process	1	1/62	38/10965	0.1941363011343359	0.2979563873804467	0.22682224216301577	0.6443143608239466	GPC3	14
BP	GO:0007566	embryo implantation	1	1/62	38/10965	0.1941363011343359	0.2979563873804467	0.22682224216301577	0.6443143608239466	BSG	14
BP	GO:0010517	regulation of phospholipase activity	1	1/62	38/10965	0.1941363011343359	0.2979563873804467	0.22682224216301577	0.6443143608239466	FGFR1	14
BP	GO:0018198	peptidyl-cysteine modification	1	1/62	38/10965	0.1941363011343359	0.2979563873804467	0.22682224216301577	0.6443143608239466	GAPDH	14
BP	GO:0032611	interleukin-1 beta production	1	1/62	38/10965	0.1941363011343359	0.2979563873804467	0.22682224216301577	0.6443143608239466	FZD5	14
BP	GO:0045670	regulation of osteoclast differentiation	1	1/62	38/10965	0.1941363011343359	0.2979563873804467	0.22682224216301577	0.6443143608239466	SFRP1	14
BP	GO:0060193	positive regulation of lipase activity	1	1/62	38/10965	0.1941363011343359	0.2979563873804467	0.22682224216301577	0.6443143608239466	FGFR1	14
BP	GO:0060999	positive regulation of dendritic spine development	1	1/62	38/10965	0.1941363011343359	0.2979563873804467	0.22682224216301577	0.6443143608239466	APOE	14
BP	GO:0061383	trabecula morphogenesis	1	1/62	38/10965	0.1941363011343359	0.2979563873804467	0.22682224216301577	0.6443143608239466	SFRP1	14
BP	GO:0070671	response to interleukin-12	1	1/62	38/10965	0.1941363011343359	0.2979563873804467	0.22682224216301577	0.6443143608239466	MIF	14
BP	GO:0071385	cellular response to glucocorticoid stimulus	1	1/62	38/10965	0.1941363011343359	0.2979563873804467	0.22682224216301577	0.6443143608239466	DDIT4	14
BP	GO:0072132	mesenchyme morphogenesis	1	1/62	38/10965	0.1941363011343359	0.2979563873804467	0.22682224216301577	0.6443143608239466	FGFR1	14
BP	GO:2000677	regulation of transcription regulatory region DNA binding	1	1/62	38/10965	0.1941363011343359	0.2979563873804467	0.22682224216301577	0.6443143608239466	SOX11	14
BP	GO:0031345	negative regulation of cell projection organization	2	2/62	144/10965	0.19567410615058697	0.2994207798814351	0.227937025415025	0.6421851235805878	SEMA6A/APOE	14
BP	GO:0043270	positive regulation of ion transport	2	2/62	144/10965	0.19567410615058697	0.2994207798814351	0.227937025415025	0.6421851235805878	APOE/MIF	14
BP	GO:0071478	cellular response to radiation	2	2/62	144/10965	0.19567410615058697	0.2994207798814351	0.227937025415025	0.6421851235805878	SFRP2/SFRP1	14
BP	GO:0097305	response to alcohol	2	2/62	144/10965	0.19567410615058697	0.2994207798814351	0.227937025415025	0.6421851235805878	CLDN3/SFRP1	14
BP	GO:0006026	aminoglycan catabolic process	1	1/62	39/10965	0.19870878665915281	0.30136764983339365	0.22941909939096963	0.639370429439013	GPC3	14
BP	GO:0019068	virion assembly	1	1/62	39/10965	0.19870878665915281	0.30136764983339365	0.22941909939096963	0.639370429439013	APOE	14
BP	GO:0032649	regulation of interferon-gamma production	1	1/62	39/10965	0.19870878665915281	0.30136764983339365	0.22941909939096963	0.639370429439013	FZD5	14
BP	GO:0046324	regulation of glucose import	1	1/62	39/10965	0.19870878665915281	0.30136764983339365	0.22941909939096963	0.639370429439013	GPC3	14
BP	GO:0050435	amyloid-beta metabolic process	1	1/62	39/10965	0.19870878665915281	0.30136764983339365	0.22941909939096963	0.639370429439013	APOE	14
BP	GO:0051289	protein homotetramerization	1	1/62	39/10965	0.19870878665915281	0.30136764983339365	0.22941909939096963	0.639370429439013	ALDOA	14
BP	GO:0051496	positive regulation of stress fiber assembly	1	1/62	39/10965	0.19870878665915281	0.30136764983339365	0.22941909939096963	0.639370429439013	SFRP1	14
BP	GO:0051965	positive regulation of synapse assembly	1	1/62	39/10965	0.19870878665915281	0.30136764983339365	0.22941909939096963	0.639370429439013	TPBG	14
BP	GO:0060324	face development	1	1/62	39/10965	0.19870878665915281	0.30136764983339365	0.22941909939096963	0.639370429439013	SOX3	14
BP	GO:0060711	labyrinthine layer development	1	1/62	39/10965	0.19870878665915281	0.30136764983339365	0.22941909939096963	0.639370429439013	FZD5	14
BP	GO:0090102	cochlea development	1	1/62	39/10965	0.19870878665915281	0.30136764983339365	0.22941909939096963	0.639370429439013	FRZB	14
BP	GO:1901862	negative regulation of muscle tissue development	1	1/62	39/10965	0.19870878665915281	0.30136764983339365	0.22941909939096963	0.639370429439013	IGFBP5	14
BP	GO:0007179	transforming growth factor beta receptor signaling pathway	2	2/62	146/10965	0.1997891306531324	0.3025588901108691	0.23032594281549695	0.637657142421913	SOX11/CDKN1C	14
BP	GO:0008361	regulation of cell size	2	2/62	146/10965	0.1997891306531324	0.3025588901108691	0.23032594281549695	0.637657142421913	SEMA6A/APOE	14
BP	GO:0009636	response to toxic substance	2	2/62	147/10965	0.20185074406142892	0.30488361590678675	0.23209566328391892	0.6343329742767807	MGST1/APOE	14
BP	GO:0071383	cellular response to steroid hormone stimulus	2	2/62	147/10965	0.20185074406142892	0.30488361590678675	0.23209566328391892	0.6343329742767807	SFRP1/DDIT4	14
BP	GO:0001895	retina homeostasis	1	1/62	40/10965	0.20325574393785784	0.30488361590678675	0.23209566328391892	0.6343329742767807	SLC2A1	14
BP	GO:0002260	lymphocyte homeostasis	1	1/62	40/10965	0.20325574393785784	0.30488361590678675	0.23209566328391892	0.6343329742767807	MIF	14
BP	GO:0003073	regulation of systemic arterial blood pressure	1	1/62	40/10965	0.20325574393785784	0.30488361590678675	0.23209566328391892	0.6343329742767807	TNNI3	14
BP	GO:0003179	heart valve morphogenesis	1	1/62	40/10965	0.20325574393785784	0.30488361590678675	0.23209566328391892	0.6343329742767807	SOX4	14
BP	GO:0006284	base-excision repair	1	1/62	40/10965	0.20325574393785784	0.30488361590678675	0.23209566328391892	0.6343329742767807	HMGA1	14
BP	GO:0009311	oligosaccharide metabolic process	1	1/62	40/10965	0.20325574393785784	0.30488361590678675	0.23209566328391892	0.6343329742767807	SLC2A1	14
BP	GO:0033627	cell adhesion mediated by integrin	1	1/62	40/10965	0.20325574393785784	0.30488361590678675	0.23209566328391892	0.6343329742767807	SFRP2	14
BP	GO:0050871	positive regulation of B cell activation	1	1/62	40/10965	0.20325574393785784	0.30488361590678675	0.23209566328391892	0.6343329742767807	MIF	14
BP	GO:0055021	regulation of cardiac muscle tissue growth	1	1/62	40/10965	0.20325574393785784	0.30488361590678675	0.23209566328391892	0.6343329742767807	FGFR1	14
BP	GO:0070664	negative regulation of leukocyte proliferation	1	1/62	40/10965	0.20325574393785784	0.30488361590678675	0.23209566328391892	0.6343329742767807	SOX11	14
BP	GO:0071384	cellular response to corticosteroid stimulus	1	1/62	40/10965	0.20325574393785784	0.30488361590678675	0.23209566328391892	0.6343329742767807	DDIT4	14
BP	GO:0045216	cell-cell junction organization	2	2/62	148/10965	0.20391496544146587	0.30542591904079414	0.23250849689983508	0.6335611714222706	FZD5/CLDN3	14
BP	GO:0060326	cell chemotaxis	2	2/62	148/10965	0.20391496544146587	0.30542591904079414	0.23250849689983508	0.6335611714222706	FGFR1/MIF	14
BP	GO:0061564	axon development	4	4/62	413/10965	0.2047658351209672	0.3064766547543579	0.23330837983762548	0.6320696621840367	NRP2/SEMA6A/BSG/APOE	14
BP	GO:0006109	regulation of carbohydrate metabolic process	2	2/62	149/10965	0.20598170137991273	0.30651261439798744	0.23333575447143395	0.6320187083562836	DDIT4/PGAM1	14
BP	GO:0062197	cellular response to chemical stress	3	3/62	278/10965	0.207638013168879	0.30651261439798744	0.23333575447143395	0.6320187083562836	SLC2A1/BNIP3/MGST1	14
BP	GO:0001658	branching involved in ureteric bud morphogenesis	1	1/62	41/10965	0.2077773131713453	0.30651261439798744	0.23333575447143395	0.6320187083562836	GPC3	14
BP	GO:0010171	body morphogenesis	1	1/62	41/10965	0.2077773131713453	0.30651261439798744	0.23333575447143395	0.6320187083562836	GPC3	14
BP	GO:0014743	regulation of muscle hypertrophy	1	1/62	41/10965	0.2077773131713453	0.30651261439798744	0.23333575447143395	0.6320187083562836	IGFBP5	14
BP	GO:0030193	regulation of blood coagulation	1	1/62	41/10965	0.2077773131713453	0.30651261439798744	0.23333575447143395	0.6320187083562836	APOE	14
BP	GO:0032527	protein exit from endoplasmic reticulum	1	1/62	41/10965	0.2077773131713453	0.30651261439798744	0.23333575447143395	0.6320187083562836	HSP90B1	14
BP	GO:0032652	regulation of interleukin-1 production	1	1/62	41/10965	0.2077773131713453	0.30651261439798744	0.23333575447143395	0.6320187083562836	FZD5	14
BP	GO:0033555	multicellular organismal response to stress	1	1/62	41/10965	0.2077773131713453	0.30651261439798744	0.23333575447143395	0.6320187083562836	APOE	14
BP	GO:0043536	positive regulation of blood vessel endothelial cell migration	1	1/62	41/10965	0.2077773131713453	0.30651261439798744	0.23333575447143395	0.6320187083562836	FGFR1	14
BP	GO:0044088	regulation of vacuole organization	1	1/62	41/10965	0.2077773131713453	0.30651261439798744	0.23333575447143395	0.6320187083562836	ENO1	14
BP	GO:0045540	regulation of cholesterol biosynthetic process	1	1/62	41/10965	0.2077773131713453	0.30651261439798744	0.23333575447143395	0.6320187083562836	APOE	14
BP	GO:0051055	negative regulation of lipid biosynthetic process	1	1/62	41/10965	0.2077773131713453	0.30651261439798744	0.23333575447143395	0.6320187083562836	APOE	14
BP	GO:0055008	cardiac muscle tissue morphogenesis	1	1/62	41/10965	0.2077773131713453	0.30651261439798744	0.23333575447143395	0.6320187083562836	TNNI3	14
BP	GO:0060113	inner ear receptor cell differentiation	1	1/62	41/10965	0.2077773131713453	0.30651261439798744	0.23333575447143395	0.6320187083562836	FGFR1	14
BP	GO:0070613	regulation of protein processing	1	1/62	41/10965	0.2077773131713453	0.30651261439798744	0.23333575447143395	0.6320187083562836	ENO1	14
BP	GO:0106118	regulation of sterol biosynthetic process	1	1/62	41/10965	0.2077773131713453	0.30651261439798744	0.23333575447143395	0.6320187083562836	APOE	14
BP	GO:1900046	regulation of hemostasis	1	1/62	41/10965	0.2077773131713453	0.30651261439798744	0.23333575447143395	0.6320187083562836	APOE	14
BP	GO:1903036	positive regulation of response to wounding	1	1/62	41/10965	0.2077773131713453	0.30651261439798744	0.23333575447143395	0.6320187083562836	CLDN3	14
BP	GO:2001238	positive regulation of extrinsic apoptotic signaling pathway	1	1/62	41/10965	0.2077773131713453	0.30651261439798744	0.23333575447143395	0.6320187083562836	SFRP1	14
BP	GO:0051051	negative regulation of transport	3	3/62	279/10965	0.20910457399108767	0.3082489840730689	0.23465758303295078	0.6295654068631442	SFRP1/APOE/BST2	14
BP	GO:0098742	cell-cell adhesion via plasma-membrane adhesion molecules	2	2/62	151/10965	0.2101223479723995	0.30952696198087853	0.23563045633508964	0.6277685756701452	CLDN3/BSG	14
BP	GO:0032103	positive regulation of response to external stimulus	3	3/62	280/10965	0.21057356799798144	0.3099691259195537	0.2359670579997013	0.627148622146555	FGFR1/CTSC/MIF	14
BP	GO:0006081	cellular aldehyde metabolic process	1	1/62	42/10965	0.21227363380329145	0.31157760841513166	0.2371915311829565	0.6249008213202937	TPI1	14
BP	GO:0032456	endocytic recycling	1	1/62	42/10965	0.21227363380329145	0.31157760841513166	0.2371915311829565	0.6249008213202937	ARL4C	14
BP	GO:0035329	hippo signaling	1	1/62	42/10965	0.21227363380329145	0.31157760841513166	0.2371915311829565	0.6249008213202937	SOX11	14
BP	GO:0042987	amyloid precursor protein catabolic process	1	1/62	42/10965	0.21227363380329145	0.31157760841513166	0.2371915311829565	0.6249008213202937	APOE	14
BP	GO:0051259	protein complex oligomerization	2	2/62	153/10965	0.21427195520441514	0.3142859557394281	0.2392532873280554	0.6211420863259294	ALDOA/MIF	14
BP	GO:0002708	positive regulation of lymphocyte mediated immunity	1	1/62	43/10965	0.2167448445241733	0.31610548753632095	0.24063842387601334	0.6186350256038767	FZD5	14
BP	GO:0014855	striated muscle cell proliferation	1	1/62	43/10965	0.2167448445241733	0.31610548753632095	0.24063842387601334	0.6186350256038767	FGFR1	14
BP	GO:0022617	extracellular matrix disassembly	1	1/62	43/10965	0.2167448445241733	0.31610548753632095	0.24063842387601334	0.6186350256038767	BSG	14
BP	GO:0035196	production of miRNAs involved in gene silencing by miRNA	1	1/62	43/10965	0.2167448445241733	0.31610548753632095	0.24063842387601334	0.6186350256038767	LIN28A	14
BP	GO:0042733	embryonic digit morphogenesis	1	1/62	43/10965	0.2167448445241733	0.31610548753632095	0.24063842387601334	0.6186350256038767	SFRP2	14
BP	GO:0048645	animal organ formation	1	1/62	43/10965	0.2167448445241733	0.31610548753632095	0.24063842387601334	0.6186350256038767	FGFR1	14
BP	GO:0061035	regulation of cartilage development	1	1/62	43/10965	0.2167448445241733	0.31610548753632095	0.24063842387601334	0.6186350256038767	FRZB	14
BP	GO:1905268	negative regulation of chromatin organization	1	1/62	43/10965	0.2167448445241733	0.31610548753632095	0.24063842387601334	0.6186350256038767	HMGA1	14
BP	GO:0050821	protein stabilization	2	2/62	155/10965	0.21842980913475626	0.31833662524468737	0.24233689948862017	0.6155804528695638	SOX4/GAPDH	14
BP	GO:0001894	tissue homeostasis	2	2/62	156/10965	0.22051160946629428	0.3194117543144679	0.24315535210971087	0.6141161667039362	SLC2A1/CLDN3	14
BP	GO:0016241	regulation of macroautophagy	2	2/62	156/10965	0.22051160946629428	0.3194117543144679	0.24315535210971087	0.6141161667039362	BNIP3/GAPDH	14
BP	GO:0030100	regulation of endocytosis	2	2/62	156/10965	0.22051160946629428	0.3194117543144679	0.24315535210971087	0.6141161667039362	APOE/GPC3	14
BP	GO:0050770	regulation of axonogenesis	2	2/62	156/10965	0.22051160946629428	0.3194117543144679	0.24315535210971087	0.6141161667039362	SEMA6A/APOE	14
BP	GO:0001954	positive regulation of cell-matrix adhesion	1	1/62	44/10965	0.22119108327527237	0.3194117543144679	0.24315535210971087	0.6141161667039362	SFRP1	14
BP	GO:0002011	morphogenesis of an epithelial sheet	1	1/62	44/10965	0.22119108327527237	0.3194117543144679	0.24315535210971087	0.6141161667039362	SOX11	14
BP	GO:0002066	columnar/cuboidal epithelial cell development	1	1/62	44/10965	0.22119108327527237	0.3194117543144679	0.24315535210971087	0.6141161667039362	FGFR1	14
BP	GO:0035904	aorta development	1	1/62	44/10965	0.22119108327527237	0.3194117543144679	0.24315535210971087	0.6141161667039362	SOX4	14
BP	GO:0045815	positive regulation of gene expression, epigenetic	1	1/62	44/10965	0.22119108327527237	0.3194117543144679	0.24315535210971087	0.6141161667039362	HMGA1	14
BP	GO:0050818	regulation of coagulation	1	1/62	44/10965	0.22119108327527237	0.3194117543144679	0.24315535210971087	0.6141161667039362	APOE	14
BP	GO:0060135	maternal process involved in female pregnancy	1	1/62	44/10965	0.22119108327527237	0.3194117543144679	0.24315535210971087	0.6141161667039362	BSG	14
BP	GO:0060420	regulation of heart growth	1	1/62	44/10965	0.22119108327527237	0.3194117543144679	0.24315535210971087	0.6141161667039362	FGFR1	14
BP	GO:2000378	negative regulation of reactive oxygen species metabolic process	1	1/62	44/10965	0.22119108327527237	0.3194117543144679	0.24315535210971087	0.6141161667039362	BNIP3	14
BP	GO:0032496	response to lipopolysaccharide	2	2/62	157/10965	0.22259521028588428	0.3212133414252001	0.24452682808812812	0.6116734856141682	MGST1/MIF	14
BP	GO:0010506	regulation of autophagy	3	3/62	290/10965	0.22538975064181838	0.3228429733908203	0.24576740151430046	0.609475722268638	FZD5/BNIP3/GAPDH	14
BP	GO:0032233	positive regulation of actin filament bundle assembly	1	1/62	45/10965	0.22561248725264926	0.3228429733908203	0.24576740151430046	0.609475722268638	SFRP1	14
BP	GO:0032609	interferon-gamma production	1	1/62	45/10965	0.22561248725264926	0.3228429733908203	0.24576740151430046	0.609475722268638	FZD5	14
BP	GO:0032612	interleukin-1 production	1	1/62	45/10965	0.22561248725264926	0.3228429733908203	0.24576740151430046	0.609475722268638	FZD5	14
BP	GO:0042102	positive regulation of T cell proliferation	1	1/62	45/10965	0.22561248725264926	0.3228429733908203	0.24576740151430046	0.609475722268638	IGFBP2	14
BP	GO:0042149	cellular response to glucose starvation	1	1/62	45/10965	0.22561248725264926	0.3228429733908203	0.24576740151430046	0.609475722268638	SLC2A1	14
BP	GO:0042246	tissue regeneration	1	1/62	45/10965	0.22561248725264926	0.3228429733908203	0.24576740151430046	0.609475722268638	SOX2	14
BP	GO:0042490	mechanoreceptor differentiation	1	1/62	45/10965	0.22561248725264926	0.3228429733908203	0.24576740151430046	0.609475722268638	FGFR1	14
BP	GO:0045844	positive regulation of striated muscle tissue development	1	1/62	45/10965	0.22561248725264926	0.3228429733908203	0.24576740151430046	0.609475722268638	FGFR1	14
BP	GO:0048636	positive regulation of muscle organ development	1	1/62	45/10965	0.22561248725264926	0.3228429733908203	0.24576740151430046	0.609475722268638	FGFR1	14
BP	GO:0070227	lymphocyte apoptotic process	1	1/62	45/10965	0.22561248725264926	0.3228429733908203	0.24576740151430046	0.609475722268638	MIF	14
BP	GO:0070828	heterochromatin organization	1	1/62	45/10965	0.22561248725264926	0.3228429733908203	0.24576740151430046	0.609475722268638	HMGA1	14
BP	GO:1902905	positive regulation of supramolecular fiber organization	2	2/62	159/10965	0.22676747341749626	0.3242695856813257	0.24685342420800618	0.6075608441206594	SFRP1/APOE	14
BP	GO:0017038	protein import	2	2/62	160/10965	0.22885596792636775	0.3255026647266123	0.2477921178076807	0.605912512516349	SIX3/APOE	14
BP	GO:0001885	endothelial cell development	1	1/62	46/10965	0.23000919291110522	0.3255026647266123	0.2477921178076807	0.605912512516349	CLDN3	14
BP	GO:0003170	heart valve development	1	1/62	46/10965	0.23000919291110522	0.3255026647266123	0.2477921178076807	0.605912512516349	SOX4	14
BP	GO:0006984	ER-nucleus signaling pathway	1	1/62	46/10965	0.23000919291110522	0.3255026647266123	0.2477921178076807	0.605912512516349	HSP90B1	14
BP	GO:0018208	peptidyl-proline modification	1	1/62	46/10965	0.23000919291110522	0.3255026647266123	0.2477921178076807	0.605912512516349	P4HA1	14
BP	GO:0031050	dsRNA processing	1	1/62	46/10965	0.23000919291110522	0.3255026647266123	0.2477921178076807	0.605912512516349	LIN28A	14
BP	GO:0035914	skeletal muscle cell differentiation	1	1/62	46/10965	0.23000919291110522	0.3255026647266123	0.2477921178076807	0.605912512516349	SOX11	14
BP	GO:0042632	cholesterol homeostasis	1	1/62	46/10965	0.23000919291110522	0.3255026647266123	0.2477921178076807	0.605912512516349	APOE	14
BP	GO:0043113	receptor clustering	1	1/62	46/10965	0.23000919291110522	0.3255026647266123	0.2477921178076807	0.605912512516349	APOE	14
BP	GO:0043392	negative regulation of DNA binding	1	1/62	46/10965	0.23000919291110522	0.3255026647266123	0.2477921178076807	0.605912512516349	SOX11	14
BP	GO:0060675	ureteric bud morphogenesis	1	1/62	46/10965	0.23000919291110522	0.3255026647266123	0.2477921178076807	0.605912512516349	GPC3	14
BP	GO:0070918	production of small RNA involved in gene silencing by RNA	1	1/62	46/10965	0.23000919291110522	0.3255026647266123	0.2477921178076807	0.605912512516349	LIN28A	14
BP	GO:0072171	mesonephric tubule morphogenesis	1	1/62	46/10965	0.23000919291110522	0.3255026647266123	0.2477921178076807	0.605912512516349	GPC3	14
BP	GO:0090329	regulation of DNA-dependent DNA replication	1	1/62	46/10965	0.23000919291110522	0.3255026647266123	0.2477921178076807	0.605912512516349	FGFR1	14
BP	GO:1901863	positive regulation of muscle tissue development	1	1/62	46/10965	0.23000919291110522	0.3255026647266123	0.2477921178076807	0.605912512516349	FGFR1	14
BP	GO:0042594	response to starvation	2	2/62	161/10965	0.2309459273032299	0.32659978987403543	0.24862731516008443	0.6044511597988582	SLC2A1/SFRP1	14
BP	GO:0061061	muscle structure development	4	4/62	435/10965	0.23110277529098414	0.32659978987403543	0.24862731516008443	0.6044511597988582	SOX11/IGFBP5/FGFR1/TNNI3	14
BP	GO:0006338	chromatin remodeling	2	2/62	162/10965	0.23303726979833955	0.3291070045603529	0.2505359570983706	0.6011299350712005	PTMA/HMGA1	14
BP	GO:0002824	positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	1	1/62	47/10965	0.23438133596811672	0.3296439351655761	0.250944700823697	0.6004219708419605	FZD5	14
BP	GO:0006805	xenobiotic metabolic process	1	1/62	47/10965	0.23438133596811672	0.3296439351655761	0.250944700823697	0.6004219708419605	MGST1	14
BP	GO:0034103	regulation of tissue remodeling	1	1/62	47/10965	0.23438133596811672	0.3296439351655761	0.250944700823697	0.6004219708419605	SFRP1	14
BP	GO:0045685	regulation of glial cell differentiation	1	1/62	47/10965	0.23438133596811672	0.3296439351655761	0.250944700823697	0.6004219708419605	LIN28A	14
BP	GO:0055092	sterol homeostasis	1	1/62	47/10965	0.23438133596811672	0.3296439351655761	0.250944700823697	0.6004219708419605	APOE	14
BP	GO:2000106	regulation of leukocyte apoptotic process	1	1/62	47/10965	0.23438133596811672	0.3296439351655761	0.250944700823697	0.6004219708419605	MIF	14
BP	GO:0031669	cellular response to nutrient levels	2	2/62	163/10965	0.23512991451046722	0.3304702634078622	0.25157375135799087	0.5993346741769587	SLC2A1/SFRP1	14
BP	GO:0010633	negative regulation of epithelial cell migration	1	1/62	48/10965	0.2387290514077558	0.33461203107152654	0.2547267128912206	0.5939255086958815	APOE	14
BP	GO:0031016	pancreas development	1	1/62	48/10965	0.2387290514077558	0.33461203107152654	0.2547267128912206	0.5939255086958815	SOX4	14
BP	GO:0033059	cellular pigmentation	1	1/62	48/10965	0.2387290514077558	0.33461203107152654	0.2547267128912206	0.5939255086958815	SHROOM3	14
BP	GO:0051851	modulation by host of symbiont process	1	1/62	48/10965	0.2387290514077558	0.33461203107152654	0.2547267128912206	0.5939255086958815	APOE	14
BP	GO:0050801	ion homeostasis	4	4/62	443/10965	0.24089386100904253	0.3374158380822903	0.2568611386652913	0.590301596550572	BNIP3/HSP90B1/APOE/TNNI3	14
BP	GO:0014910	regulation of smooth muscle cell migration	1	1/62	49/10965	0.24305247348458214	0.3390507651871941	0.2581057430685319	0.5882023319333742	IGFBP5	14
BP	GO:0033619	membrane protein proteolysis	1	1/62	49/10965	0.24305247348458214	0.3390507651871941	0.2581057430685319	0.5882023319333742	APOE	14
BP	GO:0045582	positive regulation of T cell differentiation	1	1/62	49/10965	0.24305247348458214	0.3390507651871941	0.2581057430685319	0.5882023319333742	SOX4	14
BP	GO:0060415	muscle tissue morphogenesis	1	1/62	49/10965	0.24305247348458214	0.3390507651871941	0.2581057430685319	0.5882023319333742	TNNI3	14
BP	GO:0097345	mitochondrial outer membrane permeabilization	1	1/62	49/10965	0.24305247348458214	0.3390507651871941	0.2581057430685319	0.5882023319333742	BNIP3	14
BP	GO:1903670	regulation of sprouting angiogenesis	1	1/62	49/10965	0.24305247348458214	0.3390507651871941	0.2581057430685319	0.5882023319333742	SEMA6A	14
BP	GO:0045787	positive regulation of cell cycle	3	3/62	303/10965	0.24495343077675	0.3414704075773716	0.2599477197316197	0.5851139878565541	SOX4/FGFR1/MIF	14
BP	GO:0043588	skin development	2	2/62	168/10965	0.245609898337209	0.3421530966652769	0.26046742354122854	0.584246585842281	POU3F1/IGFBP5	14
BP	GO:0014068	positive regulation of phosphatidylinositol 3-kinase signaling	1	1/62	50/10965	0.24735173572752456	0.3441123808222918	0.26195894795336055	0.5817667623987088	FGFR1	14
BP	GO:0033077	T cell differentiation in thymus	1	1/62	50/10965	0.24735173572752456	0.3441123808222918	0.26195894795336055	0.5817667623987088	FZD5	14
BP	GO:0050727	regulation of inflammatory response	2	2/62	170/10965	0.24980826897590203	0.347059287703826	0.26420230991714255	0.5780633896742424	CTSC/APOE	14
BP	GO:1902105	regulation of leukocyte differentiation	2	2/62	170/10965	0.24980826897590203	0.347059287703826	0.26420230991714255	0.5780633896742424	SOX4/SFRP1	14
BP	GO:0002821	positive regulation of adaptive immune response	1	1/62	51/10965	0.25162697094373077	0.3477027234858825	0.2646921317600542	0.5772589683472318	FZD5	14
BP	GO:0006690	icosanoid metabolic process	1	1/62	51/10965	0.25162697094373077	0.3477027234858825	0.2646921317600542	0.5772589683472318	MIF	14
BP	GO:0048704	embryonic skeletal system morphogenesis	1	1/62	51/10965	0.25162697094373077	0.3477027234858825	0.2646921317600542	0.5772589683472318	SOX11	14
BP	GO:0071466	cellular response to xenobiotic stimulus	1	1/62	51/10965	0.25162697094373077	0.3477027234858825	0.2646921317600542	0.5772589683472318	MGST1	14
BP	GO:0090181	regulation of cholesterol metabolic process	1	1/62	51/10965	0.25162697094373077	0.3477027234858825	0.2646921317600542	0.5772589683472318	APOE	14
BP	GO:1902110	positive regulation of mitochondrial membrane permeability involved in apoptotic process	1	1/62	51/10965	0.25162697094373077	0.3477027234858825	0.2646921317600542	0.5772589683472318	BNIP3	14
BP	GO:1903749	positive regulation of establishment of protein localization to mitochondrion	1	1/62	51/10965	0.25162697094373077	0.3477027234858825	0.2646921317600542	0.5772589683472318	FZD5	14
BP	GO:2000756	regulation of peptidyl-lysine acetylation	1	1/62	51/10965	0.25162697094373077	0.3477027234858825	0.2646921317600542	0.5772589683472318	SOX4	14
BP	GO:0072593	reactive oxygen species metabolic process	2	2/62	171/10965	0.2519085186072461	0.3478575236756858	0.264809974933168	0.5770656598031813	DDIT4/BNIP3	14
BP	GO:0060249	anatomical structure homeostasis	3	3/62	310/10965	0.2556062725561146	0.35121223720962064	0.2673637837381127	0.5728974212621907	SLC2A1/CLDN3/ALDOA	14
BP	GO:0006977	DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	1	1/62	52/10965	0.2558783112224088	0.35121223720962064	0.2673637837381127	0.5728974212621907	SOX4	14
BP	GO:0010823	negative regulation of mitochondrion organization	1	1/62	52/10965	0.2558783112224088	0.35121223720962064	0.2673637837381127	0.5728974212621907	BNIP3	14
BP	GO:0055117	regulation of cardiac muscle contraction	1	1/62	52/10965	0.2558783112224088	0.35121223720962064	0.2673637837381127	0.5728974212621907	TNNI3	14
BP	GO:0072078	nephron tubule morphogenesis	1	1/62	52/10965	0.2558783112224088	0.35121223720962064	0.2673637837381127	0.5728974212621907	GPC3	14
BP	GO:0075733	intracellular transport of virus	1	1/62	52/10965	0.2558783112224088	0.35121223720962064	0.2673637837381127	0.5728974212621907	BST2	14
BP	GO:0090398	cellular senescence	1	1/62	52/10965	0.2558783112224088	0.35121223720962064	0.2673637837381127	0.5728974212621907	HMGA1	14
BP	GO:0097006	regulation of plasma lipoprotein particle levels	1	1/62	52/10965	0.2558783112224088	0.35121223720962064	0.2673637837381127	0.5728974212621907	APOE	14
BP	GO:1902930	regulation of alcohol biosynthetic process	1	1/62	52/10965	0.2558783112224088	0.35121223720962064	0.2673637837381127	0.5728974212621907	APOE	14
BP	GO:0016458	gene silencing	2	2/62	173/10965	0.2561107786815814	0.35129633546430816	0.2674278043649499	0.5727934412979776	LIN28A/HMGA1	14
BP	GO:0043434	response to peptide hormone	3	3/62	311/10965	0.25713397894098894	0.35246421161450187	0.2683168616168672	0.5713520344579051	SLC2A1/IGFBP5/BSG	14
BP	GO:0009165	nucleotide biosynthetic process	2	2/62	174/10965	0.25821264434620966	0.35370263886685566	0.26925962659198405	0.5698287608209127	ENO1/ALDOA	14
BP	GO:0001776	leukocyte homeostasis	1	1/62	53/10965	0.260105887938638	0.35370263886685566	0.26925962659198405	0.5698287608209127	MIF	14
BP	GO:0032680	regulation of tumor necrosis factor production	1	1/62	53/10965	0.260105887938638	0.35370263886685566	0.26925962659198405	0.5698287608209127	MIF	14
BP	GO:0048644	muscle organ morphogenesis	1	1/62	53/10965	0.260105887938638	0.35370263886685566	0.26925962659198405	0.5698287608209127	TNNI3	14
BP	GO:0050729	positive regulation of inflammatory response	1	1/62	53/10965	0.260105887938638	0.35370263886685566	0.26925962659198405	0.5698287608209127	CTSC	14
BP	GO:0051881	regulation of mitochondrial membrane potential	1	1/62	53/10965	0.260105887938638	0.35370263886685566	0.26925962659198405	0.5698287608209127	BNIP3	14
BP	GO:0060191	regulation of lipase activity	1	1/62	53/10965	0.260105887938638	0.35370263886685566	0.26925962659198405	0.5698287608209127	FGFR1	14
BP	GO:0070542	response to fatty acid	1	1/62	53/10965	0.260105887938638	0.35370263886685566	0.26925962659198405	0.5698287608209127	SFRP1	14
BP	GO:0072088	nephron epithelium morphogenesis	1	1/62	53/10965	0.260105887938638	0.35370263886685566	0.26925962659198405	0.5698287608209127	GPC3	14
BP	GO:0072431	signal transduction involved in mitotic G1 DNA damage checkpoint	1	1/62	53/10965	0.260105887938638	0.35370263886685566	0.26925962659198405	0.5698287608209127	SOX4	14
BP	GO:1902400	intracellular signal transduction involved in G1 DNA damage checkpoint	1	1/62	53/10965	0.260105887938638	0.35370263886685566	0.26925962659198405	0.5698287608209127	SOX4	14
BP	GO:1902686	mitochondrial outer membrane permeabilization involved in programmed cell death	1	1/62	53/10965	0.260105887938638	0.35370263886685566	0.26925962659198405	0.5698287608209127	BNIP3	14
BP	GO:0006898	receptor-mediated endocytosis	2	2/62	175/10965	0.2603149051993187	0.35375244070794837	0.2692975387353008	0.5697676158367705	HSP90B1/APOE	14
BP	GO:0098656	anion transmembrane transport	2	2/62	176/10965	0.2624174907760686	0.35541531767084517	0.27056342024393876	0.5677309197120315	SLC2A1/SLC16A3	14
BP	GO:1901293	nucleoside phosphate biosynthetic process	2	2/62	176/10965	0.2624174907760686	0.35541531767084517	0.27056342024393876	0.5677309197120315	ENO1/ALDOA	14
BP	GO:0007492	endoderm development	1	1/62	54/10965	0.2643098317571685	0.35541531767084517	0.27056342024393876	0.5677309197120315	SOX2	14
BP	GO:0014909	smooth muscle cell migration	1	1/62	54/10965	0.2643098317571685	0.35541531767084517	0.27056342024393876	0.5677309197120315	IGFBP5	14
BP	GO:0038034	signal transduction in absence of ligand	1	1/62	54/10965	0.2643098317571685	0.35541531767084517	0.27056342024393876	0.5677309197120315	FGFR1	14
BP	GO:0043507	positive regulation of JUN kinase activity	1	1/62	54/10965	0.2643098317571685	0.35541531767084517	0.27056342024393876	0.5677309197120315	FZD5	14
BP	GO:0045814	negative regulation of gene expression, epigenetic	1	1/62	54/10965	0.2643098317571685	0.35541531767084517	0.27056342024393876	0.5677309197120315	HMGA1	14
BP	GO:0046889	positive regulation of lipid biosynthetic process	1	1/62	54/10965	0.2643098317571685	0.35541531767084517	0.27056342024393876	0.5677309197120315	APOE	14
BP	GO:0061333	renal tubule morphogenesis	1	1/62	54/10965	0.2643098317571685	0.35541531767084517	0.27056342024393876	0.5677309197120315	GPC3	14
BP	GO:0070373	negative regulation of ERK1 and ERK2 cascade	1	1/62	54/10965	0.2643098317571685	0.35541531767084517	0.27056342024393876	0.5677309197120315	SEMA6A	14
BP	GO:0072413	signal transduction involved in mitotic cell cycle checkpoint	1	1/62	54/10965	0.2643098317571685	0.35541531767084517	0.27056342024393876	0.5677309197120315	SOX4	14
BP	GO:0097192	extrinsic apoptotic signaling pathway in absence of ligand	1	1/62	54/10965	0.2643098317571685	0.35541531767084517	0.27056342024393876	0.5677309197120315	FGFR1	14
BP	GO:1902108	regulation of mitochondrial membrane permeability involved in apoptotic process	1	1/62	54/10965	0.2643098317571685	0.35541531767084517	0.27056342024393876	0.5677309197120315	BNIP3	14
BP	GO:1902402	signal transduction involved in mitotic DNA damage checkpoint	1	1/62	54/10965	0.2643098317571685	0.35541531767084517	0.27056342024393876	0.5677309197120315	SOX4	14
BP	GO:1902403	signal transduction involved in mitotic DNA integrity checkpoint	1	1/62	54/10965	0.2643098317571685	0.35541531767084517	0.27056342024393876	0.5677309197120315	SOX4	14
BP	GO:1903555	regulation of tumor necrosis factor superfamily cytokine production	1	1/62	54/10965	0.2643098317571685	0.35541531767084517	0.27056342024393876	0.5677309197120315	MIF	14
BP	GO:0031331	positive regulation of cellular catabolic process	3	3/62	317/10965	0.26632796127948405	0.3578945491457114	0.2724507596861781	0.5647119767961903	BNIP3/CTSC/APOE	14
BP	GO:0021675	nerve development	1	1/62	55/10965	0.26849027263619485	0.3593881535873919	0.27358778081650237	0.5629033033059823	NRP2	14
BP	GO:0033260	nuclear DNA replication	1	1/62	55/10965	0.26849027263619485	0.3593881535873919	0.27358778081650237	0.5629033033059823	FGFR1	14
BP	GO:0035794	positive regulation of mitochondrial membrane permeability	1	1/62	55/10965	0.26849027263619485	0.3593881535873919	0.27358778081650237	0.5629033033059823	BNIP3	14
BP	GO:0046849	bone remodeling	1	1/62	55/10965	0.26849027263619485	0.3593881535873919	0.27358778081650237	0.5629033033059823	SFRP1	14
BP	GO:0055017	cardiac muscle tissue growth	1	1/62	55/10965	0.26849027263619485	0.3593881535873919	0.27358778081650237	0.5629033033059823	FGFR1	14
BP	GO:0072028	nephron morphogenesis	1	1/62	55/10965	0.26849027263619485	0.3593881535873919	0.27358778081650237	0.5629033033059823	GPC3	14
BP	GO:1903037	regulation of leukocyte cell-cell adhesion	2	2/62	179/10965	0.26872650254322106	0.3594698717201366	0.27364998955200714	0.5628045641028967	IGFBP2/SOX4	14
BP	GO:0006939	smooth muscle contraction	1	1/62	56/10965	0.2726473398311128	0.36141624117147503	0.2751316825169124	0.5604593959788944	TNNI3	14
BP	GO:0007422	peripheral nervous system development	1	1/62	56/10965	0.2726473398311128	0.36141624117147503	0.2751316825169124	0.5604593959788944	POU3F1	14
BP	GO:0009410	response to xenobiotic stimulus	1	1/62	56/10965	0.2726473398311128	0.36141624117147503	0.2751316825169124	0.5604593959788944	MGST1	14
BP	GO:0014897	striated muscle hypertrophy	1	1/62	56/10965	0.2726473398311128	0.36141624117147503	0.2751316825169124	0.5604593959788944	IGFBP5	14
BP	GO:0015914	phospholipid transport	1	1/62	56/10965	0.2726473398311128	0.36141624117147503	0.2751316825169124	0.5604593959788944	APOE	14
BP	GO:0030301	cholesterol transport	1	1/62	56/10965	0.2726473398311128	0.36141624117147503	0.2751316825169124	0.5604593959788944	APOE	14
BP	GO:0045638	negative regulation of myeloid cell differentiation	1	1/62	56/10965	0.2726473398311128	0.36141624117147503	0.2751316825169124	0.5604593959788944	SFRP1	14
BP	GO:0051893	regulation of focal adhesion assembly	1	1/62	56/10965	0.2726473398311128	0.36141624117147503	0.2751316825169124	0.5604593959788944	SFRP1	14
BP	GO:0055024	regulation of cardiac muscle tissue development	1	1/62	56/10965	0.2726473398311128	0.36141624117147503	0.2751316825169124	0.5604593959788944	FGFR1	14
BP	GO:0060291	long-term synaptic potentiation	1	1/62	56/10965	0.2726473398311128	0.36141624117147503	0.2751316825169124	0.5604593959788944	APOE	14
BP	GO:0090109	regulation of cell-substrate junction assembly	1	1/62	56/10965	0.2726473398311128	0.36141624117147503	0.2751316825169124	0.5604593959788944	SFRP1	14
BP	GO:0110110	positive regulation of animal organ morphogenesis	1	1/62	56/10965	0.2726473398311128	0.36141624117147503	0.2751316825169124	0.5604593959788944	FGFR1	14
BP	GO:1901570	fatty acid derivative biosynthetic process	1	1/62	56/10965	0.2726473398311128	0.36141624117147503	0.2751316825169124	0.5604593959788944	MIF	14
BP	GO:1905710	positive regulation of membrane permeability	1	1/62	56/10965	0.2726473398311128	0.36141624117147503	0.2751316825169124	0.5604593959788944	BNIP3	14
BP	GO:0071824	protein-DNA complex subunit organization	2	2/62	181/10965	0.27293287601174054	0.3615611759690714	0.27524201556278954	0.5602852705299309	PTMA/HMGA1	14
BP	GO:0006641	triglyceride metabolic process	1	1/62	57/10965	0.27678116189825663	0.3654793720818678	0.2782247810451893	0.5556041906923622	APOE	14
BP	GO:0006942	regulation of striated muscle contraction	1	1/62	57/10965	0.27678116189825663	0.3654793720818678	0.2782247810451893	0.5556041906923622	TNNI3	14
BP	GO:0014896	muscle hypertrophy	1	1/62	57/10965	0.27678116189825663	0.3654793720818678	0.2782247810451893	0.5556041906923622	IGFBP5	14
BP	GO:0035023	regulation of Rho protein signal transduction	1	1/62	57/10965	0.27678116189825663	0.3654793720818678	0.2782247810451893	0.5556041906923622	APOE	14
BP	GO:0048678	response to axon injury	1	1/62	57/10965	0.27678116189825663	0.3654793720818678	0.2782247810451893	0.5556041906923622	BNIP3	14
BP	GO:0048667	cell morphogenesis involved in neuron differentiation	4	4/62	473/10965	0.2784263124168049	0.3674153010156165	0.2796985260629808	0.5533098222391297	NRP2/SEMA6A/BSG/APOE	14
BP	GO:0001570	vasculogenesis	1	1/62	58/10965	0.280891866698615	0.36806520463956444	0.2801932716144012	0.5525422978005017	TNNI3	14
BP	GO:0001942	hair follicle development	1	1/62	58/10965	0.280891866698615	0.36806520463956444	0.2801932716144012	0.5525422978005017	IGFBP5	14
BP	GO:0006695	cholesterol biosynthetic process	1	1/62	58/10965	0.280891866698615	0.36806520463956444	0.2801932716144012	0.5525422978005017	APOE	14
BP	GO:0016239	positive regulation of macroautophagy	1	1/62	58/10965	0.280891866698615	0.36806520463956444	0.2801932716144012	0.5525422978005017	BNIP3	14
BP	GO:0032640	tumor necrosis factor production	1	1/62	58/10965	0.280891866698615	0.36806520463956444	0.2801932716144012	0.5525422978005017	MIF	14
BP	GO:0033273	response to vitamin	1	1/62	58/10965	0.280891866698615	0.36806520463956444	0.2801932716144012	0.5525422978005017	SFRP1	14
BP	GO:0042475	odontogenesis of dentin-containing tooth	1	1/62	58/10965	0.280891866698615	0.36806520463956444	0.2801932716144012	0.5525422978005017	BSG	14
BP	GO:0043502	regulation of muscle adaptation	1	1/62	58/10965	0.280891866698615	0.36806520463956444	0.2801932716144012	0.5525422978005017	IGFBP5	14
BP	GO:0046794	transport of virus	1	1/62	58/10965	0.280891866698615	0.36806520463956444	0.2801932716144012	0.5525422978005017	BST2	14
BP	GO:0050771	negative regulation of axonogenesis	1	1/62	58/10965	0.280891866698615	0.36806520463956444	0.2801932716144012	0.5525422978005017	SEMA6A	14
BP	GO:1902653	secondary alcohol biosynthetic process	1	1/62	58/10965	0.280891866698615	0.36806520463956444	0.2801932716144012	0.5525422978005017	APOE	14
BP	GO:0002250	adaptive immune response	2	2/62	186/10965	0.2834462387623734	0.3698786217811121	0.28157375332059625	0.5504078300671464	FZD5/CTSC	14
BP	GO:0050863	regulation of T cell activation	2	2/62	186/10965	0.2834462387623734	0.3698786217811121	0.28157375332059625	0.5504078300671464	IGFBP2/SOX4	14
BP	GO:0002705	positive regulation of leukocyte mediated immunity	1	1/62	59/10965	0.28497958140152935	0.3698786217811121	0.28157375332059625	0.5504078300671464	FZD5	14
BP	GO:0031571	mitotic G1 DNA damage checkpoint	1	1/62	59/10965	0.28497958140152935	0.3698786217811121	0.28157375332059625	0.5504078300671464	SOX4	14
BP	GO:0042982	amyloid precursor protein metabolic process	1	1/62	59/10965	0.28497958140152935	0.3698786217811121	0.28157375332059625	0.5504078300671464	APOE	14
BP	GO:0044786	cell cycle DNA replication	1	1/62	59/10965	0.28497958140152935	0.3698786217811121	0.28157375332059625	0.5504078300671464	FGFR1	14
BP	GO:0044819	mitotic G1/S transition checkpoint	1	1/62	59/10965	0.28497958140152935	0.3698786217811121	0.28157375332059625	0.5504078300671464	SOX4	14
BP	GO:0046782	regulation of viral transcription	1	1/62	59/10965	0.28497958140152935	0.3698786217811121	0.28157375332059625	0.5504078300671464	IFITM3	14
BP	GO:0048207	vesicle targeting, rough ER to cis-Golgi	1	1/62	59/10965	0.28497958140152935	0.3698786217811121	0.28157375332059625	0.5504078300671464	CTSC	14
BP	GO:0048208	COPII vesicle coating	1	1/62	59/10965	0.28497958140152935	0.3698786217811121	0.28157375332059625	0.5504078300671464	CTSC	14
BP	GO:0051262	protein tetramerization	1	1/62	59/10965	0.28497958140152935	0.3698786217811121	0.28157375332059625	0.5504078300671464	ALDOA	14
BP	GO:0060349	bone morphogenesis	1	1/62	59/10965	0.28497958140152935	0.3698786217811121	0.28157375332059625	0.5504078300671464	SFRP2	14
BP	GO:0071706	tumor necrosis factor superfamily cytokine production	1	1/62	59/10965	0.28497958140152935	0.3698786217811121	0.28157375332059625	0.5504078300671464	MIF	14
BP	GO:0150116	regulation of cell-substrate junction organization	1	1/62	59/10965	0.28497958140152935	0.3698786217811121	0.28157375332059625	0.5504078300671464	SFRP1	14
BP	GO:1901983	regulation of protein acetylation	1	1/62	59/10965	0.28497958140152935	0.3698786217811121	0.28157375332059625	0.5504078300671464	SOX4	14
BP	GO:2001020	regulation of response to DNA damage stimulus	2	2/62	188/10965	0.2876492144485304	0.371861552016388	0.2830832785433055	0.5480857832341492	SFRP2/MIF	14
BP	GO:0006970	response to osmotic stress	1	1/62	60/10965	0.28904443248837175	0.371861552016388	0.2830832785433055	0.5480857832341492	SLC2A1	14
BP	GO:0022404	molting cycle process	1	1/62	60/10965	0.28904443248837175	0.371861552016388	0.2830832785433055	0.5480857832341492	IGFBP5	14
BP	GO:0022405	hair cycle process	1	1/62	60/10965	0.28904443248837175	0.371861552016388	0.2830832785433055	0.5480857832341492	IGFBP5	14
BP	GO:0030282	bone mineralization	1	1/62	60/10965	0.28904443248837175	0.371861552016388	0.2830832785433055	0.5480857832341492	GPC3	14
BP	GO:0033143	regulation of intracellular steroid hormone receptor signaling pathway	1	1/62	60/10965	0.28904443248837175	0.371861552016388	0.2830832785433055	0.5480857832341492	SFRP1	14
BP	GO:0034637	cellular carbohydrate biosynthetic process	1	1/62	60/10965	0.28904443248837175	0.371861552016388	0.2830832785433055	0.5480857832341492	SLC2A1	14
BP	GO:0044766	multi-organism transport	1	1/62	60/10965	0.28904443248837175	0.371861552016388	0.2830832785433055	0.5480857832341492	BST2	14
BP	GO:0044783	G1 DNA damage checkpoint	1	1/62	60/10965	0.28904443248837175	0.371861552016388	0.2830832785433055	0.5480857832341492	SOX4	14
BP	GO:0045621	positive regulation of lymphocyte differentiation	1	1/62	60/10965	0.28904443248837175	0.371861552016388	0.2830832785433055	0.5480857832341492	SOX4	14
BP	GO:0045833	negative regulation of lipid metabolic process	1	1/62	60/10965	0.28904443248837175	0.371861552016388	0.2830832785433055	0.5480857832341492	APOE	14
BP	GO:0060419	heart growth	1	1/62	60/10965	0.28904443248837175	0.371861552016388	0.2830832785433055	0.5480857832341492	FGFR1	14
BP	GO:0098773	skin epidermis development	1	1/62	60/10965	0.28904443248837175	0.371861552016388	0.2830832785433055	0.5480857832341492	IGFBP5	14
BP	GO:1902579	multi-organism localization	1	1/62	60/10965	0.28904443248837175	0.371861552016388	0.2830832785433055	0.5480857832341492	BST2	14
BP	GO:0042176	regulation of protein catabolic process	3	3/62	332/10965	0.28948566931790765	0.3721958605515956	0.2833377742169733	0.547695522054269	CTSC/APOE/GPC3	14
BP	GO:0033559	unsaturated fatty acid metabolic process	1	1/62	61/10965	0.29308654575620485	0.3756487144857791	0.28596629337072754	0.5436851538142549	MIF	14
BP	GO:0048661	positive regulation of smooth muscle cell proliferation	1	1/62	61/10965	0.29308654575620485	0.3756487144857791	0.28596629337072754	0.5436851538142549	IGFBP5	14
BP	GO:0051865	protein autoubiquitination	1	1/62	61/10965	0.29308654575620485	0.3756487144857791	0.28596629337072754	0.5436851538142549	UBE3D	14
BP	GO:0097306	cellular response to alcohol	1	1/62	61/10965	0.29308654575620485	0.3756487144857791	0.28596629337072754	0.5436851538142549	SFRP1	14
BP	GO:1903533	regulation of protein targeting	1	1/62	61/10965	0.29308654575620485	0.3756487144857791	0.28596629337072754	0.5436851538142549	FZD5	14
BP	GO:0016126	sterol biosynthetic process	1	1/62	62/10965	0.2971060463214209	0.38032539429292306	0.2895264620553493	0.5383117366017749	APOE	14
BP	GO:1903747	regulation of establishment of protein localization to mitochondrion	1	1/62	62/10965	0.2971060463214209	0.38032539429292306	0.2895264620553493	0.5383117366017749	FZD5	14
BP	GO:1903050	regulation of proteolysis involved in cellular protein catabolic process	2	2/62	193/10965	0.2981464308628442	0.3814192494579528	0.2903591701013656	0.5370644535585611	CTSC/APOE	14
BP	GO:0006513	protein monoubiquitination	1	1/62	63/10965	0.30110305862336295	0.38400464654763256	0.2923273291662495	0.5341305813196818	UBE3D	14
BP	GO:0006901	vesicle coating	1	1/62	63/10965	0.30110305862336295	0.38400464654763256	0.2923273291662495	0.5341305813196818	CTSC	14
BP	GO:0060021	roof of mouth development	1	1/62	63/10965	0.30110305862336295	0.38400464654763256	0.2923273291662495	0.5341305813196818	SOX11	14
BP	GO:0097194	execution phase of apoptosis	1	1/62	63/10965	0.30110305862336295	0.38400464654763256	0.2923273291662495	0.5341305813196818	BLCAP	14
BP	GO:1902106	negative regulation of leukocyte differentiation	1	1/62	63/10965	0.30110305862336295	0.38400464654763256	0.2923273291662495	0.5341305813196818	SFRP1	14
BP	GO:0006954	inflammatory response	3	3/62	340/10965	0.3019109856277344	0.3847958649118702	0.29292965195917475	0.5332366644042664	CTSC/APOE/MIF	14
BP	GO:0000075	cell cycle checkpoint	2	2/62	196/10965	0.3044353958336903	0.387148703518927	0.29472077358268584	0.5305892515461834	SOX11/SOX4	14
BP	GO:0001656	metanephros development	1	1/62	64/10965	0.3050777064279264	0.387148703518927	0.29472077358268584	0.5305892515461834	GPC3	14
BP	GO:0006919	activation of cysteine-type endopeptidase activity involved in apoptotic process	1	1/62	64/10965	0.3050777064279264	0.387148703518927	0.29472077358268584	0.5305892515461834	FAM162A	14
BP	GO:0007338	single fertilization	1	1/62	64/10965	0.3050777064279264	0.387148703518927	0.29472077358268584	0.5305892515461834	ALDOA	14
BP	GO:0043154	negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	1	1/62	64/10965	0.3050777064279264	0.387148703518927	0.29472077358268584	0.5305892515461834	SFRP2	14
BP	GO:0051341	regulation of oxidoreductase activity	1	1/62	64/10965	0.3050777064279264	0.387148703518927	0.29472077358268584	0.5305892515461834	APOE	14
BP	GO:2000177	regulation of neural precursor cell proliferation	1	1/62	64/10965	0.3050777064279264	0.387148703518927	0.29472077358268584	0.5305892515461834	SIX3	14
BP	GO:0007159	leukocyte cell-cell adhesion	2	2/62	197/10965	0.3065298143387506	0.3885641003377367	0.2957982583878123	0.529004387387096	IGFBP2/SOX4	14
BP	GO:1901137	carbohydrate derivative biosynthetic process	4	4/62	495/10965	0.30657177312222017	0.3885641003377367	0.2957982583878123	0.529004387387096	ENO1/TPI1/ALDOA/GPC3	14
BP	GO:0002688	regulation of leukocyte chemotaxis	1	1/62	65/10965	0.30903011283114323	0.3897540206081782	0.29670409694395017	0.5276764568248303	MIF	14
BP	GO:0014812	muscle cell migration	1	1/62	65/10965	0.30903011283114323	0.3897540206081782	0.29670409694395017	0.5276764568248303	IGFBP5	14
BP	GO:0021954	central nervous system neuron development	1	1/62	65/10965	0.30903011283114323	0.3897540206081782	0.29670409694395017	0.5276764568248303	NRP2	14
BP	GO:0043044	ATP-dependent chromatin remodeling	1	1/62	65/10965	0.30903011283114323	0.3897540206081782	0.29670409694395017	0.5276764568248303	PTMA	14
BP	GO:0043462	regulation of ATPase activity	1	1/62	65/10965	0.30903011283114323	0.3897540206081782	0.29670409694395017	0.5276764568248303	TNNI3	14
BP	GO:0046620	regulation of organ growth	1	1/62	65/10965	0.30903011283114323	0.3897540206081782	0.29670409694395017	0.5276764568248303	FGFR1	14
BP	GO:0046902	regulation of mitochondrial membrane permeability	1	1/62	65/10965	0.30903011283114323	0.3897540206081782	0.29670409694395017	0.5276764568248303	BNIP3	14
BP	GO:0071887	leukocyte apoptotic process	1	1/62	65/10965	0.30903011283114323	0.3897540206081782	0.29670409694395017	0.5276764568248303	MIF	14
BP	GO:0002706	regulation of lymphocyte mediated immunity	1	1/62	66/10965	0.3129604002627461	0.39277965831140976	0.29900739352320305	0.5243180727905202	FZD5	14
BP	GO:0015918	sterol transport	1	1/62	66/10965	0.3129604002627461	0.39277965831140976	0.29900739352320305	0.5243180727905202	APOE	14
BP	GO:0051963	regulation of synapse assembly	1	1/62	66/10965	0.3129604002627461	0.39277965831140976	0.29900739352320305	0.5243180727905202	TPBG	14
BP	GO:0060998	regulation of dendritic spine development	1	1/62	66/10965	0.3129604002627461	0.39277965831140976	0.29900739352320305	0.5243180727905202	APOE	14
BP	GO:0072080	nephron tubule development	1	1/62	66/10965	0.3129604002627461	0.39277965831140976	0.29900739352320305	0.5243180727905202	GPC3	14
BP	GO:0072401	signal transduction involved in DNA integrity checkpoint	1	1/62	66/10965	0.3129604002627461	0.39277965831140976	0.29900739352320305	0.5243180727905202	SOX4	14
BP	GO:0072422	signal transduction involved in DNA damage checkpoint	1	1/62	66/10965	0.3129604002627461	0.39277965831140976	0.29900739352320305	0.5243180727905202	SOX4	14
BP	GO:0090114	COPII-coated vesicle budding	1	1/62	66/10965	0.3129604002627461	0.39277965831140976	0.29900739352320305	0.5243180727905202	CTSC	14
BP	GO:0048199	vesicle targeting, to, from or within Golgi	1	1/62	67/10965	0.31686869048971245	0.39613493473732303	0.3015616308352249	0.5206239167033994	CTSC	14
BP	GO:0051492	regulation of stress fiber assembly	1	1/62	67/10965	0.31686869048971245	0.39613493473732303	0.3015616308352249	0.5206239167033994	SFRP1	14
BP	GO:0061326	renal tubule development	1	1/62	67/10965	0.31686869048971245	0.39613493473732303	0.3015616308352249	0.5206239167033994	GPC3	14
BP	GO:0097549	chromatin organization involved in negative regulation of transcription	1	1/62	67/10965	0.31686869048971245	0.39613493473732303	0.3015616308352249	0.5206239167033994	HMGA1	14
BP	GO:1900006	positive regulation of dendrite development	1	1/62	67/10965	0.31686869048971245	0.39613493473732303	0.3015616308352249	0.5206239167033994	APOE	14
BP	GO:0008202	steroid metabolic process	2	2/62	202/10965	0.31698516707538227	0.39613493473732303	0.3015616308352249	0.5206239167033994	FGFR1/APOE	14
BP	GO:0022412	cellular process involved in reproduction in multicellular organism	2	2/62	202/10965	0.31698516707538227	0.39613493473732303	0.3015616308352249	0.5206239167033994	LIN28A/SFRP1	14
BP	GO:0071396	cellular response to lipid	3	3/62	350/10965	0.31748743193028756	0.39652112618438834	0.3018556228878795	0.5202007298107272	SFRP1/DDIT4/MIF	14
BP	GO:0001892	embryonic placenta development	1	1/62	68/10965	0.32075510461979506	0.3979380137121037	0.3029342425098809	0.5186516329313989	FZD5	14
BP	GO:0002698	negative regulation of immune effector process	1	1/62	68/10965	0.32075510461979506	0.3979380137121037	0.3029342425098809	0.5186516329313989	BST2	14
BP	GO:0008585	female gonad development	1	1/62	68/10965	0.32075510461979506	0.3979380137121037	0.3029342425098809	0.5186516329313989	SFRP1	14
BP	GO:0009791	post-embryonic development	1	1/62	68/10965	0.32075510461979506	0.3979380137121037	0.3029342425098809	0.5186516329313989	FZD5	14
BP	GO:0031397	negative regulation of protein ubiquitination	1	1/62	68/10965	0.32075510461979506	0.3979380137121037	0.3029342425098809	0.5186516329313989	SOX4	14
BP	GO:0035150	regulation of tube size	1	1/62	68/10965	0.32075510461979506	0.3979380137121037	0.3029342425098809	0.5186516329313989	APOE	14
BP	GO:0035296	regulation of tube diameter	1	1/62	68/10965	0.32075510461979506	0.3979380137121037	0.3029342425098809	0.5186516329313989	APOE	14
BP	GO:0042303	molting cycle	1	1/62	68/10965	0.32075510461979506	0.3979380137121037	0.3029342425098809	0.5186516329313989	IGFBP5	14
BP	GO:0042633	hair cycle	1	1/62	68/10965	0.32075510461979506	0.3979380137121037	0.3029342425098809	0.5186516329313989	IGFBP5	14
BP	GO:0097746	regulation of blood vessel diameter	1	1/62	68/10965	0.32075510461979506	0.3979380137121037	0.3029342425098809	0.5186516329313989	APOE	14
BP	GO:2000117	negative regulation of cysteine-type endopeptidase activity	1	1/62	68/10965	0.32075510461979506	0.3979380137121037	0.3029342425098809	0.5186516329313989	SFRP2	14
BP	GO:0006959	humoral immune response	1	1/62	69/10965	0.32461976310502694	0.40200347247526574	0.30602911313906556	0.514237256282409	GAPDH	14
BP	GO:0032526	response to retinoic acid	1	1/62	69/10965	0.32461976310502694	0.40200347247526574	0.30602911313906556	0.514237256282409	IGFBP2	14
BP	GO:0097061	dendritic spine organization	1	1/62	69/10965	0.32461976310502694	0.40200347247526574	0.30602911313906556	0.514237256282409	APOE	14
BP	GO:0019932	second-messenger-mediated signaling	2	2/62	207/10965	0.32740779670303355	0.4048081899995083	0.3081642320505131	0.5112177703046363	APOE/TNNI3	14
BP	GO:0032092	positive regulation of protein binding	1	1/62	70/10965	0.32846278574521504	0.4048081899995083	0.3081642320505131	0.5112177703046363	APOE	14
BP	GO:0045471	response to ethanol	1	1/62	70/10965	0.32846278574521504	0.4048081899995083	0.3081642320505131	0.5112177703046363	CLDN3	14
BP	GO:0048010	vascular endothelial growth factor receptor signaling pathway	1	1/62	70/10965	0.32846278574521504	0.4048081899995083	0.3081642320505131	0.5112177703046363	NRP2	14
BP	GO:0050728	negative regulation of inflammatory response	1	1/62	70/10965	0.32846278574521504	0.4048081899995083	0.3081642320505131	0.5112177703046363	APOE	14
BP	GO:0051208	sequestering of calcium ion	1	1/62	70/10965	0.32846278574521504	0.4048081899995083	0.3081642320505131	0.5112177703046363	HSP90B1	14
BP	GO:0070301	cellular response to hydrogen peroxide	1	1/62	70/10965	0.32846278574521504	0.4048081899995083	0.3081642320505131	0.5112177703046363	BNIP3	14
BP	GO:1904019	epithelial cell apoptotic process	1	1/62	70/10965	0.32846278574521504	0.4048081899995083	0.3081642320505131	0.5112177703046363	SIX3	14
BP	GO:0030433	ubiquitin-dependent ERAD pathway	1	1/62	71/10965	0.33228429169141027	0.40804749643972105	0.31063018606573617	0.5077563431831781	HSP90B1	14
BP	GO:0043500	muscle adaptation	1	1/62	71/10965	0.33228429169141027	0.40804749643972105	0.31063018606573617	0.5077563431831781	IGFBP5	14
BP	GO:0046545	development of primary female sexual characteristics	1	1/62	71/10965	0.33228429169141027	0.40804749643972105	0.31063018606573617	0.5077563431831781	SFRP1	14
BP	GO:0048706	embryonic skeletal system development	1	1/62	71/10965	0.33228429169141027	0.40804749643972105	0.31063018606573617	0.5077563431831781	SOX11	14
BP	GO:0050810	regulation of steroid biosynthetic process	1	1/62	71/10965	0.33228429169141027	0.40804749643972105	0.31063018606573617	0.5077563431831781	APOE	14
BP	GO:0071158	positive regulation of cell cycle arrest	1	1/62	71/10965	0.33228429169141027	0.40804749643972105	0.31063018606573617	0.5077563431831781	SOX4	14
BP	GO:0006839	mitochondrial transport	2	2/62	211/10965	0.33571811050021816	0.4116357812537677	0.31336180331414354	0.5039539422033351	FZD5/BNIP3	14
BP	GO:0070252	actin-mediated cell contraction	1	1/62	72/10965	0.3360843994493624	0.4116357812537677	0.31336180331414354	0.5039539422033351	TNNI3	14
BP	GO:0110020	regulation of actomyosin structure organization	1	1/62	72/10965	0.3360843994493624	0.4116357812537677	0.31336180331414354	0.5039539422033351	SFRP1	14
BP	GO:1901216	positive regulation of neuron death	1	1/62	72/10965	0.3360843994493624	0.4116357812537677	0.31336180331414354	0.5039539422033351	DDIT4	14
BP	GO:1901652	response to peptide	3	3/62	362/10965	0.3362093418037596	0.4116357812537677	0.31336180331414354	0.5039539422033351	SLC2A1/IGFBP5/BSG	14
BP	GO:0002761	regulation of myeloid leukocyte differentiation	1	1/62	73/10965	0.33986322688295656	0.4156134335898849	0.31638983043366636	0.4997774842689293	SFRP1	14
BP	GO:0009060	aerobic respiration	1	1/62	73/10965	0.33986322688295656	0.4156134335898849	0.31638983043366636	0.4997774842689293	BNIP3	14
BP	GO:0002822	regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	1	1/62	74/10965	0.3436208912176294	0.4192093155639569	0.31912723109516367	0.49603613591998913	FZD5	14
BP	GO:0032231	regulation of actin filament bundle assembly	1	1/62	74/10965	0.3436208912176294	0.4192093155639569	0.31912723109516367	0.49603613591998913	SFRP1	14
BP	GO:0048194	Golgi vesicle budding	1	1/62	74/10965	0.3436208912176294	0.4192093155639569	0.31912723109516367	0.49603613591998913	CTSC	14
BP	GO:0060218	hematopoietic stem cell differentiation	1	1/62	74/10965	0.3436208912176294	0.4192093155639569	0.31912723109516367	0.49603613591998913	SFRP1	14
BP	GO:0043269	regulation of ion transport	3	3/62	367/10965	0.34401000466160137	0.4194346580900808	0.3192987753183954	0.4958027472090142	FGFR1/APOE/MIF	14
BP	GO:0006638	neutral lipid metabolic process	1	1/62	75/10965	0.3473575090437707	0.4215124828845757	0.32088053996137805	0.4936566202172298	APOE	14
BP	GO:0006639	acylglycerol metabolic process	1	1/62	75/10965	0.3473575090437707	0.4215124828845757	0.32088053996137805	0.4936566202172298	APOE	14
BP	GO:0030183	B cell differentiation	1	1/62	75/10965	0.3473575090437707	0.4215124828845757	0.32088053996137805	0.4936566202172298	SFRP1	14
BP	GO:0043473	pigmentation	1	1/62	75/10965	0.3473575090437707	0.4215124828845757	0.32088053996137805	0.4936566202172298	SHROOM3	14
BP	GO:0048041	focal adhesion assembly	1	1/62	75/10965	0.3473575090437707	0.4215124828845757	0.32088053996137805	0.4936566202172298	SFRP1	14
BP	GO:0051668	localization within membrane	1	1/62	75/10965	0.3473575090437707	0.4215124828845757	0.32088053996137805	0.4936566202172298	APOE	14
BP	GO:0106027	neuron projection organization	1	1/62	75/10965	0.3473575090437707	0.4215124828845757	0.32088053996137805	0.4936566202172298	APOE	14
BP	GO:1903321	negative regulation of protein modification by small protein conjugation or removal	1	1/62	75/10965	0.3473575090437707	0.4215124828845757	0.32088053996137805	0.4936566202172298	SOX4	14
BP	GO:0006024	glycosaminoglycan biosynthetic process	1	1/62	76/10965	0.3510731963201056	0.4252669414692188	0.3237386586335902	0.4898054370547045	GPC3	14
BP	GO:0045446	endothelial cell differentiation	1	1/62	76/10965	0.3510731963201056	0.4252669414692188	0.3237386586335902	0.4898054370547045	CLDN3	14
BP	GO:0072009	nephron epithelium development	1	1/62	76/10965	0.3510731963201056	0.4252669414692188	0.3237386586335902	0.4898054370547045	GPC3	14
BP	GO:0002576	platelet degranulation	1	1/62	77/10965	0.3547680683770581	0.42898295598687286	0.3265675113801782	0.4860270233046148	ALDOA	14
BP	GO:0050777	negative regulation of immune response	1	1/62	77/10965	0.3547680683770581	0.42898295598687286	0.3265675113801782	0.4860270233046148	BST2	14
BP	GO:0060964	regulation of gene silencing by miRNA	1	1/62	77/10965	0.3547680683770581	0.42898295598687286	0.3265675113801782	0.4860270233046148	LIN28A	14
BP	GO:0045860	positive regulation of protein kinase activity	3	3/62	376/10965	0.3580376071336855	0.4324065116496422	0.32917372693550273	0.48257483537434026	FZD5/FGFR1/MIF	14
BP	GO:0009566	fertilization	1	1/62	78/10965	0.35844223992009816	0.4324065116496422	0.32917372693550273	0.48257483537434026	ALDOA	14
BP	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	1	1/62	78/10965	0.35844223992009816	0.4324065116496422	0.32917372693550273	0.48257483537434026	FGFR1	14
BP	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	1	1/62	78/10965	0.35844223992009816	0.4324065116496422	0.32917372693550273	0.48257483537434026	SFRP2	14
BP	GO:1903362	regulation of cellular protein catabolic process	2	2/62	223/10965	0.3604695347952419	0.43459664242058543	0.3308409856120595	0.4803806940331535	CTSC/APOE	14
BP	GO:0000079	regulation of cyclin-dependent protein serine/threonine kinase activity	1	1/62	79/10965	0.3620958250330727	0.43502378979383205	0.3311661557679526	0.4799540532707992	CDKN1C	14
BP	GO:0010771	negative regulation of cell morphogenesis involved in differentiation	1	1/62	79/10965	0.3620958250330727	0.43502378979383205	0.3311661557679526	0.4799540532707992	SEMA6A	14
BP	GO:0034401	chromatin organization involved in regulation of transcription	1	1/62	79/10965	0.3620958250330727	0.43502378979383205	0.3311661557679526	0.4799540532707992	HMGA1	14
BP	GO:0042476	odontogenesis	1	1/62	79/10965	0.3620958250330727	0.43502378979383205	0.3311661557679526	0.4799540532707992	BSG	14
BP	GO:0060147	regulation of posttranscriptional gene silencing	1	1/62	79/10965	0.3620958250330727	0.43502378979383205	0.3311661557679526	0.4799540532707992	LIN28A	14
BP	GO:0060966	regulation of gene silencing by RNA	1	1/62	79/10965	0.3620958250330727	0.43502378979383205	0.3311661557679526	0.4799540532707992	LIN28A	14
BP	GO:1901214	regulation of neuron death	2	2/62	225/10965	0.36456494650790716	0.43773392055835314	0.3332292695745337	0.4772568588366135	DDIT4/APOE	14
BP	GO:0046660	female sex differentiation	1	1/62	80/10965	0.3657289371815158	0.4388747246178189	0.334097717930052	0.476126490820326	SFRP1	14
BP	GO:0006023	aminoglycan biosynthetic process	1	1/62	81/10965	0.36934168921594324	0.44217569794114087	0.33661061646899204	0.47287219079278253	GPC3	14
BP	GO:0042129	regulation of T cell proliferation	1	1/62	81/10965	0.36934168921594324	0.44217569794114087	0.33661061646899204	0.47287219079278253	IGFBP2	14
BP	GO:1990823	response to leukemia inhibitory factor	1	1/62	81/10965	0.36934168921594324	0.44217569794114087	0.33661061646899204	0.47287219079278253	NRP2	14
BP	GO:1990830	cellular response to leukemia inhibitory factor	1	1/62	81/10965	0.36934168921594324	0.44217569794114087	0.33661061646899204	0.47287219079278253	NRP2	14
BP	GO:0002819	regulation of adaptive immune response	1	1/62	82/10965	0.37293419337513234	0.4449191655847509	0.33869910830397576	0.4701859467246423	FZD5	14
BP	GO:0006626	protein targeting to mitochondrion	1	1/62	82/10965	0.37293419337513234	0.4449191655847509	0.33869910830397576	0.4701859467246423	FZD5	14
BP	GO:0007613	memory	1	1/62	82/10965	0.37293419337513234	0.4449191655847509	0.33869910830397576	0.4701859467246423	APOE	14
BP	GO:0030038	contractile actin filament bundle assembly	1	1/62	82/10965	0.37293419337513234	0.4449191655847509	0.33869910830397576	0.4701859467246423	SFRP1	14
BP	GO:0043149	stress fiber assembly	1	1/62	82/10965	0.37293419337513234	0.4449191655847509	0.33869910830397576	0.4701859467246423	SFRP1	14
BP	GO:1904029	regulation of cyclin-dependent protein kinase activity	1	1/62	82/10965	0.37293419337513234	0.4449191655847509	0.33869910830397576	0.4701859467246423	CDKN1C	14
BP	GO:0007605	sensory perception of sound	1	1/62	83/10965	0.3765065612893782	0.44787910942945164	0.3409523947847062	0.4673062548068807	FGFR1	14
BP	GO:0031532	actin cytoskeleton reorganization	1	1/62	83/10965	0.3765065612893782	0.44787910942945164	0.3409523947847062	0.4673062548068807	CLDN3	14
BP	GO:0042158	lipoprotein biosynthetic process	1	1/62	83/10965	0.3765065612893782	0.44787910942945164	0.3409523947847062	0.4673062548068807	APOE	14
BP	GO:0060048	cardiac muscle contraction	1	1/62	83/10965	0.3765065612893782	0.44787910942945164	0.3409523947847062	0.4673062548068807	TNNI3	14
BP	GO:0062013	positive regulation of small molecule metabolic process	1	1/62	83/10965	0.3765065612893782	0.44787910942945164	0.3409523947847062	0.4673062548068807	ENO1	14
BP	GO:0006897	endocytosis	3	3/62	390/10965	0.3797887658875123	0.4507981913148196	0.3431745746953895	0.46448489587731934	HSP90B1/APOE/GPC3	14
BP	GO:0003158	endothelium development	1	1/62	84/10965	0.38005890398374165	0.4507981913148196	0.3431745746953895	0.46448489587731934	CLDN3	14
BP	GO:0007044	cell-substrate junction assembly	1	1/62	84/10965	0.38005890398374165	0.4507981913148196	0.3431745746953895	0.46448489587731934	SFRP1	14
BP	GO:0030216	keratinocyte differentiation	1	1/62	84/10965	0.38005890398374165	0.4507981913148196	0.3431745746953895	0.46448489587731934	POU3F1	14
BP	GO:0045580	regulation of T cell differentiation	1	1/62	84/10965	0.38005890398374165	0.4507981913148196	0.3431745746953895	0.46448489587731934	SOX4	14
BP	GO:0090068	positive regulation of cell cycle process	2	2/62	233/10965	0.380849644937972	0.4514751423528126	0.3436899103578403	0.4638332171797158	SOX4/FGFR1	14
BP	GO:0002040	sprouting angiogenesis	1	1/62	85/10965	0.38359133188127004	0.45289379345245456	0.3447698725163859	0.4624706917207227	SEMA6A	14
BP	GO:0006903	vesicle targeting	1	1/62	85/10965	0.38359133188127004	0.45289379345245456	0.3447698725163859	0.4624706917207227	CTSC	14
BP	GO:0015698	inorganic anion transport	1	1/62	85/10965	0.38359133188127004	0.45289379345245456	0.3447698725163859	0.4624706917207227	FGFR1	14
BP	GO:0019935	cyclic-nucleotide-mediated signaling	1	1/62	85/10965	0.38359133188127004	0.45289379345245456	0.3447698725163859	0.4624706917207227	APOE	14
BP	GO:0030518	intracellular steroid hormone receptor signaling pathway	1	1/62	85/10965	0.38359133188127004	0.45289379345245456	0.3447698725163859	0.4624706917207227	SFRP1	14
BP	GO:0031214	biomineral tissue development	1	1/62	85/10965	0.38359133188127004	0.45289379345245456	0.3447698725163859	0.4624706917207227	GPC3	14
BP	GO:0110148	biomineralization	1	1/62	85/10965	0.38359133188127004	0.45289379345245456	0.3447698725163859	0.4624706917207227	GPC3	14
BP	GO:0010976	positive regulation of neuron projection development	2	2/62	235/10965	0.38489510263207716	0.4541717944801738	0.34574276341878424	0.46124690113963496	FGFR1/APOE	14
BP	GO:0007156	homophilic cell adhesion via plasma membrane adhesion molecules	1	1/62	86/10965	0.3871039548062114	0.45625348378078445	0.3473274699552089	0.45926086719835923	BSG	14
BP	GO:0008543	fibroblast growth factor receptor signaling pathway	1	1/62	86/10965	0.3871039548062114	0.45625348378078445	0.3473274699552089	0.45926086719835923	FGFR1	14
BP	GO:0034599	cellular response to oxidative stress	2	2/62	237/10965	0.3889297084235618	0.4581422282922783	0.34876529536562073	0.4574667369879504	BNIP3/MGST1	14
BP	GO:0008217	regulation of blood pressure	1	1/62	87/10965	0.39059688198720366	0.45852677450671736	0.34905803496869214	0.4571023605156262	TNNI3	14
BP	GO:0015748	organophosphate ester transport	1	1/62	87/10965	0.39059688198720366	0.45852677450671736	0.34905803496869214	0.4571023605156262	APOE	14
BP	GO:0050921	positive regulation of chemotaxis	1	1/62	87/10965	0.39059688198720366	0.45852677450671736	0.34905803496869214	0.4571023605156262	FGFR1	14
BP	GO:0060996	dendritic spine development	1	1/62	87/10965	0.39059688198720366	0.45852677450671736	0.34905803496869214	0.4571023605156262	APOE	14
BP	GO:0150115	cell-substrate junction organization	1	1/62	87/10965	0.39059688198720366	0.45852677450671736	0.34905803496869214	0.4571023605156262	SFRP1	14
BP	GO:2000134	negative regulation of G1/S transition of mitotic cell cycle	1	1/62	87/10965	0.39059688198720366	0.45852677450671736	0.34905803496869214	0.4571023605156262	SOX4	14
BP	GO:1902807	negative regulation of cell cycle G1/S phase transition	1	1/62	88/10965	0.3940702220604516	0.46233967734022113	0.35196064490247675	0.45350589520716106	SOX4	14
BP	GO:0006260	DNA replication	2	2/62	241/10965	0.3969652933830977	0.4650623822494658	0.3540333309008963	0.450955848864293	HMGA1/FGFR1	14
BP	GO:0010811	positive regulation of cell-substrate adhesion	1	1/62	89/10965	0.39752408307288645	0.4650623822494658	0.3540333309008963	0.450955848864293	SFRP1	14
BP	GO:0019218	regulation of steroid metabolic process	1	1/62	89/10965	0.39752408307288645	0.4650623822494658	0.3540333309008963	0.450955848864293	APOE	14
BP	GO:0055088	lipid homeostasis	1	1/62	89/10965	0.39752408307288645	0.4650623822494658	0.3540333309008963	0.450955848864293	APOE	14
BP	GO:1901568	fatty acid derivative metabolic process	1	1/62	89/10965	0.39752408307288645	0.4650623822494658	0.3540333309008963	0.450955848864293	MIF	14
BP	GO:0019751	polyol metabolic process	1	1/62	90/10965	0.4009585724853064	0.4685461222892078	0.3566853624075019	0.4477147127981409	TPI1	14
BP	GO:2000241	regulation of reproductive process	1	1/62	90/10965	0.4009585724853064	0.4685461222892078	0.3566853624075019	0.4477147127981409	SFRP1	14
BP	GO:0002224	toll-like receptor signaling pathway	1	1/62	91/10965	0.40437379717550537	0.4711953616150693	0.35870212200511076	0.44526605412307374	HSP90B1	14
BP	GO:0031644	regulation of nervous system process	1	1/62	91/10965	0.40437379717550537	0.4711953616150693	0.35870212200511076	0.44526605412307374	CTSC	14
BP	GO:0044773	mitotic DNA damage checkpoint	1	1/62	91/10965	0.40437379717550537	0.4711953616150693	0.35870212200511076	0.44526605412307374	SOX4	14
BP	GO:0045834	positive regulation of lipid metabolic process	1	1/62	91/10965	0.40437379717550537	0.4711953616150693	0.35870212200511076	0.44526605412307374	APOE	14
BP	GO:0048660	regulation of smooth muscle cell proliferation	1	1/62	91/10965	0.40437379717550537	0.4711953616150693	0.35870212200511076	0.44526605412307374	IGFBP5	14
BP	GO:0044089	positive regulation of cellular component biogenesis	3	3/62	408/10965	0.4075450086993253	0.474075784578873	0.36089487243000284	0.44261928832335484	TPBG/CLDN3/SFRP1	14
BP	GO:0016202	regulation of striated muscle tissue development	1	1/62	92/10965	0.40776986344137955	0.474075784578873	0.36089487243000284	0.44261928832335484	FGFR1	14
BP	GO:0036503	ERAD pathway	1	1/62	92/10965	0.40776986344137955	0.474075784578873	0.36089487243000284	0.44261928832335484	HSP90B1	14
BP	GO:0048659	smooth muscle cell proliferation	1	1/62	92/10965	0.40776986344137955	0.474075784578873	0.36089487243000284	0.44261928832335484	IGFBP5	14
BP	GO:0031647	regulation of protein stability	2	2/62	247/10965	0.40893077583260173	0.4751562582154579	0.3617173936553502	0.4416306071164157	SOX4/GAPDH	14
BP	GO:0043280	positive regulation of cysteine-type endopeptidase activity involved in apoptotic process	1	1/62	93/10965	0.4111468770040243	0.4769210806174437	0.3630608821361888	0.4400205414687749	FAM162A	14
BP	GO:0048634	regulation of muscle organ development	1	1/62	93/10965	0.4111468770040243	0.4769210806174437	0.3630608821361888	0.4400205414687749	FGFR1	14
BP	GO:1903707	negative regulation of hemopoiesis	1	1/62	93/10965	0.4111468770040243	0.4769210806174437	0.3630608821361888	0.4400205414687749	SFRP1	14
BP	GO:0001952	regulation of cell-matrix adhesion	1	1/62	94/10965	0.41450494301080776	0.4791910665116493	0.36478893131388507	0.43795834781684145	SFRP1	14
BP	GO:0014065	phosphatidylinositol 3-kinase signaling	1	1/62	94/10965	0.41450494301080776	0.4791910665116493	0.36478893131388507	0.43795834781684145	FGFR1	14
BP	GO:0043244	regulation of protein-containing complex disassembly	1	1/62	94/10965	0.41450494301080776	0.4791910665116493	0.36478893131388507	0.43795834781684145	BNIP3	14
BP	GO:0043666	regulation of phosphoprotein phosphatase activity	1	1/62	94/10965	0.41450494301080776	0.4791910665116493	0.36478893131388507	0.43795834781684145	HSP90B1	14
BP	GO:0050954	sensory perception of mechanical stimulus	1	1/62	94/10965	0.41450494301080776	0.4791910665116493	0.36478893131388507	0.43795834781684145	FGFR1	14
BP	GO:1902107	positive regulation of leukocyte differentiation	1	1/62	94/10965	0.41450494301080776	0.4791910665116493	0.36478893131388507	0.43795834781684145	SOX4	14
BP	GO:0010769	regulation of cell morphogenesis involved in differentiation	2	2/62	251/10965	0.41684635135068027	0.48162652757409685	0.3666429500974452	0.4357566613112541	SEMA6A/APOE	14
BP	GO:0002831	regulation of response to biotic stimulus	2	2/62	253/10965	0.42078503138515	0.48416238767337233	0.36857339863921446	0.43347601269018465	APOE/MIF	14
BP	GO:0006275	regulation of DNA replication	1	1/62	96/10965	0.42116465009598913	0.48416238767337233	0.36857339863921446	0.43347601269018465	FGFR1	14
BP	GO:0006900	vesicle budding from membrane	1	1/62	96/10965	0.42116465009598913	0.48416238767337233	0.36857339863921446	0.43347601269018465	CTSC	14
BP	GO:0007519	skeletal muscle tissue development	1	1/62	96/10965	0.42116465009598913	0.48416238767337233	0.36857339863921446	0.43347601269018465	SOX11	14
BP	GO:0030168	platelet activation	1	1/62	96/10965	0.42116465009598913	0.48416238767337233	0.36857339863921446	0.43347601269018465	APOE	14
BP	GO:0030856	regulation of epithelial cell differentiation	1	1/62	96/10965	0.42116465009598913	0.48416238767337233	0.36857339863921446	0.43347601269018465	FRZB	14
BP	GO:0050731	positive regulation of peptidyl-tyrosine phosphorylation	1	1/62	96/10965	0.42116465009598913	0.48416238767337233	0.36857339863921446	0.43347601269018465	MIF	14
BP	GO:0071222	cellular response to lipopolysaccharide	1	1/62	96/10965	0.42116465009598913	0.48416238767337233	0.36857339863921446	0.43347601269018465	MIF	14
BP	GO:0071346	cellular response to interferon-gamma	1	1/62	96/10965	0.42116465009598913	0.48416238767337233	0.36857339863921446	0.43347601269018465	GAPDH	14
BP	GO:0090407	organophosphate biosynthetic process	3	3/62	418/10965	0.4228242421390318	0.48579806543633447	0.3698185744883145	0.4320112797771851	ENO1/TPI1/ALDOA	14
BP	GO:0002181	cytoplasmic translation	1	1/62	97/10965	0.42446649862796515	0.4863234255636988	0.3702185100731143	0.4315418713161009	LIN28A	14
BP	GO:0003018	vascular process in circulatory system	1	1/62	97/10965	0.42446649862796515	0.4863234255636988	0.3702185100731143	0.4315418713161009	APOE	14
BP	GO:0018107	peptidyl-threonine phosphorylation	1	1/62	97/10965	0.42446649862796515	0.4863234255636988	0.3702185100731143	0.4315418713161009	DDIT4	14
BP	GO:0030048	actin filament-based movement	1	1/62	97/10965	0.42446649862796515	0.4863234255636988	0.3702185100731143	0.4315418713161009	TNNI3	14
BP	GO:0051101	regulation of DNA binding	1	1/62	97/10965	0.42446649862796515	0.4863234255636988	0.3702185100731143	0.4315418713161009	SOX11	14
BP	GO:0006119	oxidative phosphorylation	1	1/62	98/10965	0.4277498145172791	0.4884488699996977	0.37183652563842795	0.42964795156228236	PGK1	14
BP	GO:0006633	fatty acid biosynthetic process	1	1/62	98/10965	0.4277498145172791	0.4884488699996977	0.37183652563842795	0.42964795156228236	MIF	14
BP	GO:0007266	Rho protein signal transduction	1	1/62	98/10965	0.4277498145172791	0.4884488699996977	0.37183652563842795	0.42964795156228236	APOE	14
BP	GO:0032508	DNA duplex unwinding	1	1/62	98/10965	0.4277498145172791	0.4884488699996977	0.37183652563842795	0.42964795156228236	HMGA1	14
BP	GO:0044774	mitotic DNA integrity checkpoint	1	1/62	98/10965	0.4277498145172791	0.4884488699996977	0.37183652563842795	0.42964795156228236	SOX4	14
BP	GO:0046330	positive regulation of JNK cascade	1	1/62	98/10965	0.4277498145172791	0.4884488699996977	0.37183652563842795	0.42964795156228236	FZD5	14
BP	GO:0048524	positive regulation of viral process	1	1/62	99/10965	0.4310147000882676	0.49190331734211634	0.37446625778993564	0.42658730938197353	APOE	14
BP	GO:0030879	mammary gland development	1	1/62	100/10965	0.434261257109667	0.49505783310502033	0.37686766406476363	0.4238111242131552	IGFBP5	14
BP	GO:0097529	myeloid leukocyte migration	1	1/62	100/10965	0.434261257109667	0.49505783310502033	0.37686766406476363	0.4238111242131552	MIF	14
BP	GO:0030595	leukocyte chemotaxis	1	1/62	101/10965	0.43748958679758243	0.49818459051533803	0.37924793901957615	0.4210767706595113	MIF	14
BP	GO:2001056	positive regulation of cysteine-type endopeptidase activity	1	1/62	101/10965	0.43748958679758243	0.49818459051533803	0.37924793901957615	0.4210767706595113	FAM162A	14
BP	GO:0033674	positive regulation of kinase activity	3	3/62	428/10965	0.43797975816681234	0.4984661473978364	0.3794622769767052	0.42083139161344785	FZD5/FGFR1/MIF	14
BP	GO:0042098	T cell proliferation	1	1/62	102/10965	0.4406997898184355	0.500728664843538	0.38118464072422825	0.4188646069400592	IGFBP2	14
BP	GO:0042157	lipoprotein metabolic process	1	1/62	102/10965	0.4406997898184355	0.500728664843538	0.38118464072422825	0.4188646069400592	APOE	14
BP	GO:0043524	negative regulation of neuron apoptotic process	1	1/62	102/10965	0.4406997898184355	0.500728664843538	0.38118464072422825	0.4188646069400592	APOE	14
BP	GO:0071417	cellular response to organonitrogen compound	3	3/62	430/10965	0.440994525377581	0.5007862568205844	0.38122848318546604	0.41881465885177876	IGFBP5/SFRP1/HSP90B1	14
BP	GO:0031497	chromatin assembly	1	1/62	103/10965	0.4438919662919011	0.5029631777089901	0.3828856857084956	0.4169308695729608	HMGA1	14
BP	GO:0043401	steroid hormone mediated signaling pathway	1	1/62	103/10965	0.4438919662919011	0.5029631777089901	0.3828856857084956	0.4169308695729608	SFRP1	14
BP	GO:0060538	skeletal muscle organ development	1	1/62	103/10965	0.4438919662919011	0.5029631777089901	0.3828856857084956	0.4169308695729608	SOX11	14
BP	GO:0072006	nephron development	1	1/62	103/10965	0.4438919662919011	0.5029631777089901	0.3828856857084956	0.4169308695729608	GPC3	14
BP	GO:0032956	regulation of actin cytoskeleton organization	2	2/62	266/10965	0.44605989336304397	0.5048871077649588	0.38435029646209035	0.41527277960889286	SFRP1/BST2	14
BP	GO:0010498	proteasomal protein catabolic process	3	3/62	434/10965	0.4470066926521896	0.5048871077649588	0.38435029646209035	0.41527277960889286	UBE3D/HSP90B1/APOE	14
BP	GO:0007006	mitochondrial membrane organization	1	1/62	104/10965	0.44706621579382566	0.5048871077649588	0.38435029646209035	0.41527277960889286	BNIP3	14
BP	GO:0008203	cholesterol metabolic process	1	1/62	104/10965	0.44706621579382566	0.5048871077649588	0.38435029646209035	0.41527277960889286	APOE	14
BP	GO:0018210	peptidyl-threonine modification	1	1/62	104/10965	0.44706621579382566	0.5048871077649588	0.38435029646209035	0.41527277960889286	DDIT4	14
BP	GO:0030203	glycosaminoglycan metabolic process	1	1/62	104/10965	0.44706621579382566	0.5048871077649588	0.38435029646209035	0.41527277960889286	GPC3	14
BP	GO:0045930	negative regulation of mitotic cell cycle	2	2/62	268/10965	0.4498960531159448	0.5076136548686466	0.38642590736897076	0.41293376463178155	SOX4/CDKN1C	14
BP	GO:0032870	cellular response to hormone stimulus	3	3/62	436/10965	0.45000384387292625	0.5076136548686466	0.38642590736897076	0.41293376463178155	IGFBP2/SFRP1/DDIT4	14
BP	GO:0032392	DNA geometric change	1	1/62	105/10965	0.45022263735913104	0.5076136548686466	0.38642590736897076	0.41293376463178155	HMGA1	14
BP	GO:0007005	mitochondrion organization	3	3/62	439/10965	0.45448806284853616	0.5121414085476091	0.38987270456789364	0.4090771691990372	FZD5/FAM162A/BNIP3	14
BP	GO:0030968	endoplasmic reticulum unfolded protein response	1	1/62	107/10965	0.4564823901322739	0.5135426888988082	0.3909394430726537	0.4078905100624334	HSP90B1	14
BP	GO:0045766	positive regulation of angiogenesis	1	1/62	107/10965	0.4564823901322739	0.5135426888988082	0.3909394430726537	0.4078905100624334	SFRP2	14
BP	GO:1903052	positive regulation of proteolysis involved in cellular protein catabolic process	1	1/62	107/10965	0.4564823901322739	0.5135426888988082	0.3909394430726537	0.4078905100624334	CTSC	14
BP	GO:0035195	gene silencing by miRNA	1	1/62	108/10965	0.4595859167312605	0.5167508499356419	0.39338168734199885	0.4051858611717191	LIN28A	14
BP	GO:0035265	organ growth	1	1/62	109/10965	0.4626720061816303	0.5199359017988529	0.3958063395247243	0.4025172540948657	FGFR1	14
BP	GO:0016236	macroautophagy	2	2/62	275/10965	0.4632077778253548	0.5202530706609897	0.39604778745301567	0.40225240858203415	BNIP3/GAPDH	14
BP	GO:0001889	liver development	1	1/62	110/10965	0.4657407548567165	0.5225259863127295	0.39777806693756573	0.40035916709039693	FRZB	14
BP	GO:0010508	positive regulation of autophagy	1	1/62	110/10965	0.4657407548567165	0.5225259863127295	0.39777806693756573	0.40035916709039693	BNIP3	14
BP	GO:0006022	aminoglycan metabolic process	1	1/62	111/10965	0.468792258606038	0.5250882721940993	0.3997286323669044	0.398234742323864	GPC3	14
BP	GO:0019722	calcium-mediated signaling	1	1/62	111/10965	0.468792258606038	0.5250882721940993	0.3997286323669044	0.398234742323864	TNNI3	14
BP	GO:0050806	positive regulation of synaptic transmission	1	1/62	111/10965	0.468792258606038	0.5250882721940993	0.3997286323669044	0.398234742323864	APOE	14
BP	GO:0006914	autophagy	3	3/62	450/10965	0.47080605262884945	0.5267688222434019	0.4010079676870876	0.39684699823228997	FZD5/BNIP3/GAPDH	14
BP	GO:0061919	process utilizing autophagic mechanism	3	3/62	450/10965	0.47080605262884945	0.5267688222434019	0.4010079676870876	0.39684699823228997	FZD5/BNIP3/GAPDH	14
BP	GO:0061008	hepaticobiliary system development	1	1/62	112/10965	0.4718266127580949	0.5276230023867089	0.4016582207560665	0.3961433398857863	FRZB	14
BP	GO:0010948	negative regulation of cell cycle process	2	2/62	280/10965	0.47260405293989316	0.5279169932676433	0.40188202421728875	0.3959014189331993	SOX4/MIF	14
BP	GO:0030099	myeloid cell differentiation	2	2/62	280/10965	0.47260405293989316	0.5279169932676433	0.40188202421728875	0.3959014189331993	SFRP1/GPC3	14
BP	GO:0016125	sterol metabolic process	1	1/62	113/10965	0.47484391212315513	0.529842146643129	0.40334756623494594	0.3943205592092335	APOE	14
BP	GO:0035304	regulation of protein dephosphorylation	1	1/62	113/10965	0.47484391212315513	0.529842146643129	0.40334756623494594	0.3943205592092335	HSP90B1	14
BP	GO:1902903	regulation of supramolecular fiber organization	2	2/62	282/10965	0.4763358110760044	0.5312179806130223	0.4043949334306583	0.3931942942207281	SFRP1/APOE	14
BP	GO:0002685	regulation of leukocyte migration	1	1/62	114/10965	0.477844250996023	0.5326107566778051	0.40545519796340557	0.39205712752490324	MIF	14
BP	GO:0051098	regulation of binding	2	2/62	284/10965	0.4800520788277165	0.5341951748358683	0.40666135193209635	0.3907670998850277	SOX11/APOE	14
BP	GO:0006606	protein import into nucleus	1	1/62	115/10965	0.48082772315879574	0.5341951748358683	0.40666135193209635	0.3907670998850277	SIX3	14
BP	GO:0035194	post-transcriptional gene silencing by RNA	1	1/62	115/10965	0.48082772315879574	0.5341951748358683	0.40666135193209635	0.3907670998850277	LIN28A	14
BP	GO:0046165	alcohol biosynthetic process	1	1/62	115/10965	0.48082772315879574	0.5341951748358683	0.40666135193209635	0.3907670998850277	APOE	14
BP	GO:1902904	negative regulation of supramolecular fiber organization	1	1/62	115/10965	0.48082772315879574	0.5341951748358683	0.40666135193209635	0.3907670998850277	APOE	14
BP	GO:2001251	negative regulation of chromosome organization	1	1/62	115/10965	0.48082772315879574	0.5341951748358683	0.40666135193209635	0.3907670998850277	HMGA1	14
BP	GO:0016441	posttranscriptional gene silencing	1	1/62	116/10965	0.4837944218836028	0.5369097640374001	0.4087278597678783	0.3885657588357795	LIN28A	14
BP	GO:0051302	regulation of cell division	1	1/62	116/10965	0.4837944218836028	0.5369097640374001	0.4087278597678783	0.3885657588357795	SFRP2	14
BP	GO:0032874	positive regulation of stress-activated MAPK cascade	1	1/62	117/10965	0.48674443993533256	0.5395999950012438	0.41077582465468654	0.3863951238089765	FZD5	14
BP	GO:0034764	positive regulation of transmembrane transport	1	1/62	117/10965	0.48674443993533256	0.5395999950012438	0.41077582465468654	0.3863951238089765	GPC3	14
BP	GO:0031348	negative regulation of defense response	1	1/62	118/10965	0.4896778695743452	0.5425588490100196	0.4130282814870571	0.38402020966745676	APOE	14
BP	GO:0070304	positive regulation of stress-activated protein kinase signaling cascade	1	1/62	119/10965	0.49259480255916954	0.5454962411502514	0.4152644002600662	0.3816752984429779	FZD5	14
BP	GO:0048015	phosphatidylinositol-mediated signaling	1	1/62	120/10965	0.49549533014918723	0.5478213456175282	0.41703440899579963	0.37982811044471704	FGFR1	14
BP	GO:0071347	cellular response to interleukin-1	1	1/62	120/10965	0.49549533014918723	0.5478213456175282	0.41703440899579963	0.37982811044471704	SFRP1	14
BP	GO:0072655	establishment of protein localization to mitochondrion	1	1/62	120/10965	0.49549533014918723	0.5478213456175282	0.41703440899579963	0.37982811044471704	FZD5	14
BP	GO:1901699	cellular response to nitrogen compound	3	3/62	468/10965	0.4970495452880396	0.5492437624830679	0.4181172378808212	0.37870192725418317	IGFBP5/SFRP1/HSP90B1	14
BP	GO:1904018	positive regulation of vasculature development	1	1/62	121/10965	0.4983795431073016	0.5501398872332252	0.4187994216959609	0.37799392669335397	SFRP2	14
BP	GO:0008015	blood circulation	2	2/62	294/10965	0.49839671070495395	0.5501398872332252	0.4187994216959609	0.37799392669335397	APOE/TNNI3	14
BP	GO:0048017	inositol lipid-mediated signaling	1	1/62	122/10965	0.5012475317025935	0.5520987305709726	0.42029061053007244	0.3764503122085221	FGFR1	14
BP	GO:0048167	regulation of synaptic plasticity	1	1/62	122/10965	0.5012475317025935	0.5520987305709726	0.42029061053007244	0.3764503122085221	APOE	14
BP	GO:0070585	protein localization to mitochondrion	1	1/62	122/10965	0.5012475317025935	0.5520987305709726	0.42029061053007244	0.3764503122085221	FZD5	14
BP	GO:0071248	cellular response to metal ion	1	1/62	122/10965	0.5012475317025935	0.5520987305709726	0.42029061053007244	0.3764503122085221	BNIP3	14
BP	GO:0032535	regulation of cellular component size	2	2/62	297/10965	0.5038217747600033	0.5537537149266601	0.42155048371353426	0.3751504080253953	SEMA6A/APOE	14
BP	GO:0032970	regulation of actin filament-based process	2	2/62	297/10965	0.5038217747600033	0.5537537149266601	0.42155048371353426	0.3751504080253953	SFRP1/BST2	14
BP	GO:0002221	pattern recognition receptor signaling pathway	1	1/62	123/10965	0.5040993857129635	0.5537537149266601	0.42155048371353426	0.3751504080253953	HSP90B1	14
BP	GO:0007626	locomotory behavior	1	1/62	123/10965	0.5040993857129635	0.5537537149266601	0.42155048371353426	0.3751504080253953	APOE	14
BP	GO:0009755	hormone-mediated signaling pathway	1	1/62	123/10965	0.5040993857129635	0.5537537149266601	0.42155048371353426	0.3751504080253953	SFRP1	14
BP	GO:0006333	chromatin assembly or disassembly	1	1/62	124/10965	0.5069351944277575	0.5556789631227342	0.42301609791430056	0.37364310519629773	HMGA1	14
BP	GO:0034620	cellular response to unfolded protein	1	1/62	124/10965	0.5069351944277575	0.5556789631227342	0.42301609791430056	0.37364310519629773	HSP90B1	14
BP	GO:0051100	negative regulation of binding	1	1/62	124/10965	0.5069351944277575	0.5556789631227342	0.42301609791430056	0.37364310519629773	SOX11	14
BP	GO:1903708	positive regulation of hemopoiesis	1	1/62	124/10965	0.5069351944277575	0.5556789631227342	0.42301609791430056	0.37364310519629773	SOX4	14
BP	GO:0040029	regulation of gene expression, epigenetic	1	1/62	125/10965	0.5097550466503826	0.5584716261220423	0.42514204019960533	0.3714659476699891	HMGA1	14
BP	GO:2000377	regulation of reactive oxygen species metabolic process	1	1/62	126/10965	0.5125590307009062	0.5612439332968301	0.42725248641248376	0.36931540120622064	BNIP3	14
BP	GO:0050773	regulation of dendrite development	1	1/62	127/10965	0.5153472344186425	0.5639960133477624	0.42934753452758767	0.36719102663771425	APOE	14
BP	GO:0032504	multicellular organism reproduction	3	3/62	482/10965	0.5170280748212672	0.5652215401797003	0.43028047893027355	0.3662483566485012	LIN28A/SFRP1/BSG	14
BP	GO:0051169	nuclear transport	2	2/62	305/10965	0.5181079553430178	0.5652215401797003	0.43028047893027355	0.3662483566485012	SIX3/HMGA1	14
BP	GO:0045931	positive regulation of mitotic cell cycle	1	1/62	128/10965	0.5181197451647253	0.5652215401797003	0.43028047893027355	0.3662483566485012	FGFR1	14
BP	GO:0048639	positive regulation of developmental growth	1	1/62	128/10965	0.5181197451647253	0.5652215401797003	0.43028047893027355	0.3662483566485012	FGFR1	14
BP	GO:0051606	detection of stimulus	1	1/62	128/10965	0.5181197451647253	0.5652215401797003	0.43028047893027355	0.3662483566485012	SOX4	14
BP	GO:2000045	regulation of G1/S transition of mitotic cell cycle	1	1/62	128/10965	0.5181197451647253	0.5652215401797003	0.43028047893027355	0.3662483566485012	SOX4	14
BP	GO:0001701	in utero embryonic development	2	2/62	306/10965	0.5198750484123826	0.5668350687259348	0.4315087934694199	0.3650103496212318	FZD5/FGFR1	14
BP	GO:0031047	gene silencing by RNA	1	1/62	129/10965	0.5208766498246669	0.5673242491720893	0.43188118691463057	0.3646357137508712	LIN28A	14
BP	GO:0034614	cellular response to reactive oxygen species	1	1/62	129/10965	0.5208766498246669	0.5673242491720893	0.43188118691463057	0.3646357137508712	BNIP3	14
BP	GO:0003013	circulatory system process	2	2/62	308/10965	0.5233966670096166	0.569766557402511	0.4337404181724256	0.36277010616258254	APOE/TNNI3	14
BP	GO:0006694	steroid biosynthetic process	1	1/62	131/10965	0.5263439860653323	0.5723677050376587	0.4357205674955809	0.36079193940091037	APOE	14
BP	GO:0031123	RNA 3'-end processing	1	1/62	131/10965	0.5263439860653323	0.5723677050376587	0.4357205674955809	0.36079193940091037	LIN28A	14
BP	GO:0031346	positive regulation of cell projection organization	2	2/62	311/10965	0.5286475326059188	0.5745681869212634	0.4373957060588668	0.3591254847736752	FGFR1/APOE	14
BP	GO:0031099	regeneration	1	1/62	132/10965	0.5290545890618201	0.5747062026230042	0.437500771874699	0.35902117642309245	SOX2	14
BP	GO:1901136	carbohydrate derivative catabolic process	1	1/62	133/10965	0.53174992880872	0.5773284941351816	0.43949701718303563	0.35704406808814804	GPC3	14
BP	GO:0006323	DNA packaging	1	1/62	134/10965	0.5344300898513582	0.5796250234540101	0.44124527280483783	0.3553199343084178	HMGA1	14
BP	GO:0060348	bone development	1	1/62	134/10965	0.5344300898513582	0.5796250234540101	0.44124527280483783	0.3553199343084178	SFRP2	14
BP	GO:0000077	DNA damage checkpoint	1	1/62	135/10965	0.5370951562745157	0.5821376811676486	0.44315805830142135	0.35344134916001546	SOX4	14
BP	GO:0048871	multicellular organismal homeostasis	2	2/62	316/10965	0.537314214489048	0.5821376811676486	0.44315805830142135	0.35344134916001546	SLC2A1/CLDN3	14
BP	GO:0008016	regulation of heart contraction	1	1/62	136/10965	0.5397452117048922	0.5835390803047622	0.4442248872331318	0.3523971142133687	TNNI3	14
BP	GO:0010921	regulation of phosphatase activity	1	1/62	136/10965	0.5397452117048922	0.5835390803047622	0.4442248872331318	0.3523971142133687	HSP90B1	14
BP	GO:0051170	import into nucleus	1	1/62	136/10965	0.5397452117048922	0.5835390803047622	0.4442248872331318	0.3523971142133687	SIX3	14
BP	GO:0070555	response to interleukin-1	1	1/62	136/10965	0.5397452117048922	0.5835390803047622	0.4442248872331318	0.3523971142133687	SFRP1	14
BP	GO:0044272	sulfur compound biosynthetic process	1	1/62	137/10965	0.5423803393135631	0.5852440015041175	0.4455227753319536	0.3511300897232562	MGST1	14
BP	GO:0051099	positive regulation of binding	1	1/62	137/10965	0.5423803393135631	0.5852440015041175	0.4455227753319536	0.3511300897232562	APOE	14
BP	GO:0034762	regulation of transmembrane transport	2	2/62	319/10965	0.5424630072421206	0.5852440015041175	0.4455227753319536	0.3511300897232562	SLC2A1/GPC3	14
BP	GO:1903706	regulation of hemopoiesis	2	2/62	319/10965	0.5424630072421206	0.5852440015041175	0.4455227753319536	0.3511300897232562	SOX4/SFRP1	14
BP	GO:0022900	electron transport chain	1	1/62	138/10965	0.5450006218184171	0.5873641155311933	0.4471367330708376	0.3495596506091145	SH3BGRL3	14
BP	GO:1902806	regulation of cell cycle G1/S phase transition	1	1/62	138/10965	0.5450006218184171	0.5873641155311933	0.4471367330708376	0.3495596506091145	SOX4	14
BP	GO:0042060	wound healing	2	2/62	321/10965	0.5458740712312797	0.587996637357788	0.4476182465573803	0.34909221835086257	CLDN3/APOE	14
BP	GO:0010639	negative regulation of organelle organization	2	2/62	323/10965	0.5492678999794235	0.59134193638918	0.4501648884792978	0.3466283816907962	HMGA1/BNIP3	14
BP	GO:0018205	peptidyl-lysine modification	2	2/62	324/10965	0.5509583351397112	0.5928508147386929	0.4513135370227867	0.34552163974347816	SOX4/NNAT	14
BP	GO:0043112	receptor metabolic process	1	1/62	141/10965	0.552773219142077	0.5944919526622338	0.4525628694730455	0.3443210806165095	APOE	14
BP	GO:0035967	cellular response to topologically incorrect protein	1	1/62	143/10965	0.5578822214933795	0.5993582819394841	0.45626741068954274	0.34078054999382335	HSP90B1	14
BP	GO:0046578	regulation of Ras protein signal transduction	1	1/62	143/10965	0.5578822214933795	0.5993582819394841	0.45626741068954274	0.34078054999382335	APOE	14
BP	GO:0009314	response to radiation	2	2/62	329/10965	0.5593454832037008	0.6006158720743034	0.4572247635981669	0.3398702559609422	SFRP2/SFRP1	14
BP	GO:0018394	peptidyl-lysine acetylation	1	1/62	144/10965	0.5604151453768955	0.6008212530372987	0.4573811118843497	0.3397217740838281	SOX4	14
BP	GO:0071241	cellular response to inorganic substance	1	1/62	144/10965	0.5604151453768955	0.6008212530372987	0.4573811118843497	0.3397217740838281	BNIP3	14
BP	GO:0072330	monocarboxylic acid biosynthetic process	1	1/62	144/10965	0.5604151453768955	0.6008212530372987	0.4573811118843497	0.3397217740838281	MIF	14
BP	GO:0031570	DNA integrity checkpoint	1	1/62	145/10965	0.5629337906949465	0.6028915127902038	0.4589571175647185	0.3382278906610611	SOX4	14
BP	GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB signaling	1	1/62	145/10965	0.5629337906949465	0.6028915127902038	0.4589571175647185	0.3382278906610611	BST2	14
BP	GO:0046890	regulation of lipid biosynthetic process	1	1/62	146/10965	0.5654382366262694	0.6049422635855604	0.460518271858506	0.3367531337409727	APOE	14
BP	GO:1901215	negative regulation of neuron death	1	1/62	146/10965	0.5654382366262694	0.6049422635855604	0.460518271858506	0.3367531337409727	APOE	14
BP	GO:0007033	vacuole organization	1	1/62	147/10965	0.5679285619178096	0.6066576830064265	0.46182415183212117	0.33552335870090483	ENO1	14
BP	GO:0031032	actomyosin structure organization	1	1/62	147/10965	0.5679285619178096	0.6066576830064265	0.46182415183212117	0.33552335870090483	SFRP1	14
BP	GO:0090316	positive regulation of intracellular protein transport	1	1/62	147/10965	0.5679285619178096	0.6066576830064265	0.46182415183212117	0.33552335870090483	FZD5	14
BP	GO:0007093	mitotic cell cycle checkpoint	1	1/62	149/10965	0.5728671634242468	0.6116146822822864	0.4655977164804109	0.3319891583461164	SOX4	14
BP	GO:0007281	germ cell development	1	1/62	150/10965	0.5753155949948547	0.6139093088556641	0.46734452361844947	0.3303628420428893	LIN28A	14
BP	GO:0002833	positive regulation of response to biotic stimulus	1	1/62	151/10965	0.577750216641671	0.6158667244408877	0.4688346255618536	0.3289803211897709	MIF	14
BP	GO:0007160	cell-matrix adhesion	1	1/62	151/10965	0.577750216641671	0.6158667244408877	0.4688346255618536	0.3289803211897709	SFRP1	14
BP	GO:0043523	regulation of neuron apoptotic process	1	1/62	152/10965	0.5801711049871692	0.6178054527419155	0.4703105016256298	0.32761532372650753	APOE	14
BP	GO:1905475	regulation of protein localization to membrane	1	1/62	152/10965	0.5801711049871692	0.6178054527419155	0.4703105016256298	0.32761532372650753	GPC3	14
BP	GO:0045333	cellular respiration	1	1/62	154/10965	0.5849719861759346	0.6225946657847603	0.4739563373471757	0.324261665335633	BNIP3	14
BP	GO:0006986	response to unfolded protein	1	1/62	155/10965	0.5873521301826956	0.6244800886709282	0.4753916341375077	0.3229484651822711	HSP90B1	14
BP	GO:1902275	regulation of chromatin organization	1	1/62	155/10965	0.5873521301826956	0.6244800886709282	0.4753916341375077	0.3229484651822711	HMGA1	14
BP	GO:0010810	regulation of cell-substrate adhesion	1	1/62	156/10965	0.5897188432195755	0.6263473427984311	0.47681309978089254	0.32165182146328114	SFRP1	14
BP	GO:1901796	regulation of signal transduction by p53 class mediator	1	1/62	156/10965	0.5897188432195755	0.6263473427984311	0.47681309978089254	0.32165182146328114	MIF	14
BP	GO:0060047	heart contraction	1	1/62	157/10965	0.5920721998409455	0.6281965636368254	0.4782208374048676	0.3203715043959217	TNNI3	14
BP	GO:1903522	regulation of blood circulation	1	1/62	157/10965	0.5920721998409455	0.6281965636368254	0.4782208374048676	0.3203715043959217	TNNI3	14
BP	GO:0050778	positive regulation of immune response	2	2/62	355/10965	0.6011931846055565	0.6373850527640135	0.48521566548773776	0.31406518611326945	FZD5/MIF	14
BP	GO:0007623	circadian rhythm	1	1/62	161/10965	0.6013535390600049	0.6373850527640135	0.48521566548773776	0.31406518611326945	SIX3	14
BP	GO:0043393	regulation of protein binding	1	1/62	162/10965	0.603641217751071	0.6394794934564779	0.4868100791471291	0.3126404385096285	APOE	14
BP	GO:0090066	regulation of anatomical structure size	2	2/62	358/10965	0.6058298495791781	0.6412272246860472	0.4881405568041931	0.31145510780232327	SEMA6A/APOE	14
BP	GO:0045637	regulation of myeloid cell differentiation	1	1/62	163/10965	0.605915978882186	0.6412272246860472	0.4881405568041931	0.31145510780232327	SFRP1	14
BP	GO:0006473	protein acetylation	1	1/62	164/10965	0.608177894204284	0.643289195312985	0.4897102523055657	0.31006080373525163	SOX4	14
BP	GO:0003015	heart process	1	1/62	166/10965	0.6126634724675922	0.6473663468092169	0.49281402414326353	0.30731694183110886	TNNI3	14
BP	GO:0035303	regulation of dephosphorylation	1	1/62	166/10965	0.6126634724675922	0.6473663468092169	0.49281402414326353	0.30731694183110886	HSP90B1	14
BP	GO:0061136	regulation of proteasomal protein catabolic process	1	1/62	168/10965	0.6170985187475548	0.6517170151672581	0.49612601339294715	0.3044080009887551	APOE	14
BP	GO:1901617	organic hydroxy compound biosynthetic process	1	1/62	169/10965	0.619297267644253	0.653702671402267	0.49763761380987187	0.3030868010409133	APOE	14
BP	GO:0019083	viral transcription	1	1/62	170/10965	0.6214835930801605	0.6556731789205601	0.49913768211660575	0.3017796420802722	IFITM3	14
BP	GO:0006888	endoplasmic reticulum to Golgi vesicle-mediated transport	1	1/62	173/10965	0.627968717249944	0.6614947678628773	0.5035694241861649	0.2979406473297739	CTSC	14
BP	GO:0031396	regulation of protein ubiquitination	1	1/62	173/10965	0.627968717249944	0.6614947678628773	0.5035694241861649	0.2979406473297739	SOX4	14
BP	GO:0071356	cellular response to tumor necrosis factor	1	1/62	173/10965	0.627968717249944	0.6614947678628773	0.5035694241861649	0.2979406473297739	SFRP1	14
BP	GO:0051146	striated muscle cell differentiation	1	1/62	174/10965	0.6301060355904281	0.6634056362398966	0.5050240916076775	0.2966879038561679	IGFBP5	14
BP	GO:0007611	learning or memory	1	1/62	176/10965	0.6343444935788198	0.666841650012161	0.507639791021877	0.29444434334657665	APOE	14
BP	GO:0035966	response to topologically incorrect protein	1	1/62	176/10965	0.6343444935788198	0.666841650012161	0.507639791021877	0.29444434334657665	HSP90B1	14
BP	GO:0051495	positive regulation of cytoskeleton organization	1	1/62	176/10965	0.6343444935788198	0.666841650012161	0.507639791021877	0.29444434334657665	SFRP1	14
BP	GO:0032388	positive regulation of intracellular transport	1	1/62	179/10965	0.6406127360938481	0.6727417269521885	0.512131282854749	0.2906186950575259	FZD5	14
BP	GO:0051650	establishment of vesicle localization	1	1/62	179/10965	0.6406127360938481	0.6727417269521885	0.512131282854749	0.2906186950575259	CTSC	14
BP	GO:0031347	regulation of defense response	2	2/62	382/10965	0.6414909575080665	0.6729751762814685	0.5123089984619367	0.2904680158823089	CTSC/APOE	14
BP	GO:0060627	regulation of vesicle-mediated transport	2	2/62	382/10965	0.6414909575080665	0.6729751762814685	0.5123089984619367	0.2904680158823089	APOE/GPC3	14
BP	GO:0042180	cellular ketone metabolic process	1	1/62	181/10965	0.6447327058315742	0.6760304099981554	0.5146348252986882	0.28850082845737707	TPI1	14
BP	GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process	2	2/62	385/10965	0.6457701460736154	0.6767723900628493	0.5151996649498658	0.2880244280831662	UBE3D/HSP90B1	14
BP	GO:0007162	negative regulation of cell adhesion	1	1/62	182/10965	0.6467752292216373	0.6767887661207547	0.5152121313856571	0.28801391946070537	SEMA6A	14
BP	GO:0048872	homeostasis of number of cells	1	1/62	182/10965	0.6467752292216373	0.6767887661207547	0.5152121313856571	0.28801391946070537	MIF	14
BP	GO:0051091	positive regulation of DNA-binding transcription factor activity	1	1/62	182/10965	0.6467752292216373	0.6767887661207547	0.5152121313856571	0.28801391946070537	ZIC2	14
BP	GO:1901987	regulation of cell cycle phase transition	2	2/62	387/10965	0.6486010225594938	0.6783533630438743	0.5164031962435157	0.28701107836025347	SIX3/SOX4	14
BP	GO:0007610	behavior	2	2/62	391/10965	0.6542102956194371	0.6834750846877159	0.5203021574210374	0.28374437330805885	SIX3/APOE	14
BP	GO:0019080	viral gene expression	1	1/62	186/10965	0.6548304173957356	0.6834750846877159	0.5203021574210374	0.28374437330805885	IFITM3	14
BP	GO:0034612	response to tumor necrosis factor	1	1/62	186/10965	0.6548304173957356	0.6834750846877159	0.5203021574210374	0.28374437330805885	SFRP1	14
BP	GO:0046777	protein autophosphorylation	1	1/62	186/10965	0.6548304173957356	0.6834750846877159	0.5203021574210374	0.28374437330805885	FGFR1	14
BP	GO:0030522	intracellular receptor signaling pathway	1	1/62	187/10965	0.6568158069607664	0.6850309518870319	0.521486576690446	0.2827568660376359	SFRP1	14
BP	GO:0007186	G protein-coupled receptor signaling pathway	2	2/62	393/10965	0.656988749178206	0.6850309518870319	0.521486576690446	0.2827568660376359	FZD5/APOE	14
BP	GO:0006457	protein folding	1	1/62	188/10965	0.6587899598619011	0.6865601816336319	0.522650717935934	0.28178844870178493	HSP90B1	14
BP	GO:0030258	lipid modification	1	1/62	190/10965	0.6627048055665181	0.6895893818572492	0.5249567265190098	0.27987649508657664	APOE	14
BP	GO:0043122	regulation of I-kappaB kinase/NF-kappaB signaling	1	1/62	190/10965	0.6627048055665181	0.6895893818572492	0.5249567265190098	0.27987649508657664	BST2	14
BP	GO:0045088	regulation of innate immune response	1	1/62	190/10965	0.6627048055665181	0.6895893818572492	0.5249567265190098	0.27987649508657664	APOE	14
BP	GO:0051648	vesicle localization	1	1/62	193/10965	0.6684943520294538	0.6952612318116773	0.5292744783053909	0.2763190472487996	CTSC	14
BP	GO:0007596	blood coagulation	1	1/62	195/10965	0.672299615622434	0.6988646460269679	0.5320176129598955	0.2740739897262415	APOE	14
BP	GO:0031349	positive regulation of defense response	1	1/62	196/10965	0.6741860988008379	0.7001163333701009	0.5329704723100593	0.2732968511385842	CTSC	14
BP	GO:0050817	coagulation	1	1/62	196/10965	0.6741860988008379	0.7001163333701009	0.5329704723100593	0.2732968511385842	APOE	14
BP	GO:0007599	hemostasis	1	1/62	198/10965	0.6779270672735724	0.7032893539157586	0.5353859655334903	0.27133301748089134	APOE	14
BP	GO:1901991	negative regulation of mitotic cell cycle phase transition	1	1/62	198/10965	0.6779270672735724	0.7032893539157586	0.5353859655334903	0.27133301748089134	SOX4	14
BP	GO:0050890	cognition	1	1/62	199/10965	0.6797816713256796	0.7045010048284316	0.5363083467556132	0.27058544390641487	APOE	14
BP	GO:1903320	regulation of protein modification by small protein conjugation or removal	1	1/62	199/10965	0.6797816713256796	0.7045010048284316	0.5363083467556132	0.27058544390641487	SOX4	14
BP	GO:0016197	endosomal transport	1	1/62	200/10965	0.681625767218101	0.7060555650335907	0.5374917710628135	0.26962818036002023	ARL4C	14
BP	GO:0043543	protein acylation	1	1/62	201/10965	0.6834594135193065	0.7075977379120165	0.5386657653952153	0.26868062492257805	SOX4	14
BP	GO:0016358	dendrite development	1	1/62	205/10965	0.6906906629816776	0.7147237722836118	0.5440905294289936	0.26432883346282254	APOE	14
BP	GO:0016042	lipid catabolic process	1	1/62	206/10965	0.6924729286782514	0.7158460703515224	0.5449448899156967	0.26364741555030824	APOE	14
BP	GO:0110053	regulation of actin filament organization	1	1/62	206/10965	0.6924729286782514	0.7158460703515224	0.5449448899156967	0.26364741555030824	SFRP1	14
BP	GO:1901988	negative regulation of cell cycle phase transition	1	1/62	207/10965	0.6942450895130827	0.7173166785905568	0.5460644049596728	0.26275613189408953	SOX4	14
BP	GO:0007249	I-kappaB kinase/NF-kappaB signaling	1	1/62	211/10965	0.7012338067541044	0.7234448323074019	0.5507295224911174	0.25906164203819493	BST2	14
BP	GO:0032868	response to insulin	1	1/62	211/10965	0.7012338067541044	0.7234448323074019	0.5507295224911174	0.25906164203819493	SLC2A1	14
BP	GO:0033157	regulation of intracellular protein transport	1	1/62	211/10965	0.7012338067541044	0.7234448323074019	0.5507295224911174	0.25906164203819493	FZD5	14
BP	GO:0015980	energy derivation by oxidation of organic compounds	1	1/62	213/10965	0.7046689868891005	0.7266234980384091	0.5531493131676409	0.2571576225253609	BNIP3	14
BP	GO:0051493	regulation of cytoskeleton organization	2	2/62	432/10965	0.7077350309568411	0.7294185251247804	0.5552770551375675	0.25549027184171447	SFRP1/BST2	14
BP	GO:0000082	G1/S transition of mitotic cell cycle	1	1/62	217/10965	0.7114231773721971	0.7328515863291909	0.557890506880332	0.2534510285243229	SOX4	14
BP	GO:0048511	rhythmic process	1	1/62	218/10965	0.7130878371231203	0.7341978132346427	0.5589153354058735	0.2526539741365037	SIX3	14
BP	GO:0034504	protein localization to nucleus	1	1/62	223/10965	0.7212704574671718	0.7415065023660503	0.5644791471792443	0.24835209702025543	SIX3	14
BP	GO:0046394	carboxylic acid biosynthetic process	1	1/62	223/10965	0.7212704574671718	0.7415065023660503	0.5644791471792443	0.24835209702025543	MIF	14
BP	GO:0072659	protein localization to plasma membrane	1	1/62	223/10965	0.7212704574671718	0.7415065023660503	0.5644791471792443	0.24835209702025543	BSG	14
BP	GO:0016053	organic acid biosynthetic process	1	1/62	224/10965	0.7228792111105378	0.7427882529788801	0.5654548924903345	0.24760203392841895	MIF	14
BP	GO:1903827	regulation of cellular protein localization	2	2/62	450/10965	0.7290118480523031	0.7487148709726356	0.5699665889624456	0.24415060161615054	FZD5/GPC3	14
BP	GO:0044843	cell cycle G1/S phase transition	1	1/62	229/10965	0.7307869500957802	0.7501624920442926	0.5710686047982612	0.24331171505438529	SOX4	14
BP	GO:0042692	muscle cell differentiation	1	1/62	236/10965	0.7414860156017662	0.7607646520074122	0.5791396037647479	0.23721673534569881	IGFBP5	14
BP	GO:0009895	negative regulation of catabolic process	1	1/62	237/10965	0.742979898259301	0.7619164174053401	0.580016396547412	0.2365597291449745	DDIT4	14
BP	GO:0071103	DNA conformation change	1	1/62	238/10965	0.7444652866176085	0.7630583257439223	0.580885685546312	0.23590932547736873	HMGA1	14
BP	GO:0042391	regulation of membrane potential	1	1/62	239/10965	0.7459422281883838	0.7641904404605909	0.5817475190538202	0.23526546014872413	BNIP3	14
BP	GO:0019953	sexual reproduction	2	2/62	467/10965	0.7479141009387109	0.7658282111408357	0.5829942881568689	0.234335700187993	LIN28A/ALDOA	14
BP	GO:0034976	response to endoplasmic reticulum stress	1	1/62	243/10965	0.7517664677126084	0.7693889235642256	0.585704915650616	0.23232113104976074	HSP90B1	14
BP	GO:0006631	fatty acid metabolic process	1	1/62	246/10965	0.7560482455873727	0.7733853439408218	0.5887472301262849	0.23007112307952257	MIF	14
BP	GO:0031589	cell-substrate adhesion	1	1/62	247/10965	0.7574592922123922	0.7744426844144637	0.5895521410029056	0.2294777791211365	SFRP1	14
BP	GO:0048609	multicellular organismal reproductive process	2	2/62	479/10965	0.7605811416042283	0.7772472622369903	0.5916871535650423	0.22790785981945527	LIN28A/BSG	14
BP	GO:0051056	regulation of small GTPase mediated signal transduction	1	1/62	252/10965	0.76439495922956735	0.780755826948269	0.5943580830979948	0.22595182663837882	APOE	14
BP	GO:0072594	establishment of protein localization to organelle	2	2/62	490/10965	0.7717156052556622	0.787841005962497	0.5997517455875374	0.22202847933690215	SIX3/FZD5	14
BP	GO:0051301	cell division	2	2/62	493/10965	0.7746746837620672	0.7904686479760128	0.6017520640178532	0.22058241141433352	SFRP2/FGFR1	14
BP	GO:0006470	protein dephosphorylation	1	1/62	260/10965	0.7750882184861099	0.7904975270047204	0.6017740484636325	0.22056654516366941	HSP90B1	14
BP	GO:0006790	sulfur compound metabolic process	1	1/62	263/10965	0.7789738453335009	0.7940657380150739	0.604490384330753	0.21861060309983102	MGST1	14
BP	GO:0007265	Ras protein signal transduction	1	1/62	265/10965	0.7815274920377653	0.7962732937743269	0.6061709079517293	0.2174049106262841	APOE	14
BP	GO:1990778	protein localization to cell periphery	1	1/62	269/10965	0.7865480101463085	0.8009908272060671	0.6097621768614976	0.21483951813034294	BSG	14
BP	GO:1903829	positive regulation of cellular protein localization	1	1/62	275/10965	0.7938666668053651	0.8080428572840322	0.61513060439597	0.21103266512444463	FZD5	14
BP	GO:0016050	vesicle organization	1	1/62	283/10965	0.8032420400325092	0.8171803005189434	0.6220865732892746	0.20614917208492323	CTSC	14
BP	GO:0032386	regulation of intracellular transport	1	1/62	284/10965	0.8043840540296994	0.8179366099449669	0.6226623213082645	0.20574741361535379	FZD5	14
BP	GO:0050878	regulation of body fluid levels	1	1/62	287/10965	0.807771109612898	0.8209739063524847	0.6249744931912831	0.20413770696364242	APOE	14
BP	GO:0019216	regulation of lipid metabolic process	1	1/62	292/10965	0.8132884218728169	0.8261721988529803	0.6289317446895573	0.2013964841463645	APOE	14
BP	GO:0033044	regulation of chromosome organization	1	1/62	298/10965	0.8197038251831527	0.8314543990488529	0.6329528717495114	0.1986286253714183	HMGA1	14
BP	GO:0043547	positive regulation of GTPase activity	1	1/62	298/10965	0.8197038251831527	0.8314543990488529	0.6329528717495114	0.1986286253714183	SFRP1	14
BP	GO:0050804	modulation of chemical synaptic transmission	1	1/62	298/10965	0.8197038251831527	0.8314543990488529	0.6329528717495114	0.1986286253714183	APOE	14
BP	GO:0046486	glycerolipid metabolic process	1	1/62	299/10965	0.8207517639511891	0.8316951208038716	0.6331361235626067	0.19850290711294435	APOE	14
BP	GO:0099177	regulation of trans-synaptic signaling	1	1/62	299/10965	0.8207517639511891	0.8316951208038716	0.6331361235626067	0.19850290711294435	APOE	14
BP	GO:0051090	regulation of DNA-binding transcription factor activity	1	1/62	301/10965	0.8228296953814708	0.8333892077605024	0.6344257639871682	0.19761918866292985	ZIC2	14
BP	GO:0000209	protein polyubiquitination	1	1/62	302/10965	0.8238597552920436	0.8336095748812986	0.6345935206339628	0.19750436647336536	UBE3D	14
BP	GO:0006913	nucleocytoplasmic transport	1	1/62	302/10965	0.8238597552920436	0.8336095748812986	0.6345935206339628	0.19750436647336536	SIX3	14
BP	GO:0048193	Golgi vesicle transport	1	1/62	326/10965	0.8468873894648034	0.8564873943724871	0.6520094866362836	0.1857460853051703	CTSC	14
BP	GO:0043254	regulation of protein-containing complex assembly	1	1/62	342/10965	0.860565788024509	0.8698921167617205	0.6622139639244862	0.1790016656386018	APOE	14
BP	GO:0034470	ncRNA processing	1	1/62	350/10965	0.8669467423023297	0.8759107411149092	0.6667957011462631	0.1760072087457639	LIN28A	14
BP	GO:0051656	establishment of organelle localization	1	1/62	354/10965	0.8700285906154847	0.8785918641451647	0.668836732528688	0.17467988345114935	CTSC	14
BP	GO:0006401	RNA catabolic process	1	1/62	361/10965	0.8752537154972797	0.8834336567636093	0.672522594971374	0.17229311994036267	LIN28A	14
BP	GO:0043087	regulation of GTPase activity	1	1/62	363/10965	0.8767082650388394	0.884466745260422	0.6733090437911492	0.1717855521112711	SFRP1	14
BP	GO:1901990	regulation of mitotic cell cycle phase transition	1	1/62	367/10965	0.8795674833292332	0.8869152215192071	0.6751729705214443	0.17058495232486803	SOX4	14
BP	GO:0048285	organelle fission	1	1/62	369/10965	0.8809725267798422	0.8878956900551257	0.6759193618763757	0.17010511290606634	BNIP3	14
BP	GO:0016311	dephosphorylation	1	1/62	370/10965	0.8816689880236748	0.8881613958883557	0.6761216330657227	0.1699751682337296	HSP90B1	14
BP	GO:0006605	protein targeting	1	1/62	375/10965	0.8850915991180117	0.8911717180520903	0.6784132705392952	0.16850566537159783	FZD5	14
BP	GO:0007276	gamete generation	1	1/62	396/10965	0.8984337921706008	0.9041619134546705	0.6883021850655231	0.16222085174454798	LIN28A	14
BP	GO:0007264	small GTPase mediated signal transduction	1	1/62	401/10965	0.9013786407525329	0.9066808680510772	0.6902197641262945	0.16101260904323295	APOE	14
BP	GO:0034660	ncRNA metabolic process	1	1/62	408/10965	0.9053607619815361	0.9102402173376346	0.6929293539186671	0.1593110406656175	LIN28A	14
BP	GO:0007268	chemical synaptic transmission	1	1/62	436/10965	0.919767004127288	0.9238188411498751	0.7032662153823817	0.15288024541245612	APOE	14
BP	GO:0098916	anterograde trans-synaptic signaling	1	1/62	436/10965	0.919767004127288	0.9238188411498751	0.7032662153823817	0.15288024541245612	APOE	14
BP	GO:0099537	trans-synaptic signaling	1	1/62	442/10965	0.9225609647777906	0.9261717709021656	0.7050574063911017	0.15177552093216068	APOE	14
BP	GO:0099536	synaptic signaling	1	1/62	457/10965	0.9291338723753535	0.9323142817184477	0.7097334534062667	0.1489047237448592	APOE	14
BP	GO:0034655	nucleobase-containing compound catabolic process	1	1/62	463/10965	0.93160651001516	0.9343384939154977	0.711274404930029	0.14796281902273117	LIN28A	14
BP	GO:0006281	DNA repair	1	1/62	467/10965	0.9332075720722329	0.9354870238848179	0.7121487347107159	0.14742929299481083	HMGA1	14
BP	GO:0000226	microtubule cytoskeleton organization	1	1/62	469/10965	0.933994216784649	0.9358184242393065	0.7124010165030937	0.1472754695269166	GAPDH	14
BP	GO:0046700	heterocycle catabolic process	1	1/62	483/10965	0.939251194835125	0.9406263796006229	0.7160611199996535	0.145049906538925	LIN28A	14
BP	GO:0044270	cellular nitrogen compound catabolic process	1	1/62	485/10965	0.9399677499804372	0.9408847916877352	0.716257838752744	0.14493061206339047	LIN28A	14
BP	GO:0019439	aromatic compound catabolic process	1	1/62	490/10965	0.9417229571292951	0.9421821102044434	0.7172454352843921	0.14433220702355795	LIN28A	14
BP	GO:0044772	mitotic cell cycle phase transition	1	1/62	500/10965	0.9450832587175455	0.9450832587175455	0.719453963238349	0.1429969906797224	SOX4	14
MF	GO:0017147	Wnt-protein binding	4	4/58	23/11258	5.220569675353833e-6	0.0010702167834475357	9.067305225614552e-4	3.0425217647080287	FRZB/FZD5/SFRP2/SFRP1	14
MF	GO:0048029	monosaccharide binding	4	4/58	42/11258	6.135068282047815e-5	0.006288444989099011	0.005327822455462577	2.2734502560407646	P4HA1/SLC2A3/ALDOA/BSG	14
MF	GO:0061134	peptidase regulator activity	5	5/58	111/11258	2.573036080181511e-4	0.015906309026466548	0.013476462076338796	1.8704241064944391	SFRP2/CTSC/GAPDH/BST2/GPC3	14
MF	GO:0030246	carbohydrate binding	5	5/58	116/11258	3.157575601372525e-4	0.015906309026466548	0.013476462076338796	1.8704241064944391	P4HA1/SLC2A3/CLEC2A/ALDOA/BSG	14
MF	GO:0035198	miRNA binding	3	3/58	28/11258	3.8795875674308653e-4	0.015906309026466548	0.013476462076338796	1.8704241064944391	LIN28A/SOX2/SOX4	14
MF	GO:0008201	heparin binding	4	4/58	77/11258	6.487746270789499e-4	0.02030337317754295	0.017201830933476697	1.764425325069998	NRP2/FGFR1/SFRP1/APOE	14
MF	GO:0061980	regulatory RNA binding	3	3/58	34/11258	6.932859133795153e-4	0.02030337317754295	0.017201830933476697	1.764425325069998	LIN28A/SOX2/SOX4	14
MF	GO:1901681	sulfur compound binding	5	5/58	149/11258	9.895583625391675e-4	0.02130414359275721	0.018049723711450263	1.7435294414874596	NRP2/FGFR1/SFRP1/MGST1/APOE	14
MF	GO:0019838	growth factor binding	4	4/58	87/11258	0.0010271431545784307	0.02130414359275721	0.018049723711450263	1.7435294414874596	NRP2/IGFBP2/IGFBP5/FGFR1	14
MF	GO:0015145	monosaccharide transmembrane transporter activity	2	2/58	10/11258	0.0011431491683918501	0.02130414359275721	0.018049723711450263	1.7435294414874596	SLC2A1/SLC2A3	14
MF	GO:0031994	insulin-like growth factor I binding	2	2/58	10/11258	0.0011431491683918501	0.02130414359275721	0.018049723711450263	1.7435294414874596	IGFBP2/IGFBP5	14
MF	GO:0051119	sugar transmembrane transporter activity	2	2/58	12/11258	0.0016655484425983406	0.02845311922772165	0.024106622195502296	1.6178636384248848	SLC2A1/SLC2A3	14
MF	GO:0005539	glycosaminoglycan binding	4	4/58	105/11258	0.0020595468908284936	0.03247747020152625	0.027516213521190398	1.5604113291572026	NRP2/FGFR1/SFRP1/APOE	14
MF	GO:0050750	low-density lipoprotein particle receptor binding	2	2/58	15/11258	0.0026235592311211454	0.038416403027131056	0.03254791527330744	1.4874768232031212	HSP90B1/APOE	14
MF	GO:0015144	carbohydrate transmembrane transporter activity	2	2/58	16/11258	0.0029884541061932237	0.04084220611797405	0.03460315280855312	1.4608843293870823	SLC2A1/SLC2A3	14
MF	GO:0005520	insulin-like growth factor binding	2	2/58	17/11258	0.0033757364709023443	0.043251623533436284	0.036644507743347814	1.435991107939599	IGFBP2/IGFBP5	14
MF	GO:0070325	lipoprotein particle receptor binding	2	2/58	18/11258	0.0037851740500635484	0.04564474589782514	0.0386720568582344	1.4126027284072746	HSP90B1/APOE	14
MF	GO:0001968	fibronectin binding	2	2/58	19/11258	0.00421653629590874	0.048021663370071764	0.040685876539470305	1.3905563230958116	IGFBP5/SFRP2	14
MF	GO:0003713	transcription coactivator activity	5	5/58	228/11258	0.0062478544270671765	0.06741106092361954	0.057113350718342615	1.243262359957815	POU3F1/SOX11/SIX3/SOX4/HMGA1	14
MF	GO:0042803	protein homodimerization activity	7	7/58	447/11258	0.00776035546637065	0.07954364353029916	0.06739256062900828	1.1713880419823364	ENO1/FGFR1/BNIP3/TPI1/CLEC2A/APOE/BST2	14
MF	GO:0030414	peptidase inhibitor activity	3	3/58	81/11258	0.00833225369239922	0.0813386669972305	0.06891337640330183	1.16169647135363	GAPDH/BST2/GPC3	14
MF	GO:0061135	endopeptidase regulator activity	3	3/58	86/11258	0.009815271739073553	0.09146048665954902	0.07748898741373858	1.110760014207021	SFRP2/GAPDH/BST2	14
MF	GO:0016504	peptidase activator activity	2	2/58	30/11258	0.010344308362591996	0.09219927018831996	0.07811491440858945	1.1072660387607964	SFRP2/CTSC	14
MF	GO:0015036	disulfide oxidoreductase activity	2	2/58	33/11258	0.012432608018937428	0.10619519349509052	0.08997282118967875	1.0458886615603729	SH3BGRL3/PGK1	14
MF	GO:0016860	intramolecular oxidoreductase activity	2	2/58	38/11258	0.016283744925228032	0.13352670838686986	0.11312917527000528	0.9464253789402292	TPI1/MIF	14
MF	GO:0043621	protein self-association	2	2/58	40/11258	0.01794921660770784	0.1415226694069272	0.11990367369521432	0.9211675104698085	SLC2A1/CTSC	14
MF	GO:0004714	transmembrane receptor protein tyrosine kinase activity	2	2/58	42/11258	0.0196837609495137	0.14945077757964104	0.12662068447055597	0.897495343152393	NRP2/FGFR1	14
MF	GO:0051287	NAD binding	2	2/58	46/11258	0.02335391428378309	0.16798560157010867	0.1423241296999637	0.8467214631823834	LDHA/GAPDH	14
MF	GO:0016209	antioxidant activity	2	2/58	48/11258	0.025286505023954693	0.16798560157010867	0.1423241296999637	0.8467214631823834	MGST1/APOE	14
MF	GO:0016667	oxidoreductase activity, acting on a sulfur group of donors	2	2/58	48/11258	0.025286505023954693	0.16798560157010867	0.1423241296999637	0.8467214631823834	SH3BGRL3/PGK1	14
MF	GO:0016853	isomerase activity	3	3/58	123/11258	0.025402700725235944	0.16798560157010867	0.1423241296999637	0.8467214631823834	PGAM1/TPI1/MIF	14
MF	GO:0001540	amyloid-beta binding	2	2/58	51/11258	0.028303128134775816	0.18131691461340757	0.15361895204730294	0.8135552018707407	FZD5/APOE	14
MF	GO:0004857	enzyme inhibitor activity	4	4/58	230/11258	0.030504010489544275	0.18361034158487555	0.15556203523237208	0.8080963835728772	CDKN1C/GAPDH/BST2/GPC3	14
MF	GO:0001228	DNA-binding transcription activator activity, RNA polymerase II-specific	5	5/58	341/11258	0.030634609105008582	0.18361034158487555	0.15556203523237208	0.8080963835728772	POU3F1/SOX11/SIX3/SOX2/SOX4	14
MF	GO:0001216	DNA-binding transcription activator activity	5	5/58	344/11258	0.03164638205422233	0.18361034158487555	0.15556203523237208	0.8080963835728772	POU3F1/SOX11/SIX3/SOX2/SOX4	14
MF	GO:0016829	lyase activity	3	3/58	135/11258	0.03224376730270985	0.18361034158487555	0.15556203523237208	0.8080963835728772	ENO1/TPI1/ALDOA	14
MF	GO:0016835	carbon-oxygen lyase activity	2	2/58	57/11258	0.03474246415068763	0.18742645133923588	0.15879519625660551	0.7991626396343885	ENO1/TPI1	14
MF	GO:0019199	transmembrane receptor protein kinase activity	2	2/58	57/11258	0.03474246415068763	0.18742645133923588	0.15879519625660551	0.7991626396343885	NRP2/FGFR1	14
MF	GO:0016491	oxidoreductase activity	6	6/58	494/11258	0.04085011283660975	0.2012168677527463	0.17047898936689676	0.768329137869646	SH3BGRL3/P4HA1/LDHA/GAPDH/MGST1/PGK1	14
MF	GO:0004252	serine-type endopeptidase activity	2	2/58	64/11258	0.04289730736459191	0.2012168677527463	0.17047898936689676	0.768329137869646	PRSS23/CTSC	14
MF	GO:0016668	oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor	1	1/58	10/11258	0.05036046065274602	0.2012168677527463	0.17047898936689676	0.768329137869646	PGK1	14
MF	GO:0008191	metalloendopeptidase inhibitor activity	1	1/58	11/11258	0.055257250596037144	0.2012168677527463	0.17047898936689676	0.768329137869646	BST2	14
MF	GO:0017154	semaphorin receptor activity	1	1/58	11/11258	0.055257250596037144	0.2012168677527463	0.17047898936689676	0.768329137869646	NRP2	14
MF	GO:0042975	peroxisome proliferator activated receptor binding	1	1/58	11/11258	0.055257250596037144	0.2012168677527463	0.17047898936689676	0.768329137869646	HMGA1	14
MF	GO:0043295	glutathione binding	1	1/58	11/11258	0.055257250596037144	0.2012168677527463	0.17047898936689676	0.768329137869646	MGST1	14
MF	GO:1900750	oligopeptide binding	1	1/58	11/11258	0.055257250596037144	0.2012168677527463	0.17047898936689676	0.768329137869646	MGST1	14
MF	GO:1990825	sequence-specific mRNA binding	1	1/58	11/11258	0.055257250596037144	0.2012168677527463	0.17047898936689676	0.768329137869646	LIN28A	14
MF	GO:0004197	cysteine-type endopeptidase activity	2	2/58	74/11258	0.05563959539415699	0.2012168677527463	0.17047898936689676	0.768329137869646	SFRP1/CTSC	14
MF	GO:0005319	lipid transporter activity	2	2/58	74/11258	0.05563959539415699	0.2012168677527463	0.17047898936689676	0.768329137869646	SLC2A1/APOE	14
MF	GO:0042277	peptide binding	3	3/58	169/11258	0.05628924083597116	0.2012168677527463	0.17047898936689676	0.768329137869646	FZD5/MGST1/APOE	14
MF	GO:0045296	cadherin binding	4	4/58	284/11258	0.05824223000596923	0.2012168677527463	0.17047898936689676	0.768329137869646	ENO1/LDHA/ALDOA/BSG	14
MF	GO:0048018	receptor ligand activity	3	3/58	172/11258	0.05873011507934656	0.2012168677527463	0.17047898936689676	0.768329137869646	SFRP2/SEMA6A/MIF	14
MF	GO:0005324	long-chain fatty acid transporter activity	1	1/58	12/11258	0.060129223519077346	0.2012168677527463	0.17047898936689676	0.768329137869646	SLC2A1	14
MF	GO:0016505	peptidase activator activity involved in apoptotic process	1	1/58	12/11258	0.060129223519077346	0.2012168677527463	0.17047898936689676	0.768329137869646	CTSC	14
MF	GO:0046965	retinoid X receptor binding	1	1/58	12/11258	0.060129223519077346	0.2012168677527463	0.17047898936689676	0.768329137869646	HMGA1	14
MF	GO:0050839	cell adhesion molecule binding	5	5/58	412/11258	0.060351288555180696	0.2012168677527463	0.17047898936689676	0.768329137869646	ENO1/SFRP2/LDHA/ALDOA/BSG	14
MF	GO:0008236	serine-type peptidase activity	2	2/58	78/11258	0.06106577775187824	0.2012168677527463	0.17047898936689676	0.768329137869646	PRSS23/CTSC	14
MF	GO:0030546	signaling receptor activator activity	3	3/58	176/11258	0.06206187630130231	0.2012168677527463	0.17047898936689676	0.768329137869646	SFRP2/SEMA6A/MIF	14
MF	GO:0003712	transcription coregulator activity	5	5/58	416/11258	0.06239070000601595	0.2012168677527463	0.17047898936689676	0.768329137869646	POU3F1/SOX11/SIX3/SOX4/HMGA1	14
MF	GO:0004866	endopeptidase inhibitor activity	2	2/58	79/11258	0.06244985310271556	0.2012168677527463	0.17047898936689676	0.768329137869646	GAPDH/BST2	14
MF	GO:0003906	DNA-(apurinic or apyrimidinic site) endonuclease activity	1	1/58	13/11258	0.06497650299941637	0.2012168677527463	0.17047898936689676	0.768329137869646	HMGA1	14
MF	GO:0042813	Wnt-activated receptor activity	1	1/58	13/11258	0.06497650299941637	0.2012168677527463	0.17047898936689676	0.768329137869646	FZD5	14
MF	GO:0120020	cholesterol transfer activity	1	1/58	13/11258	0.06497650299941637	0.2012168677527463	0.17047898936689676	0.768329137869646	APOE	14
MF	GO:0017171	serine hydrolase activity	2	2/58	81/11258	0.06525002788357322	0.2012168677527463	0.17047898936689676	0.768329137869646	PRSS23/CTSC	14
MF	GO:0004888	transmembrane signaling receptor activity	4	4/58	296/11258	0.06578407204901701	0.2012168677527463	0.17047898936689676	0.768329137869646	NRP2/FZD5/CLDN3/FGFR1	14
MF	GO:0001222	transcription corepressor binding	1	1/58	14/11258	0.0697992120101798	0.2012168677527463	0.17047898936689676	0.768329137869646	SIX3	14
MF	GO:0004364	glutathione transferase activity	1	1/58	14/11258	0.0697992120101798	0.2012168677527463	0.17047898936689676	0.768329137869646	MGST1	14
MF	GO:0042910	xenobiotic transmembrane transporter activity	1	1/58	14/11258	0.0697992120101798	0.2012168677527463	0.17047898936689676	0.768329137869646	SLC2A1	14
MF	GO:0071813	lipoprotein particle binding	1	1/58	14/11258	0.0697992120101798	0.2012168677527463	0.17047898936689676	0.768329137869646	APOE	14
MF	GO:0071814	protein-lipid complex binding	1	1/58	14/11258	0.0697992120101798	0.2012168677527463	0.17047898936689676	0.768329137869646	APOE	14
MF	GO:0120015	sterol transfer activity	1	1/58	14/11258	0.0697992120101798	0.2012168677527463	0.17047898936689676	0.768329137869646	APOE	14
MF	GO:0004602	glutathione peroxidase activity	1	1/58	15/11258	0.07459747292296937	0.2012168677527463	0.17047898936689676	0.768329137869646	MGST1	14
MF	GO:0016769	transferase activity, transferring nitrogenous groups	1	1/58	15/11258	0.07459747292296937	0.2012168677527463	0.17047898936689676	0.768329137869646	GAPDH	14
MF	GO:0031418	L-ascorbic acid binding	1	1/58	15/11258	0.07459747292296937	0.2012168677527463	0.17047898936689676	0.768329137869646	P4HA1	14
MF	GO:0042056	chemoattractant activity	1	1/58	15/11258	0.07459747292296937	0.2012168677527463	0.17047898936689676	0.768329137869646	MIF	14
MF	GO:1901618	organic hydroxy compound transmembrane transporter activity	1	1/58	15/11258	0.07459747292296937	0.2012168677527463	0.17047898936689676	0.768329137869646	SLC16A3	14
MF	GO:0030545	receptor regulator activity	3	3/58	193/11258	0.07717748549203421	0.2054725263099612	0.17408455374143056	0.7592397614642843	SFRP2/SEMA6A/MIF	14
MF	GO:0008234	cysteine-type peptidase activity	2	2/58	93/11258	0.08288931398661614	0.21556041343628513	0.18263141574832886	0.738424514246395	SFRP1/CTSC	14
MF	GO:0015035	protein disulfide oxidoreductase activity	1	1/58	17/11258	0.08412113695074541	0.21556041343628513	0.18263141574832886	0.738424514246395	SH3BGRL3	14
MF	GO:0017134	fibroblast growth factor binding	1	1/58	17/11258	0.08412113695074541	0.21556041343628513	0.18263141574832886	0.738424514246395	FGFR1	14
MF	GO:0004713	protein tyrosine kinase activity	2	2/58	99/11258	0.09219980691703006	0.23105343057329447	0.19575772038302225	0.7082811010267144	NRP2/FGFR1	14
MF	GO:0030215	semaphorin receptor binding	1	1/58	19/11258	0.09354846213455337	0.23105343057329447	0.19575772038302225	0.7082811010267144	SEMA6A	14
MF	GO:0090482	vitamin transmembrane transporter activity	1	1/58	19/11258	0.09354846213455337	0.23105343057329447	0.19575772038302225	0.7082811010267144	SLC2A1	14
MF	GO:0016620	oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor	1	1/58	21/11258	0.10288040608532978	0.24812333232344239	0.2102200248183209	0.6773259169762934	GAPDH	14
MF	GO:0042974	retinoic acid receptor binding	1	1/58	21/11258	0.10288040608532978	0.24812333232344239	0.2102200248183209	0.6773259169762934	HMGA1	14
MF	GO:0033218	amide binding	3	3/58	223/11258	0.10735016163410965	0.2558928271510753	0.2168026520150317	0.663935409640801	FZD5/MGST1/APOE	14
MF	GO:0016866	intramolecular transferase activity	1	1/58	23/11258	0.11211791706364738	0.25976307833700996	0.2200816838285322	0.6574160998510041	PGAM1	14
MF	GO:0043394	proteoglycan binding	1	1/58	23/11258	0.11211791706364738	0.25976307833700996	0.2200816838285322	0.6574160998510041	APOE	14
MF	GO:0004175	endopeptidase activity	3	3/58	228/11258	0.11277519010728725	0.25976307833700996	0.2200816838285322	0.6574160998510041	SFRP1/PRSS23/CTSC	14
MF	GO:0016903	oxidoreductase activity, acting on the aldehyde or oxo group of donors	1	1/58	24/11258	0.116701553984903	0.26049323755777615	0.22070030396422632	0.6561970686965448	GAPDH	14
MF	GO:0045499	chemorepellent activity	1	1/58	24/11258	0.116701553984903	0.26049323755777615	0.22070030396422632	0.6561970686965448	SEMA6A	14
MF	GO:0005109	frizzled binding	1	1/58	25/11258	0.12126193406936803	0.26049323755777615	0.22070030396422632	0.6561970686965448	SFRP1	14
MF	GO:0008200	ion channel inhibitor activity	1	1/58	25/11258	0.12126193406936803	0.26049323755777615	0.22070030396422632	0.6561970686965448	TNNI3	14
MF	GO:0015248	sterol transporter activity	1	1/58	25/11258	0.12126193406936803	0.26049323755777615	0.22070030396422632	0.6561970686965448	APOE	14
MF	GO:0030291	protein serine/threonine kinase inhibitor activity	1	1/58	25/11258	0.12126193406936803	0.26049323755777615	0.22070030396422632	0.6561970686965448	CDKN1C	14
MF	GO:0016248	channel inhibitor activity	1	1/58	26/11258	0.125799173259609	0.26049323755777615	0.22070030396422632	0.6561970686965448	TNNI3	14
MF	GO:0031624	ubiquitin conjugating enzyme binding	1	1/58	26/11258	0.125799173259609	0.26049323755777615	0.22070030396422632	0.6561970686965448	UBE3D	14
MF	GO:0071889	14-3-3 protein binding	1	1/58	26/11258	0.125799173259609	0.26049323755777615	0.22070030396422632	0.6561970686965448	DDIT4	14
MF	GO:0120013	lipid transfer activity	1	1/58	26/11258	0.125799173259609	0.26049323755777615	0.22070030396422632	0.6561970686965448	APOE	14
MF	GO:0004601	peroxidase activity	1	1/58	27/11258	0.1303133869304548	0.261904356085718	0.22189586009829768	0.653850800306238	MGST1	14
MF	GO:0030332	cyclin binding	1	1/58	27/11258	0.1303133869304548	0.261904356085718	0.22189586009829768	0.653850800306238	UBE3D	14
MF	GO:0031369	translation initiation factor binding	1	1/58	27/11258	0.1303133869304548	0.261904356085718	0.22189586009829768	0.653850800306238	LIN28A	14
MF	GO:0008514	organic anion transmembrane transporter activity	2	2/58	124/11258	0.1338394173119291	0.2663794228052958	0.22568731585557797	0.6464928485816387	SLC2A1/SLC16A3	14
MF	GO:0005246	calcium channel regulator activity	1	1/58	29/11258	0.13927319639094937	0.27191433581090113	0.23037671583465308	0.637561417156498	TNNI3	14
MF	GO:0008028	monocarboxylic acid transmembrane transporter activity	1	1/58	29/11258	0.13927319639094937	0.27191433581090113	0.23037671583465308	0.637561417156498	SLC16A3	14
MF	GO:0000217	DNA secondary structure binding	1	1/58	30/11258	0.14371902011606486	0.2735960919875115	0.23180156702407909	0.6348836324465806	HMGA1	14
MF	GO:0097718	disordered domain specific binding	1	1/58	30/11258	0.14371902011606486	0.2735960919875115	0.23180156702407909	0.6348836324465806	GAPDH	14
MF	GO:0038023	signaling receptor activity	4	4/58	397/11258	0.14745913341376665	0.2735960919875115	0.23180156702407909	0.6348836324465806	NRP2/FZD5/CLDN3/FGFR1	14
MF	GO:0060089	molecular transducer activity	4	4/58	397/11258	0.14745913341376665	0.2735960919875115	0.23180156702407909	0.6348836324465806	NRP2/FZD5/CLDN3/FGFR1	14
MF	GO:0016684	oxidoreductase activity, acting on peroxide as acceptor	1	1/58	31/11258	0.148142274198116	0.2735960919875115	0.23180156702407909	0.6348836324465806	MGST1	14
MF	GO:0043531	ADP binding	1	1/58	31/11258	0.148142274198116	0.2735960919875115	0.23180156702407909	0.6348836324465806	PGK1	14
MF	GO:0042169	SH2 domain binding	1	1/58	32/11258	0.1525430712139273	0.2743099087618868	0.2324063411846538	0.6337520264369004	FGFR1	14
MF	GO:0043014	alpha-tubulin binding	1	1/58	32/11258	0.1525430712139273	0.2743099087618868	0.2324063411846538	0.6337520264369004	ARL4C	14
MF	GO:0044390	ubiquitin-like protein conjugating enzyme binding	1	1/58	32/11258	0.1525430712139273	0.2743099087618868	0.2324063411846538	0.6337520264369004	UBE3D	14
MF	GO:0016706	2-oxoglutarate-dependent dioxygenase activity	1	1/58	37/11258	0.1742141020278285	0.3095253137566115	0.2622422427206208	0.5812973496299475	P4HA1	14
MF	GO:0051015	actin filament binding	2	2/58	147/11258	0.1751460311988631	0.3095253137566115	0.2622422427206208	0.5812973496299475	SHROOM3/TNNI3	14
MF	GO:0016538	cyclin-dependent protein serine/threonine kinase regulator activity	1	1/58	38/11258	0.17848249005762862	0.3121623726788223	0.2644764646572821	0.5776129690890824	CDKN1C	14
MF	GO:0016830	carbon-carbon lyase activity	1	1/58	39/11258	0.18272919376321306	0.3121623726788223	0.2644764646572821	0.5776129690890824	ALDOA	14
MF	GO:0050661	NADP binding	1	1/58	39/11258	0.18272919376321306	0.3121623726788223	0.2644764646572821	0.5776129690890824	GAPDH	14
MF	GO:0098632	cell-cell adhesion mediator activity	1	1/58	39/11258	0.18272919376321306	0.3121623726788223	0.2644764646572821	0.5776129690890824	BSG	14
MF	GO:0019902	phosphatase binding	2	2/58	155/11258	0.1899715750083146	0.3218526684025165	0.27268647130380086	0.5643364080204245	CTSC/HSP90B1	14
MF	GO:0015631	tubulin binding	3	3/58	293/11258	0.19154533377263405	0.3218589624868031	0.2726918039040951	0.5643279151303064	ARL4C/GAPDH/ALDOA	14
MF	GO:0016836	hydro-lyase activity	1	1/58	43/11258	0.19950132215867666	0.33132102804597946	0.2807084448143087	0.5517445218825276	ENO1	14
MF	GO:0001221	transcription cofactor binding	1	1/58	44/11258	0.20364121723801665	0.33132102804597946	0.2807084448143087	0.5517445218825276	SIX3	14
MF	GO:0016765	transferase activity, transferring alkyl or aryl (other than methyl) groups	1	1/58	44/11258	0.20364121723801665	0.33132102804597946	0.2807084448143087	0.5517445218825276	MGST1	14
MF	GO:0048156	tau protein binding	1	1/58	44/11258	0.20364121723801665	0.33132102804597946	0.2807084448143087	0.5517445218825276	APOE	14
MF	GO:0098631	cell adhesion mediator activity	1	1/58	46/11258	0.2118579840726038	0.3419754861014471	0.2897353284043069	0.5379985465787743	BSG	14
MF	GO:0003779	actin binding	3	3/58	321/11258	0.22902377364490464	0.36590471043928335	0.3100091256610103	0.5086255217596379	SHROOM3/ALDOA/TNNI3	14
MF	GO:0030374	nuclear receptor transcription coactivator activity	1	1/58	51/11258	0.23203713344930166	0.36590471043928335	0.3100091256610103	0.5086255217596379	HMGA1	14
MF	GO:0048306	calcium-dependent protein binding	1	1/58	51/11258	0.23203713344930166	0.36590471043928335	0.3100091256610103	0.5086255217596379	TNNI3	14
MF	GO:0008509	anion transmembrane transporter activity	2	2/58	182/11258	0.24104512427798375	0.3759360670153327	0.3185080927215913	0.4968795285415659	SLC2A1/SLC16A3	14
MF	GO:0004860	protein kinase inhibitor activity	1	1/58	54/11258	0.24389998494165488	0.3759360670153327	0.3185080927215913	0.4968795285415659	CDKN1C	14
MF	GO:0033613	activating transcription factor binding	1	1/58	54/11258	0.24389998494165488	0.3759360670153327	0.3185080927215913	0.4968795285415659	PTMA	14
MF	GO:0019210	kinase inhibitor activity	1	1/58	56/11258	0.2517083102710036	0.3850761463101175	0.32625193397262847	0.48644690521335227	CDKN1C	14
MF	GO:0072341	modified amino acid binding	1	1/58	58/11258	0.2594373743717192	0.3939604573792773	0.33377907813905394	0.4765408891472608	MGST1	14
MF	GO:0019955	cytokine binding	1	1/58	59/11258	0.2632724308258658	0.39684447293604774	0.33622253162746024	0.47337318609705736	NRP2	14
MF	GO:0005125	cytokine activity	1	1/58	60/11258	0.26708796783917954	0.39965717815351687	0.3386055681403352	0.47030590448833876	MIF	14
MF	GO:0008233	peptidase activity	3	3/58	353/11258	0.27341267268662084	0.40507538900780254	0.3431960933827339	0.4644576643897014	SFRP1/PRSS23/CTSC	14
MF	GO:0008144	drug binding	1	1/58	62/11258	0.2746608735223637	0.40507538900780254	0.3431960933827339	0.4644576643897014	SFRP1	14
MF	GO:0015293	symporter activity	1	1/58	64/11258	0.2821568665983878	0.4102280684586489	0.3475616497852482	0.4589681499606876	SLC16A3	14
MF	GO:0051213	dioxygenase activity	1	1/58	64/11258	0.2821568665983878	0.4102280684586489	0.3475616497852482	0.4589681499606876	P4HA1	14
MF	GO:0005506	iron ion binding	1	1/58	73/11258	0.31495744694750916	0.4546920889030942	0.38523334874973325	0.4142761240628665	P4HA1	14
MF	GO:0099106	ion channel regulator activity	1	1/58	74/11258	0.31850974628385686	0.4566048810362983	0.3868539428548869	0.41245297241011913	TNNI3	14
MF	GO:0031490	chromatin DNA binding	1	1/58	77/11258	0.3290583793087335	0.46702371454953184	0.3956811958956239	0.40265458838147	ZIC2	14
MF	GO:0016922	nuclear receptor binding	1	1/58	78/11258	0.3325388027055757	0.46702371454953184	0.3956811958956239	0.40265458838147	HMGA1	14
MF	GO:0008047	enzyme activator activity	3	3/58	397/11258	0.3357833425226572	0.46702371454953184	0.3956811958956239	0.40265458838147	SFRP2/CTSC/APOE	14
MF	GO:0009055	electron transfer activity	1	1/58	80/11258	0.33944650472136706	0.46702371454953184	0.3956811958956239	0.40265458838147	SH3BGRL3	14
MF	GO:0016616	oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor	1	1/58	80/11258	0.33944650472136706	0.46702371454953184	0.3956811958956239	0.40265458838147	LDHA	14
MF	GO:0046943	carboxylic acid transmembrane transporter activity	1	1/58	80/11258	0.33944650472136706	0.46702371454953184	0.3956811958956239	0.40265458838147	SLC16A3	14
MF	GO:0005342	organic acid transmembrane transporter activity	1	1/58	81/11258	0.3428739606818395	0.46859441293184734	0.3970119544737089	0.4011964159477157	SLC16A3	14
MF	GO:0016651	oxidoreductase activity, acting on NAD(P)H	1	1/58	82/11258	0.3462839374448754	0.47012057732582424	0.3983049820732272	0.39978426132007433	PGK1	14
MF	GO:0016705	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen	1	1/58	86/11258	0.35975079774256524	0.48019554938771375	0.406840901920271	0.3905753915769389	P4HA1	14
MF	GO:0005178	integrin binding	1	1/58	87/11258	0.36307468368339335	0.48019554938771375	0.406840901920271	0.3905753915769389	SFRP2	14
MF	GO:0016614	oxidoreductase activity, acting on CH-OH group of donors	1	1/58	87/11258	0.36307468368339335	0.48019554938771375	0.406840901920271	0.3905753915769389	LDHA	14
MF	GO:0019842	vitamin binding	1	1/58	87/11258	0.36307468368339335	0.48019554938771375	0.406840901920271	0.3905753915769389	P4HA1	14
MF	GO:0001227	DNA-binding transcription repressor activity, RNA polymerase II-specific	2	2/58	253/11258	0.3758661405513807	0.48921690696335784	0.4144841573758873	0.3824920646208771	ENO1/MXI1	14
MF	GO:0051087	chaperone binding	1	1/58	91/11258	0.3762014744404173	0.48921690696335784	0.4144841573758873	0.3824920646208771	CTSC	14
MF	GO:0001217	DNA-binding transcription repressor activity	2	2/58	254/11258	0.37771753109221606	0.48921690696335784	0.4144841573758873	0.3824920646208771	ENO1/MXI1	14
MF	GO:0016247	channel regulator activity	1	1/58	92/11258	0.37944140588865316	0.48921690696335784	0.4144841573758873	0.3824920646208771	TNNI3	14
MF	GO:0002020	protease binding	1	1/58	93/11258	0.38266479819193633	0.49028927268341843	0.4153927085636151	0.38154113095541914	MIF	14
MF	GO:0042826	histone deacetylase binding	1	1/58	96/11258	0.39223656774022364	0.4994316545760612	0.42313850066777975	0.3735174571389199	SIX3	14
MF	GO:0031625	ubiquitin protein ligase binding	2	2/58	265/11258	0.3979357154903661	0.5035606276266978	0.42663673200721514	0.3699417559627878	FZD5/TPI1	14
MF	GO:0051082	unfolded protein binding	1	1/58	99/11258	0.401662446948045	0.5051582921739216	0.42799033740024167	0.3685660358025431	HSP90B1	14
MF	GO:0005198	structural molecule activity	3	3/58	450/11258	0.41071813127873513	0.5133976640984189	0.4349710632926271	0.3615396337817823	HMGA1/CLDN3/APOE	14
MF	GO:0004930	G protein-coupled receptor activity	1	1/58	106/11258	0.42310102848976894	0.5226769182370982	0.4428328190455517	0.35376020034478206	FZD5	14
MF	GO:0140297	DNA-binding transcription factor binding	2	2/58	279/11258	0.4232408215968697	0.5226769182370982	0.4428328190455517	0.35376020034478206	PTMA/HMGA1	14
MF	GO:0044389	ubiquitin-like protein ligase binding	2	2/58	281/11258	0.42681356564163286	0.5239328200990104	0.4438968694035262	0.3527179178391703	FZD5/TPI1	14
MF	GO:0005126	cytokine receptor binding	1	1/58	111/11258	0.4379502847446548	0.5344036212657991	0.4527681515217296	0.34412412975447615	MIF	14
MF	GO:0031406	carboxylic acid binding	1	1/58	116/11258	0.4524237471365363	0.5430512933780596	0.460094805686161	0.3371526697444876	P4HA1	14
MF	GO:0019903	protein phosphatase binding	1	1/58	117/11258	0.45527417099814804	0.5430512933780596	0.460094805686161	0.3371526697444876	HSP90B1	14
MF	GO:0035257	nuclear hormone receptor binding	1	1/58	117/11258	0.45527417099814804	0.5430512933780596	0.460094805686161	0.3371526697444876	HMGA1	14
MF	GO:0015291	secondary active transmembrane transporter activity	1	1/58	119/11258	0.4609313416964994	0.5430512933780596	0.460094805686161	0.3371526697444876	SLC16A3	14
MF	GO:0043021	ribonucleoprotein complex binding	1	1/58	119/11258	0.4609313416964994	0.5430512933780596	0.460094805686161	0.3371526697444876	LIN28A	14
MF	GO:0043177	organic acid binding	1	1/58	119/11258	0.4609313416964994	0.5430512933780596	0.460094805686161	0.3371526697444876	P4HA1	14
MF	GO:0051427	hormone receptor binding	1	1/58	133/11258	0.4989466042970019	0.5844803078907737	0.4951951260692049	0.30522363848645684	HMGA1	14
MF	GO:0001664	G protein-coupled receptor binding	1	1/58	142/11258	0.5219804558255514	0.6045536352781811	0.5122020529956348	0.29055868513567046	SFRP1	14
MF	GO:0019887	protein kinase regulator activity	1	1/58	142/11258	0.5219804558255514	0.6045536352781811	0.5122020529956348	0.29055868513567046	CDKN1C	14
MF	GO:0019207	kinase regulator activity	1	1/58	164/11258	0.573994407705195	0.6610609751660954	0.5600773345438036	0.25175200219597704	CDKN1C	14
MF	GO:0000287	magnesium ion binding	1	1/58	170/11258	0.5871869720163998	0.6724766997953182	0.5697491936648396	0.24431628078059875	ENO1	14
MF	GO:0140097	catalytic activity, acting on DNA	1	1/58	180/11258	0.6082878225896933	0.6927722423938173	0.5869443902181251	0.23140304383834945	HMGA1	14
MF	GO:0022804	active transmembrane transporter activity	1	1/58	189/11258	0.6263699960642624	0.7094245811777558	0.6010529185844914	0.2210872896653297	SLC16A3	14
MF	GO:0042393	histone binding	1	1/58	201/11258	0.6492088750879828	0.7312517549067937	0.6195457743754607	0.20792660079030884	PTMA	14
MF	GO:0015075	ion transmembrane transporter activity	2	2/58	432/11258	0.6581382231703938	0.7372586653001679	0.6246350694455852	0.20437363643764184	SLC2A1/SLC16A3	14
MF	GO:0004672	protein kinase activity	2	2/58	440/11258	0.6681082317659003	0.7391840373903026	0.6262663217940947	0.20324094236583276	NRP2/FGFR1	14
MF	GO:0051020	GTPase binding	2	2/58	442/11258	0.6705647619039478	0.7391840373903026	0.6262663217940947	0.20324094236583276	ENO1/BNIP3	14
MF	GO:0008017	microtubule binding	1	1/58	213/11258	0.6706742973394941	0.7391840373903026	0.6262663217940947	0.20324094236583276	GAPDH	14
MF	GO:0061629	RNA polymerase II-specific DNA-binding transcription factor binding	1	1/58	221/11258	0.6842618594746827	0.746136602086755	0.6321568130645164	0.19917517709565777	HMGA1	14
MF	GO:0061630	ubiquitin protein ligase activity	1	1/58	221/11258	0.6842618594746827	0.746136602086755	0.6321568130645164	0.19917517709565777	UBE3D	14
MF	GO:0003682	chromatin binding	2	2/58	463/11258	0.6954989194481351	0.7523479370987182	0.637419304858991	0.19557478763546818	HMGA1/ZIC2	14
MF	GO:0061659	ubiquitin-like protein ligase activity	1	1/58	229/11258	0.6972980880427144	0.7523479370987182	0.637419304858991	0.19557478763546818	UBE3D	14
MF	GO:0003924	GTPase activity	1	1/58	234/11258	0.7051755660036603	0.7568638273861275	0.6412453479779772	0.19297577253092288	ARL4C	14
MF	GO:0008289	lipid binding	2	2/58	487/11258	0.7221109732663309	0.7710039037479053	0.6532253870007928	0.18493694515382175	FZD5/APOE	14
MF	GO:0003729	mRNA binding	1	1/58	257/11258	0.7388929875255654	0.7848345204287094	0.66494323938761	0.17721542518236474	LIN28A	14
MF	GO:0005525	GTP binding	1	1/58	267/11258	0.7523425140779183	0.7856031034434116	0.6655944137004515	0.1767903317131997	ARL4C	14
MF	GO:0032550	purine ribonucleoside binding	1	1/58	271/11258	0.7575295810500118	0.7856031034434116	0.6655944137004515	0.1767903317131997	ARL4C	14
MF	GO:0001883	purine nucleoside binding	1	1/58	273/11258	0.7600829261259915	0.7856031034434116	0.6655944137004515	0.1767903317131997	ARL4C	14
MF	GO:0032549	ribonucleoside binding	1	1/58	274/11258	0.7613496708037057	0.7856031034434116	0.6655944137004515	0.1767903317131997	ARL4C	14
MF	GO:0019001	guanyl nucleotide binding	1	1/58	275/11258	0.7626098418792142	0.7856031034434116	0.6655944137004515	0.1767903317131997	ARL4C	14
MF	GO:0032561	guanyl ribonucleotide binding	1	1/58	275/11258	0.7626098418792142	0.7856031034434116	0.6655944137004515	0.1767903317131997	ARL4C	14
MF	GO:0001882	nucleoside binding	1	1/58	279/11258	0.7675854579944291	0.7867750944442898	0.6665873714162148	0.17614291836256396	ARL4C	14
MF	GO:0005543	phospholipid binding	1	1/58	316/11258	0.8090106779303675	0.8251103929140563	0.6990665716601762	0.1554814647006699	APOE	14
MF	GO:0004842	ubiquitin-protein transferase activity	1	1/58	343/11258	0.8345701258348529	0.8469647316640834	0.7175824427449231	0.1441281958171946	UBE3D	14
MF	GO:0019787	ubiquitin-like protein transferase activity	1	1/58	362/11258	0.8505095640114462	0.8588889685829875	0.7276851338443796	0.1380564973546258	UBE3D	14
MF	GO:0015318	inorganic molecular entity transmembrane transporter activity	1	1/58	386/11258	0.868500620793085	0.8727579767773648	0.7394355130591281	0.13109969528949608	SLC16A3	14
MF	GO:0005509	calcium ion binding	1	1/58	396/11258	0.8753525865435984	0.8753525865435984	0.7416337703706994	0.12981050276899878	HSP90B1	14
CC	GO:0005788	endoplasmic reticulum lumen	7	7/63	196/11368	9.94810075247986e-5	0.01571799918891818	0.01298488940323687	1.8865617450542005	IGFBP5/P4HA1/PRSS23/CTSC/HSP90B1/APOE/GPC3	14
CC	GO:0009986	cell surface	9	9/63	391/11368	2.8057529597063106e-4	0.022165448381679855	0.01831122984229382	1.737282486075966	ENO1/FZD5/TPBG/HILPDA/SFRP1/CLEC2A/BST2/MIF/GPC3	14
CC	GO:0062023	collagen-containing extracellular matrix	6	6/63	225/11368	0.001491384411568408	0.06078794568916488	0.05021788984314753	1.2991415403035205	SFRP2/SFRP1/CTSC/HSP90B1/APOE/GPC3	14
CC	GO:0035577	azurophil granule membrane	3	3/63	43/11368	0.0017093144096371727	0.06078794568916488	0.05021788984314753	1.2991415403035205	BRI3/MGST1/BST2	14
CC	GO:0045177	apical part of cell	6	6/63	239/11368	0.002025590913212963	0.06078794568916488	0.05021788984314753	1.2991415403035205	SLC2A1/IGFBP2/SHROOM3/MGST1/SLC16A3/BST2	14
CC	GO:0005766	primary lysosome	4	4/63	111/11368	0.0032942711028045076	0.06078794568916488	0.05021788984314753	1.2991415403035205	BRI3/CTSC/MGST1/BST2	14
CC	GO:0042582	azurophil granule	4	4/63	111/11368	0.0032942711028045076	0.06078794568916488	0.05021788984314753	1.2991415403035205	BRI3/CTSC/MGST1/BST2	14
CC	GO:0031430	M band	2	2/63	16/11368	0.0034502053675383964	0.06078794568916488	0.05021788984314753	1.2991415403035205	ENO1/ALDOA	14
CC	GO:0030667	secretory granule membrane	5	5/63	184/11368	0.0034626045012815434	0.06078794568916488	0.05021788984314753	1.2991415403035205	BRI3/MGST1/SLC2A3/BSG/BST2	14
CC	GO:0016324	apical plasma membrane	5	5/63	190/11368	0.003970577569925917	0.06273512560482948	0.051826486175875125	1.2854482352306797	SLC2A1/IGFBP2/SHROOM3/SLC16A3/BST2	14
CC	GO:0031012	extracellular matrix	6	6/63	295/11368	0.00570531461464115	0.07816445187371035	0.06457289828341163	1.1899497203272507	SFRP2/SFRP1/CTSC/HSP90B1/APOE/GPC3	14
CC	GO:0030017	sarcomere	4	4/63	131/11368	0.0059365406486362295	0.07816445187371035	0.06457289828341163	1.1899497203272507	ENO1/SLC2A1/ALDOA/TNNI3	14
CC	GO:0031672	A band	2	2/63	23/11368	0.007095113765010032	0.08403942973260127	0.0694263110382582	1.158475910334564	ENO1/ALDOA	14
CC	GO:0005667	transcription regulator complex	6	6/63	312/11368	0.00744653174845834	0.08403942973260127	0.0694263110382582	1.158475910334564	POU3F1/SIX3/SOX2/HMGA1/MXI1/SIX6	14
CC	GO:0030669	clathrin-coated endocytic vesicle membrane	2	2/63	25/11368	0.008353582603880912	0.08546352716455874	0.07060278060230037	1.1511781944658281	FZD5/APOE	14
CC	GO:0030016	myofibril	4	4/63	146/11368	0.008654534396411012	0.08546352716455874	0.07060278060230037	1.1511781944658281	ENO1/SLC2A1/ALDOA/TNNI3	14
CC	GO:0043292	contractile fiber	4	4/63	153/11368	0.010162213286075798	0.09444880583529272	0.07802566238225381	1.1077625357964114	ENO1/SLC2A1/ALDOA/TNNI3	14
CC	GO:0042470	melanosome	3	3/63	90/11368	0.01353637707972622	0.11256566203140751	0.0929922857554599	1.031553077175026	SLC2A1/HSP90B1/BSG	14
CC	GO:0048770	pigment granule	3	3/63	90/11368	0.01353637707972622	0.11256566203140751	0.0929922857554599	1.031553077175026	SLC2A1/HSP90B1/BSG	14
CC	GO:0045334	clathrin-coated endocytic vesicle	2	2/63	35/11368	0.015990746078288102	0.12632689401847602	0.10436065861619605	0.9814631887470079	FZD5/APOE	14
CC	GO:0101002	ficolin-1-rich granule	3	3/63	108/11368	0.021933580043117903	0.15752298394602857	0.13013224523189568	0.8856150770653701	PGAM1/ALDOA/MIF	14
CC	GO:1904813	ficolin-1-rich granule lumen	3	3/63	108/11368	0.021933580043117903	0.15752298394602857	0.13013224523189568	0.8856150770653701	PGAM1/ALDOA/MIF	14
CC	GO:0072562	blood microparticle	2	2/63	44/11368	0.024628393045329638	0.16616561005168295	0.1372720562718767	0.862417860738876	SLC2A1/APOE	14
CC	GO:0043296	apical junction complex	3	3/63	114/11368	0.025240345830635388	0.16616561005168295	0.1372720562718767	0.862417860738876	FZD5/SHROOM3/CLDN3	14
CC	GO:0034774	secretory granule lumen	4	4/63	215/11368	0.03113952099452968	0.18331522175473705	0.1514396235682038	0.819760478563905	PGAM1/CTSC/ALDOA/MIF	14
CC	GO:0060205	cytoplasmic vesicle lumen	4	4/63	217/11368	0.032061942503462955	0.18331522175473705	0.1514396235682038	0.819760478563905	PGAM1/CTSC/ALDOA/MIF	14
CC	GO:0031983	vesicle lumen	4	4/63	218/11368	0.032529163702354986	0.18331522175473705	0.1514396235682038	0.819760478563905	PGAM1/CTSC/ALDOA/MIF	14
CC	GO:0045121	membrane raft	4	4/63	222/11368	0.03443821278041633	0.18331522175473705	0.1514396235682038	0.819760478563905	SLC2A1/BSG/BST2/PGK1	14
CC	GO:0016328	lateral plasma membrane	2	2/63	53/11368	0.03475665933780865	0.18331522175473705	0.1514396235682038	0.819760478563905	CLDN3/SLC16A3	14
CC	GO:0098857	membrane microdomain	4	4/63	223/11368	0.03492553435692695	0.18331522175473705	0.1514396235682038	0.819760478563905	SLC2A1/BSG/BST2/PGK1	14
CC	GO:0099055	integral component of postsynaptic membrane	2	2/63	54/11368	0.03596691059744841	0.18331522175473705	0.1514396235682038	0.819760478563905	NRP2/SLC16A3	14
CC	GO:0098936	intrinsic component of postsynaptic membrane	2	2/63	56/11368	0.03843576284787983	0.18908818967978328	0.1562087642924259	0.8062946031280005	NRP2/SLC16A3	14
CC	GO:0098589	membrane region	4	4/63	232/11368	0.039493102907802835	0.18908818967978328	0.1562087642924259	0.8062946031280005	SLC2A1/BSG/BST2/PGK1	14
CC	GO:0030864	cortical actin cytoskeleton	2	2/63	64/11368	0.04892556591344531	0.22735998277424588	0.1878257019587374	0.7262449794016268	SLC2A1/SHROOM3	14
CC	GO:0002116	semaphorin receptor complex	1	1/63	10/11368	0.05407777000859826	0.232801090545483	0.1923206877257821	0.7159739966668606	NRP2	14
CC	GO:0098688	parallel fiber to Purkinje cell synapse	1	1/63	10/11368	0.05407777000859826	0.232801090545483	0.1923206877257821	0.7159739966668606	SLC16A3	14
CC	GO:0005811	lipid droplet	2	2/63	68/11368	0.05451671107710678	0.232801090545483	0.1923206877257821	0.7159739966668606	HILPDA/GAPDH	14
CC	GO:0099699	integral component of synaptic membrane	2	2/63	72/11368	0.06032226623769029	0.24483813387743902	0.20226468088475977	0.6940799463740429	NRP2/SLC16A3	14
CC	GO:0043083	synaptic cleft	1	1/63	12/11368	0.06454271727307781	0.24483813387743902	0.20226468088475977	0.6940799463740429	APOE	14
CC	GO:0031225	anchored component of membrane	2	2/63	76/11368	0.06633043544721881	0.24483813387743902	0.20226468088475977	0.6940799463740429	BST2/GPC3	14
CC	GO:0030665	clathrin-coated vesicle membrane	2	2/63	77/11368	0.06786279215749699	0.24483813387743902	0.20226468088475977	0.6940799463740429	FZD5/APOE	14
CC	GO:0099240	intrinsic component of synaptic membrane	2	2/63	77/11368	0.06786279215749699	0.24483813387743902	0.20226468088475977	0.6940799463740429	NRP2/SLC16A3	14
CC	GO:0034358	plasma lipoprotein particle	1	1/63	13/11368	0.06973237990180225	0.24483813387743902	0.20226468088475977	0.6940799463740429	APOE	14
CC	GO:0045120	pronucleus	1	1/63	13/11368	0.06973237990180225	0.24483813387743902	0.20226468088475977	0.6940799463740429	SLC2A1	14
CC	GO:1990777	lipoprotein particle	1	1/63	13/11368	0.06973237990180225	0.24483813387743902	0.20226468088475977	0.6940799463740429	APOE	14
CC	GO:0002080	acrosomal membrane	1	1/63	14/11368	0.07489370619560987	0.2572435995414426	0.21251303359852688	0.6726144291603194	BSG	14
CC	GO:0030863	cortical cytoskeleton	2	2/63	83/11368	0.07729821604750445	0.2586701798583923	0.21369155431339537	0.6702126420267142	SLC2A1/SHROOM3	14
CC	GO:0005765	lysosomal membrane	4	4/63	296/11368	0.08136004804143342	0.2586701798583923	0.21369155431339537	0.6702126420267142	BRI3/IFITM3/MGST1/BST2	14
CC	GO:0098852	lytic vacuole membrane	4	4/63	296/11368	0.08136004804143342	0.2586701798583923	0.21369155431339537	0.6702126420267142	BRI3/IFITM3/MGST1/BST2	14
CC	GO:0005865	striated muscle thin filament	1	1/63	16/11368	0.08513195792807848	0.2586701798583923	0.21369155431339537	0.6702126420267142	TNNI3	14
CC	GO:0016327	apicolateral plasma membrane	1	1/63	16/11368	0.08513195792807848	0.2586701798583923	0.21369155431339537	0.6702126420267142	CLDN3	14
CC	GO:0032994	protein-lipid complex	1	1/63	16/11368	0.08513195792807848	0.2586701798583923	0.21369155431339537	0.6702126420267142	APOE	14
CC	GO:0031674	I band	2	2/63	90/11368	0.08879357241636249	0.2647053668261372	0.21867731836403076	0.6601962604931416	SLC2A1/ALDOA	14
CC	GO:0042383	sarcolemma	2	2/63	91/11368	0.09047559819607694	0.26472489842555846	0.2186934537293088	0.660164216741917	SLC2A1/BSG	14
CC	GO:0036379	myofilament	1	1/63	18/11368	0.09525868074903399	0.2736522101517703	0.2260684480934012	0.6457600470094478	TNNI3	14
CC	GO:0070820	tertiary granule	2	2/63	96/11368	0.09902503732808765	0.27448887005783795	0.22675962616370357	0.6444342676590817	SLC2A3/ALDOA	14
CC	GO:0031307	integral component of mitochondrial outer membrane	1	1/63	19/11368	0.1002805929175632	0.27448887005783795	0.22675962616370357	0.6444342676590817	BNIP3	14
CC	GO:0005923	bicellular tight junction	2	2/63	97/11368	0.10076173710983925	0.27448887005783795	0.22675962616370357	0.6444342676590817	FZD5/CLDN3	14
CC	GO:0031306	intrinsic component of mitochondrial outer membrane	1	1/63	20/11368	0.10527507019716476	0.28192306934155986	0.2329011365646464	0.6328283920898369	BNIP3	14
CC	GO:0070160	tight junction	2	2/63	102/11368	0.10957126298363172	0.28853765919023017	0.23836555456088307	0.6227565028955393	FZD5/CLDN3	14
CC	GO:0043204	perikaryon	2	2/63	104/11368	0.11315123811255372	0.2930802560948113	0.2421182661942478	0.6159724447254814	FZD5/SLC2A3	14
CC	GO:0005774	vacuolar membrane	4	4/63	337/11368	0.11638311458021677	0.29658922747861693	0.24501708332677216	0.6108036342644495	BRI3/IFITM3/MGST1/BST2	14
CC	GO:0030139	endocytic vesicle	3	3/63	218/11368	0.12010010704241646	0.30120344305875874	0.24882896028838164	0.6040990751006016	FZD5/HSP90B1/APOE	14
CC	GO:0030135	coated vesicle	3	3/63	225/11368	0.1286630946517074	0.3176370149214026	0.26240499567124537	0.5810279011111534	FZD5/CTSC/APOE	14
CC	GO:0030666	endocytic vesicle membrane	2	2/63	114/11368	0.13148621162695	0.3196126374932015	0.2640370889350899	0.5783350640828379	FZD5/APOE	14
CC	GO:0005911	cell-cell junction	4	4/63	360/11368	0.1385201624633106	0.3301157837212625	0.27271390527272854	0.5642927174699821	SLC2A1/FZD5/SHROOM3/CLDN3	14
CC	GO:0005938	cell cortex	3	3/63	234/11368	0.13998580702104169	0.3301157837212625	0.27271390527272854	0.5642927174699821	ENO1/SLC2A1/SHROOM3	14
CC	GO:0005775	vacuolar lumen	2	2/63	120/11368	0.14279804163493995	0.3303362479290925	0.27289603426520637	0.5640027754669732	CTSC/GPC3	14
CC	GO:0046658	anchored component of plasma membrane	1	1/63	28/11368	0.14426076650067965	0.3303362479290925	0.27289603426520637	0.5640027754669732	GPC3	14
CC	GO:0099061	integral component of postsynaptic density membrane	1	1/63	30/11368	0.15374298544259146	0.3469497178011005	0.286620686258071	0.5426924684972039	SLC16A3	14
CC	GO:0015629	actin cytoskeleton	4	4/63	377/11368	0.15590778458150717	0.3469497178011005	0.286620686258071	0.5426924684972039	SLC2A1/SHROOM3/ALDOA/TNNI3	14
CC	GO:0060076	excitatory synapse	1	1/63	32/11368	0.16312178401140653	0.3482870523486788	0.2877254796218266	0.5410216773200169	SLC16A3	14
CC	GO:0099146	intrinsic component of postsynaptic density membrane	1	1/63	32/11368	0.16312178401140653	0.3482870523486788	0.2877254796218266	0.5410216773200169	SLC16A3	14
CC	GO:0101003	ficolin-1-rich granule membrane	1	1/63	32/11368	0.16312178401140653	0.3482870523486788	0.2877254796218266	0.5410216773200169	SLC2A3	14
CC	GO:1904724	tertiary granule lumen	1	1/63	33/11368	0.16777274798523167	0.35273499228424904	0.2913999936258953	0.5355104620658176	ALDOA	14
CC	GO:0030662	coated vesicle membrane	2	2/63	134/11368	0.16993075113223416	0.35273499228424904	0.2913999936258953	0.5355104620658176	FZD5/APOE	14
CC	GO:0090575	RNA polymerase II transcription regulator complex	2	2/63	135/11368	0.17190249623979226	0.35273499228424904	0.2913999936258953	0.5355104620658176	HMGA1/MXI1	14
CC	GO:0030136	clathrin-coated vesicle	2	2/63	137/11368	0.17585766626222102	0.3539969870953381	0.2924425476337237	0.5339594413643929	FZD5/APOE	14
CC	GO:0099738	cell cortex region	1	1/63	35/11368	0.17699849354766906	0.3539969870953381	0.2924425476337237	0.5339594413643929	ENO1	14
CC	GO:0014704	intercalated disc	1	1/63	37/11368	0.1861235717608919	0.3663442807036139	0.30264284348599685	0.5190695912749328	SLC2A1	14
CC	GO:0005741	mitochondrial outer membrane	2	2/63	143/11368	0.18780940972780208	0.3663442807036139	0.30264284348599685	0.5190695912749328	BNIP3/MGST1	14
CC	GO:0031093	platelet alpha granule lumen	1	1/63	38/11368	0.19064869884403202	0.36706609570079657	0.30323914634842625	0.5182147346175079	ALDOA	14
CC	GO:0070821	tertiary granule membrane	1	1/63	39/11368	0.19514906353713235	0.36706609570079657	0.30323914634842625	0.5182147346175079	SLC2A3	14
CC	GO:0099060	integral component of postsynaptic specialization membrane	1	1/63	39/11368	0.19514906353713235	0.36706609570079657	0.30323914634842625	0.5182147346175079	SLC16A3	14
CC	GO:0005771	multivesicular body	1	1/63	40/11368	0.1996247991710951	0.37062085129376954	0.3061757865451527	0.5140291578102889	BST2	14
CC	GO:0016323	basolateral plasma membrane	2	2/63	151/11368	0.20391758992894524	0.37062085129376954	0.3061757865451527	0.5140291578102889	SLC2A1/SLC16A3	14
CC	GO:0098948	intrinsic component of postsynaptic specialization membrane	1	1/63	41/11368	0.20407603837061994	0.37062085129376954	0.3061757865451527	0.5140291578102889	SLC16A3	14
CC	GO:0045211	postsynaptic membrane	2	2/63	154/11368	0.21000041542638537	0.3770462004246464	0.31148386977119363	0.5065644384132985	NRP2/SLC16A3	14
CC	GO:0030496	midbody	2	2/63	160/11368	0.22222196025212715	0.39293375323589763	0.3246088301215943	0.4886396705204964	SLC2A1/HSP90B1	14
CC	GO:0031968	organelle outer membrane	2	2/63	161/11368	0.22426516371648939	0.39293375323589763	0.3246088301215943	0.4886396705204964	BNIP3/MGST1	14
CC	GO:0019867	outer membrane	2	2/63	162/11368	0.22630994648396635	0.39293375323589763	0.3246088301215943	0.4886396705204964	BNIP3/MGST1	14
CC	GO:0016529	sarcoplasmic reticulum	1	1/63	47/11368	0.23027638736941525	0.39547466526486535	0.3267079180069507	0.48584033995047093	HSP90B1	14
CC	GO:0005796	Golgi lumen	1	1/63	52/11368	0.2514601396016065	0.41213415558251165	0.3404705882227278	0.4679203989473033	GPC3	14
CC	GO:0031091	platelet alpha granule	1	1/63	52/11368	0.2514601396016065	0.41213415558251165	0.3404705882227278	0.4679203989473033	ALDOA	14
CC	GO:0005778	peroxisomal membrane	1	1/63	53/11368	0.2556275142220642	0.41213415558251165	0.3404705882227278	0.4679203989473033	MGST1	14
CC	GO:0005901	caveola	1	1/63	53/11368	0.2556275142220642	0.41213415558251165	0.3404705882227278	0.4679203989473033	SLC2A1	14
CC	GO:0031903	microbody membrane	1	1/63	53/11368	0.2556275142220642	0.41213415558251165	0.3404705882227278	0.4679203989473033	MGST1	14
CC	GO:0044291	cell-cell contact zone	1	1/63	53/11368	0.2556275142220642	0.41213415558251165	0.3404705882227278	0.4679203989473033	SLC2A1	14
CC	GO:0016528	sarcoplasm	1	1/63	54/11368	0.2597720539130949	0.4145857022047373	0.34249584992263443	0.4653446865558447	HSP90B1	14
CC	GO:0030424	axon	4	4/63	470/11368	0.2628738016916337	0.4153406066727813	0.34311948852381663	0.4645546141560479	NRP2/FZD5/SEMA6A/BSG	14
CC	GO:0035579	specific granule membrane	1	1/63	56/11368	0.2679931203165955	0.41923676247546626	0.34633816486980556	0.4604996485628906	SLC2A3	14
CC	GO:0098839	postsynaptic density membrane	1	1/63	58/11368	0.27612431592236464	0.4277219795660158	0.3533479378160291	0.4517974389402666	SLC16A3	14
CC	GO:0001669	acrosomal vesicle	1	1/63	60/11368	0.2841666075018554	0.4317146537047418	0.3566463494962558	0.4477622169026447	BSG	14
CC	GO:0033116	endoplasmic reticulum-Golgi intermediate compartment membrane	1	1/63	60/11368	0.2841666075018554	0.4317146537047418	0.3566463494962558	0.4477622169026447	CTSC	14
CC	GO:0035578	azurophil granule lumen	1	1/63	63/11368	0.29606543948222497	0.4339719504572426	0.35851113828579667	0.4454973470508098	CTSC	14
CC	GO:0005791	rough endoplasmic reticulum	1	1/63	64/11368	0.2999882946182372	0.4339719504572426	0.35851113828579667	0.4454973470508098	LIN28A	14
CC	GO:0000792	heterochromatin	1	1/63	65/11368	0.30388963374058764	0.4339719504572426	0.35851113828579667	0.4454973470508098	HMGA1	14
CC	GO:0005844	polysome	1	1/63	65/11368	0.30388963374058764	0.4339719504572426	0.35851113828579667	0.4454973470508098	LIN28A	14
CC	GO:0043235	receptor complex	2	2/63	202/11368	0.30857670268947557	0.4339719504572426	0.35851113828579667	0.4454973470508098	NRP2/FGFR1	14
CC	GO:0032592	integral component of mitochondrial membrane	1	1/63	67/11368	0.31162822779811805	0.4339719504572426	0.35851113828579667	0.4454973470508098	BNIP3	14
CC	GO:0010494	cytoplasmic stress granule	1	1/63	68/11368	0.31546571312231186	0.4339719504572426	0.35851113828579667	0.4454973470508098	LIN28A	14
CC	GO:0098573	intrinsic component of mitochondrial membrane	1	1/63	68/11368	0.31546571312231186	0.4339719504572426	0.35851113828579667	0.4454973470508098	BNIP3	14
CC	GO:0005925	focal adhesion	3	3/63	358/11368	0.31886010138229126	0.4339719504572426	0.35851113828579667	0.4454973470508098	HMGA1/HSP90B1/BSG	14
CC	GO:0043025	neuronal cell body	3	3/63	359/11368	0.3203882185218591	0.4339719504572426	0.35851113828579667	0.4454973470508098	FZD5/SLC2A3/APOE	14
CC	GO:0005770	late endosome	2	2/63	208/11368	0.32086057578902794	0.4339719504572426	0.35851113828579667	0.4454973470508098	IFITM3/BST2	14
CC	GO:0099634	postsynaptic specialization membrane	1	1/63	70/11368	0.3230776317540942	0.4339719504572426	0.35851113828579667	0.4454973470508098	SLC16A3	14
CC	GO:0030055	cell-substrate junction	3	3/63	361/11368	0.32344498583462955	0.4339719504572426	0.35851113828579667	0.4454973470508098	HMGA1/HSP90B1/BSG	14
CC	GO:0043202	lysosomal lumen	1	1/63	71/11368	0.32685229180007513	0.4339719504572426	0.35851113828579667	0.4454973470508098	GPC3	14
CC	GO:0044853	plasma membrane raft	1	1/63	71/11368	0.32685229180007513	0.4339719504572426	0.35851113828579667	0.4454973470508098	SLC2A1	14
CC	GO:0030134	COPII-coated ER to Golgi transport vesicle	1	1/63	72/11368	0.3306062358220807	0.4352982104990729	0.3596067828240176	0.44417212529458916	CTSC	14
CC	GO:0000932	P-body	1	1/63	73/11368	0.3343395756895745	0.4365756442888659	0.36066209121798387	0.4428995034816058	LIN28A	14
CC	GO:0005635	nuclear envelope	3	3/63	373/11368	0.3417903845202912	0.4426465635590657	0.36567737429263253	0.43690191011271706	BNIP3/GAPDH/SLC16A3	14
CC	GO:0097060	synaptic membrane	2	2/63	226/11368	0.35738146293613504	0.4590753751537345	0.37924947714232565	0.4210750092870706	NRP2/SLC16A3	14
CC	GO:1990204	oxidoreductase complex	1	1/63	81/11368	0.3634777747238228	0.4631410355351936	0.38260818391981344	0.4172457447289977	P4HA1	14
CC	GO:0030018	Z disc	1	1/63	83/11368	0.3705639362205897	0.4683928153828254	0.3869467628745526	0.41234878221684107	SLC2A1	14
CC	GO:0030175	filopodium	1	1/63	84/11368	0.3740778460139528	0.46908174341432174	0.3875158972909787	0.41171047647604064	ARL4C	14
CC	GO:0031965	nuclear membrane	2	2/63	238/11368	0.3813621837454041	0.47445059080136887	0.3919511876040622	0.40676801531162377	GAPDH/SLC16A3	14
CC	GO:0044297	cell body	3	3/63	409/11368	0.3965515167583711	0.4894932784986143	0.40437819143123366	0.3932122744372899	FZD5/SLC2A3/APOE	14
CC	GO:0042581	specific granule	1	1/63	95/11368	0.4114792702398615	0.5039823619992102	0.4163478540166694	0.3805436694856176	SLC2A3	14
CC	GO:0014069	postsynaptic density	2	2/63	262/11368	0.42817178478815243	0.5106721101800477	0.4218743615078341	0.37481686711398843	BNIP3/SLC16A3	14
CC	GO:0098978	glutamatergic synapse	2	2/63	262/11368	0.42817178478815243	0.5106721101800477	0.4218743615078341	0.37481686711398843	NRP2/APOE	14
CC	GO:0032279	asymmetric synapse	2	2/63	267/11368	0.4377020013894122	0.5106721101800477	0.4218743615078341	0.37481686711398843	BNIP3/SLC16A3	14
CC	GO:0099572	postsynaptic specialization	2	2/63	272/11368	0.4471488361411011	0.5106721101800477	0.4218743615078341	0.37481686711398843	BNIP3/SLC16A3	14
CC	GO:0030425	dendrite	3	3/63	443/11368	0.4472435716978699	0.5106721101800477	0.4218743615078341	0.37481686711398843	FZD5/BNIP3/APOE	14
CC	GO:0097447	dendritic tree	3	3/63	443/11368	0.4472435716978699	0.5106721101800477	0.4218743615078341	0.37481686711398843	FZD5/BNIP3/APOE	14
CC	GO:0005793	endoplasmic reticulum-Golgi intermediate compartment	1	1/63	107/11368	0.44977447626805445	0.5106721101800477	0.4218743615078341	0.37481686711398843	CTSC	14
CC	GO:0005769	early endosome	2	2/63	275/11368	0.4527758142816427	0.5106721101800477	0.4218743615078341	0.37481686711398843	FZD5/APOE	14
CC	GO:0098794	postsynapse	3	3/63	450/11368	0.4574929486109436	0.5106721101800477	0.4218743615078341	0.37481686711398843	NRP2/BNIP3/SLC16A3	14
CC	GO:0098984	neuron to neuron synapse	2	2/63	278/11368	0.4583712955714935	0.5106721101800477	0.4218743615078341	0.37481686711398843	BNIP3/SLC16A3	14
CC	GO:0005777	peroxisome	1	1/63	110/11368	0.45895847876940987	0.5106721101800477	0.4218743615078341	0.37481686711398843	MGST1	14
CC	GO:0031902	late endosome membrane	1	1/63	110/11368	0.45895847876940987	0.5106721101800477	0.4218743615078341	0.37481686711398843	IFITM3	14
CC	GO:0042579	microbody	1	1/63	110/11368	0.45895847876940987	0.5106721101800477	0.4218743615078341	0.37481686711398843	MGST1	14
CC	GO:0031901	early endosome membrane	1	1/63	117/11368	0.47980519588227866	0.5301344122335666	0.4379524791269971	0.35857301089445215	FZD5	14
CC	GO:0009897	external side of plasma membrane	1	1/63	131/11368	0.5191552524134613	0.5696286797314367	0.470579322363079	0.3273671599923583	CLEC2A	14
CC	GO:0005912	adherens junction	1	1/63	136/11368	0.5324865306796599	0.5802267023957673	0.47933451763541074	0.3193612956507783	SHROOM3	14
CC	GO:0005798	Golgi-associated vesicle	1	1/63	140/11368	0.5428890725822214	0.5875100922465136	0.4853514419624763	0.3139436757639422	CTSC	14
CC	GO:0098858	actin-based cell projection	1	1/63	157/11368	0.5846163577122296	0.6283631599900156	0.5191008117172681	0.28474829201489993	ARL4C	14
CC	GO:0010008	endosome membrane	2	2/63	385/11368	0.63467053377553	0.6775536779495522	0.5597378818503963	0.2520152999864897	FZD5/IFITM3	14
CC	GO:0099568	cytoplasmic region	1	1/63	182/11368	0.639256258678621	0.6778690528269941	0.5599984180582763	0.251813199832249	ENO1	14
CC	GO:0036464	cytoplasmic ribonucleoprotein granule	1	1/63	194/11368	0.6629069889652639	0.6982620283767446	0.576845379871528	0.23894058141525693	LIN28A	14
CC	GO:0035770	ribonucleoprotein granule	1	1/63	204/11368	0.6814448493168148	0.7130350078944155	0.5890495734770654	0.22984815414062482	LIN28A	14
CC	GO:0000151	ubiquitin ligase complex	1	1/63	259/11368	0.7668256214376462	0.7970950538628164	0.6584929159159842	0.18144889282846355	UBE3D	14
CC	GO:0098552	side of membrane	1	1/63	284/11368	0.7977606590210107	0.8238312687929392	0.6805801287829744	0.1671207353546499	CLEC2A	14
CC	GO:0031301	integral component of organelle membrane	1	1/63	290/11368	0.8045619178201675	0.8254596299713407	0.6819253438803881	0.16626316862140741	BNIP3	14
CC	GO:0031300	intrinsic component of organelle membrane	1	1/63	314/11368	0.8295870497324251	0.8456435732756333	0.6985996208273054	0.15577165441645627	BNIP3	14
CC	GO:0005874	microtubule	1	1/63	344/11368	0.856471916198287	0.8643896262936007	0.7140860337135675	0.14624946089028526	SHROOM3	14
CC	GO:0098793	presynapse	1	1/63	347/11368	0.8589188058740209	0.8643896262936007	0.7140860337135675	0.14624946089028526	SLC2A1	14
CC	GO:0099513	polymeric cytoskeletal fiber	1	1/63	477/11368	0.9333358120683144	0.9333358120683144	0.7710435755927447	0.11292107706616257	SHROOM3	14
